Literatures

Primary Site >> Stomach Cancer

Gene >> ERBB2

1.
Journal:	Mol Cell Biol. 1986 Mar;6(3):955-8.
Title:	Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.
Author:	Fukushige, S\|Matsubara, K\|Yoshida, M\|Sasaki, M\|Suzuki, T\|Semba, K\|Toyoshima, K\|Yamamoto, T
PMID:	2430175

2.
Journal:	Nature. 1986 Jan 16-22;319(6050):230-4.
Title:	Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.
Author:	Yamamoto, T\|Ikawa, S\|Akiyama, T\|Semba, K\|Nomura, N\|Miyajima, N\|Saito, T\|Toyoshima, K
PMID:	3003577

3.
Journal:	Oncogene. 1988 Mar;2(3):283-7.
Title:	Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
Author:	Yokota, J\|Yamamoto, T\|Miyajima, N\|Toyoshima, K\|Nomura, N\|Sakamoto, H\|Yoshida, T\|Terada, M\|Sugimura, T
PMID:	3281095

4.
Journal:	Jpn J Cancer Res. 1989 Jan;80(1):10-4.
Title:	A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product.
Author:	Masuko, T\|Sugahara, K\|Kozono, M\|Otsuki, S\|Akiyama, T\|Yamamoto, T\|Toyoshima, K\|Hashimoto, Y
PMID:	2565325

5.
Journal:	Princess Takamatsu Symp. 1989;20:93-101.
Title:	Regulation of expression and transforming ability of the c-erbB-2 gene.
Author:	Matsuda, S\|Akiyama, T\|Yamada, Y\|Ishii, S\|Aizawa, S\|Mori, S\|Toyoshima, K\|Yamamoto, T
PMID:	2577338

6.
Journal:	Oncogene. 1990 Sep;5(9):1403-8.
Title:	Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.
Author:	Kury, F D\|Schneeberger, C\|Sliutz, G\|Kubista, E\|Salzer, H\|Medl, M\|Leodolter, S\|Swoboda, H\|Zeillinger, R\|Spona, J
PMID:	1699198

7.
Journal:	Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;58(4):273-7.
Title:	DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas.
Author:	Oda, N\|Tsujino, T\|Tsuda, T\|Yoshida, K\|Nakayama, H\|Yasui, W\|Tahara, E
PMID:	1970690

8.
Journal:	Cancer Res. 1990 Dec 15;50(24):8002-9.
Title:	Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
Author:	Kameda, T\|Yasui, W\|Yoshida, K\|Tsujino, T\|Nakayama, H\|Ito, M\|Ito, H\|Tahara, E
PMID:	1979253

9.
Journal:	Exp Pathol. 1990;40(4):291-300.
Title:	Growth factors in progression of human esophageal and gastric carcinomas.
Author:	Yoshida, K\|Yasui, W\|Ito, H\|Tahara, E
PMID:	2098274

10.
Journal:	Cancer Res. 1990 Dec 15;50(24):7811-4.
Title:	Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
Author:	Ranzani, G N\|Pellegata, N S\|Previdere, C\|Saragoni, A\|Vio, A\|Maltoni, M\|Amadori, D
PMID:	2253224

11.
Journal:	Cancer Res. 1990 Oct 1;50(19):6417-22.
Title:	Gene amplification in gastric and esophageal adenocarcinomas.
Author:	Houldsworth, J\|Cordon-Cardo, C\|Ladanyi, M\|Kelsen, D P\|Chaganti, R S
PMID:	2400999

12.
Journal:	Cancer. 1991 Jun 1;67(11):2914-8.
Title:	Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma.
Author:	Yonemura, Y\|Ninomiya, I\|Ohoyama, S\|Kimura, H\|Yamaguchi, A\|Fushida, S\|Kosaka, T\|Miwa, K\|Miyazaki, I\|Endou, Y
PMID:	1673870

13.
Journal:	Int J Cancer. 1991 Jul 9;48(5):668-71.
Title:	c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: an immunohistochemical study on archival material.
Author:	Jain, S\|Filipe, M I\|Gullick, W J\|Linehan, J\|Morris, R W
PMID:	1676988

14.
Journal:	Curr Probl Cancer. 1991 Sep-Oct;15(5):235-94.
Title:	Therapy of upper gastrointestinal tract cancers.
Author:	Kelsen, D\|Atiq, O T
PMID:	1743044

15.
Journal:	Princess Takamatsu Symp. 1991;22:371-80.
Title:	Biological significance of gene amplification in carcinogenesis.
Author:	Terada, M\|Sakamoto, H\|Ohmura, Y\|Tsuruta, H\|Akiyama, N\|Sasaki, H\|Katoh, M\|Hattori, Y\|Yoshida, T
PMID:	1844251

16.
Journal:	Int J Cancer. 1991 Apr 1;47(6):938-42.
Title:	Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth-factor/receptor gene expression in human gastric carcinoma cells.
Author:	Takekura, N\|Yasui, W\|Kyo, E\|Yoshida, K\|Kameda, T\|Kitadai, Y\|Abe, K\|Umezawa, K\|Tahara, E
PMID:	1849125

17.
Journal:	Nihon Geka Gakkai Zasshi. 1991 Sep;92(9):1090-3.
Title:	[Cancer metastasis and recurrence from the standpoint of amplification and expression of oncogenes in human malignant tumors].
Author:	Kikuchi, K\|Ueda, M\|Kitagawa, Y\|Ando, N\|Abe, O
PMID:	1944161

18.
Journal:	Gan To Kagaku Ryoho. 1991 Jan;18(1):7-13.
Title:	[Molecular diagnosis of gastric cancer].
Author:	Yasui, W\|Yoshida, K\|Ito, H\|Tahara, E
PMID:	1987903

19.
Journal:	Am J Surg Pathol. 1991 Feb;15(2):169-74.
Title:	Extraction of DNA from paraffin blocks for Southern blot analysis.
Author:	Mies, C\|Houldsworth, J\|Chaganti, R S
PMID:	1989465

20.
Journal:	Gan To Kagaku Ryoho. 1991 Jun;18(7):1075-83.
Title:	[Oncogene and patient prognosis].
Author:	Ito, H\|Tahara, E
PMID:	2053766

21.
Journal:	Gan To Kagaku Ryoho. 1992 Jan;19(1):26-33.
Title:	[New prognostic factors in human gastric carcinomas].
Author:	Yasui, W\|Nakayama, H\|Kuniyasu, H\|Ito, M\|Yokozaki, H\|Ito, H\|Tahara, E
PMID:	1346086

22.
Journal:	J Cancer Res Clin Oncol. 1992;118(6):474-9.
Title:	Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.
Author:	Jaehne, J\|Urmacher, C\|Thaler, H T\|Friedlander-Klar, H\|Cordon-Cardo, C\|Meyer, H J
PMID:	1352299

23.
Journal:	Anticancer Res. 1992 May-Jun;12(3):1013-8.
Title:	Tumor-specific methylation patterns of erbB2 (HER2/neu) sequences in gastro-intestinal cancer.
Author:	Holzmann, K\|Welter, C\|Klein, V\|Pistorius, G\|Seitz, G\|Blin, N
PMID:	1352439

24.
Journal:	Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5867-71.
Title:	Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
Author:	Batra, J K\|Kasprzyk, P G\|Bird, R E\|Pastan, I\|King, C R
PMID:	1352878

25.
Journal:	Mod Pathol. 1992 Jul;5(4):384-90.
Title:	c-erbB-2 expression in primary gastric carcinomas and their metastases.
Author:	David, L\|Seruca, R\|Nesland, J M\|Soares, P\|Sansonetty, F\|Holm, R\|Borresen, A L\|Sobrinho-Simoes, M
PMID:	1353880

26.
Journal:	Nihon Geka Gakkai Zasshi. 1992 Mar;93(3):337.
Title:	[Expression of soluble c-erbB-2 protein in serum of gastric cancer patients: preliminary report].
Author:	Nakai, M\|Yonemura, Y\|Tsugawa, K\|Fushida, Y\|Yamaguchi, A\|Miwa, K\|Miyazaki, I
PMID:	1355258

27.
Journal:	Cancer Invest. 1992;10(6):575-9.
Title:	Clinical significance of erbB-2 (HER-2/neu) protein.
Author:	Paik, S
PMID:	1358410

28.
Journal:	Br J Cancer. 1992 Jul;66(1):84-7.
Title:	Specific detection of c-erbB-2 mRNA expression in gastric cancers by the polymerase chain reaction following reverse transcription.
Author:	Ninomiya, I\|Endo, Y\|Yonemura, Y\|Noguchi, M\|Fushida, S\|Nakai, M\|Takamura, H\|Harada, F\|Suzuki, T\|Miyazaki, I
PMID:	1379062

29.
Journal:	Gastroenterol Jpn. 1992 Apr;27(2):172-8.
Title:	Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.
Author:	Sasaki, K\|Tomita, Y\|Azuma, M\|Shida, S\|Simizu, B
PMID:	1577221

30.
Journal:	J Natl Cancer Inst. 1993 Sep 1;85(17):1419-24.
Title:	Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.
Author:	Pantel, K\|Schlimok, G\|Braun, S\|Kutter, D\|Lindemann, F\|Schaller, G\|Funke, I\|Izbicki, J R\|Riethmuller, G
PMID:	7688814

31.
Journal:	J Korean Med Sci. 1993 Aug;8(4):293-304.
Title:	Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
Author:	Jang, W I\|Yang, W I\|Lee, C I\|Kim, H S\|Song, K S\|Cho, M Y\|Park, J K\|Shim, Y H
PMID:	7911025

32.
Journal:	Int J Cancer. 1993 Jan 2;53(1):75-9.
Title:	An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator?
Author:	Ohguri, T\|Sato, Y\|Koizumi, W\|Saigenji, K\|Kameya, T
PMID:	8093216

33.
Journal:	Semin Cancer Biol. 1993 Feb;4(1):33-40.
Title:	Amplified genes in cancer in upper digestive tract.
Author:	Yoshida, T\|Sakamoto, H\|Terada, M
PMID:	8095412

34.
Journal:	Jpn J Cancer Res. 1993 Feb;84(2):147-52.
Title:	Construction of immunoradiometric assay for circulating c-erbB-2 protooncogene product in advanced breast cancer patients.
Author:	Hosono, M\|Saga, T\|Sakahara, H\|Kobayashi, H\|Shirato, M\|Endo, K\|Yamamoto, T\|Akiyama, T\|Toyoshima, K\|Konishi, J
PMID:	8096502

35.
Journal:	Gan To Kagaku Ryoho. 1993 Apr;20(6):788-95.
Title:	[Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
Author:	Takamura, H\|Yonemura, Y\|Hirono, Y\|Ninomiya, I\|Sahara, H\|Tsugawa, K\|Matsumoto, H\|Sugiyama, K\|Fujimura, T\|Nishimura, G
PMID:	8098198

36.
Journal:	Hum Pathol. 1993 Jun;24(6):584-9.
Title:	Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells.
Author:	Sasano, H\|Date, F\|Imatani, A\|Asaki, S\|Nagura, H
PMID:	8099338

37.
Journal:	Cancer Lett. 1993 Jun 15;70(1-2):45-50.
Title:	neu mutations and loss of normal allele in schwannomas induced by N-ethyl-N-nitrosourea in rats.
Author:	Ohgaki, H\|Vogeley, K T\|Kleihues, P\|Wechsler, W
PMID:	8330300

38.
Journal:	Cancer. 1993 Oct 1;72(7):2083-8.
Title:	Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
Author:	Mizutani, T\|Onda, M\|Tokunaga, A\|Yamanaka, N\|Sugisaki, Y
PMID:	8397058

39.
Journal:	Cancer Genet Cytogenet. 1993 Feb;65(2):111-4.
Title:	DNA amplification in human gastric carcinomas.
Author:	Mor, O\|Ranzani, G N\|Ravia, Y\|Rotman, G\|Gutman, M\|Manor, A\|Amadori, D\|Houldsworth, J\|Hollstein, M\|Schwab, M\|Shiloh, Y
PMID:	8453595

40.
Journal:	APMIS. 1994 Apr;102(4):295-307.
Title:	Alteration of immunoreactivity by hydrated autoclaving, microwave treatment, and simple heating of paraffin-embedded tissue sections.
Author:	Igarashi, H\|Sugimura, H\|Maruyama, K\|Kitayama, Y\|Ohta, I\|Suzuki, M\|Tanaka, M\|Dobashi, Y\|Kino, I
PMID:	7516673

41.
Journal:	Zhonghua Yi Xue Za Zhi (Taipei). 1994 Aug;54(2):82-6.
Title:	Serum c-erbB-2 oncoprotein in the diagnosis of gastric cancer in comparison with CA 19-9, CEA, TPA, CA 125 and AFP.
Author:	Perng, C L\|Lin, H J\|Lee, S D
PMID:	7525029

42.
Journal:	Gan To Kagaku Ryoho. 1994 Nov;21(15):2541-8.
Title:	[Metastasis-related genes].
Author:	Yokozaki, H\|Tahara, E
PMID:	7526801

43.
Journal:	J Clin Pathol. 1994 Feb;47(2):117-21.
Title:	Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.
Author:	Chiu, K Y\|Loke, S L\|Ho, F C
PMID:	7907612

44.
Journal:	Arch Pathol Lab Med. 1994 Mar;118(3):235-9.
Title:	Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
Author:	Lee, E Y\|Cibull, M L\|Strodel, W E\|Haley, J V
PMID:	7907854

45.
Journal:	Chirurg. 1994 Apr;65(4):307-11.
Title:	[Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer].
Author:	Jahne, J\|Urmacher, C\|Albino, A\|Meyer, H J\|Pichlmayr, R
PMID:	7912666

46.
Journal:	Semin Surg Oncol. 1994 Mar-Apr;10(2):95-9.
Title:	Expression of p185erbB2 and p21ras in carcinoma, dysplasia, and intestinal metaplasia of the stomach: an immunohistochemical and in situ hybridization study.
Author:	Li, J\|Zhao, A\|Lu, Y\|Wang, Y
PMID:	7914379

47.
Journal:	Virchows Arch. 1994;425(2):139-44.
Title:	Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines.
Author:	Tannapfel, A\|Yasui, W\|Yokozaki, H\|Wittekind, C\|Tahara, E
PMID:	7952499

48.
Journal:	J Korean Med Sci. 1994 Jun;9(3):248-53.
Title:	The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
Author:	Kim, J P\|Oh, S T\|Hwang, T S\|Chi, J G
PMID:	7993593

49.
Journal:	Br J Cancer. 1995 May;71(5):969-73.
Title:	Prolonged survival of mice with human gastric cancer treated with an anti-c-ErbB-2 monoclonal antibody.
Author:	Ohnishi, Y\|Nakamura, H\|Yoshimura, M\|Tokuda, Y\|Iwasawa, M\|Ueyama, Y\|Tamaoki, N\|Shimamura, K
PMID:	7734322

50.
Journal:	Nihon Geka Gakkai Zasshi. 1995 Apr;96(4):213-22.
Title:	[Correlation of DNA ploidy, c-erB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
Author:	Takamura, H\|Yonemura, Y\|Fonseca, L\|Ninomiya, I\|Tsugawa, K\|Miwa, K\|Miyazaki, I
PMID:	7753016

51.
Journal:	J La State Med Soc. 1995 Apr;147(4):138-45.
Title:	Gastric carcinoma: recent issues in prognostic factors.
Author:	Chen, B F\|Marrogi, A J\|Freeman, S M\|Clejan, S
PMID:	7775839

52.
Journal:	Rinsho Byori. 1995 Jan;43(1):51-5.
Title:	[Rearrangement of the c-erbB2 oncogene--analysis of the gastrocolic carcinoma].
Author:	Kobayashi, H\|Kawamura, M\|Kusano, M\|Watanabe, H\|Fukuchi, K\|Takagi, Y\|Gomi, K
PMID:	7884965

53.
Journal:	Cancer. 1995 Mar 15;75(6 Suppl):1418-25.
Title:	Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
Author:	Tokunaga, A\|Onda, M\|Okuda, T\|Teramoto, T\|Fujita, I\|Mizutani, T\|Kiyama, T\|Yoshiyuki, T\|Nishi, K\|Matsukura, N
PMID:	7889468

54.
Journal:	Zhonghua Yi Xue Za Zhi. 1995 Nov;75(11):679-82, 710-1.
Title:	[Multiple gene alterations involved in the processor of human gastric carcinogenesis].
Author:	Lu, Y\|Li, Z\|Sun, M
PMID:	8697090

55.
Journal:	Zhonghua Zhong Liu Za Zhi. 1995 Sep;17(5):336-9.
Title:	[Expression of ras and erbB2 in benign and malignant lesions of the stomach].
Author:	Zhao, A\|Li, J\|Lu, Y
PMID:	8697969

56.
Journal:	Biol Pharm Bull. 1995 Sep;18(9):1279-82.
Title:	Immunoselective cell growth inhibition by antibody-adriamycin conjugates targeting c-erbB-2 product on human cancer cells.
Author:	Suzuki, S\|Tanaka, M\|Masuko, T\|Hashimoto, Y
PMID:	8845823

57.
Journal:	Oncology. 1996 May-Jun;53(3):192-7.
Title:	Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain.
Author:	Lee, H R\|Kim, J H\|Uhm, H D\|Ahn, J B\|Rha, S Y\|Cho, J Y\|Lee, J I\|Lee, K H\|Chung, H C\|Roh, J K\|Min, J S\|Lee, K S\|Shin, D H\|Kim, B S\|Hong, S W\|Choi, J H
PMID:	8643220

58.
Journal:	Br J Cancer. 1996 Jun;73(11):1362-5.
Title:	In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product.
Author:	Tokuda, Y\|Ohnishi, Y\|Shimamura, K\|Iwasawa, M\|Yoshimura, M\|Ueyama, Y\|Tamaoki, N\|Tajima, T\|Mitomi, T
PMID:	8645580

59.
Journal:	Nihon Geka Gakkai Zasshi. 1996 Apr;97(4):252-6.
Title:	[Genetic alterations in stomach cancer].
Author:	Tahara, E\|Yasui, W\|Yokozaki, H
PMID:	8692139

60.
Journal:	Mod Pathol. 1996 Apr;9(4):439-44.
Title:	Expression of bcl-2 by breast cancer: a possible diagnostic application.
Author:	Alsabeh, R\|Wilson, C S\|Ahn, C W\|Vasef, M A\|Battifora, H
PMID:	8729986

61.
Journal:	Zhonghua Zhong Liu Za Zhi. 1996 Jan;18(1):6-9.
Title:	[Activation of proto-oncogenes induced by MNNG on primary culture of human gastric epithelium and immortalized human gastric epithelial cell line].
Author:	Wang, B\|Su, X\|Ke, Y
PMID:	8732101

62.
Journal:	Oncogene. 1996 Sep 5;13(5):883-9.
Title:	Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells.
Author:	Shibata, T\|Ochiai, A\|Kanai, Y\|Akimoto, S\|Gotoh, M\|Yasui, N\|Machinami, R\|Hirohashi, S
PMID:	8806677

63.
Journal:	Dermatology. 1996;192(4):379-81.
Title:	Fibropapule multiplex of the nose: a variant of Cowden's disease?
Author:	Yamamoto, T\|Katayama, I\|Nishioka, K
PMID:	8864382

64.
Journal:	Nihon Rinsho. 1996 Apr;54(4):1066-71.
Title:	[Multistep stomach carcinogenesis].
Author:	Yokozaki, H\|Tahara, E
PMID:	8920675

65.
Journal:	J Dermatol. 1996 Mar;23(3):191-5.
Title:	Hereditary onset of multiple seborrheic keratoses: a variant of Leser Trelat sign?
Author:	Yamamoto, T\|Yokoyama, A
PMID:	8935630

66.
Journal:	Zhonghua Yi Xue Za Zhi. 1996 Sep;76(9):671-5.
Title:	[Correlation of multiple gene changes with malignant phenotype of human gastric carcinoma].
Author:	Gao, C\|Lu, Y
PMID:	9275549

67.
Journal:	Zhonghua Zhong Liu Za Zhi. 1996 May;18(3):199-202.
Title:	[Multiple genetic expression abnormalities in gastric cancer].
Author:	Zhu, Y\|Zhang, Y\|Wang, R
PMID:	9387254

68.
Journal:	Zhonghua Zhong Liu Za Zhi. 1996 Jul;18(4):299-301.
Title:	[Clinical significance of c-erbB2 oncoprotein expression in stomach carcinoma].
Author:	Gong, Z\|Luo, E\|Lu, Q
PMID:	9387327

69.
Journal:	Int J Oncol. 1996 Mar;8(3):589-96.
Title:	Growth inhibition of gastric cancer cell lines by the tyrphostin RG13022 and its effects on intracellular signalling.
Author:	McLaughlin, M\|Brunton, V\|Morrison, V\|Rae, A\|Cooke, T\|Bartlett, J
PMID:	21544401

70.
Journal:	Oncol Rep. 1996 Sep;3(5):901-5.
Title:	Histogenesis of the gastric differentiated adenocarcinoma-expression of oncogene protein products and mucin histochemistry in minute gastric cancer.
Author:	Wada, R\|Abe, H\|Matsukuma, S\|Kuwabara, N\|Suda, K
PMID:	21594479

71.
Journal:	Hepatogastroenterology. 1997 Jan-Feb;44(13):294-8.
Title:	c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.
Author:	Orita, H\|Maehara, Y\|Emi, Y\|Kakeji, Y\|Baba, H\|Korenaga, D\|Sugimachi, K
PMID:	9058162

72.
Journal:	Pathol Int. 1997 Feb-Mar;47(2-3):179-82.
Title:	Amplification of the c-erbB-2 gene detected by FISH in gastric cancers.
Author:	Sato, T\|Abe, K\|Kurose, A\|Uesugi, N\|Todoroki, T\|Sasaki, K
PMID:	9088037

73.
Journal:	Gastroenterology. 1997 May;112(5):1457-65.
Title:	Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection.
Author:	Wu, M S\|Shun, C T\|Wang, H P\|Sheu, J C\|Lee, W J\|Wang, T H\|Lin, J T
PMID:	9136822

74.
Journal:	Tumour Biol. 1997;18(3):188-96.
Title:	Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases.
Author:	Molina, R\|Jo, J\|Filella, X\|Bruix, J\|Castells, A\|Hague, M\|Ballesta, A M
PMID:	9143415

75.
Journal:	Hepatogastroenterology. 1997 Mar-Apr;44(14):604-9.
Title:	Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Author:	Shun, C T\|Wu, M S\|Lin, J T\|Chen, S Y\|Wang, H P\|Lee, W J\|Wang, T H\|Chuang, S M
PMID:	9164544

76.
Journal:	Am J Gastroenterol. 1997 Aug;92(8):1374-7.
Title:	Low epithelial cell proliferation and absence of oncoprotein expression in juvenile polyposis of the stomach, with or without tumors.
Author:	Mitomi, H\|Uesugi, H\|Nishiyama, Y\|Ohida, M\|Arai, N\|Kobayashi, N\|Okayasu, I
PMID:	9260812

77.
Journal:	Am J Pathol. 1997 Sep;151(3):761-8.
Title:	Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization.
Author:	Ishikawa, T\|Kobayashi, M\|Mai, M\|Suzuki, T\|Ooi, A
PMID:	9284825

78.
Journal:	Eur J Surg Oncol. 1997 Aug;23(4):304-9.
Title:	c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan.
Author:	McCulloch, P\|Taggart, T\|Ochiai, A\|O'Dowd, G\|Nash, J\|Sasako, M
PMID:	9315057

79.
Journal:	Br J Cancer. 1997;76(12):1604-9.
Title:	Multiple simultaneous gastric carcinomas.
Author:	Wittekind, C\|Klimpfinger, M\|Hermanek, P\|Tannapfel, A
PMID:	9413949

80.
Journal:	Virchows Arch. 1997 Dec;431(6):383-9.
Title:	Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer.
Author:	Tsujimoto, H\|Sugihara, H\|Hagiwara, A\|Hattori, T
PMID:	9428926

81.
Journal:	Cancer Lett. 1997 Dec 9;120(2):235-41.
Title:	Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1.
Author:	Kim, J D\|Kim, J M\|Pyo, J O\|Kim, S Y\|Kim, B S\|Yu, R\|Han, I S
PMID:	9461043

82.
Journal:	Zhonghua Zhong Liu Za Zhi. 1997 Sep;19(5):378-81.
Title:	[Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
Author:	Wei, Z\|Wu, Y\|Zhai, Z
PMID:	10920922

83.
Journal:	Breast Cancer. 1997 Dec 25;4(4):269-272.
Title:	A Humanized Anti-c-erbB-2 Monoclonal Antibody for the Treatment of Breast Cancer.
Author:	Tokuda\|Okumura\|Ohta\|Kubota\|Ohnishi\|Shimamura\|Yoshimura\|Ueyama\|Tamaoki\|Tajima
PMID:	11091613

84.
Journal:	Lab Invest. 1998 Mar;78(3):345-51.
Title:	Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization.
Author:	Ooi, A\|Kobayashi, M\|Mai, M\|Nakanishi, I
PMID:	9520947

85.
Journal:	Cancer Detect Prev. 1998;22(2):139-46.
Title:	Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach.
Author:	Yonemura, Y\|Ninomiya, I\|Tsugawa, K\|Fushida, S\|Fujimura, T\|Miyazaki, I\|Uchibayashi, T\|Endou, Y\|Sasaki, T
PMID:	9544434

86.
Journal:	J Gastroenterol Hepatol. 1998 Mar;13(3):305-10.
Title:	Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages.
Author:	Wu, M S\|Shun, C T\|Sheu, J C\|Wang, H P\|Wang, J T\|Lee, W J\|Chen, C J\|Wang, T H\|Lin, J T
PMID:	9570245

87.
Journal:	Anticancer Res. 1998 Jul-Aug;18(4A):2727-32.
Title:	Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
Author:	Slesak, B\|Harlozinska, A\|Porebska, I\|Bojarowski, T\|Lapinska, J\|Rzeszutko, M\|Wojnar, A
PMID:	9703936

88.
Journal:	Oncology. 1998 Sep-Oct;55(5):475-81.
Title:	Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features.
Author:	Tsugawa, K\|Yonemura, Y\|Hirono, Y\|Fushida, S\|Kaji, M\|Miwa, K\|Miyazaki, I\|Yamamoto, H
PMID:	9732228

89.
Journal:	Am J Gastroenterol. 1998 Sep;93(9):1575-8.
Title:	Multiple early gastric stump carcinomas after gastrectomy for peptic ulcer.
Author:	Yamashita, Y\|Chung, Y S\|Maeda, K\|Sawada, T\|Yoshikawa, K\|Maekawa, Z\|Yamamoto, T\|Sowa, M
PMID:	9732951

90.
Journal:	Int J Cancer. 1998 Oct 5;78(2):202-8.
Title:	Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes.
Author:	Kono, K\|Rongcun, Y\|Charo, J\|Ichihara, F\|Celis, E\|Sette, A\|Appella, E\|Sekikawa, T\|Matsumoto, Y\|Kiessling, R
PMID:	9754653

91.
Journal:	Mod Pathol. 1998 Sep;11(9):870-7.
Title:	Prognostic factors in gastric cancer.
Author:	Brien, T P\|Depowski, P L\|Sheehan, C E\|Ross, J S\|McKenna, B J
PMID:	9758367

92.
Journal:	J Cutan Pathol. 1998 Aug;25(7):365-9.
Title:	Cathepsin D expression in skin metastasis of breast cancer.
Author:	Inoue, H\|Kawada, A\|Takasu, H\|Maruyama, R\|Hata, Y\|Hiruma, M\|Tajima, S\|Ishibashi, A
PMID:	9765021

93.
Journal:	Jpn J Cancer Res. 1998 Aug;89(8):829-36.
Title:	Expression of cadherin-catenin cell adhesion molecules, phosphorylated tyrosine residues and growth factor receptor-tyrosine kinases in gastric cancers.
Author:	Akimoto, S\|Ochiai, A\|Inomata, M\|Hirohashi, S
PMID:	9765619

94.
Journal:	Pol J Pathol. 1998;49(2):83-92.
Title:	HER-2/Neu expression as a progression marker in pancreatic intraepithelial neoplasia.
Author:	Tomaszewska, R\|Okon, K\|Nowak, K\|Stachura, J
PMID:	9798411

95.
Journal:	Genes Chromosomes Cancer. 1998 Dec;23(4):307-16.
Title:	Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2.
Author:	Nessling, M\|Solinas-Toldo, S\|Wilgenbus, K K\|Borchard, F\|Lichter, P
PMID:	9824203

96.
Journal:	Gan To Kagaku Ryoho. 1998 Nov;25(13):2021-7.
Title:	[New molecular prognostic markers in gastric carcinoma].
Author:	Yoshida, K\|Yasui, W\|Yokozaki, H\|Nishimoto, N\|Kagawa, Y\|Toge, T\|Tahara, E\|Yoshida, T\|Terada, M
PMID:	9838902

97.
Journal:	Glycoconj J. 1998 May;15(5):469-75.
Title:	Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: glycan composition varies with disease.
Author:	Goodarzi, M T\|Turner, G A
PMID:	9881748

98.
Journal:	Acta Gastroenterol Latinoam. 1998;28(4):287-90.
Title:	[MMP-2 expression (type IV collagenase) in gastric cancer].
Author:	Sundblad, A\|Ricci, L
PMID:	10347682

99.
Journal:	Genes Chromosomes Cancer. 1999 Jan;24(1):24-9.
Title:	Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer.
Author:	Vidgren, V\|Varis, A\|Kokkola, A\|Monni, O\|Puolakkainen, P\|Nordling, S\|Forozan, F\|Kallioniemi, A\|Vakkari, M L\|Kivilaakso, E\|Knuutila, S
PMID:	9892105

100.
Journal:	Cancer Res. 1999 Jan 15;59(2):431-5.
Title:	Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.
Author:	Kawashima, I\|Tsai, V\|Southwood, S\|Takesako, K\|Sette, A\|Celis, E
PMID:	9927058

101.
Journal:	Cancer Res. 1999 Feb 1;59(3):748-52.
Title:	Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
Author:	van Dekken, H\|Geelen, E\|Dinjens, W N\|Wijnhoven, B P\|Tilanus, H W\|Tanke, H J\|Rosenberg, C
PMID:	9973227

102.
Journal:	Pathol Oncol Res. 1999;5(2):104-6.
Title:	Expression of c-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67.
Author:	Dursun, A\|Poyraz, A\|Celik, B\|Akyol, G
PMID:	10393360

103.
Journal:	J Int Med Res. 1999 Mar-Apr;27(2):74-8.
Title:	The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer.
Author:	Gurel, S\|Dolar, E\|Yerci, O\|Samli, B\|Ozturk, H\|Nak, S G\|Gulten, M\|Memik, F
PMID:	10446693

104.
Journal:	Int J Cancer. 1999 Nov 26;83(5):670-3.
Title:	Inhibition by rat C-erbB-2/neu antisense oligonucleotide of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Author:	Uedo, N\|Tatsuta, M\|Baba, M\|Hirasawa, R\|Iishi, H\|Yano, H\|Sakai, N\|Uehara, H\|Nakaizumi, A
PMID:	10521805

105.
Journal:	Gastroenterology. 1999 Nov;117(5):1119-27.
Title:	Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells.
Author:	Noguchi, H\|Sakamoto, C\|Wada, K\|Akamatsu, T\|Uchida, T\|Tatsuguchi, A\|Matsui, H\|Fukui, H\|Fujimori, T\|Kasuga, M
PMID:	10535875

106.
Journal:	Rev Esp Enferm Dig. 1999 Dec;91(12):826-37.
Title:	Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types.
Author:	Pelaez Bujan, M del C\|Ruibal Morell, A\|Aza Gonzalez, J
PMID:	10619912

107.
Journal:	Gan To Kagaku Ryoho. 1999 Dec;26(14):2139-46.
Title:	[Molecular biology in gastric cancer].
Author:	Kikuchi, K\|Ueda, M\|Kitajima, M
PMID:	10635296

108.
Journal:	Zhonghua Yi Xue Za Zhi. 1999 Apr;79(4):295-7.
Title:	[Reversion of the malignant phenotype of gastric cancer by c-erbB-2 specific ribozyme].
Author:	Bi, F\|Zhang, X\|Hui, H
PMID:	11601058

109.
Journal:	Zhonghua Zhong Liu Za Zhi. 1999 Sep;21(5):339-41.
Title:	[Gene detection and localization by FISH with short DNA fragment cloned in plasmid].
Author:	Zheng, S\|Qiao, H\|Lu, G
PMID:	11776569

110.
Journal:	Zhonghua Zhong Liu Za Zhi. 1999 Mar;21(2):125-7.
Title:	[Helicobacter pylori infection and expression of PCNA, p53, c-erbB-2 in carcinoma and precancerours lesions of the stomach].
Author:	Lu, W\|Chen, L\|Gong, H
PMID:	11776853

111.
Journal:	World J Gastroenterol. 1999 Apr;5(2):152-155.
Title:	Study of differential polymerase chain reaction of C-erbB-2 oncogene amplification in gastric cancer.
Author:	Ji, Feng\|Peng, Qing-Bi\|Zhan, Jing-Biao\|Li, You-Ming
PMID:	11819416

112.
Journal:	Int J Mol Med. 2000 Feb;5(2):185-90.
Title:	Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: association with Helicobacter pylori infection.
Author:	Haruma, K\|Ito, M\|Kohmoto, K\|Kamada, T\|Kitada, Y\|Yasui, W\|Tahara, E\|Kajiyama, G
PMID:	10639599

113.
Journal:	Cytometry. 2000 Feb 15;42(1):27-34.
Title:	Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients.
Author:	Danesi, D T\|Spano, M\|Fabiano, A\|Altavista, P\|Pasqualetti, P\|Toscano, M G\|Antonini, F\|Catalano, P\|Mecozzi, A\|Picconi, A\|Daffina, A\|Cucchiara, G
PMID:	10679740

114.
Journal:	Tumour Biol. 2000 May-Jun;21(3):139-44.
Title:	Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.
Author:	Kono, K\|Naganuma, H\|Sekikawa, T\|Amemiya, H\|Takahashi, A\|Iizuka, H\|Matsumoto, Y
PMID:	10754464

115.
Journal:	Histol Histopathol. 2000 Apr;15(2):455-62.
Title:	Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer.
Author:	Sanz-Ortega, J\|Steinberg, S M\|Moro, E\|Saez, M\|Lopez, J A\|Sierra, E\|Sanz-Esponera, J\|Merino, M J
PMID:	10809364

116.
Journal:	J Clin Oncol. 2000 Jun;18(11):2201-9.
Title:	c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
Author:	Allgayer, H\|Babic, R\|Gruetzner, K U\|Tarabichi, A\|Schildberg, F W\|Heiss, M M
PMID:	10829039

117.
Journal:	Cancer Chemother Pharmacol. 2000;46 Suppl:S77-82.
Title:	Development of a cancer vaccine: peptides, proteins, and DNA.
Author:	Shiku, H\|Wang, L\|Ikuta, Y\|Okugawa, T\|Schmitt, M\|Gu, X\|Akiyoshi, K\|Sunamoto, J\|Nakamura, H
PMID:	10950153

118.
Journal:	Int J Biol Markers. 2000 Jul-Sep;15(3):231-4.
Title:	C-erbB-2 oncoprotein content in gastric cancer and in adjacent mucosa.
Author:	Garcia, I\|Vizoso, F\|Andicoechea, A\|Fernandez, P\|Suarez, C\|Garcia-Munz, J L\|Allende, M T
PMID:	11012099

119.
Journal:	Pathol Int. 2000 Oct;50(10):767-77.
Title:	Molecular characteristics of eight gastric cancer cell lines established in Japan.
Author:	Yokozaki, H
PMID:	11107048

120.
Journal:	Oncogene. 2000 Nov 20;19(49):5680-9.
Title:	Tyrosine kinases and gastric cancer.
Author:	Lin, W\|Kao, H W\|Robinson, D\|Kung, H J\|Wu, C W\|Chen, H C
PMID:	11114748

121.
Journal:	Surg Oncol. 2000 Jul;9(1):5-11.
Title:	The use of molecular biology in diagnosis and prognosis of gastric cancer.
Author:	Becker, K F\|Keller, G\|Hoefler, H
PMID:	11525306

122.
Journal:	Int Rev Cytol. 2001;204:49-95.
Title:	Genetic and epigenetic changes in stomach cancer.
Author:	Yokozaki, H\|Yasui, W\|Tahara, E
PMID:	11243597

123.
Journal:	Oncogene. 2001 Apr 19;20(17):2101-11.
Title:	Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
Author:	Aigner, A\|Juhl, H\|Malerczyk, C\|Tkybusch, A\|Benz, C C\|Czubayko, F
PMID:	11360194

124.
Journal:	Anticancer Res. 2001 Mar-Apr;21(2B):1339-45.
Title:	Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma.
Author:	Emoto, K\|Sawada, H\|Yamada, Y\|Fujimoto, H\|Takahama, Y\|Ueno, M\|Takayama, T\|Uchida, H\|Kamada, K\|Naito, A\|Hirao, S\|Nakajima, Y
PMID:	11396210

125.
Journal:	Chemotherapy. 2001 Jul-Aug;47(4):297-303.
Title:	Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the her-2/neu (c-erbB-2) gene.
Author:	Funato, T\|Kozawa, K\|Fujimaki, S\|Miura, T\|Kaku, M
PMID:	11399867

126.
Journal:	Clin Cancer Res. 2001 Aug;7(8):2448-57.
Title:	Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
Author:	Konecny, G\|Untch, M\|Arboleda, J\|Wilson, C\|Kahlert, S\|Boettcher, B\|Felber, M\|Beryt, M\|Lude, S\|Hepp, H\|Slamon, D\|Pegram, M
PMID:	11489825

127.
Journal:	Ann Oncol. 2001;12 Suppl 1:S21-2.
Title:	Modulation of p27/Cdk2 complex formation through 4D5-mediated inhibition of HER2 receptor signaling.
Author:	Lane, H A\|Motoyama, A B\|Beuvink, I\|Hynes, N E
PMID:	11521716

128.
Journal:	Kurume Med J. 2001;48(3):197-200.
Title:	Evaluation of the epidermal growth factor receptor (EGFR) and c-erbB-2 in superspreading-type and penetrating-type gastric carcinoma.
Author:	Aoyagi, K\|Kohfuji, K\|Yano, S\|Murakami, N\|Miyagi, M\|Takeda, J\|Shirouzu, K
PMID:	11680933

129.
Journal:	J Gastroenterol. 2001 Oct;36(10):661-8.
Title:	Risk factors for lymph node metastasis of submucosal invasive differentiated type gastric carcinoma: clinical significance of histological heterogeneity.
Author:	Mita, T\|Shimoda, T
PMID:	11686475

130.
Journal:	J Am Chem Soc. 2001 Nov 28;123(47):11586-93.
Title:	Total synthesis and biological evaluation of the nakijiquinones.
Author:	Stahl, P\|Kissau, L\|Mazitschek, R\|Huwe, A\|Furet, P\|Giannis, A\|Waldmann, H
PMID:	11716712

131.
Journal:	Cancer Gene Ther. 2001 Nov;8(11):835-42.
Title:	Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme.
Author:	Bi, F\|Fan, D\|Hui, H\|Wang, C\|Zhang, X
PMID:	11773973

132.
Journal:	Int J Biol Markers. 2001 Oct-Dec;16(4):250-4.
Title:	C-erbB-2 oncoprotein in gastric carcinoma: correlation with clinical stage and prognosis.
Author:	Oshima, C T\|Lanzoni, V P\|Iriya, K\|Forones, N M
PMID:	11820720

133.
Journal:	J Surg Res. 2002 Feb;102(2):169-77.
Title:	Expression of HER2 in human gastric cancer cells directly correlates with antitumor activity of a recombinant disulfide-stabilized anti-HER2 immunotoxin.
Author:	Shinohara, Hisashi\|Morita, Shinsho\|Kawai, Masaru\|Miyamoto, Akiko\|Sonoda, Toyooki\|Pastan, Ira\|Tanigawa, Nobuhiko
PMID:	11796015

134.
Journal:	J Biol Chem. 2002 Apr 5;277(14):11918-26.
Title:	Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
Author:	Pero, Stephanie C\|Oligino, Lyn\|Daly, Roger J\|Soden, Amy L\|Liu, Chen\|Roller, Peter P\|Li, Peng\|Krag, David N
PMID:	11809769

135.
Journal:	Dig Dis Sci. 2002 Jan;47(1):114-21.
Title:	p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis.
Author:	Kubicka, Stefan\|Claas, Christiane\|Staab, Sven\|Kuhnel, Florian\|Zender, Lars\|Trautwein, Christian\|Wagner, Siegfried\|Rudolph, Karl Lenhard\|Manns, Michael
PMID:	11837710

136.
Journal:	Int J Cancer. 2002 Mar 10;98(2):216-20.
Title:	Frequencies of HER-2/neu overexpression relating to HLA haplotype in patients with gastric cancer.
Author:	Kono, Koji\|Takahashi, Akihiro\|Amemiya, Hideki\|Ichihara, Fumiko\|Sugai, Hidemitsu\|Iizuka, Hidehiko\|Fujii, Hideki\|Matsumoto, Yoshiro
PMID:	11857411

137.
Journal:	Int J Cancer. 2002 Apr 20;98(6):833-7.
Title:	Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.
Author:	Takehana, Takuo\|Kunitomo, Kazuyoshi\|Kono, Koji\|Kitahara, Fumiaki\|Iizuka, Hidehiko\|Matsumoto, Yoshiro\|Fujino, Masayuki A\|Ooi, Akishi
PMID:	11948459

138.
Journal:	Cancer Res. 2002 May 1;62(9):2625-9.
Title:	Targets of gene amplification and overexpression at 17q in gastric cancer.
Author:	Varis, Asta\|Wolf, Maija\|Monni, Outi\|Vakkari, Marja-Leena\|Kokkola, Arto\|Moskaluk, Chris\|Frierson, Henry Jr\|Powell, Steven M\|Knuutila, Sakari\|Kallioniemi, Anne\|El-Rifai, Wa'el
PMID:	11980659

139.
Journal:	Appl Immunohistochem Mol Morphol. 2002 Sep;10(3):237-41.
Title:	C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
Author:	Vlasoff, Dmitry M\|Baschinsky, Dmitry Y\|De Young, Barry R\|Morrison, Carl D\|Nuovo, Gerard J\|Frankel, Wendy L
PMID:	12373150

140.
Journal:	Cancer Res. 2002 Oct 15;62(20):5813-7.
Title:	Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer.
Author:	Kono, Koji\|Takahashi, Akihiro\|Ichihara, Fumiko\|Sugai, Hidemitsu\|Fujii, Hideki\|Matsumoto, Yoshirou
PMID:	12384543

141.
Journal:	Clin Cancer Res. 2002 Nov;8(11):3394-400.
Title:	Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer.
Author:	Kono, Koji\|Takahashi, Akihiro\|Sugai, Hidemitsu\|Fujii, Hideki\|Choudhury, A Raja\|Kiessling, Rolf\|Matsumoto, Yoshiro
PMID:	12429626

142.
Journal:	Int J Surg Pathol. 2002 Oct;10(4):247-56.
Title:	c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.
Author:	Pinto-de-Sousa, Joao\|David, Leonor\|Almeida, Raquel\|Leitao, Dina\|Preto, John R\|Seixas, Mario\|Pimenta, Amadeu
PMID:	12490974

143.
Journal:	Anticancer Res. 2002 Sep-Oct;22(5):3061-5.
Title:	Clinical significance of soluble c-erbB-2 levels in the serum and urine of patients with gastric cancer.
Author:	Tsigris, Christos\|Karayiannakis, Anastasios J\|Syrigos, Konstantinos N\|Zbar, Andrew\|Diamantis, Theodoros\|Kalahanis, Nikolaos\|Alexiou, Dimitrios
PMID:	12530043

144.
Journal:	Pathol Oncol Res. 2002;8(4):252-6.
Title:	The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma.
Author:	Ghaderi, Abbas\|Vasei, Mohammad\|Maleck-Hosseini, S A\|Gharesi-Fard, Behronz\|Khodami, Maliheh\|Doroudchi, Mehrnoosh\|Modjtahedi, Helmout
PMID:	12579211

145.
Journal:	Arq Gastroenterol. 2002 Oct-Dec;39(4):253-9. Epub 2003 Jul 16.
Title:	[Genetics and environmental factors in gastric carcinogenesis].
Author:	Cesar, Ana Cristina Gobbo\|Silva, Ana Elizabete\|Tajara, Eloiza Helena
PMID:	12870086

146.
Journal:	J Clin Gastroenterol. 2003 Jan;36(1):30-3.
Title:	Clinicopathologic characteristics and prognoses of gastric cancer in patients with a positive familial history of cancer.
Author:	Lee, Wei-Jei\|Hong, Rey-Long\|Lai, I-Ru\|Chen, Chaung-Nien\|Lee, Po-Huang\|Huang, Ming-Tegh
PMID:	12488704

147.
Journal:	Int J Colorectal Dis. 2003 Mar;18(2):160-6. Epub 2002 Aug 10.
Title:	Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis.
Author:	Ougolkov, Andrei\|Yamashita, Kaname\|Bilim, Vladimir\|Takahashi, Yutaka\|Mai, Masayoshi\|Minamoto, Toshinari
PMID:	12548420

148.
Journal:	Oncogene. 2003 Mar 6;22(9):1294-301.
Title:	Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas.
Author:	Kobayashi, Michimoto\|Iwamatsu, Akihiro\|Shinohara-Kanda, Azusa\|Ihara, Sayoko\|Fukui, Yasuhisa
PMID:	12618754

149.
Journal:	Ann Surg Oncol. 2003 Mar;10(2):171-5.
Title:	Detection of bone marrow micrometastasis in gastric cancer patients by immunomagnetic separation.
Author:	Matsunami, Katsuhiro\|Nakamura, Tsutomu\|Oguma, Hidetoshi\|Kitamura, Yoichi\|Takasaki, Ken
PMID:	12620913

150.
Journal:	Ann Surg Oncol. 2003 Apr;10(3):234-41.
Title:	Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer.
Author:	Garcia, I\|Vizoso, F\|Martin, A\|Sanz, L\|Abdel-Lah, O\|Raigoso, P\|Garcia-Muniz, J L
PMID:	12679307

151.
Journal:	J Pathol. 2003 May;200(1):39-46.
Title:	Tumour suppressor gene expression correlates with gastric cancer prognosis.
Author:	Lee, Hye Seung\|Lee, Hyeon Kook\|Kim, Hee Sung\|Yang, Han-Kwang\|Kim, Woo Ho
PMID:	12692839

152.
Journal:	Biomed Sci Instrum. 2003;39:324-8.
Title:	Sustained delivery of Her-2/neu antibody by TCPL delivery device using adult male rats as a model.
Author:	Brinkley, Jack\|Copeland, Lynn\|Streckfus, Charles\|Tucci, Michelle\|Benghuzzi, Hamed
PMID:	12724914

153.
Journal:	Int J Oncol. 2003 Jun;22(6):1369-74.
Title:	MGC9753 gene, located within PPP1R1B-STARD3-ERBB2-GRB7 amplicon on human chromosome 17q12, encodes the seven-transmembrane receptor with extracellular six-cystein domain.
Author:	Katoh, Masuko\|Katoh, Masaru
PMID:	12739007

154.
Journal:	Rev Esp Enferm Dig. 2003 Feb;95(2):97-104, 89-96.
Title:	Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Author:	Jorge, O\|Cuello Carrion, F D\|Jorge, A\|Ciocca, D R
PMID:	12760717

155.
Journal:	Recent Results Cancer Res. 2003;162:65-72.
Title:	Molecular mechanisms of carcinogenesis in gastric cancer.
Author:	Hofler, Heinz\|Becker, Karl-Friedrich
PMID:	12790321

156.
Journal:	World J Gastroenterol. 2003 Jun;9(6):1156-64.
Title:	Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.
Author:	Wang, Li-Dong\|Zheng, Shu\|Zheng, Zuo-Yu\|Casson, Alan G
PMID:	12800215

157.
Journal:	Jpn J Clin Oncol. 2003 Apr;33(4):173-9.
Title:	Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Author:	Lee, Kyu Eun\|Lee, Hyuk-Joon\|Kim, Yoon Ho\|Yu, Hang Jong\|Yang, Han-Kwang\|Kim, Woo-Ho\|Lee, Kuhn Uk\|Choe, Kuk Jin\|Kim, Jin-Pok
PMID:	12810831

158.
Journal:	Int J Cancer. 2003 Nov 20;107(4):593-6.
Title:	A single nucleotide polymorphism in the transmembrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer.
Author:	Kuraoka, Kazuya\|Matsumura, Shunji\|Hamai, Yoichi\|Nakachi, Kei\|Imai, Kazue\|Matsusaki, Keisuke\|Oue, Naohide\|Ito, Reiko\|Nakayama, Hirofumi\|Yasui, Wataru
PMID:	14520697

159.
Journal:	Int J Oncol. 2003 Nov;23(5):1381-7.
Title:	HER2 testing in gastric cancer: molecular morphology and storage time-related changes in archival samples.
Author:	Risio, Mauro\|De Rosa, Giovanni\|Sarotto, Ivana\|Casorzo, Laura\|Capussotti, Lorenzo\|Torchio, Bruno\|Aglietta, Massimo\|Chiecchio, Laura
PMID:	14532980

160.
Journal:	Int J Biol Markers. 2003 Jul-Sep;18(3):200-6.
Title:	Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.
Author:	Garcia, I\|del Casar, J M\|Corte, M D\|Allende, M T\|Garcia-Muniz, J L\|Vizoso, F
PMID:	14535591

161.
Journal:	Gan To Kagaku Ryoho. 2003 Oct;30(11):1802-4.
Title:	[Generation of HER2 specific, HLA-A24 restricted CTLs derived from gastric cancer patients].
Author:	Mimura, Kousaku\|Kono, Koji\|Sugai, Hidemitsu\|Miyagawa, Naoto\|Omata, Hideo\|Fujii, Hideki\|Matsumoto, Yoshiro
PMID:	14619524

162.
Journal:	Orv Hetil. 2003 Dec 21;144(51):2499-508.
Title:	[Effect of learning about the human genome on the development of pathology].
Author:	Szentirmay, Zoltan
PMID:	14974156

163.
Journal:	Cancer Res Treat. 2003 Apr;35(2):109-16.
Title:	The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines.
Author:	Im, Seock Ah\|Lee, Kyung Eun\|Nam, Eunmi\|Nam, Seung Hyun\|Kim, Do Yeun\|Seong, Chu Myong\|Park, Hae Young\|Han, Woon Sup\|Seoh, Ju Young\|Lee, Soon Nam
PMID:	26680923

164.
Journal:	Int J Cancer. 2004 Jan 1;108(1):71-7.
Title:	Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.
Author:	Choudhury, Aniruddha\|Charo, Jehad\|Parapuram, Sunil K\|Hunt, Richard C\|Hunt, D Margaret\|Seliger, Barbara\|Kiessling, Rolf
PMID:	14618618

165.
Journal:	Oncol Rep. 2004 Feb;11(2):333-9.
Title:	Overexpression of gastrin and c-met protein involved in human gastric carcinomas and intestinal metaplasia.
Author:	Tang, Zhuobin\|Zhao, Min\|Ji, Jiafu\|Yang, Guibin\|Hu, Fulian\|He, Jingsheng\|Shen, Hui\|Gao, Zhian\|Zhao, Ailian\|Li, Jiyou\|Lu, Youyong
PMID:	14719064

166.
Journal:	Int J Cancer. 2004 Apr 20;109(4):548-53.
Title:	Coamplified and overexpressed genes at ERBB2 locus in gastric cancer.
Author:	Varis, Asta\|Zaika, Alexander\|Puolakkainen, Pauli\|Nagy, Balint\|Madrigal, Irene\|Kokkola, Arto\|Vayrynen, Aki\|Karkkainen, Paivi\|Moskaluk, Christopher\|El-Rifai, Wa'el\|Knuutila, Sakari
PMID:	14991576

167.
Journal:	Int J Oncol. 2004 Apr;24(4):757-63.
Title:	Evolutionary recombination hotspot around GSDML-GSDM locus is closely linked to the oncogenomic recombination hotspot around the PPP1R1B-ERBB2-GRB7 amplicon.
Author:	Katoh, Masuko\|Katoh, Masaru
PMID:	15010812

168.
Journal:	Clin Cancer Res. 2004 Mar 1;10(5):1698-705.
Title:	Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma.
Author:	Lee, Hye Seung\|Chang, Mee Soo\|Yang, Han-Kwang\|Lee, Byung Lan\|Kim, Woo Ho
PMID:	15014022

169.
Journal:	Cancer Sci. 2004 Aug;95(8):621-5.
Title:	Monoclonal antibodies as effective therapeutic agents for solid tumors.
Author:	Hinoda, Yuji\|Sasaki, Shigeru\|Ishida, Tadao\|Imai, Kohzoh
PMID:	15298722

170.
Journal:	Cancer Lett. 2004 Oct 28;214(2):215-24.
Title:	Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.
Author:	Gong, Soo Jung\|Jin, Choon Jo\|Rha, Sun Young\|Chung, Hyun Cheol
PMID:	15363548

171.
Journal:	Virchows Arch. 2004 Sep;445(3):255-62. Epub 2004 Jul 28.
Title:	A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements.
Author:	Kimura, Mikihiko\|Tsuda, Hitoshi\|Morita, Daisaku\|Ichikura, Takashi\|Ogata, Sho\|Aida, Shinsuke\|Yoshizumi, Yutaka\|Maehara, Tadaaki\|Mochizuki, Hidetaka\|Matsubara, Osamu
PMID:	15517369

172.
Journal:	Jpn J Clin Oncol. 2004 Dec;34(12):727-32.
Title:	Prognostic implications of the expression of erbB2, topoisomerase II alpha and thymidylate synthase in metastatic gastric cancer after fluorouracil-based therapy.
Author:	Liu, Jacqueline Ming\|Chen, Li-Tzong\|Li, Anna F Y\|Wu, Chew Wen\|Lan, Chieh\|Chung, Tsai Rong\|Shiah, Her-Shyong\|Lee, Kuan Der\|Liu, Tsang Wu\|Peng, Jacqueline Whang
PMID:	15640503

173.
Journal:	Int J Biol Markers. 2004 Oct-Dec;19(4):268-74.
Title:	Membranous levels of c-erbB-2 oncoprotein in gastric cancer: their relationship with clinicopathological parameters and their prognostic significance.
Author:	Vizoso, F J\|Corte, M D\|Alvarez, A\|Garcia, I\|del Casar, J M\|Bongera, M\|Gonzalez, L O\|Garcia-Muniz, J L\|Allende, M T
PMID:	15646832

174.
Journal:	Cancer Res Treat. 2004 Aug;36(4):240-5.
Title:	Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer.
Author:	Song, Hong Suk\|Do, Young Rok\|Kim, In Ho\|Sohn, Soo Sang\|Kwon, Kun Young
PMID:	20368841

175.
Journal:	Cancer Immunol Immunother. 2005 Aug;54(8):750-8.
Title:	CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.
Author:	Dittmann, Jasmin\|Keller-Matschke, Karin\|Weinschenk, Toni\|Kratt, Thomas\|Heck, Tobias\|Becker, Horst-Dieter\|Stevanovic, Stefan\|Rammensee, Hans-Georg\|Gouttefangeas, Cecile
PMID:	15614528

176.
Journal:	Biochem Biophys Res Commun. 2005 Feb 18;327(3):907-14.
Title:	Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells.
Author:	Shida, Dai\|Kitayama, Joji\|Yamaguchi, Hironori\|Yamashita, Hiroharu\|Mori, Ken\|Watanabe, Toshiaki\|Nagawa, Hirokazu
PMID:	15649431

177.
Journal:	Ann Oncol. 2005 Feb;16(2):273-8.
Title:	Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.
Author:	Tanner, M\|Hollmen, M\|Junttila, T T\|Kapanen, A I\|Tommola, S\|Soini, Y\|Helin, H\|Salo, J\|Joensuu, H\|Sihvo, E\|Elenius, K\|Isola, J
PMID:	15668283

178.
Journal:	Br J Cancer. 2005 May 9;92(9):1767-72.
Title:	Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer.
Author:	Songun, I\|Litvinov, S V\|van de Velde, C J H\|Pals, S T\|Hermans, J\|van Krieken, J H J M
PMID:	15870832

179.
Journal:	Jpn J Clin Oncol. 2005 Jun;35(6):324-31. Epub 2005 May 31.
Title:	Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
Author:	Kimura, Mikihiko\|Tsuda, Hitoshi\|Morita, Daisaku\|Shinto, Eiji\|Tanimoto, Takao\|Ichikura, Takashi\|Mochizuki, Hidetaka\|Matsubara, Osamu
PMID:	15928192

180.
Journal:	Int J Oncol. 2005 Sep;27(3):681-5.
Title:	Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model.
Author:	Matsui, Yoko\|Inomata, Masafumi\|Tojigamori, Manabu\|Sonoda, Kazuya\|Shiraishi, Norio\|Kitano, Seigo
PMID:	16077916

181.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2005 Apr;34(4):215-9.
Title:	[Monoclonal antibody against G3BP: preparation, characterization and its application in analysis of human tumors].
Author:	Ning, Jun-yu\|You, Jiang-feng\|Pei, Fei\|Wang, Jie-liang\|Cui, Xiang-lin\|Zheng, Jie
PMID:	16091175

182.
Journal:	J Surg Oncol. 2005 Sep 15;91(4):243-52.
Title:	The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Author:	Al-Moundhri, M S\|Nirmala, V\|Al-Hadabi, I\|Al-Mawaly, K\|Burney, I\|Al-Nabhani, M\|Thomas, V\|Ganguly, S S\|Grant, C
PMID:	16121348

183.
Journal:	Jpn J Clin Oncol. 2005 Oct;35(10):580-6.
Title:	Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach.
Author:	Honda, Teiichiro\|Tamura, Gen\|Endoh, Yasushi\|Nishizuka, Satoshi\|Kawata, Sumio\|Motoyama, Teiichi
PMID:	16254038

184.
Journal:	Int J Oncol. 2005 Dec;27(6):1677-83.
Title:	Epithelial-mesenchymal transition in gastric cancer (Review).
Author:	Katoh, Masaru
PMID:	16273224

185.
Journal:	Rinsho Byori. 2005 Oct;53(10):881-6.
Title:	Nonrandom chromosomal numerical abnormality as a new molecular cytogenetic tumor marker--a retrospective study of 60 gastric cancer cases.
Author:	Kitayama, Yasuhiko\|Sugimura, Haruhiko
PMID:	16296333

186.
Journal:	APMIS. 2005 Oct;113(10):683-7.
Title:	ERBB2 kinase domain mutation in a gastric cancer metastasis.
Author:	Lee, Jong Woo\|Soung, Young Hwa\|Kim, Su Young\|Park, Won Sang\|Nam, Suk Woo\|Kim, Sang Ho\|Lee, Jung Young\|Yoo, Nam Jin\|Lee, Sug Hyung
PMID:	16309427

187.
Journal:	Rev Med Chil. 2005 Jul;133(7):753-60.
Title:	[Clinical and molecular features of cardial gastric cancer associated to Epstein Barr virus].
Author:	Corvalan, Alejandro\|Akiba, Suminori\|Valenzuela, Maria Teresa\|Cumsille, Miguel Angel\|Koriyama, Chihaya\|Argandona, Jorge\|Backhouse, Claudia\|Bal, Matilde\|Mena, Fernando\|Palma, Mariana\|Eizuru, Yoshito
PMID:	16341380

188.
Journal:	Tumori. 2005 Nov-Dec;91(6):513-21.
Title:	Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
Author:	Im, Seock-Ah\|Lee, Kyung Eun\|Nam, Eunmi\|Kim, Do Yeun\|Lee, Joo-Ho\|Han, Ho-Seong\|Seoh, Ju-Young\|Park, Hae-Young\|Cho, Min-Sun\|Han, Woon Sup\|Lee, Soon Nam
PMID:	16457151

189.
Journal:	Int J Cancer. 2006 Mar 15;118(6):1426-9.
Title:	Somatic mutations of the ERBB4 kinase domain in human cancers.
Author:	Soung, Young Hwa\|Lee, Jong Woo\|Kim, Su Young\|Wang, Young Pil\|Jo, Keon Hyun\|Moon, Seok Whan\|Park, Won Sang\|Nam, Suk Woo\|Lee, Jung Young\|Yoo, Nam Jin\|Lee, Sug Hyung
PMID:	16187281

190.
Journal:	Oncol Rep. 2006 Jan;15(1):65-71.
Title:	Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.
Author:	Yano, Tomonori\|Doi, Toshihiko\|Ohtsu, Atsushi\|Boku, Narikazu\|Hashizume, Kaoru\|Nakanishi, Mamoru\|Ochiai, Atsushi
PMID:	16328035

191.
Journal:	Clin Cancer Res. 2006 Jan 1;12(1):57-61.
Title:	Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
Author:	Lee, Jong Woo\|Soung, Young Hwa\|Seo, Si Hyung\|Kim, Su Young\|Park, Cho Hyun\|Wang, Young Pil\|Park, Kyeongmee\|Nam, Suk Woo\|Park, Won Sang\|Kim, Sang Ho\|Lee, Jung Young\|Yoo, Nam Jin\|Lee, Sug Hyung
PMID:	16397024

192.
Journal:	Eur J Cancer. 2006 Oct;42(15):2425-32.
Title:	A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2
Author:	Menendez, Javier A\|Papadimitropoulou, Adriana\|Vellon, Luciano\|Lupu, Ruth
PMID:	16406575

193.
Journal:	Cancer Genet Cytogenet. 2006 Feb;165(1):41-50.
Title:	Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.
Author:	Bizari, Lucimari\|Borim, Aldenis Albanese\|Leite, Katia Ramos Moreira\|Goncalves, Fernanda de Toledo\|Cury, Patricia Maluf\|Tajara, Eloiza Helena\|Silva, Ana Elizabete
PMID:	16490596

194.
Journal:	Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):281-7.
Title:	Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.
Author:	Cunningham, Steven C\|Kamangar, Farin\|Kim, Min P\|Hammoud, Sommer\|Haque, Raqeeb\|Iacobuzio-Donahue, Christine A\|Maitra, Anirban\|Ashfaq, Raheela\|Hustinx, Steven\|Heitmiller, Richard E\|Choti, Michael A\|Lillemoe, Keith D\|Cameron, John L\|Yeo, Charles J\|Schulick,
PMID:	16492916

195.
Journal:	Nan Fang Yi Ke Da Xue Xue Bao. 2006 Mar;26(3):344-7.
Title:	[Association of HER-2/neu expression with prognosis of gastric cancer].
Author:	Chen, Bin\|Luo, Rong-cheng\|Cui, Fei\|Qian, Xin-yu
PMID:	16546744

196.
Journal:	Gastric Cancer. 2006;9(1):44-9.
Title:	Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma.
Author:	Urano, Naomi\|Fujiwara, Yoshiyuki\|Doki, Yuichirou\|Tsujie, Masaki\|Yamamoto, Hirofumi\|Miyata, Hiroshi\|Takiguchi, Shuji\|Yasuda, Takushi\|Yano, Masahiko\|Monden, Morito
PMID:	16557436

197.
Journal:	Clin Transl Oncol. 2006 Jan;8(1):15-21.
Title:	Mediterranean diet, olive oil and cancer.
Author:	Colomer, Ramon\|Menendez, Javier A
PMID:	16632435

198.
Journal:	Am Surg. 2006 Apr;72(4):332-8.
Title:	Increased epithelial cadherin expression among Japanese intestinal-type gastric cancers compared with specimens from American patients of European descent.
Author:	Theuer, Charles P\|Al-Kuran, Rasha\|Akiyama, Yoshiyuki\|Okumura, Minoru\|Ziogas, Al\|Carpenter, Philip M
PMID:	16676859

199.
Journal:	World J Gastroenterol. 2006 May 28;12(20):3283-7.
Title:	Investigation of HER-2 codon 655 single nucleotide polymorphism frequency and c-ErbB-2 protein expression alterations in gastric cancer patients.
Author:	Satiroglu-Tufan, N-Lale\|Bir, Ferda\|Calli-Demirkan, Nese
PMID:	16718853

200.
Journal:	Dig Dis Sci. 2006 Aug;51(8):1371-9. Epub 2006 Jul 26.
Title:	HER-2/neu amplification is an independent prognostic factor in gastric cancer.
Author:	Park, Dong Il\|Yun, Jung Won\|Park, Jung Ho\|Oh, Suk Joong\|Kim, Hong Joo\|Cho, Yong Kyun\|Sohn, Chong Il\|Jeon, Woo Kyu\|Kim, Byung Ik\|Yoo, Chang Hak\|Son, Byung Ho\|Cho, Eun Yoon\|Chae, Seoung Wan\|Kim, Eo-Jin\|Sohn, Jin Hee\|Ryu, Seung Ho\|Sepulveda, Antonia R
PMID:	16868827

201.
Journal:	Hum Pathol. 2006 Oct;37(10):1333-43. Epub 2006 Aug 10.
Title:	Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.
Author:	Kanta, Sammy Yasmin\|Yamane, Tetsu\|Dobashi, Yoh\|Mitsui, Fumihiko\|Kono, Koji\|Ooi, Akishi
PMID:	16949920

202.
Journal:	Oncology. 2006;70(4):285-9. Epub 2006 Oct 16.
Title:	Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas.
Author:	Soung, Young Hwa\|Lee, Jong Woo\|Nam, Suk Woo\|Lee, Jung Young\|Yoo, Nam Jin\|Lee, Sug Hyung
PMID:	17047397

203.
Journal:	Br J Cancer. 2006 Dec 4;95(11):1504-13. Epub 2006 Nov 7.
Title:	Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis.
Author:	Yokoyama, H\|Ikehara, Y\|Kodera, Y\|Ikehara, S\|Yatabe, Y\|Mochizuki, Y\|Koike, M\|Fujiwara, M\|Nakao, A\|Tatematsu, M\|Nakanishi, H
PMID:	17088902

204.
Journal:	Cancer Chemother Pharmacol. 2007 May;59(6):795-805.
Title:	Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models.
Author:	Fujimoto-Ouchi, Kaori\|Sekiguchi, Fumiko\|Yasuno, Hideyuki\|Moriya, Yoichiro\|Mori, Kazushige\|Tanaka, Yutaka
PMID:	17031648

205.
Journal:	Anticancer Res. 2007 Jan-Feb;27(1B):505-11.
Title:	Collision carcinoma of the residual cervical esophagus 27 years after esophageal cancer surgery.
Author:	Naritaka, Yoshihiko\|Ogawa, Kenji\|Shimakawa, Takeshi\|Wagatsuma, Yoshihisa\|Isohata, Noriyuki\|Asaka, Shiniichi\|Miyaki, Akira\|Shiozawa, Shunichi\|Katsube, Takao\|Yoshimatsu, Kazuhiko\|Aiba, Motohiko\|Ide, Hiroko
PMID:	17348434

206.
Journal:	J Egypt Natl Canc Inst. 2007 Jun;19(2):147-57.
Title:	Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
Author:	Ismail, Hoda M\|Moneer, Manar\|El-Baradie, Manal\|Khorshid, Ola\|Touny, Ahmed
PMID:	19034345

207.
Journal:	J Cancer Res Clin Oncol. 2008 Feb;134(2):153-61.
Title:	Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance.
Author:	del Casar, Jose M\|Corte, Maria D\|Alvarez, Ana\|Garcia, Isabel\|Bongera, Miguel\|Gonzalez, Luis O\|Garcia-Muniz, Jose L\|Allende, Maria T\|Astudillo, Aurora\|Vizoso, Francisco J
PMID:	17628829

208.
Journal:	Breast Cancer Res Treat. 2008 Jul;110(1):99-109.
Title:	The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Author:	Li, Wen-Feng\|Hu, Zhen\|Rao, Nan-Yan\|Song, Chuang-Gui\|Zhang, Bin\|Cao, Ming-Zhi\|Su, Feng-Xi\|Wang, Yong-Sheng\|He, Ping-Qing\|Di, Gen-Hong\|Shen, Kun-Wei\|Wu, Jiong\|Lu, Jin-Song\|Luo, Jian-Min\|Liu, Xiao-Yi\|Zhou, Jie\|Wang, Lei\|Zhao, Lin\|Liu, Yan-Bing\|Yuan, Wen-Tao\|
PMID:	17851763

209.
Journal:	Int J Oncol. 2008 Jan;32(1):89-95.
Title:	Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.
Author:	Kim, Sun Young\|Kim, Hwang Phill\|Kim, Yu Jung\|Oh, Do Youn\|Im, Seock-Ah\|Lee, Dongsoon\|Jong, Hyun-Soon\|Kim, Tae-You\|Bang, Yung-Jue
PMID:	18097546

210.
Journal:	Dig Dis Sci. 2008 Aug;53(8):2090-100.
Title:	Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies.
Author:	Cangiano, Jose\|Centeno, Barbara A\|Garrett, Christopher R\|Caceres, William\|de Jesus, Ana\|Lee, Ji-Hyun\|Pavia, Orestes\|Jove, Richard\|Baez, Luis\|Sullivan, Daniel M\|Muro-Cacho, Carlos A\|Munoz-Antonia, Teresita
PMID:	18224443

211.
Journal:	Carcinogenesis. 2008 Apr;29(4):704-12.
Title:	Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
Author:	Kim, Kwang-Kyu\|Lee, Jung Joon\|Yang, Young\|You, Kwan-Hee\|Lee, Jeong-Hyung
PMID:	18258606

212.
Journal:	Gan To Kagaku Ryoho. 2008 Feb;35(2):351-60.
Title:	[Future directions of anticancer drug development in Japan].
Author:	Akaza, Hideyuki\|Kawai, Koji\|Tsuruo, Takashi\|Tsukagoshi, Shigeru\|Aiba, Keisuke\|Shimada, Yasuhiro\|Kakeji, Yoshihiro\|Ishikawa, Hideki\|Ikeda, Tadashi\|Nakamura, Seigo\|Tamura, Tomohide\|Yamamoto, Nobuyuki\|Isonishi, Seiji\|Hinotsu, Shiro\|Hirose, Masaru\|Katsura, Ju
PMID:	18281781

213.
Journal:	Cancer Res. 2008 Apr 1;68(7):2340-8.
Title:	FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.
Author:	Kunii, Kaiko\|Davis, Lenora\|Gorenstein, Julie\|Hatch, Harold\|Yashiro, Masakazu\|Di Bacco, Alessandra\|Elbi, Cem\|Lutterbach, Bart
PMID:	18381441

214.
Journal:	Histopathology. 2008 Jun;52(7):797-805.
Title:	Assessment of a HER2 scoring system for gastric cancer: results from a validation study.
Author:	Hofmann, M\|Stoss, O\|Shi, D\|Buttner, R\|van de Vijver, M\|Kim, W\|Ochiai, A\|Ruschoff, J\|Henkel, T
PMID:	18422971

215.
Journal:	Ann Oncol. 2008 Sep;19(9):1523-9.
Title:	HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.
Author:	Gravalos, C\|Jimeno, A
PMID:	18441328

216.
Journal:	Clin Cancer Res. 2008 May 15;14(10):3022-9.
Title:	Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
Author:	Matsubara, Junichi\|Yamada, Yasuhide\|Hirashima, Yoshinori\|Takahari, Daisuke\|Okita, Natsuko T\|Kato, Ken\|Hamaguchi, Tetsuya\|Shirao, Kuniaki\|Shimada, Yasuhiro\|Shimoda, Tadakazu
PMID:	18483367

217.
Journal:	Anticancer Res. 2008 Mar-Apr;28(2B):1399-404.
Title:	Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
Author:	Pryczynicz, Anna\|Guzinska-Ustymowicz, Katarzyna\|Kemona, Andrzej\|Czyzewska, Jolanta
PMID:	18505086

218.
Journal:	Int J Cancer. 2008 Aug 15;123(4):817-25.
Title:	Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes.
Author:	Myllykangas, Samuel\|Junnila, Siina\|Kokkola, Arto\|Autio, Reija\|Scheinin, Ilari\|Kiviluoto, Tuula\|Karjalainen-Lindsberg, Marja-Liisa\|Hollmen, Jaakko\|Knuutila, Sakari\|Puolakkainen, Pauli\|Monni, Outi
PMID:	18506690

219.
Journal:	Oncology. 2008;74(1-2):76-83.
Title:	Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer.
Author:	Matsubara, Junichi\|Yamada, Yasuhide\|Nakajima, Takako E\|Kato, Ken\|Hamaguchi, Tetsuya\|Shirao, Kuniaki\|Shimada, Yasuhiro\|Shimoda, Tadakazu
PMID:	18544998

220.
Journal:	J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1204-7.
Title:	Does hyaluronic acid stimulate tumor growth after endoscopic mucosal resection?
Author:	Sohn, Dae Kyung\|Chang, Hee Jin\|Choi, Hyo Seong\|Jeong, Seung-Yong\|Kook, Myeong-Cherl\|Kim, Chan Gyoo\|Choi, Il Ju
PMID:	18637056

221.
Journal:	Cancer Lett. 2008 Dec 18;272(2):296-306.
Title:	The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.
Author:	Kim, Jin Won\|Kim, Hwang-Phill\|Im, Seock-Ah\|Kang, Soyeong\|Hur, Hyung Seok\|Yoon, Young-Kwang\|Oh, Do-Youn\|Kim, Jee Hyun\|Lee, Dong Soon\|Kim, Tae-You\|Bang, Yung-Jue
PMID:	18774637

222.
Journal:	J Pathol. 2008 Dec;216(4):471-82.
Title:	Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
Author:	Tsukamoto, Y\|Uchida, T\|Karnan, S\|Noguchi, T\|Nguyen, L T\|Tanigawa, M\|Takeuchi, I\|Matsuura, K\|Hijiya, N\|Nakada, C\|Kishida, T\|Kawahara, K\|Ito, H\|Murakami, K\|Fujioka, T\|Seto, M\|Moriyama, M
PMID:	18798223

223.
Journal:	Semin Diagn Pathol. 2008 Nov;25(4):274-87.
Title:	Molecular targets and biological modifiers in gastric cancer.
Author:	Carneiro, Fatima\|Oliveira, Carla\|Leite, Marina\|Seruca, Raquel
PMID:	19013893

224.
Journal:	Clin Cancer Res. 2008 Dec 1;14(23):7843-9.
Title:	High expression of HER3 is associated with a decreased survival in gastric cancer.
Author:	Hayashi, Mikiko\|Inokuchi, Mikito\|Takagi, Yoko\|Yamada, Hiroyuki\|Kojima, Kazuyuki\|Kumagai, Jiro\|Kawano, Tatsuyuki\|Sugihara, Kenichi
PMID:	19047113

225.
Journal:	BMC Cancer. 2008 Dec 6;8:363.
Title:	Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.
Author:	Liang, Zhiyong\|Zeng, Xuan\|Gao, Jie\|Wu, Shafei\|Wang, Peng\|Shi, Xiaohua\|Zhang, Jing\|Liu, Tonghua
PMID:	19061514

226.
Journal:	Hum Pathol. 2009 Mar;40(3):314-22.
Title:	Comparative analysis of protein expressions in primary and metastatic gastric carcinomas.
Author:	Kim, Ji Hun\|Kim, Min A\|Lee, Hye Seung\|Kim, Woo Ho
PMID:	18835621

227.
Journal:	Int J Oncol. 2009 Jan;34(1):25-32.
Title:	Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation.
Author:	Patel, Dipa\|Bassi, Rajiv\|Hooper, Andrea\|Prewett, Marie\|Hicklin, Daniel J\|Kang, Xiaoqiang
PMID:	19082474

228.
Journal:	Br J Cancer. 2009 Feb 10;100(3):487-93.
Title:	Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients.
Author:	Barros-Silva, J D\|Leitao, D\|Afonso, L\|Vieira, J\|Dinis-Ribeiro, M\|Fragoso, M\|Bento, M J\|Santos, L\|Ferreira, P\|Rego, S\|Brandao, C\|Carneiro, F\|Lopes, C\|Schmitt, F\|Teixeira, M R
PMID:	19156142

229.
Journal:	J Cancer Res Clin Oncol. 2009 Oct;135(10):1331-9.
Title:	Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.
Author:	Yu, Guan Zhen\|Chen, Ying\|Wang, Jie Jun
PMID:	19337752

230.
Journal:	Curr Opin Oncol. 2009 Jul;21(4):381-5.
Title:	Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
Author:	Wagner, Anna D\|Moehler, Markus
PMID:	19412098

231.
Journal:	Cancer Biol Ther. 2009 Jul;8(14):1360-8. Epub 2009 Jul 13.
Title:	Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression.
Author:	Cai, Xin-Ze\|Wang, Jian\|Li, Xiao-Dong\|Wang, Gui-Ling\|Liu, Fu-Nan\|Cheng, Mao-Sheng\|Li, Feng
PMID:	19448398

232.
Journal:	Expert Opin Investig Drugs. 2009 Jul;18(7):945-55.
Title:	Novel investigational drugs for gastric cancer.
Author:	Vecchione, Loredana\|Orditura, Michele\|Ciardiello, Fortunato\|De Vita, Ferdinando
PMID:	19466878

233.
Journal:	Surgery. 2009 Aug;146(2):213-9.
Title:	ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas.
Author:	Arrington, Amanda K\|Dahlberg, Peter S\|Davydova, Julia\|Vickers, Selwyn M\|Yamamoto, Masato
PMID:	19628076

234.
Journal:	World J Surg. 2009 Oct;33(10):2112-8.
Title:	Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.
Author:	Zhang, Xiu Li\|Yang, Yun Sheng\|Xu, Dong Ping\|Qu, Jian Hui\|Guo, Ming Zhou\|Gong, Yan\|Huang, Jin
PMID:	19636613

235.
Journal:	Cancer Res. 2009 Aug 15;69(16):6685-93.
Title:	A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.
Author:	Min, Chengyin\|Yu, Ziyang\|Kirsch, Kathrin H\|Zhao, Yingshe\|Vora, Siddharth R\|Trackman, Philip C\|Spicer, Douglas B\|Rosenberg, Lynn\|Palmer, Julie R\|Sonenshein, Gail E
PMID:	19654310

236.
Journal:	Zhonghua Yi Xue Za Zhi. 2009 Apr 14;89(14):962-6.
Title:	[Differential expression of immunohistochemical markers between cardiac carcinoma and carcinoma in antrum of stomach and correlation thereof with clinicopathological factors].
Author:	Ye, Yan-wei\|Shi, Ying-qiang\|Wang, Chun-meng\|Li, Bai-zhou\|Zhu, Lei
PMID:	19671307

237.
Journal:	Carcinogenesis. 2009 Nov;30(11):1857-64.
Title:	Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.
Author:	Kubo, Takashi\|Kuroda, Yukie\|Shimizu, Hiroko\|Kokubu, Akiko\|Okada, Naoko\|Hosoda, Fumie\|Arai, Yasuhito\|Nakamura, Yu\|Taniguchi, Hirokazu\|Yanagihara, Kazuyoshi\|Imoto, Issei\|Inazawa, Johji\|Hirohashi, Setsuo\|Shibata, Tatsuhiro
PMID:	19734198

238.
Journal:	Exp Oncol. 2009 Sep;31(3):182-4.
Title:	Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue.
Author:	Bazas, V M\|Lukyanova, N Yu\|Lisovenko, G S\|Rozumiy, D O\|Potebnya, G P
PMID:	19783961

239.
Journal:	Expert Opin Biol Ther. 2009 Dec;9(12):1543-51.
Title:	Trastuzumab for gastric cancer.
Author:	Meza-Junco, Judith\|Au, Heather-Jane\|Sawyer, Michael B
PMID:	19916733

240.
Journal:	Dig Surg. 2009;26(5):384-91.
Title:	Study on the different expression of molecular markers between cardiac cancer and distal gastric cancer and their correlations with clinicopathological features.
Author:	Ye, Yan-wei\|Fu, Hong\|Zhou, Ye\|Du, Chun-yan\|Li, Bai-zhou\|Zhu, Lei\|Shi, Ying-qiang
PMID:	19923826

241.
Journal:	Folia Histochem Cytobiol. 2009;47(4):653-61.
Title:	Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
Author:	Czyzewska, Jolanta\|Guzinska-Ustymowicz, Katarzyna\|Kemona, Andrzej
PMID:	20430735

242.
Journal:	Mol Med Rep. 2009 Nov-Dec;2(6):943-6.
Title:	HER 2/neu protein expression in gastric cancer is associated with poor survival.
Author:	Xie, S D\|Xu, C Y\|Shen, J G\|Jiang, Z N\|Shen, J Y\|Wang, L B
PMID:	21475925

243.
Journal:	Genet Mol Biol. 2009 Apr;32(2):242-50.
Title:	Peripheral position of CCND1 and HER-2/neu oncogenes within chromosome territories in esophageal and gastric cancers non-related to amplification and overexpression.
Author:	Bizari, Lucimari\|Tajara, Eloiza Helena\|Silva, Ana Elizabete
PMID:	21637674

244.
Journal:	Gut. 2010 Mar;59(3):292-9.
Title:	Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein.
Author:	Zhang, De-Xin\|Zhao, Peng-Tao\|Xia, Lin\|Liu, Li-Li\|Liang, Jie\|Zhai, Hui-Hong\|Zhang, Hong-Bo\|Guo, Xue-Gang\|Wu, Kai-Chun\|Xu, Yan-Ming\|Jia, Lin-Tao\|Yang, An-Gang\|Chen, Si-Yi\|Fan, Dai-Ming
PMID:	19951902

245.
Journal:	Int J Oncol. 2010 Jan;36(1):101-6.
Title:	Use of protein array to investigate receptor tyrosine kinases activated in gastric cancer.
Author:	Gong, Jian\|Morishita, Asahiro\|Kurokohchi, Kazutaka\|Tani, Joji\|Kato, Kiyohito\|Miyoshi, Hisaaki\|Inoue, Hideyuki\|Kobayashi, Mitsuyoshi\|Liu, Shi\|Murota, Masayuki\|Muramatsu, Akemi\|Izuishi, Kunihiko\|Suzuki, Yasuyuki\|Yoshida, Hirohito\|Uchida, Naohito\|Deguchi, Ka
PMID:	19956838

246.
Journal:	Chin J Cancer. 2010 Jan;29(1):76-81.
Title:	[Relationship between HER2/neu gene amplification and protein expression and prognosis in patients with advanced gastric carcinoma].
Author:	Song, Yan\|Huang, Jing\|Wang, Jin-Wan
PMID:	20038314

247.
Journal:	Cancer Immunol Immunother. 2010 Jun;59(6):841-50.
Title:	Circulating tumour-derived microvesicles in plasma of gastric cancer patients.
Author:	Baran, Jaroslaw\|Baj-Krzyworzeka, Monika\|Weglarczyk, Kazimierz\|Szatanek, Rafal\|Zembala, Maria\|Barbasz, Jakub\|Czupryna, Antoni\|Szczepanik, Antoni\|Zembala, Marek
PMID:	20043223

248.
Journal:	World J Gastroenterol. 2010 Jan 21;16(3):339-44.
Title:	Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.
Author:	Zheng, Yao\|Wang, Lin\|Zhang, Jian-Ping\|Yang, Jing-Yan\|Zhao, Zhu-Mei\|Zhang, Xiao-Ying
PMID:	20082479

249.
Journal:	Cancer Chemother Pharmacol. 2010 May;65(6):1009-21.
Title:	A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer.
Author:	Bamias, Aristotelis\|Karina, M\|Papakostas, P\|Kostopoulos, I\|Bobos, M\|Vourli, G\|Samantas, E\|Christodoulou, Ch\|Pentheroudakis, G\|Pectasides, D\|Dimopoulos, M A\|Fountzilas, G
PMID:	20130877

250.
Journal:	Cancer Treat Rev. 2010 Aug;36(5):384-92.
Title:	Advanced gastric cancer--slow but steady progress.
Author:	Power, Derek G\|Kelsen, David P\|Shah, Manish A
PMID:	20176443

251.
Journal:	Clin Cancer Res. 2010 Mar 1;16(5):1509-19.
Title:	Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo.
Author:	Wainberg, Zev A\|Anghel, Adrian\|Desai, Amrita J\|Ayala, Raul\|Luo, Tong\|Safran, Brent\|Fejzo, Marlena S\|Hecht, J Randolph\|Slamon, Dennis J\|Finn, Richard S
PMID:	20179222

252.
Journal:	Oncology. 2010;78(1):26-33.
Title:	Targeted HER2 treatment in advanced gastric cancer.
Author:	Jorgensen, Jan Trost
PMID:	20185938

253.
Journal:	BMC Cancer. 2010 Mar 1;10:73.
Title:	Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines.
Author:	Junnila, Siina\|Kokkola, Arto\|Karjalainen-Lindsberg, Marja-Liisa\|Puolakkainen, Pauli\|Monni, Outi
PMID:	20187983

254.
Journal:	Cell Oncol. 2010;32(1-2):57-65.
Title:	HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series.
Author:	Grabsch, Heike\|Sivakumar, Shivan\|Gray, Sally\|Gabbert, Helmut E\|Muller, Wolfram
PMID:	20208134

255.
Journal:	Biochem Biophys Res Commun. 2010 Apr 16;394(4):1042-6.
Title:	Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.
Author:	Asaoka, Yoshinari\|Tada, Motohisa\|Ikenoue, Tsuneo\|Seto, Motoko\|Imai, Mitsuho\|Miyabayashi, Koji\|Yamamoto, Keisuke\|Yamamoto, Shinzo\|Kudo, Yotaro\|Mohri, Dai\|Isomura, Yoshihiro\|Ijichi, Hideaki\|Tateishi, Keisuke\|Kanai, Fumihiko\|Ogawa, Seishi\|Omata, Masao\|Koike,
PMID:	20331976

256.
Journal:	J Control Release. 2010 Sep 15;146(3):264-75.
Title:	The role of HER2 in cancer therapy and targeted drug delivery.
Author:	Tai, Wanyi\|Mahato, Rubi\|Cheng, Kun
PMID:	20385184

257.
Journal:	J Natl Compr Canc Netw. 2010 Apr;8(4):437-47.
Title:	Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease.
Author:	Shah, Manish A\|Kelsen, David P
PMID:	20410336

258.
Journal:	Mol Cancer Ther. 2010 May;9(5):1198-207.
Title:	Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplification.
Author:	Tanizaki, Junko\|Okamoto, Isamu\|Takezawa, Ken\|Tsukioka, Sayaka\|Uchida, Junji\|Kiniwa, Mamoru\|Fukuoka, Masahiro\|Nakagawa, Kazuhiko
PMID:	20424000

259.
Journal:	Onkologie. 2010;33 Suppl 4:26-30.
Title:	[HER2 testing and targeted therapy in advanced gastric cancer].
Author:	Hohler, Thomas\|Ruschoff, Josef\|Ridwelski, Karsten\|Moehler, Markus
PMID:	20431310

260.
Journal:	Pathologe. 2010 May;31(3):208-17.
Title:	[Her2 testing in gastric cancer. What is different in comparison to breast cancer?].
Author:	Ruschoff, J\|Nagelmeier, I\|Baretton, G\|Dietel, M\|Hofler, H\|Schildhaus, H U\|Buttner, R\|Schlake, W\|Stoss, O\|Kreipe, H H
PMID:	20443098

261.
Journal:	Arch Biochem Biophys. 2010 Jul;499(1-2):49-55.
Title:	HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion.
Author:	Bao, Wei\|Fu, Hai-Jing\|Jia, Lin-Tao\|Zhang, Yong\|Li, Wei\|Jin, Bo-Quan\|Yao, Li-Bo\|Chen, Si-Yi\|Yang, An-Gang
PMID:	20460098

262.
Journal:	Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):309-14.
Title:	Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
Author:	Bittoni, A\|Maccaroni, E\|Scartozzi, M\|Berardi, R\|Cascinu, S
PMID:	20496540

263.
Journal:	Biol Pharm Bull. 2010;33(6):931-7.
Title:	Down-regulation of human epidermal growth factor receptor 2/neu oncogene by corosolic acid induces cell cycle arrest and apoptosis in NCI-N87 human gastric cancer cells.
Author:	Lee, Myung Sun\|Cha, Eun Young\|Thuong, Phuong Thien\|Kim, Ji Yeon\|Ahn, Moon Sang\|Sul, Ji Young
PMID:	20522955

264.
Journal:	Cancer Invest. 2010 Dec;28(10):1038-47.
Title:	The sequence-dependent cytotoxic effect of trastuzumab in combination with 5-Fluorouracil or cisplatin on gastric cancer cell lines.
Author:	Li, Xiao-Ling\|Yi, Shao-Qiong\|Xu, Jian-Ming\|Zhang, Yang\|Yingying-Feng\|Chen, Wei\|Song, San-Tai
PMID:	20590442

265.
Journal:	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Aug;26(8):735-7.
Title:	[Expression of a chimeric gene containing poly-arginine as the protein transduction domain and its killing activity against HER2 positive gastric cancer SGC-7901 cells].
Author:	Zhao, Zhi-ning\|Wang, Tao\|Ren, Jun-lin\|Zhang, Rui\|Zhao, Jing\|Wen, Wei-hong\|Jia, Lin-tao\|Yang, An-gang
PMID:	20619096

266.
Journal:	Braz J Med Biol Res. 2010 Aug;43(8):717-21. Epub 2010 Jul 23.
Title:	Cytogenetic characterization and evaluation of c-MYC gene amplification in PG100, a new Brazilian gastric cancer cell line.
Author:	Ribeiro, H F\|Alcantara, D F A\|Matos, L A\|Sousa, J M C\|Leal, M F\|Smith, M A C\|Burbano, R R\|Bahia, M O
PMID:	20658094

267.
Journal:	Virchows Arch. 2010 Sep;457(3):299-307.
Title:	HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing.
Author:	Ruschoff, Josef\|Dietel, Manfred\|Baretton, Gustavo\|Arbogast, Susanne\|Walch, Axel\|Monges, Genevieve\|Chenard, Marie-Pierre\|Penault-Llorca, Frederique\|Nagelmeier, Iris\|Schlake, Werner\|Hofler, H\|Kreipe, H H
PMID:	20665045

268.
Journal:	J Clin Pathol. 2010 Sep;63(9):839-42.
Title:	A study of HER2 gene amplification and protein expression in gastric cancer.
Author:	Yan, Benedict\|Yau, Ee Xuan\|Bte Omar, Siti Shyba\|Ong, Chee Wee\|Pang, Brendan\|Yeoh, Khay Guan\|Salto-Tellez, Manuel
PMID:	20696687

269.
Journal:	J Mol Med (Berl). 2010 Nov;88(11):1113-21.
Title:	Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes.
Author:	Meyerhuber, Peter\|Conrad, Heinke\|Starck, Lilian\|Leisegang, Matthias\|Busch, Dirk H\|Uckert, Wolfgang\|Bernhard, Helga
PMID:	20700725

270.
Journal:	Gan To Kagaku Ryoho. 2010 Aug;37(8):1489-96.
Title:	[Impact of HER2, EGFR, IGF-1R, and VEGFR expressions on the outcome of chemotherapy for advanced gastric cancer].
Author:	Matsubara, Junichi\|Hirashima, Yoshinori\|Yamada, Yasuhide
PMID:	20716873

271.
Journal:	Dtsch Med Wochenschr. 2010 Aug;135(34-35):1671-82; quiz 1683-6.
Title:	[Diagnosis and treatment of gastric cancer].
Author:	Lordick, F\|Grenacher, L\|Rocken, C\|Ebert, M\|Moehler, M\|Schumacher, G
PMID:	20721843

272.
Journal:	Lancet. 2010 Aug 28;376(9742):687-97.
Title:	Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Author:	Bang, Yung-Jue\|Van Cutsem, Eric\|Feyereislova, Andrea\|Chung, Hyun C\|Shen, Lin\|Sawaki, Akira\|Lordick, Florian\|Ohtsu, Atsushi\|Omuro, Yasushi\|Satoh, Taroh\|Aprile, Giuseppe\|Kulikov, Evgeny\|Hill, Julie\|Lehle, Michaela\|Ruschoff, Josef\|Kang, Yoon-Koo
PMID:	20728210

273.
Journal:	Int J Oncol. 2010 Nov;37(5):1345-52.
Title:	Induction of apoptosis by 5,7-dihydroxy-8-nitrochrysin in breast cancer cells: the role of reactive oxygen species and Akt.
Author:	Zhao, Xiao-Chun\|Tian, Li\|Cao, Jian-Guo\|Liu, Fei
PMID:	20878083

274.
Journal:	J Proteome Res. 2010 Dec 3;9(12):6317-22.
Title:	Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier.
Author:	Balluff, Benjamin\|Elsner, Mareike\|Kowarsch, Andreas\|Rauser, Sandra\|Meding, Stephan\|Schuhmacher, Christoph\|Feith, Marcus\|Herrmann, Ken\|Rocken, Christoph\|Schmid, Roland M\|Hofler, Heinz\|Walch, Axel\|Ebert, Matthias P
PMID:	21058730

275.
Journal:	Cancer Treat Rev. 2010 Nov;36 Suppl 3:S11-5.
Title:	Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.
Author:	De Vita, F\|Giuliani, F\|Silvestris, N\|Catalano, G\|Ciardiello, F\|Orditura, M
PMID:	21129604

276.
Journal:	Bull Cancer. 2010 Dec;97(12):1429-40.
Title:	[HER2 and gastric cancer: a novel therapeutic target for trastuzumab].
Author:	Bouche, O\|Penault-Llorca, F
PMID:	21134821

277.
Journal:	World J Gastrointest Oncol. 2010 Jul 15;2(7):287-94.
Title:	Recent advances in chemotherapy for advanced gastric cancer.
Author:	Kim, Jong Gwang\|Chung, Ho Young\|Yu, Wansik
PMID:	21160659

278.
Journal:	Magy Onkol. 2010 Dec;54(4):343-50.
Title:	[Pathology background of targeted therapy; quality control in pathology].
Author:	Kulka, Janina\|Szirtes, Ildiko\|Szasz, A Marcell\|Kupcsulik, Peter\|Kenessey, Istvan\|Lotz, Gabor\|Timar, Jozsef
PMID:	21163765

279.
Journal:	Patholog Res Int. 2010 Dec 6;2011:674182.
Title:	Her-2/neu testing and therapy in gastroesophageal adenocarcinoma.
Author:	Moelans, Cathy B\|van Diest, Paul J\|Milne, Anya N A\|Offerhaus, G Johan A
PMID:	21188213

280.
Journal:	Dis Markers. 2010;29(5):207-12.
Title:	Expression of HER2 in colorectal cancer does not correlate with prognosis.
Author:	Kruszewski, Wieslaw Janusz\|Rzepko, Robert\|Ciesielski, Maciej\|Szefel, Jaroslaw\|Zielinski, Jacek\|Szajewski, Mariusz\|Jasinski, Wojciech\|Kawecki, Krzysztof\|Wojtacki, Janusz
PMID:	21206005

281.
Journal:	Rev Gastroenterol Peru. 2010 Oct-Dec;30(4):324-7.
Title:	[HER2 expression in gastric cancer in Peru].
Author:	Beltran Garate, Brady\|Yabar Berrocal, Alejandro
PMID:	21263759

282.
Journal:	Oncol Lett. 2010 May;1(3):559-563.
Title:	Simultaneous detection of expression and gene mutations of HER2/neu in Chinese patients with gastric cancer.
Author:	Zhang, Xiuli\|Qu, Jianhui\|Sun, Gang\|Yang, Jing\|Yang, Yunsheng
PMID:	22966343

283.
Journal:	Pharmacogenomics J. 2011 Apr;11(2):81-92.
Title:	Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.
Author:	Roukos, D H
PMID:	20975737

284.
Journal:	Cancer Res. 2011 Jan 1;71(1):29-39.
Title:	Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing.
Author:	Zang, Zhi Jiang\|Ong, Choon Kiat\|Cutcutache, Ioana\|Yu, Willie\|Zhang, Shen Li\|Huang, Dachuan\|Ler, Lian Dee\|Dykema, Karl\|Gan, Anna\|Tao, Jiong\|Lim, Siyu\|Liu, Yujing\|Futreal, P Andrew\|Grabsch, Heike\|Furge, Kyle A\|Goh, Liang Kee\|Rozen, Steve\|Teh, Bin Tean\|Tan,
PMID:	21097718

285.
Journal:	Int J Oncol. 2011 Jan;38(1):33-9.
Title:	Feasibility of tailored, selective and effective anticancer chemotherapy by direct injection of docetaxel-loaded immunoliposomes into Her2/neu positive gastric tumor xenografts.
Author:	Yamamoto, Yuji\|Yoshida, Motohira\|Sato, Mitsunori\|Sato, Koichi\|Kikuchi, Satoshi\|Sugishita, Hiroki\|Kuwabara, Jun\|Matsuno, Yusuke\|Kojima, You\|Morimoto, Masamitsu\|Horiuchi, Atsushi\|Watanabe, Yuji
PMID:	21109923

286.
Journal:	Int J Oncol. 2011 Feb;38(2):375-83.
Title:	Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
Author:	Bai, Zhigang\|Ye, Yingjiang\|Liang, Bin\|Xu, Feng\|Zhang, Hui\|Zhang, Yanbin\|Peng, Jiarou\|Shen, Danhua\|Cui, Zhirong\|Zhang, Zhongtao\|Wang, Shan
PMID:	21165559

287.
Journal:	Adv Anat Pathol. 2011 Jan;18(1):53-9.
Title:	HER2 testing in gastric cancer.
Author:	Albarello, Luca\|Pecciarini, Lorenza\|Doglioni, Claudio
PMID:	21169738

288.
Journal:	Clin Cancer Res. 2011 May 1;17(9):2725-33.
Title:	MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Author:	Nishida, Naohiro\|Mimori, Koshi\|Fabbri, Muller\|Yokobori, Takehiko\|Sudo, Tomoya\|Tanaka, Fumiaki\|Shibata, Kohei\|Ishii, Hideshi\|Doki, Yuichiro\|Mori, Masaki
PMID:	21220473

289.
Journal:	J Surg Oncol. 2011 Feb;103(2):116-23.
Title:	ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Author:	Wang, Yuan-Yu\|Ye, Zai-Yuan\|Li, Li\|Zhao, Zhong-Sheng\|Shao, Qin-Shu\|Tao, Hou-Quan
PMID:	21259244

290.
Journal:	Ann Surg Oncol. 2011 Jul;18(7):2010-7.
Title:	Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.
Author:	Thompson, Sarah K\|Sullivan, Thomas R\|Davies, Ruth\|Ruszkiewicz, Andrew R
PMID:	21267790

291.
Journal:	Dtsch Med Wochenschr. 2011 Feb;136(5):179-81.
Title:	[Recent results of research on cancer of the colon, gastric cancer, sarcoma and bronchial carcinoma].
Author:	Hacker, U T\|Wolf, J\|Wendtner, C-M
PMID:	21271476

292.
Journal:	Cancer Lett. 2011 Mar 28;302(2):155-65.
Title:	Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer.
Author:	Nam, Hyun-Jin\|Kim, Hwang-Phill\|Yoon, Young-Kwang\|Hur, Hyung-Seok\|Song, Sang-Hyun\|Kim, Maeng-Sup\|Lee, Gwan-Sun\|Han, Sae-Won\|Im, Seock-Ah\|Kim, Tae-You\|Oh, Do-Youn\|Bang, Yung-Jue
PMID:	21306821

293.
Journal:	Histopathology. 2011 Feb;58(3):383-94.
Title:	HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH).
Author:	Boers, James E\|Meeuwissen, Harriette\|Methorst, Natalie
PMID:	21323962

294.
Journal:	Cell Tissue Res. 2011 May;344(2):287-98.
Title:	Interaction between adipose tissue stromal cells and gastric cancer cells in vitro.
Author:	Nomoto-Kojima, Namie\|Aoki, Shigehisa\|Uchihashi, Kazuyoshi\|Matsunobu, Aki\|Koike, Eisuke\|Ootani, Akifumi\|Yonemitsu, Nobuhisa\|Fujimoto, Kazuma\|Toda, Shuji
PMID:	21384185

295.
Journal:	Cell Oncol (Dordr). 2011 Apr;34(2):89-95.
Title:	Low frequency of HER2 amplification and overexpression in early onset gastric cancer.
Author:	Moelans, Cathy B\|Milne, Anya N\|Morsink, Folkert H\|Offerhaus, G Johan A\|van Diest, Paul J
PMID:	21394646

296.
Journal:	Expert Opin Investig Drugs. 2011 May;20(5):595-604.
Title:	New targeted therapies for gastric cancer.
Author:	Asaoka, Yoshinari\|Ikenoue, Tsuneo\|Koike, Kazuhiko
PMID:	21406037

297.
Journal:	Ann Oncol. 2011 Dec;22(12):2610-5.
Title:	Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.
Author:	Iqbal, S\|Goldman, B\|Fenoglio-Preiser, C M\|Lenz, H J\|Zhang, W\|Danenberg, K D\|Shibata, S I\|Blanke, C D
PMID:	21415234

298.
Journal:	Clin Transl Oncol. 2011 Mar;13(3):179-84.
Title:	Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer.
Author:	Gravalos, Cristina\|Gomez-Martin, Carlos\|Rivera, Fernando\|Ales, Inmaculada\|Queralt, Bernardo\|Marquez, Antonia\|Jimenez, Ulpiano\|Alonso, Vicente\|Garcia-Carbonero, Rocio\|Sastre, Javier\|Colomer, Ramon\|Cortes-Funes, Hernan\|Jimeno, Antonio
PMID:	21421462

299.
Journal:	Curr Med Chem. 2011;18(11):1629-39.
Title:	Incorporation of targeted agents in the management of patients with advanced gastric cancer.
Author:	Pentheroudakis, G\|Stoyianni, A
PMID:	21428884

300.
Journal:	Cancer Lett. 2011 Jul 28;306(2):171-9.
Title:	Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer.
Author:	Barok, Mark\|Tanner, Minna\|Koninki, Katri\|Isola, Jorma
PMID:	21458915

301.
Journal:	Ann Surg Oncol. 2011 Oct;18(10):2833-40.
Title:	Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
Author:	Kim, Kab Choong\|Koh, Young Wha\|Chang, Heung-Moon\|Kim, Tae Hwan\|Yook, Jeong Hwan\|Kim, Byung Sik\|Jang, Se Jin\|Park, Young Soo
PMID:	21468783

302.
Journal:	World J Gastroenterol. 2011 Mar 21;17(11):1501-6.
Title:	Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.
Author:	Yan, Shi-Yan\|Hu, Ying\|Fan, Jian-Gao\|Tao, Guo-Quan\|Lu, Yong-Ming\|Cai, Xu\|Yu, Bao-Hua\|Du, Yi-Qun
PMID:	21472111

303.
Journal:	Cancer Res. 2011 Apr 15;71(8):3132-41.
Title:	Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis.
Author:	Gentile, Alessandra\|Lazzari, Luca\|Benvenuti, Silvia\|Trusolino, Livio\|Comoglio, Paolo M
PMID:	21487037

304.
Journal:	Curr Opin Oncol. 2011 Jul;23(4):396-402.
Title:	How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?
Author:	Lorenzen, Sylvie\|Lordick, Florian
PMID:	21505336

305.
Journal:	Mod Pathol. 2011 Jul;24(7):908-16.
Title:	Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation.
Author:	Langer, Rupert\|Rauser, Sandra\|Feith, Marcus\|Nahrig, Jorg M\|Feuchtinger, Annette\|Friess, Helmut\|Hofler, Heinz\|Walch, Axel
PMID:	21516080

306.
Journal:	Diagn Mol Pathol. 2011 Jun;20(2):94-100.
Title:	Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.
Author:	Im, Seock-Ah\|Kim, Jin Won\|Kim, Jin-Soo\|Kim, Min A\|Jordan, Bruce\|Pickl, Marlene\|Han, Sae-Won\|Oh, Do-Youn\|Lee, Hyuk Joon\|Kim, Tae-You\|Kim, Woo Ho\|Yang, Han-Kwang\|Bang, Yung-Jue
PMID:	21532492

307.
Journal:	Onco Targets Ther. 2011 Mar 24;4:21-6.
Title:	New developments in the treatment of metastatic gastric cancer: focus on trastuzumab.
Author:	Rose, Jeffrey S\|Bekaii-Saab, Tanios S
PMID:	21552412

308.
Journal:	Gan To Kagaku Ryoho. 2011 May;38(5):709-14.
Title:	[Standardization of evaluation for target molecule in cancer therapy].
Author:	Ochiai, Atsushi
PMID:	21566428

309.
Journal:	Cancer. 2011 Dec 1;117(23):5304-13.
Title:	Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
Author:	Ye, Yan Wei\|Zhou, Ye\|Yuan, Lin\|Wang, Chun Meng\|Du, Chun Yan\|Zhou, Xiao Yan\|Zheng, Bi Qiang\|Cao, Xi\|Sun, Meng Hong\|Fu, Hong\|Shi, Ying Qiang
PMID:	21567388

310.
Journal:	Ann Pathol. 2011 Apr;31(2):78-87.
Title:	[HER2 and gastric cancer. Recommendations for clinical practice in 2011].
Author:	Penault-Llorca, Frederique\|Chenard, Marie-Pierre\|Bouche, Olivier\|Emile, Jean-Francois\|Bibeau, Frederic\|Metges, Jean-Philippe\|Andre, Thierry\|Monges, Genevieve
PMID:	21601111

311.
Journal:	Dig Liver Dis. 2011 Oct;43(10):823-7.
Title:	Gastric metastasis of breast cancer: a single centre retrospective study.
Author:	Almubarak, Maher M\|Lae, Marick\|Cacheux, Wulfran\|de Cremoux, Patricia\|Pierga, Jean-Yves\|Reyal, Fabien\|Bennett, Simon P\|Falcou, Marie-Christine\|Salmon, Remy J\|Baranger, Bernard\|Mariani, Pascale
PMID:	21616731

312.
Journal:	Arch Pathol Lab Med. 2011 Jun;135(6):693-5.
Title:	Where and by whom should gastric cancer HER2/neu status be assessed?: lessons from breast cancer.
Author:	Salto-Tellez, Manuel\|Yau, Ee Xuan\|Yan, Benedict\|Fox, Stephen B
PMID:	21631260

313.
Journal:	Curr Cancer Drug Targets. 2011 Jul;11(6):681-7.
Title:	Esophagogastric cancer: integration of targeted therapies into systemic chemotherapy.
Author:	Moehler, M\|Schwarz, S\|Wagner, A D
PMID:	21651462

314.
Journal:	Pathology. 2011 Aug;43(5):459-64.
Title:	Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Author:	Clauditz, Till Sebastian\|Reiff, Maren\|Gravert, Linn\|Gnoss, Alexander\|Tsourlakis, Maria-Christina\|Munscher, Adrian\|Sauter, Guido\|Bokemeyer, Carsten\|Knecht, Rainald\|Wilczak, Waldemar
PMID:	21670724

315.
Journal:	Gastrointest Cancer Res. 2011 Mar;4(2):62-6.
Title:	HER2 Testing in Gastric/Gastroesophageal Junction Adenocarcinomas: Unique Features of a Familiar Test.
Author:	Ross, Jeffrey S\|Mulcahy, Mary
PMID:	21673877

316.
Journal:	Hum Pathol. 2011 Dec;42(12):1937-45.
Title:	Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer.
Author:	Rossi, Elena\|Klersy, Catherine\|Manca, Rachele\|Zuffardi, Orsetta\|Solcia, Enrico
PMID:	21676433

317.
Journal:	Mol Cytogenet. 2011 Jun 20;4(1):14.
Title:	Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridization.
Author:	Yk, Wang\|Cf, Gao\|T, Yun\|Z, Chen\|Xw, Zhang\|Xx, Lv\|Nl, Meng\|Wz, Zhao
PMID:	21689422

318.
Journal:	Clin Cancer Res. 2011 Aug 1;17(15):5060-70.
Title:	Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models.
Author:	Yamashita-Kashima, Yoriko\|Iijima, Shigeyuki\|Yorozu, Keigo\|Furugaki, Koh\|Kurasawa, Mitsue\|Ohta, Masateru\|Fujimoto-Ouchi, Kaori
PMID:	21700765

319.
Journal:	J Clin Oncol. 2011 Aug 1;29(22):3030-6.
Title:	Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Author:	Begnami, Maria D\|Fukuda, Emy\|Fregnani, Jose H T G\|Nonogaki, Suely\|Montagnini, Andre L\|da Costa, Wilson L Jr\|Soares, Fernando A
PMID:	21709195

320.
Journal:	Wien Klin Wochenschr. 2011 Jul;123(13-14):450-4.
Title:	Prognostic significance of HER2/neu expression in gastric cancer.
Author:	Ananiev, Julian\|Gulubova, Maya\|Manolova, Irena\|Tchernev, Georgi
PMID:	21739203

321.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):296-9.
Title:	[Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma].
Author:	Wu, Hong-mei\|Liu, Yan-hui\|Lin, Feng\|Xu, Fang-ping\|Luo, Dong-lan\|Zhang, Fen\|Zhuang, Heng-guo\|Luo, Xin-lan\|Wu, Wu-lin\|Lin, Xing-tao
PMID:	21756821

322.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):300-3.
Title:	[Dual-color silver-enhanced in-situ hybridization and fluorescence in-situ hybridization for determination of HER2 gene status in gastric carcinoma].
Author:	Long, Xiao-yu\|Bu, Hong\|Wei, Bing\|Liu, Xiao-yu\|Chen, Min\|Chen, Jie\|Liu, Jian-ping
PMID:	21756822

323.
Journal:	J Clin Pathol. 2011 Oct;64(10):880-3.
Title:	Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples.
Author:	Yan, Benedict\|Yau, Ee Xuan\|Choo, Shoa Nian\|Ong, Chee Wee\|Yong, Kol Jia\|Pang, Brendan\|Salto-Tellez, Manuel
PMID:	21757431

324.
Journal:	Biomaterials. 2011 Oct;32(30):7641-50.
Title:	The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.
Author:	Ren, Jun-Lin\|Meng, Yan-Ling\|Hu, Bin\|Jia, Lin-Tao\|Zhang, Rui\|Xu, Yan-Ming\|Xie, Qiao-Sheng\|Zhang, Ying-Qi\|Jin, Bo-Quan\|Chen, Si-Yi\|Wang, Tao\|Yang, An-Gang
PMID:	21767874

325.
Journal:	Histopathology. 2011 Jul;59(1):8-17.
Title:	Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method.
Author:	Garcia-Garcia, Elena\|Gomez-Martin, Carlos\|Angulo, Barbara\|Conde, Esther\|Suarez-Gauthier, Ana\|Adrados, Magdalena\|Perna, Cristian\|Rodriguez-Peralto, Jose Luis\|Hidalgo, Manuel\|Lopez-Rios, Fernando
PMID:	21771023

326.
Journal:	Gan To Kagaku Ryoho. 2011 Jul;38(7):1073-8.
Title:	[Relation of HER2 status and prognosis in gastric cancer patients].
Author:	Fuse, Nozomu
PMID:	21772089

327.
Journal:	Clin Cancer Res. 2011 Aug 1;17(15):5071-81.
Title:	HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors.
Author:	Zielinski, Rafal\|Lyakhov, Ilya\|Hassan, Moinuddin\|Kuban, Monika\|Shafer-Weaver, Kimberly\|Gandjbakhche, Amir\|Capala, Jacek
PMID:	21791637

328.
Journal:	Mol Med Rep. 2011 Nov-Dec;4(6):1151-5.
Title:	The role of neuregulin4 and HER4 in gastrointestinal malignant lymphoma.
Author:	Ebi, Masahide\|Kataoka, Hiromi\|Shimura, Takaya\|Hirata, Yoshikazu\|Mizushima, Takashi\|Mizoshita, Tsutomu\|Tanaka, Mamoru\|Tsukamoto, Hironobu\|Ozeki, Keiji\|Tanida, Satoshi\|Kamiya, Takeshi\|Inagaki, Hiroshi\|Joh, Takashi
PMID:	21805036

329.
Journal:	Virchows Arch. 2011 Sep;459(3):283-9.
Title:	Quality assessment of HER2 testing by monitoring of positivity rates.
Author:	Choritz, Harald\|Busche, Guntram\|Kreipe, Hans
PMID:	21809092

330.
Journal:	Br J Cancer. 2011 Sep 6;105(6):760-5.
Title:	Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.
Author:	Wainberg, Z A\|Lin, L-S\|DiCarlo, B\|Dao, K M\|Patel, R\|Park, D J\|Wang, H-J\|Elashoff, R\|Ryba, N\|Hecht, J R
PMID:	21811258

331.
Journal:	Drugs. 2011 Jul 30;71(11):1367-84.
Title:	Targeted therapies for gastric cancer: current status.
Author:	Yoong, Jaclyn\|Michael, Michael\|Leong, Trevor
PMID:	21812503

332.
Journal:	Clin Transl Oncol. 2011 Sep;13(9):597-8.
Title:	HER2 in gastric cancer: a biomarker with clinical impact, but not without translational challenges.
Author:	Lordick, Florian
PMID:	21865130

333.
Journal:	Clin Transl Oncol. 2011 Sep;13(9):636-51.
Title:	Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.
Author:	Gomez-Martin, Carlos\|Concha, Angel\|Corominas, Jose Maria\|Garcia-Caballero, Tomas\|Garcia-Garcia, Elena\|Iglesias, Mar\|Lopez, Jose Antonio\|Ramon y Cajal, Santiago\|Rojo, Federico\|Palacios, Jose\|Vera-Sempere, Francisco\|Aranda, Enrique\|Colomer, Ramon\|Garcia-Alf
PMID:	21865135

334.
Journal:	Nan Fang Yi Ke Da Xue Xue Bao. 2011 Aug;31(8):1458-60.
Title:	[Efficacy of trsatuzumab (Herceptin) combined with FOLFIRI regimen in the treatment of HER2-positive advanced gastric cancer].
Author:	Sun, Jie\|Pan, Sai-ying\|Chen, Qian-qi\|Gao, Xiao-ping\|Li, Wei
PMID:	21868346

335.
Journal:	Curr Oncol. 2011 Aug;18(4):e202-9.
Title:	Systemic therapy for advanced gastric cancer: a clinical practice guideline.
Author:	Mackenzie, M\|Spithoff, K\|Jonker, D
PMID:	21874111

336.
Journal:	Mol Cancer. 2011 Sep 1;10:107.
Title:	Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4.
Author:	Manu, Kanjoormana Aryan\|Shanmugam, Muthu K\|Rajendran, Peramaiyan\|Li, Feng\|Ramachandran, Lalitha\|Hay, Hui Sin\|Kannaiyan, Radhamani\|Swamy, Shivananju Nanjunda\|Vali, Shireen\|Kapoor, Shweta\|Ramesh, Bhargavi\|Bist, Pradeep\|Koay, Evelyn S\|Lim, Lina H K\|Ahn, Kwan
PMID:	21880153

337.
Journal:	Gastroenterology. 2011 Dec;141(6):2076-2087.e6.
Title:	HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.
Author:	Bao, Wei\|Fu, Hai-Jing\|Xie, Qiao-Sheng\|Wang, Lei\|Zhang, Rui\|Guo, Zhang-Yan\|Zhao, Jing\|Meng, Yan-Ling\|Ren, Xin-Ling\|Wang, Tao\|Li, Qing\|Jin, Bo-Quan\|Yao, Li-Bo\|Wang, Rui-An\|Fan, Dai-Ming\|Chen, Si-Yi\|Jia, Lin-Tao\|Yang, An-Gang
PMID:	21925125

338.
Journal:	Med Hypotheses. 2011 Dec;77(6):948-52.
Title:	Co-expression of erythropoietin receptor with human epidermal growth factor 2 may counteract trastuzumab inhibition in gastric cancer.
Author:	Li, Rui\|Yuan, Lingyan\|Wang, Jin\|Wang, Jiejun
PMID:	21944379

339.
Journal:	World J Surg Oncol. 2011 Sep 28;9:112.
Title:	Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?
Author:	Sbitti, Yassir\|Essaidi, Ismail\|Debbagh, Adil\|Kadiri, Habiba\|Oukabli, Mohamed\|Moussaid, Yassine\|Slimani, Khaoula\|Fetohi, Mohamed\|Elkaoui, Hakim\|Albouzidi, Abderrahmane\|Mahi, Mohamed\|Ali, Abdelmounaim Ait\|Ichou, Mohamed\|Errihani, Hassan
PMID:	21955806

340.
Journal:	Br J Cancer. 2011 Oct 25;105(9):1273-8.
Title:	Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial.
Author:	Shiroiwa, T\|Fukuda, T\|Shimozuma, K
PMID:	21959871

341.
Journal:	Expert Opin Pharmacother. 2011 Nov;12(16):2493-503.
Title:	Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma.
Author:	Kaur, Antarpreet\|Dasanu, Constantin A
PMID:	21967344

342.
Journal:	Onkologie. 2011;34(10):548-51.
Title:	Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).
Author:	Weissinger, Florian\|Reymond, Marc\|Dumke, Klaus\|Kruger, Martin
PMID:	21985855

343.
Journal:	Br J Cancer. 2011 Nov 8;105(10):1522-32.
Title:	An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells.
Author:	Yashiro, M\|Qiu, H\|Hasegawa, T\|Zhang, X\|Matsuzaki, T\|Hirakawa, K
PMID:	21997136

344.
Journal:	Appl Immunohistochem Mol Morphol. 2011 Dec;19(6):506-8.
Title:	HER2 testing in gastric and gastroesophageal junction cancers: a new therapeutic target and diagnostic challenge.
Author:	Hicks, David G\|Whitney-Miller, Christa
PMID:	22089490

345.
Journal:	Histopathology. 2011 Nov;59(5):822-31.
Title:	Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma.
Author:	Kim, Min A\|Lee, Hyuk-Joon\|Yang, Han-Kwang\|Bang, Yung-Jue\|Kim, Woo Ho
PMID:	22092393

346.
Journal:	Histopathology. 2011 Nov;59(5):832-40.
Title:	Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections.
Author:	Lee, Stephen\|de Boer, Willem Bastiaan\|Fermoyle, Soraya\|Platten, Michael\|Kumarasinghe, Marian Priyanthi
PMID:	22092394

347.
Journal:	Int J Surg Case Rep. 2011;2(8):301-5.
Title:	Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation.
Author:	Arrangoiz, Rodrigo\|Papavasiliou, Pavlos\|Dushkin, Holly\|Farma, Jeffrey M
PMID:	22096760

348.
Journal:	Pathobiology. 2011;78(6):302-10.
Title:	Molecular pathology of gastric carcinoma.
Author:	Jang, Bo-Gun\|Kim, Woo Ho
PMID:	22104201

349.
Journal:	J Oncol. 2011;2011:391564.
Title:	HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain.
Author:	Cidon, E U\|Centeno, R G\|Lagarto, E G\|Peral, J I
PMID:	22131990

350.
Journal:	Cesk Patol. 2011 Oct;47(4):160-3.
Title:	[Predictive diagnosis of HER2 in gastric adenocarcinoma].
Author:	Daum, O\|Skalova, A\|Rozkos, T\|Laco, J
PMID:	22145214

351.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):553-7.
Title:	[Guidelines for HER2 detection in gastric cancer].
Author:
PMID:	22169647

352.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2011 Sep;40(9):645-8.
Title:	[Standardization of HER2 testing in gastric cancer].
Author:	Long, Xiao-yu\|Bu, Hong\|Liu, Jian-ping
PMID:	22177257

353.
Journal:	Asian Pac J Cancer Prev. 2011;12(6):1417-23.
Title:	Effect of HER-2/neu over-expression on prognosis in gastric cancer: a meta-analysis.
Author:	Wang, Shuyi\|Zheng, Gang\|Chen, Liangdong\|Xiong, Bin
PMID:	22229170

354.
Journal:	Iran J Cancer Prev. 2011 Fall;4(4):170-6.
Title:	The Prognostic Significance of Her2-Neu Over expression in Gastric Carcinomas.
Author:	Ansari, J\|Chehrei, A\|Amini, M\|Alizade, S H\|Sanei, M H
PMID:	26322194

355.
Journal:	Breast Cancer Res Treat. 2012 Feb;131(3):837-48.
Title:	The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
Author:	Li, Ji-Yu\|Ou, Zhou-Luo\|Yu, San-Jian\|Gu, Xiao-Li\|Yang, Chen\|Chen, Ao-Xiang\|Di, Gen-Hong\|Shen, Zhen-Zhou\|Shao, Zhi-Ming
PMID:	21479551

356.
Journal:	Med Oncol. 2012 Jun;29(2):734-41.
Title:	Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.
Author:	Balta, A Z\|Filiz, A I\|Kurt, Y\|Sucullu, I\|Yucel, E\|Akin, M L
PMID:	21547408

357.
Journal:	Invest New Drugs. 2012 Aug;30(4):1766-7.
Title:	Reversible posterior leukoencephalopathy syndrome and trastuzumab.
Author:	Kaneda, Hiroyasu\|Okamoto, Isamu\|Satoh, Taroh\|Nakagawa, Kazuhiko
PMID:	21633924

358.
Journal:	Oncogene. 2012 Feb 9;31(6):671-82.
Title:	Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
Author:	Jiang, J\|Zhang, Y\|Chuai, S\|Wang, Z\|Zheng, D\|Xu, F\|Zhang, Y\|Li, C\|Liang, Y\|Chen, Z
PMID:	21743497

359.
Journal:	Biotech Histochem. 2012 Jan;87(1):40-5.
Title:	HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options.
Author:	Koltz, B R\|Hicks, D G\|Whitney-Miller, C L
PMID:	21745161

360.
Journal:	Int J Cancer. 2012 Jun 15;130(12):2845-56.
Title:	Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review.
Author:	Chua, Terence C\|Merrett, Neil D
PMID:	21780108

361.
Journal:	Hum Pathol. 2012 Mar;43(3):413-22.
Title:	Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
Author:	Park, Young Soo\|Hwang, Hee Sang\|Park, Hye Jin\|Ryu, Min-Hee\|Chang, Heung-Moon\|Yook, Jeong Hwan\|Kim, Byung Sik\|Jang, Se Jin\|Kang, Yoon-Koo
PMID:	21855114

362.
Journal:	Cell Biochem Biophys. 2012 Jan;62(1):221-8.
Title:	Intratumoral heterogeneity determines discordant results of diagnostic tests for human epidermal growth factor receptor (HER) 2 in gastric cancer specimens.
Author:	Yang, Jiyuan\|Luo, Hesheng\|Li, Yan\|Li, Junchuan\|Cai, Zhiqiang\|Su, Xiaoyan\|Dai, Danqing\|Du, Wei\|Chen, Tingxuan\|Chen, Ming
PMID:	21927816

363.
Journal:	Ir J Med Sci. 2012 Sep;181(3):451-2.
Title:	Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland.
Author:	Collins, I M\|King, F\|O'Byrne, K
PMID:	22012551

364.
Journal:	Cancer Sci. 2012 Feb;103(2):342-9.
Title:	Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
Author:	Ono, Naomi\|Yamazaki, Toshikazu\|Nakanishi, Yoshito\|Fujii, Toshihiko\|Sakata, Kiyoaki\|Tachibana, Yukako\|Suda, Atsushi\|Hada, Kihito\|Miura, Takaaki\|Sato, Shigeo\|Saitoh, Ryoichi\|Nakano, Kohnosuke\|Tsukuda, Takuo\|Mio, Toshiyuki\|Ishii, Nobuya\|Kondoh, Osamu\|Aoki, Y
PMID:	22050138

365.
Journal:	J Clin Gastroenterol. 2012 Apr;46(4):e31-7.
Title:	HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.
Author:	Liu, Wei\|Zhong, Shan\|Chen, Juan\|Yu, Yinghao
PMID:	22064554

366.
Journal:	J Clin Pathol. 2012 Mar;65(3):237-41.
Title:	HER2 status in unusual histological variants of gastric adenocarcinomas.
Author:	Giuffre, Giuseppe\|Ieni, Antonio\|Barresi, Valeria\|Caruso, Rosario Alberto\|Tuccari, Giovanni
PMID:	22067088

367.
Journal:	Cancer Chemother Pharmacol. 2012 Apr;69(4):949-55.
Title:	Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer.
Author:	Satoh, Taroh\|Omuro, Yasushi\|Sasaki, Yasutsuna\|Hamamoto, Yasuo\|Boku, Narikazu\|Tamura, Takao\|Ohtsu, Atsushi
PMID:	22116464

368.
Journal:	Mol Cancer Ther. 2012 Feb;11(2):439-51.
Title:	Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer.
Author:	Nam, Hyun-Jin\|Ching, Keith A\|Kan, Julie\|Kim, Hwang-Phill\|Han, Sae-Won\|Im, Seock-Ah\|Kim, Tae-You\|Christensen, James G\|Oh, Do-Youn\|Bang, Yung-Jue
PMID:	22135232

369.
Journal:	Gastric Cancer. 2012 Jul;15(3):313-22.
Title:	Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study.
Author:	Sawaki, Akira\|Ohashi, Yasuo\|Omuro, Yasushi\|Satoh, Taroh\|Hamamoto, Yasuo\|Boku, Narikazu\|Miyata, Yoshinori\|Takiuchi, Hiroya\|Yamaguchi, Kensei\|Sasaki, Yasutsuna\|Nishina, Tomohiro\|Satoh, Atsushi\|Baba, Eishi\|Tamura, Takao\|Abe, Takashi\|Hatake, Kiyohiko\|Ohtsu, A
PMID:	22179434

370.
Journal:	Anticancer Res. 2012 Jan;32(1):105-14.
Title:	Trastuzumab has opposing effects on SN-38-induced double-strand breaks and cytotoxicity in HER2-positive gastric cancer cells depending on administration sequence.
Author:	Yamade, Mihoko\|Sugimoto, Mitsushige\|Nishino, Masafumi\|Uotani, Takahiro\|Sahara, Shu\|Iwaizumi, Moriya\|Yamada, Takanori\|Osawa, Satoshi\|Sugimoto, Ken\|Miyajima, Hiroaki\|Furuta, Takahisa
PMID:	22213294

371.
Journal:	Anticancer Res. 2012 Jan;32(1):115-9.
Title:	Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma.
Author:	Romiti, Adriana\|Di Rocco, Roberta\|Milione, Massimo\|Ruco, Luigi\|Ziparo, Vincenzo\|Zullo, Angelo\|Duranti, Enrico\|Sarcina, Ida\|Barucca, Viola\|D'Antonio, Chiara\|Marchetti, Paolo
PMID:	22213295

372.
Journal:	Mod Pathol. 2012 May;25(5):637-50.
Title:	HER2 testing in gastric cancer: a practical approach.
Author:	Ruschoff, Josef\|Hanna, Wedad\|Bilous, Michael\|Hofmann, Manfred\|Osamura, Robert Y\|Penault-Llorca, Frederique\|van de Vijver, Marc\|Viale, Giuseppe
PMID:	22222640

373.
Journal:	Arch Pathol Lab Med. 2012 May;136(5):496-503.
Title:	Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
Author:	McIntire, Maria\|Redston, Mark
PMID:	22229849

374.
Journal:	Mol Cancer Ther. 2012 Mar;11(3):660-9.
Title:	MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.
Author:	Chen, Chin-Tung\|Kim, Hyaehwan\|Liska, David\|Gao, Sizhi\|Christensen, James G\|Weiser, Martin R
PMID:	22238368

375.
Journal:	World J Gastroenterol. 2012 Jan 14;18(2):150-5.
Title:	Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.
Author:	Tsapralis, Dimitrios\|Panayiotides, Ioannis\|Peros, George\|Liakakos, Theodore\|Karamitopoulou, Eva
PMID:	22253521

376.
Journal:	Hepatogastroenterology. 2012 Jan-Feb;59(113):300-3.
Title:	Her-2/neu assessment for gastric carcinoma: validation of scoring system.
Author:	Mrklic, Ivana\|Bendic, Antonia\|Kunac, Nenad\|Bezic, Josko\|Forempoher, Gea\|Durdov, Merica Glavina\|Karaman, Ivana\|Prusac, Ivana Kuzmic\|Pisac, Valdi Pesutic\|Vilovic, Katarina\|Tomic, Snjezana
PMID:	22260838

377.
Journal:	BMC Cancer. 2012 Jan 25;12:37.
Title:	Biomarkers for antitumor activity of bevacizumab in gastric cancer models.
Author:	Yamashita-Kashima, Yoriko\|Fujimoto-Ouchi, Kaori\|Yorozu, Keigo\|Kurasawa, Mitsue\|Yanagisawa, Mieko\|Yasuno, Hideyuki\|Mori, Kazushige
PMID:	22273502

378.
Journal:	Hepatogastroenterology. 2012 Jun;59(116):1290-3.
Title:	HER-2/neu and TOPIIa expression in gastric cancer reflect disease severity.
Author:	Liu, Hong-Qi\|Zhang, Shao-Lan\|Song, Shu
PMID:	22281973

379.
Journal:	Am J Surg Pathol. 2012 Apr;36(4):577-82.
Title:	Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.
Author:	Fox, Stephen B\|Kumarasinghe, Marian Priyanthi\|Armes, Jane E\|Bilous, Michael\|Cummings, Margaret C\|Farshid, Gelareh\|Fitzpatrick, Nicole\|Francis, Glenn D\|McCloud, Philip I\|Raymond, Wendy\|Morey, Adrienne
PMID:	22314190

380.
Journal:	Gut. 2012 May;61(5):673-84.
Title:	A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.
Author:	Deng, Niantao\|Goh, Liang Kee\|Wang, Hannah\|Das, Kakoli\|Tao, Jiong\|Tan, Iain Beehuat\|Zhang, Shenli\|Lee, Minghui\|Wu, Jeanie\|Lim, Kiat Hon\|Lei, Zhengdeng\|Goh, Glenn\|Lim, Qing-Yan\|Tan, Angie Lay-Keng\|Sin Poh, Dianne Yu\|Riahi, Sudep\|Bell, Sandra\|Shi, Michael M\|
PMID:	22315472

381.
Journal:	Clin Ther. 2012 Feb;34(2):468-79.
Title:	Costs of trastuzumab in combination with chemotherapy for HER2-positive advanced gastric or gastroesophageal junction cancer: an economic evaluation in the Chinese context.
Author:	Wu, Bin\|Ye, Ming\|Chen, Huafeng\|Shen, Jinfang F
PMID:	22325735

382.
Journal:	Gan To Kagaku Ryoho. 2012 Feb;39(2):285-7.
Title:	[A case of hepatoid adenocarcinoma of the stomach].
Author:	Takahashi, Makoto\|Shida, Takashi\|Otsuka, Yasuhiro\|Ogasawara, Takeshi\|Nakano, Shigeharu\|Nomura, Satoru\|Takahashi, Makoto\|Kondo, Fukuo\|Miyazaki, Masaru
PMID:	22333645

383.
Journal:	Jpn J Clin Oncol. 2012 Apr;42(4):278-86.
Title:	Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation study.
Author:	Ito, Yoshinori\|Suenaga, Mitsukuni\|Hatake, Kiyohiko\|Takahashi, Shunji\|Yokoyama, Masahiro\|Onozawa, Yusuke\|Yamazaki, Kentaro\|Hironaka, Shuichi\|Hashigami, Kiyoshi\|Hasegawa, Hirotaka\|Takenaka, Nobuko\|Boku, Narikazu
PMID:	22371427

384.
Journal:	Br J Cancer. 2012 Mar 13;106(6):1033-8.
Title:	Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer.
Author:	Harder, J\|Ihorst, G\|Heinemann, V\|Hofheinz, R\|Moehler, M\|Buechler, P\|Kloeppel, G\|Rocken, C\|Bitzer, M\|Boeck, S\|Endlicher, E\|Reinacher-Schick, A\|Schmoor, C\|Geissler, M
PMID:	22374460

385.
Journal:	Expert Rev Gastroenterol Hepatol. 2012 Apr;6(2):199-208; quiz 209.
Title:	Management of advanced gastric cancer.
Author:	Price, Timothy J\|Shapiro, Jeremy D\|Segelov, Eva\|Karapetis, Christos S\|Pavlakis, Nick\|Van Cutsem, Eric\|Shah, Manish A\|Kang, Yoon-Koo\|Tebbutt, Niall C
PMID:	22375525

386.
Journal:	J Med Assoc Thai. 2012 Jan;95(1):88-95.
Title:	Human epidermal growth-factor receptor 2 overexpression in gastric carcinoma in Thai patients.
Author:	Sornmayura, Pattana\|Rerkamnuaychoke, Budsaba\|Jinawath, Artit\|Euanorasetr, Chakrapan
PMID:	22379747

387.
Journal:	Am J Clin Pathol. 2012 Apr;137(4):583-94.
Title:	HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization.
Author:	Radu, Oana M\|Foxwell, Tyler\|Cieply, Kathleen\|Navina, Sarah\|Dacic, Sanja\|Nason, Katie S\|Davison, Jon M
PMID:	22431535

388.
Journal:	Pathology. 2012 Apr;44(3):216-20.
Title:	Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas.
Author:	Cho, Eun Yoon\|Srivastava, Amitabh\|Park, Kyeongmee\|Kim, Jiyun\|Lee, Min Hyeong\|Do, Ingu\|Lee, Jeeyun\|Kim, Kyoung-Mee\|Sohn, Tae Sung\|Kang, Won Ki\|Kim, Sung
PMID:	22437741

389.
Journal:	Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S29-34.
Title:	Current status of targeted therapies in advanced gastric cancer.
Author:	De Vita, Ferdinando\|Giuliani, Francesco\|Silvestris, Nicola\|Rossetti, Sabrina\|Pizzolorusso, Antonio\|Santabarbara, Giuseppe\|Galizia, Gennaro\|Colucci, Giuseppe\|Ciardiello, Fortunato\|Orditura, Michele
PMID:	22443228

390.
Journal:	Sci Transl Med. 2012 Mar 28;4(127):127rv2.
Title:	Improving treatment of HER2-positive cancers: opportunities and challenges.
Author:	Stern, Howard M
PMID:	22461643

391.
Journal:	Cancer Immunol Immunother. 2012 Nov;61(11):1905-16.
Title:	Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells.
Author:	Yoshida, Ryosuke\|Tazawa, Hiroshi\|Hashimoto, Yuuri\|Yano, Shuya\|Onishi, Teppei\|Sasaki, Tsuyoshi\|Shirakawa, Yasuhiro\|Kishimoto, Hiroyuki\|Uno, Futoshi\|Nishizaki, Masahiko\|Kagawa, Shunsuke\|Fujiwara, Toshiyoshi
PMID:	22465967

392.
Journal:	J Cancer. 2012;3:137-44.
Title:	HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature.
Author:	Jorgensen, Jan Trost\|Hersom, Maria
PMID:	22481979

393.
Journal:	Anticancer Res. 2012 Apr;32(4):1547-53.
Title:	The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen.
Author:	Kim, Jin Won\|Im, Seock-Ah\|Kim, Miso\|Cha, Yongjun\|Lee, Kyung-Hun\|Keam, Bhumsuk\|Kim, Min A\|Han, Sae-Won\|Oh, Do-Youn\|Kim, Tae-You\|Kim, Woo Ho\|Bang, Yung-Jue
PMID:	22493400

394.
Journal:	Surg Oncol. 2012 Sep;21(3):164-71.
Title:	Dendritic cell therapy in advanced gastric cancer: a promising new hope?
Author:	Tewari, Mallika\|Sahai, Shipra\|Mishra, Raghvendra R\|Shukla, Sunit K\|Shukla, Hari S
PMID:	22521560

395.
Journal:	Hepatogastroenterology. 2012 Nov-Dec;59(120):2439-44.
Title:	Trastuzumab combined with docetaxel-based regimens in previously treated metastatic gastric cancer patients with HER2 over-expression.
Author:	Dai, Guang-Hai\|Shi, Yan\|Chen, Li\|Lv, Ya-Li\|Zhong, Mei
PMID:	22534547

396.
Journal:	J Surg Oncol. 2012 Nov;106(6):757-64.
Title:	Tumor size predicts survival in mucinous gastric carcinoma.
Author:	Sung, Chang Ohk\|Lee, Sun Mi\|Choi, Jong Sun\|Kim, Kyoung-Mee\|Choi, Min-Gew\|Noh, Jae Hyung\|Sohn, Tae Sung\|Bae, Jae Moon\|Kim, Woo Ho\|Park, Cheol-Keun\|Kim, Sung
PMID:	22535583

397.
Journal:	Biomaterials. 2012 Jul;33(21):5349-62.
Title:	Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles.
Author:	Li, Wei\|Zhao, He\|Qian, Weizhu\|Li, Huafei\|Zhang, Li\|Ye, Zengwei\|Zhang, Ge\|Xia, Mao\|Li, Jinfeng\|Gao, Jie\|Li, Bohua\|Kou, Geng\|Dai, Jianxin\|Wang, Hao\|Guo, Yajun
PMID:	22542611

398.
Journal:	Curr Treat Options Oncol. 2012 Sep;13(3):377-89.
Title:	Targeted therapy for gastric cancer.
Author:	Smyth, Elizabeth C\|Cunningham, David
PMID:	22552927

399.
Journal:	J Clin Pathol. 2012 Aug;65(8):751-7.
Title:	HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer.
Author:	Gomez-Martin, Carlos\|Garralda, Elena\|Echarri, M Jose\|Ballesteros, Anabel\|Arcediano, Alberto\|Rodriguez-Peralto, Jose Luis\|Hidalgo, Manuel\|Lopez-Rios, Fernando
PMID:	22569536

400.
Journal:	J Surg Oncol. 2012 Dec;106(7):872-9.
Title:	The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients.
Author:	Ye, Yan-Wei\|Zhang, Xiefu\|Zhou, Ye\|Wu, Jianghong\|Zhao, Chunlin\|Yuan, Lin\|Wang, Guojun\|Du, Chunyan\|Wang, Chunmeng\|Shi, Yingqiang
PMID:	22585711

401.
Journal:	J Transl Med. 2012 Jul 3;10:97.
Title:	The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer.
Author:	Natsume, Hiroko\|Shinmura, Kazuya\|Tao, Hong\|Igarashi, Hisaki\|Suzuki, Masaya\|Nagura, Kiyoko\|Goto, Masanori\|Yamada, Hidetaka\|Maeda, Matsuyoshi\|Konno, Hiroyuki\|Nakamura, Satoki\|Sugimura, Haruhiko
PMID:	22591714

402.
Journal:	Int J Oncol. 2012 Aug;41(2):551-8.
Title:	Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification.
Author:	Tomioka, Hideo\|Mukohara, Toru\|Kataoka, Yu\|Ekyalongo, Roudy Chiminch\|Funakoshi, Yohei\|Imai, Yasuo\|Kiyota, Naomi\|Fujiwara, Yutaka\|Minami, Hironobu
PMID:	22614071

403.
Journal:	J Clin Pathol. 2012 Aug;65(8):693-8.
Title:	PTEN deletion is rare but often homogeneous in gastric cancer.
Author:	Mina, Sormeh\|Bohn, Benjamin A\|Simon, Ronald\|Krohn, Antje\|Reeh, Matthias\|Arnold, Dirk\|Bokemeyer, Carsten\|Sauter, Guido\|Izbicki, Jakob R\|Marx, Andreas\|Stahl, Phillip R
PMID:	22639407

404.
Journal:	Arch Pathol Lab Med. 2012 Jun;136(6):610-7.
Title:	Quantitation of HER2/neu expression in primary gastroesophageal adenocarcinomas using conventional light microscopy and quantitative image analysis.
Author:	Jeung, Jennifer\|Patel, Roshan\|Vila, Lizette\|Wakefield, Dara\|Liu, Chen
PMID:	22646266

405.
Journal:	World J Gastroenterol. 2012 May 21;18(19):2402-7.
Title:	Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.
Author:	Dang, Hai-Zhen\|Yu, Yang\|Jiao, Shun-Chang
PMID:	22654433

406.
Journal:	Ann Oncol. 2012 Oct;23(10):2656-62.
Title:	Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.
Author:	Janjigian, Y Y\|Werner, D\|Pauligk, C\|Steinmetz, K\|Kelsen, D P\|Jager, E\|Altmannsberger, H-M\|Robinson, E\|Tafe, L J\|Tang, L H\|Shah, M A\|Al-Batran, S-E
PMID:	22689179

407.
Journal:	Pathol Int. 2012 Jul;62(7):477-84.
Title:	Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization.
Author:	Kiyose, Shin-ichiro\|Nagura, Kiyoko\|Tao, Hong\|Igarashi, Hisaki\|Yamada, Hidetaka\|Goto, Masanori\|Maeda, Matsuyoshi\|Kurabe, Nobuya\|Suzuki, Masaya\|Tsuboi, Masaru\|Kahyo, Tomoaki\|Shinmura, Kazuya\|Hattori, Naohiko\|Sugimura, Haruhiko
PMID:	22691185

408.
Journal:	J Hematol Oncol. 2012 Jun 18;5:31.
Title:	Novel targeted agents for gastric cancer.
Author:	Liu, Lian\|Wu, Ning\|Li, Jin
PMID:	22709792

409.
Journal:	Cancer Lett. 2012 Dec 1;325(1):72-9.
Title:	A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2.
Author:	Kim, Hye-Lin\|Jeon, Kyung-Hwa\|Jun, Kyu-Yeon\|Choi, Yongmun\|Kim, Dae-Kee\|Na, Younghwa\|Kwon, Youngjoo
PMID:	22732416

410.
Journal:	J Clin Gastroenterol. 2012 Sep;46(8):637-48.
Title:	Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer.
Author:	Bang, Yung-Jue
PMID:	22751336

411.
Journal:	Cancer Res. 2012 Sep 1;72(17):4383-93.
Title:	Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.
Author:	Dulak, Austin M\|Schumacher, Steven E\|van Lieshout, Jasper\|Imamura, Yu\|Fox, Cameron\|Shim, Byoungyong\|Ramos, Alex H\|Saksena, Gordon\|Baca, Sylvan C\|Baselga, Jose\|Tabernero, Josep\|Barretina, Jordi\|Enzinger, Peter C\|Corso, Giovanni\|Roviello, Franco\|Lin, Lin\|Ba
PMID:	22751462

412.
Journal:	Target Oncol. 2012 Dec;7(4):213-6.
Title:	Peritoneal metastatic lesions of gastric cancer exhibit low expression of human epidermal growth factor receptor 2.
Author:	Imano, Motohiro\|Satou, Takao\|Itoh, Tatsuki\|Yasuda, Atsushi\|Kato, Hiroaki\|Shinkai, Masayuki\|Peng, Ying-Feng\|Tsubaki, Masahiro\|Yasuda, Takushi\|Imamoto, Haruhiko\|Nishida, Shozo\|Takeyama, Yoshifumi\|Okuno, Kiyokata\|Shiozaki, Hitoshi
PMID:	22752927

413.
Journal:	Indian J Gastroenterol. 2012 Jun;31(3):106-10.
Title:	HER2 expression in gastric cancer in Indian population--an immunohistochemistry and fluorescence in situ hybridization study.
Author:	Sekaran, Anuradha\|Kandagaddala, Raja Sekhar\|Darisetty, Santosh\|Lakhtakia, Sandeep\|Ayyagari, Santa\|Rao, Guduru Venkat\|Rebala, Pradeep\|Reddy, Duvvuru Bhaskara\|Reddy, Duvvuru Nageshwar
PMID:	22760626

414.
Journal:	Indian J Gastroenterol. 2012 Jun;31(3):103-5.
Title:	HER2 as a therapeutic target in the gastric cancer: is it sufficient?
Author:	Chaturvedi, Rupesh\|Singh, Amar B
PMID:	22763895

415.
Journal:	Int J Surg Oncol. 2012;2012:868645.
Title:	Immunohistochemical biomarkers in gastric cancer research and management.
Author:	Lastraioli, Elena\|Romoli, Maria Raffaella\|Arcangeli, Annarosa
PMID:	22778942

416.
Journal:	Biomaterials. 2012 Oct;33(29):7093-102.
Title:	HER2 monoclonal antibody conjugated RNase-A-associated CdTe quantum dots for targeted imaging and therapy of gastric cancer.
Author:	Ruan, Jing\|Song, Hua\|Qian, Qirong\|Li, Chao\|Wang, Kan\|Bao, Chenchen\|Cui, Daxiang
PMID:	22796163

417.
Journal:	BMC Cancer. 2012 Jul 23;12:307.
Title:	A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II).
Author:	Tsuburaya, Akira\|Morita, Satoshi\|Kodera, Yasuhiro\|Kobayashi, Michiya\|Shitara, Kohei\|Yamaguchi, Kensei\|Yoshikawa, Takaki\|Yoshida, Kazuhiro\|Yoshino, Shigefumi\|Sakamoto, Jun-ichi
PMID:	22824079

418.
Journal:	Pathol Int. 2012 Aug;62(8):513-7.
Title:	Comparison of HER2 immunohistochemical results using a monoclonal antibody (SV2-61gamma) and a polyclonal antibody (for Dako HercepTest) in advanced gastric cancer.
Author:	Tamura, Gen\|Osakabe, Mitsumasa\|Yanagawa, Naoki\|Ogata, Shin-ya\|Nomura, Takashi\|Fukushima, Norimasa\|Ito, Yoshimasa\|Tabuchi, Minori
PMID:	22827758

419.
Journal:	Cytopathology. 2012 Oct;23(5):286-94.
Title:	Molecular diagnosis on tissues and cells: how it affects training and will affect practice in the future.
Author:	Boyd, C\|Boyle, D P
PMID:	22846108

420.
Journal:	Histopathology. 2012 Nov;61(5):769-76.
Title:	Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
Author:	Fassan, Matteo\|Mastracci, Luca\|Grillo, Federica\|Zagonel, Vittorina\|Bruno, Sara\|Battaglia, Giorgio\|Pitto, Francesca\|Nitti, Donato\|Celiento, Tiziana\|Zaninotto, Giovanni\|Fiocca, Roberto\|Rugge, Massimo
PMID:	22882541

421.
Journal:	Mod Pathol. 2012 Dec;25(12):1566-73.
Title:	Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung.
Author:	Grob, Tobias J\|Kannengiesser, Ivonne\|Tsourlakis, Maria C\|Atanackovic, Djordje\|Koenig, Alexandra M\|Vashist, Yogesh K\|Klose, Hans\|Marx, Andreas H\|Koops, Susan\|Simon, Ronald\|Izbicki, Jakob R\|Bokemeyer, Carsten\|Sauter, Guido\|Wilczak, Waldemar
PMID:	22899293

422.
Journal:	Infect Agent Cancer. 2012 Aug 28;7(1):21.
Title:	Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile.
Author:	Tang, Weihua\|Morgan, Douglas R\|Meyers, Michael O\|Dominguez, Ricardo L\|Martinez, Enrique\|Kakudo, Kennichi\|Kuan, Pei Fen\|Banet, Natalie\|Muallem, Hind\|Woodward, Kimberly\|Speck, Olga\|Gulley, Margaret L
PMID:	22929309

423.
Journal:	J Gastrointest Oncol. 2012 Sep;3(3):243-51.
Title:	Genetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine.
Author:	Van Ness, Michael\|Gregg, Jeffrey\|Wang, Jun\|Chen, Mingyi
PMID:	22943015

424.
Journal:	Clin Cancer Res. 2012 Nov 1;18(21):5992-6000.
Title:	Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
Author:	Terashima, Masanori\|Kitada, Koji\|Ochiai, Atsushi\|Ichikawa, Wataru\|Kurahashi, Issei\|Sakuramoto, Shinichi\|Katai, Hitoshi\|Sano, Takeshi\|Imamura, Hiroshi\|Sasako, Mitsuru
PMID:	22977193

425.
Journal:	Curr Top Med Chem. 2012;12(15):1678-82.
Title:	Targetting esophageal and gastric cancers with monoclonal antibodies.
Author:	Norguet, Emmanuelle\|Dahan, Laetitia\|Seitz, Jean-Francois
PMID:	22978338

426.
Journal:	Bioorg Med Chem. 2012 Oct 15;20(20):6171-80.
Title:	Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy.
Author:	Kawakita, Youichi\|Miwa, Kazuhiro\|Seto, Masaki\|Banno, Hiroshi\|Ohta, Yoshikazu\|Tamura, Toshiya\|Yusa, Tadashi\|Miki, Hiroshi\|Kamiguchi, Hidenori\|Ikeda, Yukihiro\|Tanaka, Toshimasa\|Kamiyama, Keiji\|Ishikawa, Tomoyasu
PMID:	22980219

427.
Journal:	Arkh Patol. 2012 Jul-Aug;74(4):21-6.
Title:	[Determination of the possibilities of targeted therapy for gastric cancer].
Author:	Zavalishina, L E\|Andreeva, Iu Iu\|Frank, G A
PMID:	22997951

428.
Journal:	Onkologie. 2012;35(9):505-8.
Title:	Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 cases.
Author:	Al-Batran, Salah-Eddin\|Hozaeel, Wael\|Jager, Elke
PMID:	23007148

429.
Journal:	Cancer Sci. 2012 Dec;103(12):2181-5.
Title:	Apoptosis signal-regulating kinase-1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer.
Author:	Hayakawa, Yoku\|Hirata, Yoshihiro\|Sakitani, Kosuke\|Nakagawa, Hayato\|Nakata, Wachiko\|Kinoshita, Hiroto\|Takahashi, Ryota\|Takeda, Kohsuke\|Ichijo, Hidenori\|Maeda, Shin\|Koike, Kazuhiko
PMID:	23110662

430.
Journal:	Pathol Int. 2012 Nov;62(11):728-34.
Title:	Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).
Author:	Kiyose, Shinichiro\|Igarashi, Hisaki\|Nagura, Kiyoko\|Kamo, Takaharu\|Kawane, Kazunori\|Mori, Hiroki\|Ozawa, Takachika\|Maeda, Matsuyoshi\|Konno, Keisuke\|Hoshino, Hideaki\|Konno, Hiroyuki\|Ogura, Hiroyuki\|Shinmura, Kazuya\|Hattori, Naohiko\|Sugimura, Haruhiko
PMID:	23121603

431.
Journal:	World J Gastroenterol. 2012 Nov 21;18(43):6263-8.
Title:	Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.
Author:	Tanaka, Takehiro\|Fujimura, Atsushi\|Ichimura, Koichi\|Yanai, Hiroyuki\|Sato, Yasuharu\|Takata, Katsuyohi\|Okada, Hiroyuki\|Kawano, Seiji\|Tanabe, Shunsuke\|Yoshino, Tadashi
PMID:	23180947

432.
Journal:	Nihon Rinsho. 2012 Oct;70(10):1705-14.
Title:	[Genetic and epigenetic alterations in gastric carcinogenesis].
Author:	Ushijima, Toshikazu\|Yoshida, Satoshi
PMID:	23198549

433.
Journal:	Nihon Rinsho. 2012 Oct;70(10):1783-9.
Title:	[Recent advance of chemotherapy in gastric cancer].
Author:	Terazawa, Tetsuji\|Shimada, Yasuhiro
PMID:	23198562

434.
Journal:	Nihon Rinsho. 2012 Oct;70(10):1819-26.
Title:	[Molecular targeting agents for advanced or recurrent gastric cancer patients].
Author:	Fuse, Nozomu
PMID:	23198568

435.
Journal:	Nihon Shokakibyo Gakkai Zasshi. 2012 Dec;109(12):2014-20.
Title:	[Molecular target for Her2 positive gastric cancer].
Author:	Boku, Narikazu
PMID:	23221049

436.
Journal:	Gan To Kagaku Ryoho. 2012 Dec;39(13):2541-4.
Title:	[A case of HER2-positive and AFP-producing gastric cancer successfully treated by trastuzumab/docetaxel/S-1 combination therapy].
Author:	Amano, Ichiro\|Sawai, Naoki\|Mizuno, Chiemi\|Shaura, Yukie\|Nishiwaki, Masatake\|Horimoto, Ryuji\|Oya, Hirohisa\|Kato, Ryusuke\|Seki, Kojiro\|Hashimoto, Hiroaki\|Amakata, Yoshiro\|Matsumoto, Junko\|Tanaka, Izumi\|Mizuno, Masayuki\|Shima, Toshihide\|Okanoue, Takeshi
PMID:	23235175

437.
Journal:	Gan To Kagaku Ryoho. 2012 Dec;39(13):2553-5.
Title:	[A complete response of scirrhous gastric carcinoma treated with trastuzumab combination therapy].
Author:	Nishi, Tomohiro\|Hamamoto, Yasuo\|Uemoto, Junko\|Onodera, Kei\|Warita, Etsuko\|Yamanaka, Yasuhiro
PMID:	23235178

438.
Journal:	World J Gastroenterol. 2012 Dec 7;18(45):6577-86.
Title:	Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
Author:	Sukawa, Yasutaka\|Yamamoto, Hiroyuki\|Nosho, Katsuhiko\|Kunimoto, Hiroaki\|Suzuki, Hiromu\|Adachi, Yasushi\|Nakazawa, Mayumi\|Nobuoka, Takayuki\|Kawayama, Mariko\|Mikami, Masashi\|Matsuno, Takashi\|Hasegawa, Tadashi\|Hirata, Koichi\|Imai, Kohzoh\|Shinomura, Yasuhisa
PMID:	23236232

439.
Journal:	World J Surg Oncol. 2012 Dec 18;10:274.
Title:	Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial.
Author:	Zhou, Fei\|Li, Ning\|Jiang, Weihua\|Hua, Zhaolai\|Xia, Lin\|Wei, Qingyi\|Wang, Liwei
PMID:	23249720

440.
Journal:	Gan To Kagaku Ryoho. 2012 Nov;39(12):2339-41.
Title:	[A case of unresectable HER2-positive advanced gastric cancer successfully treated by combination therapy with trastuzumab and paclitaxel].
Author:	Ojima, Eisuke\|Nishimura, Genichi\|Nishijima, Koji\|Futagami, Fumio\|Nakamura, Takashi\|Hosokawa, Ayumu
PMID:	23268070

441.
Journal:	Yao Xue Xue Bao. 2012 Oct;47(10):1297-305.
Title:	[Development of antibody drugs targeting against HER2 for cancer therapy].
Author:	Tang, Qin\|Ding, Qian\|Lin, Li\|Zhang, Zhen-zhen\|Dai, Zheng\|Zhan, Jin-biao
PMID:	23289141

442.
Journal:	Rom J Morphol Embryol. 2012;53(4):997-1005.
Title:	Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
Author:	Badescu, Alina\|Georgescu, Claudia Valentina\|Vere, C C\|Craitoiu, Stefania\|Grigore, Diana
PMID:	23303024

443.
Journal:	Pan Afr Med J. 2012;13:79. Epub 2012 Dec 17.
Title:	[The search for protein overexpression and HER2 gene amplification in gastric cancer by immunohistochemistry and in situ hybridization: experience of the CHU Hassan II of Fez].
Author:	El Fatemi, Hinde\|Hammas, Nawal\|Idrissi, Karima\|Mellas, Nawfel\|Bennani, Amal\|Amarti, Afaf\|Cayre, Anne\|Penault-llorca, Frederique\|Mesbahi, Omar
PMID:	23397021

444.
Journal:
Title:	Trastuzumab (Herceptin) Therapy and ERBB2 (HER2) Genotype
Author:	Dean, Laura
PMID:	28520362

445.
Journal:	Gastric Cancer. 2013 Jan;16(1):84-93.
Title:	HER2 expression and its clinicopathological features in resectable gastric cancer.
Author:	Kataoka, Yoshiki\|Okabe, Hiroshi\|Yoshizawa, Akihiko\|Minamiguchi, Sachiko\|Yoshimura, Kenichi\|Haga, Hironori\|Sakai, Yoshiharu
PMID:	22410801

446.
Journal:	Dis Esophagus. 2013 Apr;26(3):299-304.
Title:	Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Author:	Phillips, B E\|Tubbs, R R\|Rice, T W\|Rybicki, L A\|Plesec, T\|Rodriguez, C P\|Videtic, G M\|Saxton, J P\|Ives, D I\|Adelstein, D J
PMID:	22676551

447.
Journal:	J Oncol Pharm Pract. 2013 Mar;19(1):75-81.
Title:	Targeted therapy for gastric cancer--current status.
Author:	Kulig, Jan\|Kolodziejczyk, Piotr\|Kulig, Piotr\|Legutko, Janusz
PMID:	22711713

448.
Journal:	Gastric Cancer. 2013 Apr;16(2):261-7.
Title:	Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment.
Author:	Shitara, Kohei\|Yatabe, Yasushi\|Matsuo, Keitaro\|Sugano, Masato\|Kondo, Chihiro\|Takahari, Daisuke\|Ura, Takashi\|Tajika, Masahiro\|Ito, Seiji\|Muro, Kei
PMID:	22797858

449.
Journal:	Appl Immunohistochem Mol Morphol. 2013 Jan;21(1):21-30.
Title:	Tissue pattern recognition error rates and tumor heterogeneity in gastric cancer.
Author:	Potts, Steven J\|Huff, Sarah E\|Lange, Holger\|Zakharov, Vladislav\|Eberhard, David A\|Krueger, Joseph S\|Hicks, David G\|Young, George David\|Johnson, Trevor\|Whitney-Miller, Christa L
PMID:	22820657

450.
Journal:	Pathol Oncol Res. 2013 Jan;19(1):103-9.
Title:	HER2 status of gastric carcinoma and corresponding lymph node metastasis.
Author:	Pagni, Fabio\|Zannella, Stefano\|Ronchi, Susanna\|Garanzini, Cristina\|Leone, Biagio Eugenio
PMID:	22907801

451.
Journal:	Dig Dis Sci. 2013 Feb;58(2):397-404.
Title:	Are biopsy specimens predictive of HER2 status in gastric cancer patients?
Author:	Pirrelli, M\|Caruso, M L\|Di Maggio, M\|Armentano, R\|Valentini, A M
PMID:	22918687

452.
Journal:	Curr Pharm Des. 2013;19(5):958-64.
Title:	Irinotecan resistance is accompanied by upregulation of EGFR and Src signaling in human cancer models.
Author:	Petitprez, Amelie\|Larsen, Annette K
PMID:	22973964

453.
Journal:	Crit Rev Oncol Hematol. 2013 Mar;85(3):350-62.
Title:	Advanced HER2-positive gastric cancer: current and future targeted therapies.
Author:	Pazo Cid, Roberto A\|Anton, Antonio
PMID:	23021388

454.
Journal:	Hum Pathol. 2013 Apr;44(4):487-94.
Title:	In situ analysis of HER2 mRNA in gastric carcinoma: comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry.
Author:	Kim, Min A\|Jung, Jung Eun\|Lee, Hee Eun\|Yang, Han-Kwang\|Kim, Woo Ho
PMID:	23084583

455.
Journal:	Cancer Treat Rev. 2013 Feb;39(1):60-7.
Title:	Current questions for the treatment of advanced gastric cancer.
Author:	Cervantes, A\|Roda, D\|Tarazona, N\|Rosello, S\|Perez-Fidalgo, J A
PMID:	23102520

456.
Journal:	Indian J Gastroenterol. 2013 Sep;32(5):350.
Title:	Over-expression of HER2 in Indian patients with gastric cancer.
Author:	Patil, Prachi S\|Mehta, Shaesta A\|Mohandas, K M
PMID:	23111642

457.
Journal:	Ann Oncol. 2013 Mar;24(3):693-701.
Title:	A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status.
Author:	Bria, E\|De Manzoni, G\|Beghelli, S\|Tomezzoli, A\|Barbi, S\|Di Gregorio, C\|Scardoni, M\|Amato, E\|Frizziero, M\|Sperduti, I\|Corbo, V\|Brunelli, M\|Bersani, S\|Tortora, G\|Scarpa, A
PMID:	23131390

458.
Journal:	Ann Oncol. 2013 Mar;24(3):725-33.
Title:	Her2/neu testing in gastric cancer: evaluating the risk of sampling errors.
Author:	Warneke, V S\|Behrens, H-M\|Boger, C\|Becker, T\|Lordick, F\|Ebert, M P A\|Rocken, C
PMID:	23139264

459.
Journal:	Mol Cancer Ther. 2013 Jan;12(1):16-26.
Title:	Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.
Author:	Nam, Hyun-Jin\|Im, Seock-Ah\|Oh, Do-Youn\|Elvin, Paul\|Kim, Hwang-Phill\|Yoon, Young-Kwang\|Min, Ahrum\|Song, Sang-Hyun\|Han, Sae-Won\|Kim, Tae-You\|Bang, Yung-Jue
PMID:	23144237

460.
Journal:	Eur J Cancer. 2013 Apr;49(6):1448-57.
Title:	Clinical significance of intratumoral HER2 heterogeneity in gastric cancer.
Author:	Lee, Hee Eun\|Park, Kyoung Un\|Yoo, Seol Bong\|Nam, Soo Kyung\|Park, Do Joong\|Kim, Hyung-Ho\|Lee, Hye Seung
PMID:	23146959

461.
Journal:	Gastric Cancer. 2013 Oct;16(4):571-80.
Title:	Lapatinib acts on gastric cancer through both antiproliferative function and augmentation of trastuzumab-mediated antibody-dependent cellular cytotoxicity.
Author:	Shiraishi, Kensuke\|Mimura, Kousaku\|Izawa, Shinichiro\|Inoue, Ayako\|Shiba, Shugo\|Maruyama, Takanori\|Watanabe, Mitsuaki\|Kawaguchi, Yoshihiko\|Inoue, Masayuki\|Fujii, Hideki\|Kono, Koji
PMID:	23187882

462.
Journal:	Cancer Lett. 2013 Mar 1;330(1):33-40.
Title:	Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers.
Author:	Kim, Jeong Goo\|Takeshima, Hideyuki\|Niwa, Tohru\|Rehnberg, Emil\|Shigematsu, Yasuyuki\|Yoda, Yukie\|Yamashita, Satoshi\|Kushima, Ryoji\|Maekita, Takao\|Ichinose, Masao\|Katai, Hitoshi\|Park, Won Sang\|Hong, Young Seon\|Park, Cho Hyun\|Ushijima, Toshikazu
PMID:	23196062

463.
Journal:	Appl Immunohistochem Mol Morphol. 2013 Oct;21(5):414-9.
Title:	Image cytometric HER2 in gastric carcinoma: is a new algorithm needed?
Author:	Ormenisan, Claudia\|Wang, Jason\|Lawson, Diane\|Cohen, Cynthia
PMID:	23197004

464.
Journal:	J Natl Cancer Inst. 2013 Feb 20;105(4):266-73.
Title:	HER3 overexpression and survival in solid tumors: a meta-analysis.
Author:	Ocana, Alberto\|Vera-Badillo, Francisco\|Seruga, Bostjan\|Templeton, Arnoud\|Pandiella, Atanasio\|Amir, Eitan
PMID:	23221996

465.
Journal:	Ann Oncol. 2013 May;24(5):1253-61.
Title:	Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial.
Author:	Okines, A F C\|Thompson, L C\|Cunningham, D\|Wotherspoon, A\|Reis-Filho, J S\|Langley, R E\|Waddell, T S\|Noor, D\|Eltahir, Z\|Wong, R\|Stenning, S
PMID:	23233651

466.
Journal:	Mod Pathol. 2013 May;26(5):677-84.
Title:	Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas.
Author:	Cho, Eun Yoon\|Park, Kyeongmee\|Do, Ingu\|Cho, Junhun\|Kim, Jiyun\|Lee, Jeeyun\|Kim, Seonwoo\|Kim, Kyoung-Mee\|Sohn, Tae Sung\|Kang, Won Ki\|Kim, Sung
PMID:	23238628

467.
Journal:	Ann Surg Oncol. 2013 Dec;20 Suppl 3:S477-84.
Title:	A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.
Author:	Cho, Junhun\|Jeong, Jiyun\|Sung, Jiyoun\|Sung, Chang Ohk\|Kim, Kyoung-Mee\|Park, Cheol Keun\|Choi, Min Gew\|Sohn, Tae Sung\|Bae, Jae Moon\|Kim, Sung
PMID:	23274580

468.
Journal:	Adv Exp Med Biol. 2013;779:55-65.
Title:	Impact of genetic targets on cancer therapy in esophagogastric cancer.
Author:	Jiang, Yixing
PMID:	23288635

469.
Journal:	Biotech Histochem. 2013 May;88(3-4):121-31.
Title:	The evolving role of HER2 evaluation for diagnosis and clinical decision making for breast and gastric adenocarcinoma.
Author:	Hicks, D G\|Whitney-Miller, C L
PMID:	23293935

470.
Journal:	Gan To Kagaku Ryoho. 2013 Jan;40(1):61-5.
Title:	[HER2 testing for advanced recurrent gastric cancer in a general hospital].
Author:	Kimura, Yutaka\|Taniguchi, Hirokazu\|Fujita, Shoichiro\|Kim, Chiwan\|Danno, Katsuki\|Kanoh, Toshiyuki\|Yoshida, Tetsuya\|Ohnishi, Tadashi\|Tono, Takeshi\|Kojima, Keiko\|Monden, Takushi\|Imaoka, Shingi
PMID:	23306919

471.
Journal:	Hepatogastroenterology. 2013 Jul-Aug;60(125):1083-8.
Title:	Status of tissue expression and serum levels of HER2 in gastric cancer patients in Japan.
Author:	Narita, Toru\|Seshimo, Akiyoshi\|Suzuki, Mamoru\|Murata, Jun\|Kameoka, Shingo
PMID:	23321006

472.
Journal:	Br J Surg. 2013 Apr;100(5):668-73.
Title:	Suitability of endoscopic submucosal dissection for treatment of submucosal gastric cancers.
Author:	Lee, I S\|Yook, J H\|Park, Y S\|Kim, K C\|Oh, S T\|Kim, B S
PMID:	23334982

473.
Journal:	Mod Pathol. 2013 Jun;26(6):816-24.
Title:	HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.
Author:	Fusco, Nicola\|Rocco, Elena Guerini\|Del Conte, Claudia\|Pellegrini, Caterina\|Bulfamante, Gaetano\|Di Nuovo, Franca\|Romagnoli, Solange\|Bosari, Silvano
PMID:	23348899

474.
Journal:	Pharmacoeconomics. 2013 Mar;31(3):185-94.
Title:	Trastuzumab for the treatment of HER2-positive metastatic gastric cancer : a NICE single technology appraisal.
Author:	Spackman, Eldon\|Rice, Stephen\|Norman, Gill\|Suh, Dong-Churl\|Eastwood, Alison\|Palmer, Stephen
PMID:	23371465

475.
Journal:	PLoS One. 2013;8(1):e54644.
Title:	A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.
Author:	Lee, Jeeyun\|Kim, Sung\|Kim, Phillip\|Liu, Xinjun\|Lee, Tani\|Kim, Kyoung-Mee\|Do, In-Gu\|Park, Joon Oh\|Park, Se Hoon\|Jang, Jiryeon\|Hoe, Nicholas\|Harvie, Gulia\|Kuller, Anne\|Jain, Anjali\|Meyer, Gary\|Leesman, Glen\|Park, Young Suk\|Choi, Min Gew\|Sohn, Tae Sung\|Bae,
PMID:	23372746

476.
Journal:	Mol Cancer Ther. 2013 Apr;12(4):509-19.
Title:	Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancer.
Author:	Wainberg, Zev A\|Anghel, Adrian\|Rogers, Amy M\|Desai, Amrita J\|Kalous, Ondrej\|Conklin, Dylan\|Ayala, Raul\|O'Brien, Neil A\|Quadt, Cornelia\|Akimov, Mikhail\|Slamon, Dennis J\|Finn, Richard S
PMID:	23395886

477.
Journal:	Cancer. 2013 May 1;119(9):1627-35.
Title:	Identification of ROS1 rearrangement in gastric adenocarcinoma.
Author:	Lee, Jeeyun\|Lee, Seung Eun\|Kang, So Young\|Do, In-Gu\|Lee, Sujin\|Ha, Sang Yun\|Cho, Jeonghee\|Kang, Won Ki\|Jang, Jiryeon\|Ou, Sai-Hong Ignatius\|Kim, Kyoung-Mee
PMID:	23400546

478.
Journal:	Gan To Kagaku Ryoho. 2013 Feb;40(2):237-40.
Title:	[Two cases of unresectable advanced gastric cancer treated with S-1, CDDP and trastuzumab].
Author:	Ogino, Takeo\|Kawamura, Masatoshi\|Tsutsumi, Kenji\|Sakamoto, Nobuyuki\|Kodama, Hitomi\|Machida, Takeshi\|Takahashi, Tsuyoshi\|Takanashi, Shuichiro\|Nakamura, Yasushi\|Ishii, Rie
PMID:	23411963

479.
Journal:	Oncol Lett. 2013 Feb;5(2):559-563.
Title:	The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel.
Author:	Bar-Sela, Gil\|Hershkovitz, Dov\|Haim, Nissim\|Kaidar-Person, Orit\|Shulman, Katerina\|Ben-Izhak, Ofer
PMID:	23420289

480.
Journal:	Mol Cancer Ther. 2013 May;12(5):737-46.
Title:	Y-box binding protein-1 contributes to both HER2/ErbB2 expression and lapatinib sensitivity in human gastric cancer cells.
Author:	Shibata, Tomohiro\|Kan, Hitoshi\|Murakami, Yuichi\|Ureshino, Hiroki\|Watari, Kosuke\|Kawahara, Akihiko\|Kage, Masayoshi\|Hattori, Satoshi\|Ono, Mayumi\|Kuwano, Michihiko
PMID:	23445612

481.
Journal:	Ther Adv Med Oncol. 2013 Mar;5(2):143-51.
Title:	Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
Author:	Gunturu, Krishna S\|Woo, Yanghee\|Beaubier, Nike\|Remotti, Helen E\|Saif, M Wasif
PMID:	23450234

482.
Journal:	Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):561-6.
Title:	HER2 in situ hybridization in gastric and gastroesophageal adenocarcinoma: comparison of automated dual ISH to FISH.
Author:	Grin, Andrea\|Brezden-Masley, Christine\|Bauer, Sharon\|Streutker, Catherine J
PMID:	23455182

483.
Journal:	Int J Oncol. 2013 May;42(5):1589-96.
Title:	Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening.
Author:	Sugishita, Yoshiyuki\|Kammori, Makoto\|Yamada, Osamu\|Poon, Steven S S\|Kobayashi, Makio\|Onoda, Naoyoshi\|Yamazaki, Kazuko\|Fukumori, Tatsuya\|Yoshikawa, Kei-Ichi\|Onose, Hiroyuki\|Ishii, Shinnya\|Yamada, Emiko\|Yamada, Tetsu
PMID:	23467725

484.
Journal:	Anal Quant Cytopathol Histpathol. 2013 Feb;35(1):27-35.
Title:	Heterogeneous target protein expression in synchronous multiple gastric carcinomas.
Author:	Kang, Gyhyun\|Park, Ha Young\|Ahn, Sumin\|Kim, Kyoung-Mee\|Park, Cheol Keun\|Choi, Min Gew\|Sohn, Tae Sung\|Bae, Jae Moon\|Kim, Sung
PMID:	23469621

485.
Journal:	Med Mol Morphol. 2013 Jun;46(2):114-21.
Title:	Immunohistochemical analysis of invasive micropapillary carcinoma pattern in four cases of gastric cancer.
Author:	Ohtsuki, Yuji\|Kuroda, Naoto\|Yunoki, Shigeru\|Murakami, Shinzo\|Mizukami, Yuji\|Okada, Yuhei\|Iguchi, Mitsuko\|Lee, Gang-Hong\|Furihata, Mutsuo
PMID:	23471758

486.
Journal:	Mol Oncol. 2013 Jun;7(3):580-94.
Title:	Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab.
Author:	Mamidi, Srinivas\|Cinci, Marc\|Hasmann, Max\|Fehring, Volker\|Kirschfink, Michael
PMID:	23474221

487.
Journal:	APMIS. 2013 Jul;121(7):582-91.
Title:	Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
Author:	Zhou, Fang\|Qiu, Wensheng\|Sun, Lingling\|Xiang, Jinyu\|Sun, Xiaoxiao\|Sui, Aihua\|Ding, Aiping\|Yue, Lu
PMID:	23489260

488.
Journal:	Ann Oncol. 2013 Jul;24(7):1754-61.
Title:	Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.
Author:	Gordon, M A\|Gundacker, H M\|Benedetti, J\|Macdonald, J S\|Baranda, J C\|Levin, W J\|Blanke, C D\|Elatre, W\|Weng, P\|Zhou, J Y\|Lenz, H J\|Press, M F
PMID:	23524864

489.
Journal:	Asian Pac J Cancer Prev. 2013;14(1):127-31.
Title:	Effect of MUC1 siRNA on drug resistance of gastric cancer cells to trastuzumab.
Author:	Deng, Min\|Jing, Da-Dao\|Meng, Xiang-Jun
PMID:	23534710

490.
Journal:	Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Mar;16(3):276-80.
Title:	[Clinical study of the predictors to neoadjuvant chemotherapy in patients with advanced gastric cancer].
Author:	Qu, Jian-jun\|Shi, Yi-ran\|Hao, Feng-yun
PMID:	23536352

491.
Journal:	Mol Cancer Ther. 2013 Jun;12(6):925-36.
Title:	Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion.
Author:	Wang, Jing\|Pursell, Natalie W\|Samson, Maria Elena S\|Atoyan, Ruzanna\|Ma, Anna W\|Selmi, Abdelkader\|Xu, Wanlu\|Cai, Xiong\|Voi, Maurizio\|Savagner, Pierre\|Lai, Cheng-Jung
PMID:	23536719

492.
Journal:	Int J Biol Markers. 2013 Apr 23;28(1):71-83.
Title:	The expression of Egfl7 in human normal tissues and epithelial tumors.
Author:	Fan, Chun\|Yang, Lian-Yue\|Wu, Fan\|Tao, Yi-Ming\|Liu, Lin-Sen\|Zhang, Jin-Fan\|He, Ya-Ning\|Tang, Li-Li\|Chen, Guo-Dong\|Guo, Lei
PMID:	23558933

493.
Journal:	Int J Surg Pathol. 2013 Jun;21(3):240-6.
Title:	HER2 amplification in gastric cancer is a rare event restricted to the intestinal phenotype.
Author:	Cruz-Reyes, Carolina\|Gamboa-Dominguez, Armando
PMID:	23564704

494.
Journal:	Anticancer Res. 2013 Apr;33(4):1257-66.
Title:	A review on biomarkers for prediction of treatment outcome in gastric cancer.
Author:	Pietrantonio, Filippo\|De Braud, Filippo\|Da Prat, Valentina\|Perrone, Federica\|Pierotti, Marco Alessandro\|Gariboldi, Manuela\|Fanetti, Giuseppe\|Biondani, Pamela\|Pellegrinelli, Alessandro\|Bossi, Ilaria\|Di Bartolomeo, Maria
PMID:	23564763

495.
Journal:	Korean J Gastroenterol. 2013 Mar 25;61(3):117-27.
Title:	[Perspectives of the stomach cancer treatment: the introduction of molecular targeted therapy and the hope for cure].
Author:	Cheung, Dae Young\|Kim, Jae Kwang
PMID:	23575230

496.
Journal:	J Nucl Med. 2013 Jun;54(6):936-43.
Title:	Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET.
Author:	Janjigian, Yelena Y\|Viola-Villegas, Nerissa\|Holland, Jason P\|Divilov, Vadim\|Carlin, Sean D\|Gomes-DaGama, Erica M\|Chiosis, Gabriela\|Carbonetti, Gregory\|de Stanchina, Elisa\|Lewis, Jason S
PMID:	23578997

497.
Journal:	World J Gastroenterol. 2013;19(14):2171-8.
Title:	Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
Author:	He, Chao\|Bian, Xue-Yi\|Ni, Xing-Zhi\|Shen, Dan-Ping\|Shen, Yan-Ying\|Liu, Hua\|Shen, Zhi-Yong\|Liu, Qiang
PMID:	23599643

498.
Journal:	Drugs. 2013 May;73(7):755-65.
Title:	Trastuzumab emtansine: first global approval.
Author:	Ballantyne, Anita\|Dhillon, Sohita
PMID:	23620199

499.
Journal:	Proc Natl Acad Sci U S A. 2013 May 14;110(20):8170-5.
Title:	Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.
Author:	Mahlknecht, Georg\|Maron, Ruth\|Mancini, Maicol\|Schechter, Bilha\|Sela, Michael\|Yarden, Yosef
PMID:	23630281

500.
Journal:	J Immunol. 2013 Jun 1;190(11):5600-8.
Title:	Catecholamine-Induced beta2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression.
Author:	Shi, Ming\|Yang, Zhengyan\|Hu, Meiru\|Liu, Dan\|Hu, Yabin\|Qian, Lu\|Zhang, Wei\|Chen, Hongyu\|Guo, Liang\|Yu, Ming\|Song, Lun\|Ma, Yuanfang\|Guo, Ning
PMID:	23630346

501.
Journal:	Diagn Pathol. 2013 May 9;8:76.
Title:	HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
Author:	Shan, Ling\|Ying, Jianming\|Lu, Ning
PMID:	23656792

502.
Journal:	PLoS One. 2013 May 2;8(5):e62365.
Title:	Flotillin2 expression correlates with HER2 levels and poor prognosis in gastric cancer.
Author:	Zhu, Zhi\|Wang, Jinou\|Sun, Zhe\|Sun, Xuren\|Wang, Zhenning\|Xu, Huimian
PMID:	23658725

503.
Journal:	J Natl Compr Canc Netw. 2013 May 1;11(5):531-46.
Title:	Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.
Author:	Ajani, Jaffer A\|Bentrem, David J\|Besh, Stephen\|D'Amico, Thomas A\|Das, Prajnan\|Denlinger, Crystal\|Fakih, Marwan G\|Fuchs, Charles S\|Gerdes, Hans\|Glasgow, Robert E\|Hayman, James A\|Hofstetter, Wayne L\|Ilson, David H\|Keswani, Rajesh N\|Kleinberg, Lawrence R\|Kor
PMID:	23667204

504.
Journal:	Ann Oncol. 2013 Jul;24(7):1715-7.
Title:	'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer.
Author:	Santini, D\|Vincenzi, B\|Pantano, F\|Schiavon, G\|Tonini, G
PMID:	23670095

505.
Journal:	World J Gastroenterol. 2013 Jun 7;19(21):3316-23.
Title:	Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population.
Author:	Fan, Xiang-Shan\|Chen, Jie-Yu\|Li, Chang-Feng\|Zhang, Yi-Fen\|Meng, Fan-Qing\|Wu, Hong-Yan\|Feng, An-Ning\|Huang, Qin
PMID:	23745034

506.
Journal:	Clin Transl Sci. 2013 Jun;6(3):184-90.
Title:	Clinical significance of vimentin expression and Her-2 status in patients with gastric carcinoma.
Author:	Zhao, Wenwen\|Yue, Lu\|Zhou, Fang\|Xu, Congcong\|Liang, Wanhua\|Sui, Aihua\|Ding, Aiping\|Qiu, Wensheng
PMID:	23751022

507.
Journal:	Mod Pathol. 2013 Dec;26(12):1605-12.
Title:	Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice.
Author:	Buza, Natalia\|English, Diana P\|Santin, Alessandro D\|Hui, Pei
PMID:	23765245

508.
Journal:	Oncol Rep. 2013 Sep;30(3):1087-93.
Title:	Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model.
Author:	Yamashita-Kashima, Yoriko\|Shu, Sei\|Harada, Naoki\|Fujimoto-Ouchi, Kaori
PMID:	23783223

509.
Journal:	Ann Oncol. 2013 Sep;24(9):2360-4.
Title:	HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance.
Author:	Sheng, W Q\|Huang, D\|Ying, J M\|Lu, N\|Wu, H M\|Liu, Y H\|Liu, J P\|Bu, H\|Zhou, X Y\|Du, X
PMID:	23788757

510.
Journal:	Virology. 2013 Sep 1;443(2):294-305.
Title:	Epstein-Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration.
Author:	Banerjee, Aditi Sengupta\|Pal, Anindita Deb\|Banerjee, Subrata
PMID:	23791019

511.
Journal:	Pathol Oncol Res. 2013 Oct;19(4):855-65.
Title:	HER2 in gastric cancer: an immunohistochemical study on tissue microarrays and the corresponding whole-tissue sections with a supplemental fish study.
Author:	Gasljevic, Gorana\|Lamovec, Janez\|Contreras, Juan Antonio\|Zadnik, Vesna\|Blas, Mateja\|Gasparov, Slavko
PMID:	23800891

512.
Journal:	Discov Med. 2013 Jun;15(85):333-41.
Title:	Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part I: Targeting receptor tyrosine kinase gene amplification.
Author:	Lee, Jeeyun\|Ou, Sai-Hong Ignatius
PMID:	23819947

513.
Journal:	Pathol Res Pract. 2013 Aug;209(8):479-85.
Title:	Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Author:	Xu, Cong-cong\|Yue, Lu\|Wei, Hong-jun\|Zhao, Wen-wen\|Sui, Ai-hua\|Wang, Xiu-mei\|Qiu, Wen-sheng
PMID:	23822993

514.
Journal:	J Biol Chem. 2013 Aug 30;288(35):25254-64.
Title:	Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface.
Author:	Collier, Timothy S\|Diraviyam, Karthikeyan\|Monsey, John\|Shen, Wei\|Sept, David\|Bose, Ron
PMID:	23843458

515.
Journal:	Rev Invest Clin. 2013 Mar-Apr;65(2):150-5.
Title:	Analysis of the polymorphisms EGFR-r521K and ERBB2-I655V in Mexican patients with gastric cancer and premalignant gastric lesions.
Author:	Torres-Jasso, Juan Heriberto\|Bustos-Carpinteyro, Andrea Rebeca\|Marin, Maria Eugenia\|Santiago, Ernesto\|Leoner, Carlos\|Flores-Luna, Lourdes\|Torres, Javier\|Sanchez-Lopez, Josefina Yoaly
PMID:	23844533

516.
Journal:	Gan To Kagaku Ryoho. 2013 Apr;40(4):511-4.
Title:	[A case of AFP-producing gastric cancer with peritoneal metastasis treated effectively with chemotherapy, mainly using S-1 and trastuzumab].
Author:	Nishiwada, Satoshi\|Watanabe, Akihiko\|Yoshikawa, Takahiro\|Ishioka, Kohei\|Mukogawa, Tomohide\|Matsusaka, Masanori\|Ko, Saiho\|Ishikawa, Hirofumi
PMID:	23848022

517.
Journal:	Jpn J Clin Oncol. 2013 Aug;43(8):838-40.
Title:	A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5).
Author:	Sakai, Daisuke\|Satoh, Taroh\|Kurokawa, Yukinori\|Kudo, Toshihiro\|Nishikawa, Kazuhiro\|Oka, Yoshio\|Tsujinaka, Toshimasa\|Shimokawa, Toshio\|Doki, Yuichiro\|Furukawa, Hiroshi
PMID:	23852648

518.
Journal:	Gan To Kagaku Ryoho. 2013 Jun;40(6):755-9.
Title:	[Comparison of HER2 immunohistochemical results for advanced gastric cancer obtained on using 3 different antibodies].
Author:	Abe, Mitsunobu\|Tsuchiya, Kohki\|Yanagawa, Naoki\|Ogata, Shin-ya\|Nomura, Takashi\|Fukushima, Norimasa\|Tamura, Gen
PMID:	23863652

519.
Journal:	Gan To Kagaku Ryoho. 2013 Jul;40(7):933-6.
Title:	[A case of HER2-positive gastric cancer successfully treated with trastuzumab plus capecitabine plus cisplatin chemotherapy as third-line treatment].
Author:	Murata, Yoriko\|Matsuura, Tetsuya\|Kanoshima, Kenji\|Kuwabara, Hiroki\|Fuyuki, Akiko\|Tomeno, Wataru\|Taniguchi, Reo\|Uchiyama, Takashi\|Kuriyama, Hitoshi\|Hata, Yasuo
PMID:	23863740

520.
Journal:	Arch Med Res. 2013 Jul;44(5):380-9.
Title:	Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis.
Author:	Chen, Cheng\|Yang, Jing-mo\|Hu, Ting-ting\|Xu, Ting-juan\|Yan, Guang\|Hu, Shi-lian\|Wei, Wei\|Xu, Wei-ping
PMID:	23871709

521.
Journal:	PLoS One. 2013 Jul 11;8(7):e69098.
Title:	Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
Author:	Berezowska, Sabina\|Novotny, Alexander\|Bauer, Karina\|Feuchtinger, Annette\|Slotta-Huspenina, Julia\|Becker, Karen\|Langer, Rupert\|Walch, Axel
PMID:	23874879

522.
Journal:	Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jul;16(7):668-72.
Title:	[Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer].
Author:	Li, Gang\|Gu, Rong-min\|Wen, Xu\|Ming, Xue-zhi\|Xia, Lei\|Xu, Xin-yu\|Zhang, Ji\|Chen, Huan-qiu
PMID:	23888453

523.
Journal:	Pathol Res Pract. 2013 Sep;209(9):548-54.
Title:	HER2 status in gastric cancer: a comparison of two novel in situ hybridization methods (IQ FISH and dual color SISH) and two immunohistochemistry methods (A0485 and HercepTest).
Author:	Pala, Emel Ebru\|Bayol, Umit\|Ozguzer, Alp\|Akman, Ozlem
PMID:	23910175

524.
Journal:	Discov Med. 2013 Aug;16(86):7-14.
Title:	Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway.
Author:	Lee, Jeeyun\|Ou, Sai-Hong Ignatius
PMID:	23911227

525.
Journal:	Cancer Res. 2013 Oct 1;73(19):6013-23.
Title:	Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110alpha inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers.
Author:	Garrett, Joan T\|Sutton, Cammie R\|Kurupi, Richard\|Bialucha, Carl Uli\|Ettenberg, Seth A\|Collins, Scott D\|Sheng, Qing\|Wallweber, Jerry\|Defazio-Eli, Lisa\|Arteaga, Carlos L
PMID:	23918797

526.
Journal:	Cancer Med. 2013 Jun;2(3):325-33.
Title:	Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.
Author:	Werner, Dominique\|Atmaca, Akin\|Pauligk, Claudia\|Pustowka, Anette\|Jager, Elke\|Al-Batran, Salah-Eddin
PMID:	23930209

527.
Journal:	Pol Przegl Chir. 2013 Jul;85(7):401-6.
Title:	Brain metastasis as the first symptom of gastric cancer--case report and literature review.
Author:	Murawa, Dawid\|Nowaczyk, Piotr\|Szymkowiak, Malgorzata\|Karaszewska, Boguslawa
PMID:	23945118

528.
Journal:	Oncol Lett. 2013 Jul;6(1):13-18.
Title:	HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma.
Author:	Huang, Jun-Xing\|Zhao, Kun\|Lin, Mei\|Wang, Qi\|Xiao, Wei\|Lin, Mao-Song\|Yu, Hong\|Chen, Ping\|Qian, Rong-Yu
PMID:	23946770

529.
Journal:	Gan To Kagaku Ryoho. 2013 Aug;40(8):976-80.
Title:	[Therapeutic strategy for recurrent gastric cancer and efforts aimed at finding a cure].
Author:	Asayama, Masako\|Yamada-Murano, Toko\|Hara, Hiroki\|Ooki, Akira\|Yoshii, Takako\|Yamaguchi, Kensei
PMID:	23986038

530.
Journal:	Genome Med. 2013 Aug 31;5(8):78.
Title:	Clinical and molecular characterization of HER2 amplified-pancreatic cancer.
Author:	Chou, Angela\|Waddell, Nicola\|Cowley, Mark J\|Gill, Anthony J\|Chang, David K\|Patch, Ann-Marie\|Nones, Katia\|Wu, Jianmin\|Pinese, Mark\|Johns, Amber L\|Miller, David K\|Kassahn, Karin S\|Nagrial, Adnan M\|Wasan, Harpreet\|Goldstein, David\|Toon, Christopher W\|Chin, V
PMID:	24004612

531.
Journal:	J Cancer Res Clin Oncol. 2013 Nov;139(11):1835-43.
Title:	Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer.
Author:	Kang, Byung Woog\|Lee, Dakeun\|Chung, Ho Young\|Han, Jae Ho\|Kim, Young-Bae
PMID:	24005419

532.
Journal:	Helicobacter. 2013 Sep;18 Suppl 1:39-43.
Title:	Helicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects.
Author:	Venerito, Marino\|Selgrad, Michael\|Malfertheiner, Peter
PMID:	24011244

533.
Journal:	Med Oncol. 2013 Dec;30(4):726.
Title:	CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Author:	Zhou, Fang\|Qiu, Wensheng\|Yao, Ruyong\|Xiang, Jinyu\|Sun, Xiaoxiao\|Liu, Shihai\|Lv, Jing\|Yue, Lu
PMID:	24026662

534.
Journal:	Am J Pathol. 2013 Nov;183(5):1446-1460.
Title:	Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients.
Author:	Onsum, Matthew D\|Geretti, Elena\|Paragas, Violette\|Kudla, Arthur J\|Moulis, Sharon P\|Luus, Lia\|Wickham, Thomas J\|McDonagh, Charlotte F\|MacBeath, Gavin\|Hendriks, Bart S
PMID:	24035511

535.
Journal:	Drugs. 2013 Sep;73(14):1605-15.
Title:	Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.
Author:	Sanford, Mark
PMID:	24057416

536.
Journal:	Nat Rev Clin Oncol. 2013 Nov;10(11):643-55.
Title:	Gastric cancer-molecular and clinical dimensions.
Author:	Wadhwa, Roopma\|Song, Shumei\|Lee, Ju-Seog\|Yao, Yixin\|Wei, Qingyi\|Ajani, Jaffer A
PMID:	24061039

537.
Journal:	Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Sep;16(9):898-901.
Title:	[Analysis of the protein expression and gene amplification of HER2 in gastric cancer].
Author:	Liu, Jun-lin\|Li, Zhen-kai\|Xin, Fang-jie\|Zhao, Han\|Zhao, Wei\|Gao, Yuan\|Hu, Ji-lin\|Zhang, Xian-xiang\|Zhang, Mao-shen\|Zhang, Bing-yuan\|Lu, Yun
PMID:	24062004

538.
Journal:	Int J Surg Pathol. 2013 Oct;21(5):455-75.
Title:	The utility of immunohistochemistry for providing genetic information on tumors.
Author:	Chan, John K C\|Ip, Yiu-Tung\|Cheuk, Wah
PMID:	24065374

539.
Journal:	J Gastrointest Dig Syst. 2013 Jul 3;3(123):15519.
Title:	Mucins in Gastric Cancer - An Update.
Author:	Boltin, Doron\|Niv, Yaron
PMID:	24077811

540.
Journal:	World J Gastroenterol. 2013 Oct 7;19(37):6165-9.
Title:	HER2 therapies and gastric cancer: a step forward.
Author:	de Mello, Ramon Andrade\|Marques, Andrea Marin\|Araujo, Antonio
PMID:	24115812

541.
Journal:	J Clin Oncol. 2013 Dec 10;31(35):4445-52.
Title:	Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.
Author:	Gomez-Martin, Carlos\|Plaza, Jose Carlos\|Pazo-Cid, Roberto\|Salud, Antonieta\|Pons, Francesc\|Fonseca, Paula\|Leon, Ana\|Alsina, Maria\|Visa, Laura\|Rivera, Fernando\|Galan, M Carmen\|Del Valle, Elena\|Vilardell, Felipe\|Iglesias, Mar\|Fernandez, Soledad\|Landolfi, Ste
PMID:	24127447

542.
Journal:	Ann Oncol. 2013 Dec;24(12):3123-8.
Title:	HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab.
Author:	Sclafani, F\|Roy, A\|Cunningham, D\|Wotherspoon, A\|Peckitt, C\|Gonzalez de Castro, D\|Tabernero, J\|Glimelius, B\|Cervantes, A\|Eltahir, Z\|Oates, J\|Chau, I
PMID:	24146218

543.
Journal:	World J Gastroenterol. 2013 Oct 14;19(38):6383-97.
Title:	Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies.
Author:	Luis, Michael\|Tavares, Ana\|Carvalho, Liliana S\|Lara-Santos, Lucio\|Araujo, Antonio\|de Mello, Ramon Andrade
PMID:	24151357

544.
Journal:	World J Gastroenterol. 2013 Oct 14;19(38):6438-46.
Title:	HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays.
Author:	Abrahao-Machado, Lucas Faria\|Jacome, Alexandre Andrade dos Anjos\|Wohnrath, Durval Renato\|dos Santos, Jose Sebastiao\|Carneseca, Estela Cristina\|Fregnani, Jose Humberto Tavares Guerreiro\|Scapulatempo-Neto, Cristovam
PMID:	24151362

545.
Journal:	Exp Mol Med. 2013 Nov 1;45:e52.
Title:	Combined blockade of HER2 and VEGF exerts greater growth inhibition of HER2-overexpressing gastric cancer xenografts than individual blockade.
Author:	Singh, Rohit\|Kim, Woo Jin\|Kim, Pyeung-Hyeun\|Hong, Hyo Jeong
PMID:	24176949

546.
Journal:	Br J Cancer. 2013 Dec 10;109(12):3057-66.
Title:	Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.
Author:	Aparicio, T\|Svrcek, M\|Zaanan, A\|Beohou, E\|Laforest, A\|Afchain, P\|Mitry, Emmanuel\|Taieb, J\|Di Fiore, F\|Gornet, J-M\|Thirot-Bidault, A\|Sobhani, I\|Malka, D\|Lecomte, T\|Locher, C\|Bonnetain, F\|Laurent-Puig, P
PMID:	24196786

547.
Journal:	J Immunol. 2013 Dec 15;191(12):6261-72.
Title:	The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
Author:	Mimura, Kousaku\|Shiraishi, Kensuke\|Mueller, Anja\|Izawa, Shinichiro\|Kua, Ley-Fang\|So, Jimmy\|Yong, Wei-Peng\|Fujii, Hideki\|Seliger, Barbara\|Kiessling, Rolf\|Kono, Koji
PMID:	24244023

548.
Journal:	PLoS One. 2013 Nov 14;8(11):e80290.
Title:	HER2 status in gastric and gastroesophageal junction cancer assessed by local and central laboratories: Chinese results of the HER-EAGLE study.
Author:	Huang, Dan\|Lu, Ning\|Fan, Qinhe\|Sheng, Weiqi\|Bu, Hong\|Jin, Xiaolong\|Li, Guimei\|Liu, Yanhui\|Li, Xianghong\|Sun, Wenyong\|Zhang, Huizhong\|Li, Xiaobing\|Zhou, Zongguang\|Yan, Min\|Wang, Xuan\|Sha, Weihong\|Ji, Jiafu\|Cheng, Xiangdong\|Zhou, Zhiwei\|Xu, Jianming\|Du, Xia
PMID:	24244671

549.
Journal:	Breast Cancer Res. 2013 Nov 19;15(6):R110.
Title:	A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors.
Author:	Hudis, Clifford\|Swanton, Charles\|Janjigian, Yelena Y\|Lee, Ray\|Sutherland, Stephanie\|Lehman, Robert\|Chandarlapaty, Sarat\|Hamilton, Nicola\|Gajria, Devika\|Knowles, James\|Shah, Jigna\|Shannon, Keith\|Tetteh, Ernestina\|Sullivan, Daniel M\|Moreno, Carolina\|Yan, Li
PMID:	24252402

550.
Journal:	Oncol Lett. 2013 Dec;6(6):1591-1594.
Title:	HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily.
Author:	Ieni, A\|Barresi, V\|Giuffre, G\|Caruso, R A\|Lanzafame, S\|Villari, L\|Salomone, E\|Roz, E\|Cabibi, D\|Franco, V\|Certo, G\|Labate, A\|Nagar, C\|Magliolo, E\|Broggi, B\|Fazzari, C\|Italia, F\|Tuccari, G
PMID:	24260051

551.
Journal:	Exp Mol Med. 2013 Nov 22;45:e64.
Title:	Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line.
Author:	Lee, Yong Yook\|Kim, Hwang-Phill\|Kang, Min Jueng\|Cho, Byoung-Kyu\|Han, Sae-Won\|Kim, Tae-You\|Yi, Eugene C
PMID:	24263233

552.
Journal:	Gut Microbes. 2013 Nov-Dec;4(6):454-74.
Title:	Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.
Author:	Pachathundikandi, Suneesh Kumar\|Tegtmeyer, Nicole\|Backert, Steffen
PMID:	24280762

553.
Journal:	J Gastrointest Oncol. 2013 Dec;4(4):E19-22.
Title:	A case report of trastuzumab dose in gastric cancer.
Author:	Kyi, Chrisann\|Shah, Manish A
PMID:	24294514

554.
Journal:	Biomark Res. 2013 Dec 11;1(1):32.
Title:	The progress of targeted therapy in advanced gastric cancer.
Author:	Qiu, Miao-Zhen\|Xu, Rui-Hua
PMID:	24330856

555.
Journal:	Gan To Kagaku Ryoho. 2013 Nov;40(12):2203-6.
Title:	[Two cases of human epidermal growth factor receptor 2-positive advanced gastric cancer successfully treated with S-1, cisplatin, and trastuzumab combination therapy followed by curative resection].
Author:	Yasuyama, Akinobu\|Mikata, Shoki\|Soma, Yoshihito\|Yoshikawa, Yukihiro\|Watase, Chikashi\|Kubota, Michiyo\|Miyake, Yuichiro\|Matsuura, Yusuke\|Kim, Ho Min\|Murakami, Masahiro\|Hirota, Masaki\|Morishima, Hirotaka\|Matsunami, Nobuki\|Hasegawa, Junichi\|Miwa, Hideaki\|Nezu
PMID:	24394060

556.
Journal:	Gan To Kagaku Ryoho. 2013 Nov;40(12):2253-5.
Title:	[A case of HER2-positive advanced gastric cancer successfully treated with a combination of capecitabine, cisplatin, and trastuzumab as first-line chemotherapy].
Author:	Deguchi, Koichi\|Nishikawa, Kazuhiro\|Iwase, Kazuhiro\|Kawada, Junji\|Aono, Toyokazu\|Yoshida, Hiroshi\|Nomura, Masaya\|Tamagawa, Hiroshi\|Matsuda, Chu\|Deguchi, Takashi\|Higashi, Shigeyoshi\|Okumura, Yuichiro\|Noguchi, Yuki\|Nomura, Masatoshi\|Takagi, Mari\|Fukui, Akik
PMID:	24394076

557.
Journal:	Gan To Kagaku Ryoho. 2013 Nov;40(12):2256-8.
Title:	[A case of SPT therapy( S-1+CDDP+trastuzumab) was successful for HER2-positive gastric cancer accompanied by distant lymph node metastasis].
Author:	Hyuga, Nozomu\|Kobayashi, Kenji\|Watanabe, Risa\|Chono, Akihiro\|Matsumoto, Takashi\|Takemoto, Hiroyoshi\|Takachi, Ko\|Nishioka, Kiyonori\|Aoki, Taro\|Uemura, Yoshio\|Yoshida, Kyotaro
PMID:	24394077

558.
Journal:	Indian J Surg. 2013 Jun;75(Suppl 1):456-9.
Title:	Synchronous rectal and gastric cancer in a fighter pilot: aeromedical concerns.
Author:	Gu, Guo-Li\|Wei, Xue-Ming\|Xu, Xian-Rong\|Li, De-Chang\|Wang, Shi-Lin\|Gu, Jin
PMID:	24426647

559.
Journal:	ScientificWorldJournal. 2013 Dec 24;2013:196541.
Title:	Profiling the prognosis of gastric cancer patients: is it worth correlating the survival with the clinical/pathological and molecular features of gastric cancers?
Author:	Lorenzon, Laura\|Mercantini, Paolo\|Ferri, Mario\|La Torre, Marco\|Sparagna, Alessandra\|Balducci, Genoveffa\|Tarantino, Giulia\|Romiti, Adriana\|Pilozzi, Emanuela\|Ziparo, Vincenzo
PMID:	24453810

560.
Journal:	Int J Hematol Oncol Stem Cell Res. 2013;7(3):15-20.
Title:	Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran.
Author:	Sanaat, Zohreh\|Halimi, Monireh\|Ghojezadeh, Morteza\|Pirovi, Amir Hossein\|Gharamaleki, Jalil Vaez\|Ziae, Ali Esfahani Jamal Eivazi\|Kermani, Iraj Aswadi
PMID:	24505530

561.
Journal:	Int J Mol Cell Med. 2013 Fall;2(4):199-203.
Title:	HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma.
Author:	Movagharnejad, Kourosh\|Sharbatdaran, Majid\|Sheffaee, Shahryar\|Kashifard, Mehrdad\|Sedaghat, Sadegh
PMID:	24551813

562.
Journal:	Mol Clin Oncol. 2013 Mar;1(2):249-252.
Title:	Metachronous liver and bone metastasis from small early gastric carcinoma without lymph node involvement: A case report.
Author:	Namikawa, Tsutomu\|Shiga, Mai\|Ichikawa, Kengo\|Kitagawa, Hiroyuki\|Kobayashi, Michiya\|Hanazaki, Kazuhiro
PMID:	24649155

563.
Journal:	Rev Med Chil. 2013 Nov;141(11):1411-9.
Title:	[HER2 gene amplification and overexpression in advanced gastric cancer].
Author:	Roa, Ivan\|Slater, Jeannie\|Carvajal, Daniel\|Schalper, Kurt\|de Toro, Gonzalo\|Ares, Raul\|Game, Anakaren\|Leon, Jorge\|de Aretxabala, Xabier
PMID:	24718467

564.
Journal:	Transl Lung Cancer Res. 2013 Apr;2(2):122-7.
Title:	HER2 driven non-small cell lung cancer (NSCLC): potential therapeutic approaches.
Author:	Garrido-Castro, Ana Christina\|Felip, Enriqueta
PMID:	25806223

565.
Journal:	Chin Clin Oncol. 2013 Mar;2(1):5.
Title:	Molecular therapy for gastric cancer.
Author:	Yamada, Yasuhide
PMID:	25841446

566.
Journal:	Gastric Cancer. 2014 Jan;17(1):34-42.
Title:	Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population.
Author:	Aizawa, Masaki\|Nagatsuma, Akiko K\|Kitada, Koji\|Kuwata, Takeshi\|Fujii, Satoshi\|Kinoshita, Taira\|Ochiai, Atsushi
PMID:	23430266

567.
Journal:	Gastric Cancer. 2014 Jan;17(1):76-86.
Title:	Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors.
Author:	Jacome, Alexandre Andrade Anjos\|Wohnrath, Durval R\|Scapulatempo Neto, Cristovam\|Carneseca, Estela C\|Serrano, Sergio V\|Viana, Luciano Souza\|Nunes, Joao S\|Martinez, Edson Z\|Santos, Jose Sebastiao
PMID:	23455716

568.
Journal:	Gastric Cancer. 2014 Jan;17(1):107-15.
Title:	Effects of a human compact anti-ErbB2 antibody on gastric cancer.
Author:	Fedele, Carmine\|Carvalho, Silvia\|Riccio, Gennaro\|Paciello, Rolando\|Laccetti, Paolo\|Schmitt, Fernando\|De Lorenzo, Claudia
PMID:	23460348

569.
Journal:	Gastric Cancer. 2014 Jan;17(1):1-12.
Title:	HER2-positive gastric cancer.
Author:	Boku, Narikazu
PMID:	23563986

570.
Journal:	Appl Immunohistochem Mol Morphol. 2014;22(2):146-52.
Title:	HER2 gene amplification and protein expression in pancreatic ductal adenocarcinomas.
Author:	Aumayr, Klaus\|Soleiman, Afschin\|Sahora, Klaus\|Schindl, Martin\|Werba, Gregor\|Schoppmann, Sebastian F\|Birner, Peter
PMID:	23702645

571.
Journal:	Int J Cancer. 2014 Jun 1;134(11):2513-22.
Title:	Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update.
Author:	Duffy, M J\|Lamerz, R\|Haglund, C\|Nicolini, A\|Kalousova, M\|Holubec, L\|Sturgeon, C
PMID:	23852704

572.
Journal:	Oncogene. 2014 Jun 19;33(25):3334-41.
Title:	Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer.
Author:	Kim, H-P\|Han, S-W\|Song, S-H\|Jeong, E-G\|Lee, M-Y\|Hwang, D\|Im, S-A\|Bang, Y-J\|Kim, T-Y
PMID:	23873022

573.
Journal:	Gastric Cancer. 2014;17(3):450-62.
Title:	Lapatinib sensitivities of two novel trastuzumab-resistant HER2 gene-amplified gastric cancer cell lines.
Author:	Oshima, Yukiko\|Tanaka, Harunari\|Murakami, Hiroki\|Ito, Yuichi\|Furuya, Tomomi\|Kondo, Eisaku\|Kodera, Yasuhiro\|Nakanishi, Hayao
PMID:	23948998

574.
Journal:	Gastric Cancer. 2014;17(3):402-11.
Title:	Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.
Author:	Oh, Ho Suk\|Eom, Dae-Woon\|Kang, Gil Hyun\|Ahn, Yong Chel\|Lee, Sang Jin\|Kim, Ji-Hoon\|Jang, Hyuk Jai\|Kim, Eun Jung\|Oh, Kwang Hoon\|Ahn, Heui June
PMID:	23955257

575.
Journal:	Gastric Cancer. 2014 Apr;17(2):213-25.
Title:	Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
Author:	Lordick, Florian\|Lorenzen, Sylvie\|Yamada, Yasuhide\|Ilson, David
PMID:	24048758

576.
Journal:	Clin Exp Med. 2014 Nov;14(4):447-55.
Title:	Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer.
Author:	Li, Xiaoxiao\|Tang, Dongfang\|Yao, Yasai\|Qi, Weiwei\|Liang, Jun
PMID:	24101296

577.
Journal:	J Pathol. 2014 Jan;232(2):219-29.
Title:	Biomarkers of drugs targeting HER-family signalling in cancer.
Author:	Montemurro, Filippo\|Scaltriti, Maurizio
PMID:	24105684

578.
Journal:	J Surg Oncol. 2014 Feb;109(2):61-6.
Title:	HER2 in resected gastric cancer: Is there prognostic value?
Author:	Fisher, Sarah B\|Fisher, Kevin E\|Squires, Malcolm H 3rd\|Patel, Sameer H\|Kooby, David A\|El-Rayes, Bassel F\|Cardona, Kenneth\|Russell, Maria C\|Staley, Charles A 3rd\|Farris, Alton B 3rd\|Maithel, Shishir K
PMID:	24122802

579.
Journal:	Ann Surg Oncol. 2014 Jan;21(1):343-50.
Title:	The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab.
Author:	Eto, Kojiro\|Iwatsuki, Masaaki\|Watanabe, Masayuki\|Ida, Satoshi\|Ishimoto, Takatsugu\|Iwagami, Shiro\|Baba, Yoshifumi\|Sakamoto, Yasuo\|Miyamoto, Yuji\|Yoshida, Naoya\|Baba, Hideo
PMID:	24154840

580.
Journal:	Int J Cancer. 2014 May 15;134(10):2468-77.
Title:	HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: a prospective cohort observation.
Author:	Qiu, Miao-Zhen\|Li, Qian\|Wang, Zhi-Qiang\|Liu, Tian-Shu\|Liu, Qing\|Wei, Xiao-Li\|Jin, Ying\|Wang, De-Shen\|Ren, Chao\|Bai, Long\|Zhang, Dong-Sheng\|Wang, Feng-Hua\|Li, Yu-Hong\|Xu, Rui-Hua
PMID:	24155030

581.
Journal:	Mol Cell Biochem. 2014 Jan;386(1-2):117-24.
Title:	The siRNA cocktail targeting VEGF and HER2 inhibition on the proliferation and induced apoptosis of gastric cancer cell.
Author:	Liu, Kun\|Chen, Honglin\|You, Qingsheng\|Shi, Hai\|Wang, Zhiwei
PMID:	24158524

582.
Journal:	J Surg Oncol. 2014 Mar;109(3):189-97.
Title:	TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
Author:	Shinmura, Kazuya\|Kiyose, Shinichiro\|Nagura, Kiyoko\|Igarashi, Hisaki\|Inoue, Yusuke\|Nakamura, Satoki\|Maeda, Matsuyoshi\|Baba, Megumi\|Konno, Hiroyuki\|Sugimura, Haruhiko
PMID:	24178904

583.
Journal:	Dig Dis Sci. 2014 Feb;59(2):328-35.
Title:	HER2 mRNA status contributes to the discrepancy between gene amplification and protein overexpression in gastric cancer.
Author:	Ma, Gui-Fen\|Liu, Yi-Mei\|Gao, Hong\|Miao, Qing\|Luo, Tian-Cheng\|Zeng, Xiao-Qing\|Chen, Shi-Yao
PMID:	24185685

584.
Journal:	Cancer Res. 2014 Jan 1;74(1):93-103.
Title:	T lymphocytes expressing a CD16 signaling receptor exert antibody-dependent cancer cell killing.
Author:	Kudo, Ko\|Imai, Chihaya\|Lorenzini, Paolo\|Kamiya, Takahiro\|Kono, Koji\|Davidoff, Andrew M\|Chng, Wee Joo\|Campana, Dario
PMID:	24197131

585.
Journal:	Lab Chip. 2014 Jan 7;14(1):147-56.
Title:	Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.
Author:	Galletti, Giuseppe\|Sung, Matthew S\|Vahdat, Linda T\|Shah, Manish A\|Santana, Steven M\|Altavilla, Giuseppe\|Kirby, Brian J\|Giannakakou, Paraskevi
PMID:	24202699

586.
Journal:	J Clin Pathol. 2014 Apr;67(4):307-12.
Title:	Association of HER1 amplification with poor prognosis in well differentiated gastric carcinomas.
Author:	Kandel, Christine\|Leclair, Francois\|Bou-Hanna, Chantal\|Laboisse, Christian L\|Mosnier, Jean-Francois
PMID:	24218028

587.
Journal:	Int J Clin Oncol. 2014 Oct;19(5):863-70.
Title:	Efficacy of S-1 plus cisplatin combination chemotherapy in patients with HER2-positive advanced gastric cancer.
Author:	Honma, Yoshitaka\|Shimada, Yasuhiro\|Takashima, Atsuo\|Iwasa, Satoru\|Kato, Ken\|Hamaguchi, Tetsuya\|Yamada, Yasuhide\|Taniguchi, Hirokazu\|Sekine, Shigeki\|Kushima, Ryoji
PMID:	24218279

588.
Journal:	Gene. 2014 Feb 10;535(2):225-32.
Title:	Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.
Author:	Qiu, Yue\|Zhang, Zuo-Yang\|Du, Wei-Dong\|Ye, Lei\|Xu, Song\|Zuo, Xian-Bo\|Zhou, Fu-Sheng\|Chen, Gang\|Ma, Xue-Ling\|Schneider, Marion E\|Xia, Hong-Zhen\|Zhou, Yuan\|Wu, Ji-Feng\|Yuan-Hong, Xu\|Zhang, Xue-Jun
PMID:	24291029

589.
Journal:	Anticancer Drugs. 2014 Mar;25(3):315-22.
Title:	Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells.
Author:	Ding, Xiaodi\|Qu, Xiujuan\|Fan, Yibo\|Che, Xiaofang\|Qu, Jinglei\|Xu, Ling\|Liu, Jing\|Liu, Yunpeng
PMID:	24300914

590.
Journal:	Histopathology. 2014 Jun;64(7):1027-31.
Title:	Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach.
Author:	Ishida, Michihiro\|Sekine, Shigeki\|Taniguchi, Hirokazu\|Fukagawa, Takeo\|Katai, Hitoshi\|Kushima, Ryoji
PMID:	24329753

591.
Journal:	Cell Oncol (Dordr). 2014 Feb;37(1):41-52.
Title:	High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.
Author:	Labots, Mariette\|Buffart, Tineke E\|Haan, Josien C\|van Grieken, Nicole C T\|Tijssen, Marianne\|van de Velde, Cornelis J H\|Grabsch, Heike I\|Ylstra, Bauke\|Carvalho, Beatriz\|Fijneman, Remond J A\|Verheul, Henk M W\|Meijer, Gerrit A
PMID:	24379144

592.
Journal:	Anticancer Res. 2014 Jan;34(1):301-6.
Title:	Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.
Author:	Palacio, Sofia\|Loaiza-Bonilla, Arturo\|Kittaneh, Muaiad\|Kyriakopoulos, Christos\|Ochoa, Roberto E\|Escobar, Mauricio\|Arango, Belisario\|Restrepo, Maria H\|Merchan, Jaime R\|Rocha Lima, Caio M S R\|Hosein, Peter J
PMID:	24403478

593.
Journal:	Gastric Cancer. 2014 Oct;17(4):638-47.
Title:	Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization.
Author:	Yamashita-Kashima, Yoriko\|Shu, Sei\|Yorozu, Keigo\|Hashizume, Kaoru\|Moriya, Yoichiro\|Fujimoto-Ouchi, Kaori\|Harada, Naoki
PMID:	24414131

594.
Journal:	Protein Eng Des Sel. 2014 Mar;27(3):83-8.
Title:	Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells.
Author:	D'Avino, Chiara\|Paciello, Rolando\|Riccio, Gennaro\|Coppola, Carmela\|Laccetti, Paolo\|Maurea, Nicola\|Raines, Ronald T\|De Lorenzo, Claudia
PMID:	24421342

595.
Journal:	Tumour Biol. 2014 May;35(5):4849-58.
Title:	Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.
Author:	Liang, Ji-wang\|Zhang, Jian-jun\|Zhang, Tao\|Zheng, Zhi-chao
PMID:	24449506

596.
Journal:	Br J Cancer. 2014 Feb 18;110(4):967-75.
Title:	FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study.
Author:	Su, X\|Zhan, P\|Gavine, P R\|Morgan, S\|Womack, C\|Ni, X\|Shen, D\|Bang, Y-J\|Im, S-A\|Ho Kim, W\|Jung, E-J\|Grabsch, H I\|Kilgour, E
PMID:	24457912

597.
Journal:	Digestion. 2014;89(1):12-7.
Title:	HER2 expression and PI3K-Akt pathway alterations in gastric cancer.
Author:	Sukawa, Yasutaka\|Yamamoto, Hiroyuki\|Nosho, Katsuhiko\|Ito, Miki\|Igarashi, Hisayoshi\|Naito, Takafumi\|Mitsuhashi, Kei\|Matsunaga, Yasutaka\|Takahashi, Taiga\|Mikami, Masashi\|Adachi, Yasushi\|Suzuki, Hiromu\|Shinomura, Yasuhisa
PMID:	24458107

598.
Journal:	Cancer Cell Int. 2014 Jan 29;14(1):10.
Title:	Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines.
Author:	Cui, Hai\|Cheng, Ying\|Piao, Su-Zhou\|Xu, Yun-Jie\|Sun, Hong-Hua\|Cui, Xian\|Li, Xiang-Zi\|Zhang, Song-Nan\|Piao, Long-Zhen\|Jin, Yong-Min\|Lin, Zhen-Hua\|Shen, Xiong-Hu
PMID:	24472145

599.
Journal:	Br J Cancer. 2014 Mar 4;110(5):1163-8.
Title:	Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1).
Author:	Kurokawa, Y\|Sugimoto, N\|Miwa, H\|Tsuda, M\|Nishina, S\|Okuda, H\|Imamura, H\|Gamoh, M\|Sakai, D\|Shimokawa, T\|Komatsu, Y\|Doki, Y\|Tsujinaka, T\|Furukawa, H
PMID:	24473399

600.
Journal:	Hum Pathol. 2014 Apr;45(4):725-34.
Title:	Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization.
Author:	Tajiri, Ryosuke\|Ooi, Akishi\|Fujimura, Takashi\|Dobashi, Yoh\|Oyama, Takeru\|Nakamura, Ritsuko\|Ikeda, Hiroko
PMID:	24491355

601.
Journal:	MAbs. 2014 Mar-Apr;6(2):403-8.
Title:	The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancer.
Author:	Han, Siqi\|Meng, Yanchun\|Tong, Qing\|Li, Guangchao\|Zhang, Xunmin\|Chen, Yalin\|Hu, Shi\|Zheng, Lei\|Tan, Wenlong\|Li, Hui\|Chen, Yang\|Zhang, Ge\|Li, Bohua\|Guo, Yajun
PMID:	24492292

602.
Journal:	Asian Pac J Trop Med. 2014 Apr;7(4):257-61.
Title:	Correlations of beta-catenin, Ki67 and Her-2/neu with gastric cancer.
Author:	Wu, Hong-Wen\|Qin, Cheng-Yong\|Huang, Ji-Lai\|Kong, Xian-Yi\|Wang, Wen-Ji\|Bai, Wen-Kun
PMID:	24507671

603.
Journal:	Anticancer Res. 2014 Feb;34(2):867-72.
Title:	HER2-positive gastric cancer with paraaortic nodal metastasis successfully resected after chemotherapy with trastuzumab: a case report.
Author:	Ikari, Naoki\|Nakajima, Go\|Taniguchi, Kiyoaki\|Sasagawa, Tsuyoshi\|Narumiya, Kosuke\|Yamada, Takuji\|Kudo, Kenji\|Kitamura, Yoichi\|Hayashi, Kazuhiko\|Nishikawa, Toshio\|Yamamoto, Masakazu
PMID:	24511024

604.
Journal:	Br J Cancer. 2014 Mar 4;110(5):1169-78.
Title:	HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma.
Author:	Liu, Y J\|Shen, D\|Yin, X\|Gavine, P\|Zhang, T\|Su, X\|Zhan, P\|Xu, Y\|Lv, J\|Qian, J\|Liu, C\|Sun, Y\|Qian, Z\|Zhang, J\|Gu, Y\|Ni, X
PMID:	24518603

605.
Journal:	Gastroenterology. 2014 Jun;146(7):1739-51.e14.
Title:	Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.
Author:	Chaturvedi, Rupesh\|Asim, Mohammad\|Piazuelo, M Blanca\|Yan, Fang\|Barry, Daniel P\|Sierra, Johanna Carolina\|Delgado, Alberto G\|Hill, Salisha\|Casero, Robert A Jr\|Bravo, Luis E\|Dominguez, Ricardo L\|Correa, Pelayo\|Polk, D Brent\|Washington, M Kay\|Rose, Kristie L\|
PMID:	24530706

606.
Journal:	Pharmacogenomics. 2014 Feb;15(3):375-84.
Title:	Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents.
Author:	Kim, Hark Kyun\|Green, Jeffrey E
PMID:	24533716

607.
Journal:	Tumour Biol. 2014 Jun;35(6):5315-21.
Title:	Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis.
Author:	Gu, Jianchun\|Zheng, Leizhen\|Wang, Yajie\|Zhu, Meiling\|Wang, Qin\|Li, Xiaoping
PMID:	24557541

608.
Journal:	Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Feb;17(2):108-11.
Title:	[Risk factors and prognosis of liver metastasis from gastric cancer].
Author:	Hu, Xiang
PMID:	24577761

609.
Journal:	J Hematol Oncol. 2014 Mar 11;7:22.
Title:	A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors.
Author:	Zhang, Jian\|Cao, Junning\|Li, Jin\|Zhang, Yifan\|Chen, Zhiyu\|Peng, Wei\|Sun, Si\|Zhao, Naiqing\|Wang, Jiachen\|Zhong, Dafang\|Zhang, Xiaofang\|Zhang, Jing
PMID:	24612546

610.
Journal:	Pathology. 2014 Apr;46(3):184-7.
Title:	HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2: CEP17 ratio?
Author:	Kumarasinghe, Marian Priyanthi\|de Boer, Willem Bastiaan\|Khor, Tze Sheng\|Ooi, Esther M\|Jene, Nic\|Jayasinghe, Sureshini\|Fox, Stephen B
PMID:	24614718

611.
Journal:	J Surg Oncol. 2014 Jun;109(8):812-7.
Title:	Prognostic implication of TSC1 and mTOR expression in gastric carcinoma.
Author:	Byeon, Sun-Ju\|Han, Nayoung\|Choi, Jiwoon\|Kim, Min A\|Kim, Woo Ho
PMID:	24615476

612.
Journal:	Int J Cancer. 2014 Sep 15;135(6):1390-8.
Title:	Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
Author:	Mimura, Kousaku\|Kamiya, Takahiro\|Shiraishi, Kensuke\|Kua, Ley-Fang\|Shabbir, Asim\|So, Jimmy\|Yong, Wei-Peng\|Suzuki, Yoshiyuki\|Yoshimoto, Yuya\|Nakano, Takashi\|Fujii, Hideki\|Campana, Dario\|Kono, Koji
PMID:	24615495

613.
Journal:	Med Oncol. 2014 Apr;31(4):903.
Title:	Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway.
Author:	Wu, Xiaoyu\|Chen, Yun\|Li, Gang\|Xia, Lei\|Gu, Rongmin\|Wen, Xu\|Ming, Xuezhi\|Chen, Huanqiu
PMID:	24623015

614.
Journal:	Virchows Arch. 2014 May;464(5):539-45.
Title:	Interpretation of HER2 tests in gastric cancer: confirmation of interobserver differences and validation of a QA/QC educational program.
Author:	Kushima, Ryoji\|Kuwata, Takeshi\|Yao, Takashi\|Kuriki, Hiroshi\|Hashizume, Kaoru\|Masuda, Shinobu\|Tsuda, Hitoshi\|Ochiai, Atsushi
PMID:	24633707

615.
Journal:	Mol Clin Oncol. 2014 Mar;2(2):175-181.
Title:	Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review).
Author:	Shimoyama, Shouji
PMID:	24649329

616.
Journal:	Hum Pathol. 2014 Apr;45(4):810-6.
Title:	HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer.
Author:	Chao, Wan-Ru\|Lee, Ming-Yung\|Lin, Wea-Long\|Chen, Chi-Kuan\|Lin, Jau-Chen\|Koo, Chiew-Loon\|Sheu, Gwo-Tarng\|Han, Chih-Ping
PMID:	24656091

617.
Journal:	Hum Pathol. 2014 May;45(5):970-5.
Title:	Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status.
Author:	Wang, Tao\|Hsieh, Eugene T\|Henry, Pauline\|Hanna, Wedad\|Streutker, Catherine J\|Grin, Andrea
PMID:	24656529

618.
Journal:	Tumour Biol. 2014 Jul;35(7):6177.
Title:	Comment on Gu et al. entitled "Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis".
Author:	Li, Jun\|Jing, Juehua
PMID:	24664586

619.
Journal:	Expert Rev Gastroenterol Hepatol. 2014 Jul;8(5):555-69.
Title:	Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
Author:	Al-Batran, Salah-Eddin\|Werner, Dominique
PMID:	24665840

620.
Journal:	Cancer Immunol Immunother. 2014 Jun;63(6):581-6.
Title:	Combining trastuzumab and cetuximab combats trastuzumab-resistant gastric cancer by effective inhibition of EGFR/ErbB2 heterodimerization and signaling.
Author:	Zheng, Lei\|Tan, Wenlong\|Zhang, Jinrong\|Yuan, Dongcai\|Yang, Jingci\|Liu, Hongmei
PMID:	24668364

621.
Journal:	Eur Rev Med Pharmacol Sci. 2014;18(5):689-92.
Title:	Feasibility of intraperitoneal Trastuzumab treatment in a patient with peritoneal carcinomatosis from gastric cancer.
Author:	Berretta, M\|Fisichella, R\|Borsatti, E\|Lleshi, A\|Ioffredo, S\|Meneguzzo, N\|Canzonieri, V\|Di Grazia, A\|Cannizzaro, R\|Tirelli, U\|Berretta, S
PMID:	24668709

622.
Journal:	Cancer Med. 2014 Jun;3(3):674-80.
Title:	Comparison of HER2 expression between primary colorectal cancer and their corresponding metastases.
Author:	Lee, Won-Suk\|Park, Yeon Ho\|Lee, Jung Nam\|Baek, Jeong-Heum\|Lee, Tae-Hoon\|Ha, Seung Yeon
PMID:	24668895

623.
Journal:	Clin Chem Lab Med. 2014 Jul;52(7):1033-40.
Title:	The quantification of HER2 and MYC gene fragments in cell-free plasma as putative biomarkers for gastric cancer diagnosis.
Author:	Park, Kyoung Un\|Lee, Hee Eun\|Nam, Soo Kyung\|Nam, Kyung Han\|Park, Do Joong\|Kim, Hyung-Ho\|Kim, Woo Ho\|Lee, Hye Seung
PMID:	24670359

624.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2014 Jan;43(1):4-7.
Title:	[Dual-color silver-enhanced in-situ hybridization for determination of HER2 gene amplification in gastric carcinoma].
Author:	Fan, Daming\|Li, Yujun\|Ran, Wenwen\|Yu, Wenjuan\|Li, Hong
PMID:	24713241

625.
Journal:	PLoS One. 2014 Apr 11;9(4):e94606.
Title:	Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.
Author:	Nielsen, Trine Ostergaard\|Friis-Hansen, Lennart\|Poulsen, Steen Seier\|Federspiel, Birgitte\|Sorensen, Boe Sandahl
PMID:	24728052

626.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):83-7.
Title:	[HER2 protein testing in gastric cancer: a retrospective analysis of 1 471 cases during two different periods in a single medical center].
Author:	Fan, Xiangshan\|Sun, Qi\|Chen, Jieyu\|Zhang, Yifen\|Wu, Hongyan\|Zhou, Qiang\|Zheng, Yusheng\|Meng, Fanqing
PMID:	24742566

627.
Journal:	Gan To Kagaku Ryoho. 2014 Apr;41(4):491-3.
Title:	[A case of advanced gastric cancer in which the serum HER2-ECD level could be used as a biomarker].
Author:	Terakawa, Hirofumi\|Oyama, Katsunobu\|Watanabe, Toshifumi\|Tsukada, Tomoya\|Okamoto, Koichi\|Kinoshita, Jun\|Furukawa, Hiroyuki\|Makino, Isamu\|Nakamura, Keishi\|Hayashi, Hironori\|Inokuchi, Masafumi\|Nakagawara, Hisatoshi\|Miyashita, Tomoharu\|Tajima, Hidehiro\|Takamu
PMID:	24743367

628.
Journal:	Ann Surg Oncol. 2014 Dec;21 Suppl 4:S584-90.
Title:	Prognostic impact of major receptor tyrosine kinase expression in gastric cancer.
Author:	Kurokawa, Yukinori\|Matsuura, Nariaki\|Kawabata, Ryohei\|Nishikawa, Kazuhiro\|Ebisui, Chikara\|Yokoyama, Yuhki\|Shaker, Mohammed Nouri\|Hamakawa, Takuya\|Takahashi, Tsuyoshi\|Takiguchi, Shuji\|Mori, Masaki\|Doki, Yuichiro
PMID:	24743909

629.
Journal:	World J Gastroenterol. 2014 Apr 14;20(14):3905-15.
Title:	Treatment options in patients with metastatic gastric cancer: current status and future perspectives.
Author:	Bilici, Ahmet
PMID:	24744580

630.
Journal:	World J Gastroenterol. 2014 Apr 14;20(14):3927-37.
Title:	An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
Author:	Yamamoto, Hiroyuki\|Watanabe, Yoshiyuki\|Maehata, Tadateru\|Morita, Ryo\|Yoshida, Yoshihito\|Oikawa, Ritsuko\|Ishigooka, Shinya\|Ozawa, Shun-Ichiro\|Matsuo, Yasumasa\|Hosoya, Kosuke\|Yamashita, Masaki\|Taniguchi, Hiroaki\|Nosho, Katsuhiko\|Suzuki, Hiromu\|Yasuda, Hiros
PMID:	24744582

631.
Journal:	Clin Genet. 2014 Jul;86(1):37-43.
Title:	Innovative personalized medicine in gastric cancer: time to move forward.
Author:	Lee, J\|Kim, K-M\|Kang, W K\|Ou, S-H I
PMID:	24749947

632.
Journal:	Recent Results Cancer Res. 2014;201:125-43.
Title:	Lapatinib.
Author:	Nolting, Minna\|Schneider-Merck, Tanja\|Trepel, Martin
PMID:	24756789

633.
Journal:	Hum Pathol. 2014 Jun;45(6):1258-68.
Title:	ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts.
Author:	Wiegand, Kimberly C\|Sy, Keiyan\|Kalloger, Steve E\|Li-Chang, Hector\|Woods, Ryan\|Kumar, Aalok\|Streutker, Catherine J\|Hafezi-Bakhtiari, Sara\|Zhou, Chen\|Lim, Howard J\|Huntsman, David G\|Clarke, Blaise\|Schaeffer, David F
PMID:	24767857

634.
Journal:	Mol Cancer. 2014 Apr 28;13:92.
Title:	Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.
Author:	Liu, Xiang-Hua\|Sun, Ming\|Nie, Feng-Qi\|Ge, Ying-Bin\|Zhang, Er-Bao\|Yin, Dan-Dan\|Kong, Rong\|Xia, Rui\|Lu, Kai-Hua\|Li, Jin-Hai\|De, Wei\|Wang, Ke-Ming\|Wang, Zhao-Xia
PMID:	24775712

635.
Journal:	World J Gastroenterol. 2014 Apr 28;20(16):4526-35.
Title:	Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects.
Author:	Jorgensen, Jan Trost
PMID:	24782605

636.
Journal:	World J Gastroenterol. 2014 Apr 28;20(16):4536-45.
Title:	Targeting receptor tyrosine kinases in gastric cancer.
Author:	Morishita, Asahiro\|Gong, Jian\|Masaki, Tsutomu
PMID:	24782606

637.
Journal:	Expert Opin Investig Drugs. 2014 Jul;23(7):925-42.
Title:	The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey.
Author:	Aprile, Giuseppe\|Giampieri, Riccardo\|Bonotto, Marta\|Bittoni, Alessandro\|Ongaro, Elena\|Cardellino, Giovanni Gerardo\|Graziano, Francesco\|Giuliani, Francesco\|Fasola, Gianpiero\|Cascinu, Stefano\|Scartozzi, Mario
PMID:	24806575

638.
Journal:	Curr Treat Options Oncol. 2014 Sep;15(3):395-404.
Title:	HER2 directed therapy for gastric/esophageal cancers.
Author:	Won, Elizabeth\|Janjigian, Yelena J\|Ilson, David H
PMID:	24811128

639.
Journal:	Case Rep Oncol Med. 2014;2014:731581.
Title:	Importance of HER2 Work-Up and Treatment Even in Patients with Poor Performance Status: A Case Report.
Author:	Suner, Ali\|Buyukhatipoglu, Hakan\|Balakan, Ozan\|Kalender, Mehmet Emin\|Ulas, Turgay\|Sevinc, Alper\|Camci, Celalettin
PMID:	24822142

640.
Journal:	J Clin Oncol. 2014 Jul 1;32(19):2039-49.
Title:	Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.
Author:	Satoh, Taroh\|Xu, Rui-Hua\|Chung, Hyun Cheol\|Sun, Guo-Ping\|Doi, Toshihiko\|Xu, Jian-Ming\|Tsuji, Akihito\|Omuro, Yasushi\|Li, Jin\|Wang, Jin-Wan\|Miwa, Hiroto\|Qin, Shu-Kui\|Chung, Ik-Joo\|Yeh, Kun-Huei\|Feng, Ji-Feng\|Mukaiyama, Akihira\|Kobayashi, Mikiro\|Ohtsu, Atsus
PMID:	24868024

641.
Journal:	Virchows Arch. 2014 Aug;465(2):145-54.
Title:	Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.
Author:	Yoshida, Hiroshi\|Yamamoto, Noriko\|Taniguchi, Hirokazu\|Oda, Ichiro\|Katai, Hitoshi\|Kushima, Ryoji\|Tsuda, Hitoshi
PMID:	24889042

642.
Journal:	J Transl Med. 2014 Jun 6;12:160.
Title:	The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing.
Author:	Werner, Dominique\|Battmann, Achim\|Steinmetz, Kristina\|Jones, Tobin\|Lamb, Tiffany\|Martinez, Michele\|Altmannsberger, Hans-Michael\|Al-Batran, Salah-Eddin
PMID:	24906218

643.
Journal:	J Chin Med Assoc. 2014 Jul;77(7):345-53.
Title:	Update on treatment of gastric cancer.
Author:	Kuo, Chen-Yu\|Chao, Yee\|Li, Chung-Pin
PMID:	24907022

644.
Journal:	Exp Ther Med. 2014 Jun;7(6):1757-1761.
Title:	miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression.
Author:	Shen, Zhi-Yong\|Zhang, Zi-Zhen\|Liu, Hua\|Zhao, En-Hao\|Cao, Hui
PMID:	24926380

645.
Journal:	Genes Chromosomes Cancer. 2014 Nov;53(11):883-94.
Title:	Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.
Author:	Qian, Ziliang\|Zhu, Guanshan\|Tang, Lili\|Wang, Mei\|Zhang, Lianhai\|Fu, Jiangang\|Huang, Chunlei\|Fan, Shuqiong\|Sun, Yun\|Lv, Jing\|Dong, Hua\|Gao, Beirong\|Su, Xinying\|Yu, Dehua\|Zang, Jie\|Zhang, Xiaolin\|Ji, Jiafu\|Ji, Qunsheng
PMID:	24935174

646.
Journal:	Nanoscale Res Lett. 2014 May 19;9(1):244.
Title:	BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer.
Author:	Li, Chao\|Ji, Yang\|Wang, Can\|Liang, Shujing\|Pan, Fei\|Zhang, Chunlei\|Chen, Feng\|Fu, Hualin\|Wang, Kan\|Cui, Daxiang
PMID:	24940175

647.
Journal:	Cancer Lett. 2014 Aug 28;351(1):30-40.
Title:	A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond.
Author:	Gomez-Martin, Carlos\|Lopez-Rios, Fernando\|Aparicio, Jorge\|Barriuso, Jorge\|Garcia-Carbonero, Rocio\|Pazo, Roberto\|Rivera, Fernando\|Salgado, Mercedes\|Salud, Antonieta\|Vazquez-Sequeiros, Enrique\|Lordick, Florian
PMID:	24943493

648.
Journal:	Oncotarget. 2014 Jul 15;5(13):4868-80.
Title:	Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo.
Author:	Guan, Siao-Syun\|Chang, Jungshan\|Cheng, Chun-Chia\|Luo, Tsai-Yueh\|Ho, Ai-Sheng\|Wang, Chia-Chi\|Wu, Cheng-Tien\|Liu, Shing-Hwa
PMID:	24947902

649.
Journal:	Oncologist. 2014 Jul;19(7):712-9.
Title:	Quality of life in the trastuzumab for gastric cancer trial.
Author:	Satoh, Taroh\|Bang, Yung-Jue\|Gotovkin, Evgeny A\|Hamamoto, Yasuo\|Kang, Yoon-Koo\|Moiseyenko, Vladimir M\|Ohtsu, Atsushi\|Van Cutsem, Eric\|Al-Sakaff, Nedal\|Urspruch, Alexa\|Hill, Julie\|Weber, Harald A\|Chung, Hyun-Cheol
PMID:	24951609

650.
Journal:	Expert Rev Anticancer Ther. 2014 Aug;14(8):887-900.
Title:	Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.
Author:	Garrido, Marcelo\|Fonseca, Paula J\|Vieitez, Jose Maria\|Frunza, Madalina\|Lacave, Angel J
PMID:	24953238

651.
Journal:	Oncol Lett. 2014 Jul;8(1):394-396.
Title:	Sudden hearing loss due to internal auditory canal metastasis of Her2-positive gastric cancer: A case report.
Author:	Kim, Chang-Hee\|Shin, Jung Eun\|Roh, Hong Gee\|Lee, Jong Sik\|Yoon, So Young
PMID:	24959283

652.
Journal:	Br J Cancer. 2014 Aug 12;111(4):660-6.
Title:	A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer.
Author:	Kang, Y-K\|Rha, S Y\|Tassone, P\|Barriuso, J\|Yu, R\|Szado, T\|Garg, A\|Bang, Y-J
PMID:	24960402

653.
Journal:	Contemp Oncol (Pozn). 2014;18(2):95-9.
Title:	Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer.
Author:	Chen, Ming\|Li, Yan\|Ming, Zhou\|Biao, Ai\|Zheng, Liu Xue
PMID:	24966791

654.
Journal:	Clin Cancer Res. 2014 Sep 1;20(17):4559-73.
Title:	Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer.
Author:	Zhang, Zhe\|Wang, Jiping\|Ji, Dongmei\|Wang, Chenchen\|Liu, Rujiao\|Wu, Zheng\|Liu, Lian\|Zhu, Dan\|Chang, Jinjia\|Geng, Ruixuan\|Xiong, Lei\|Fang, Qiangyi\|Li, Jin
PMID:	24973425

655.
Journal:	Anticancer Res. 2014 Jul;34(7):3695-9.
Title:	Molecular-targeted therapy for chemotherapy-refractory gastric cancer: a case report and literature review.
Author:	Kuo, Hung-Yang\|Yeh, Kun-Huei
PMID:	24982389

656.
Journal:	Anticancer Res. 2014 Jul;34(7):3807-10.
Title:	MicroRNA signature for HER2-positive breast and gastric cancer.
Author:	Kang, Han Sung\|Kim, Joseph\|Jang, Sang-Geun\|Kwon, Sun Young\|Park, Young Soo\|Green, Jeffrey E\|Kim, Hark Kyun\|Ro, Jungsil
PMID:	24982406

657.
Journal:	Cancers (Basel). 2014 Jul 7;6(3):1441-63.
Title:	The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma.
Author:	Matsuoka, Tasuku\|Yashiro, Masakazu
PMID:	25003395

658.
Journal:	Oncotarget. 2014 Aug 30;5(16):6594-602.
Title:	Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer.
Author:	Li, Yilin\|Zhang, Xiaotian\|Ge, Sai\|Gao, Jing\|Gong, Jifang\|Lu, Ming\|Zhang, Qiyue\|Cao, Yanshuo\|Wang, Daisy Dandan\|Lin, Peter Ping\|Shen, Lin
PMID:	25026283

659.
Journal:	Pathol Int. 2014 Jul;64(7):309-14.
Title:	Overexpression of miR-17 in gastric cancer is correlated with proliferation-associated oncogene amplification.
Author:	Park, Dongmin\|Lee, Seok Cheol\|Park, Jun Won\|Cho, Soo Young\|Kim, Hark Kyun
PMID:	25047501

660.
Journal:	Anticancer Res. 2014 Aug;34(8):4207-12.
Title:	Significance of accurate human epidermal growth factor receptor-2 (HER2) evaluation as a new biomarker in gastric cancer.
Author:	Kimura, Yasue\|Oki, Eiji\|Yoshida, Ayae\|Aishima, Shinichi\|Zaitsu, Yoko\|Ohtsu, Hajime\|Ando, Koji\|Ida, Satoshi\|Saeki, Hiroshi\|Morita, Masaru\|Kusumoto, Tetsuya\|Oda, Yoshinao\|Maehara, Yoshihiko
PMID:	25075048

661.
Journal:	Cancer Lett. 2014 Oct 28;353(2):167-75.
Title:	Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH.
Author:	Das, Kakoli\|Gunasegaran, Bavani\|Tan, Iain Beehuat\|Deng, Niantao\|Lim, Kiat Hon\|Tan, Patrick
PMID:	25086186

662.
Journal:	Clin Cancer Res. 2014 Oct 1;20(19):5032-40.
Title:	Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors.
Author:	Shimizu, Toshio\|LoRusso, Patricia M\|Papadopoulos, Kyri P\|Patnaik, Amita\|Beeram, Muralidhar\|Smith, Lon S\|Rasco, Drew W\|Mays, Theresa A\|Chambers, Glenda\|Ma, Anna\|Wang, Jing\|Laliberte, Robert\|Voi, Maurizio\|Tolcher, Anthony W
PMID:	25107918

663.
Journal:	Mol Med Rep. 2014 Oct;10(4):1839-44.
Title:	A germline mutation in the miR125a coding region reduces miR125a expression and is associated with human gastric cancer.
Author:	Shang, Hua\|Wang, Tao\|Shang, Feng\|Huang, Kun-Ming\|Li, Yan-Qing
PMID:	25109760

664.
Journal:	Tumour Biol. 2014 Nov;35(11):11513-21.
Title:	Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancer.
Author:	Wang, Qinchuan\|Zhou, Jichun\|Guo, Jufeng\|Teng, Rongyue\|Shen, Jianguo\|Huang, Yasheng\|Xie, Shuduo\|Wei, Qun\|Zhao, Wenhe\|Chen, Wenjun\|Yuan, Xiaoming\|Chen, Yongxia\|Wang, Linbo
PMID:	25128063

665.
Journal:	Oncologist. 2014 Oct;19(10):1046-55.
Title:	How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.
Author:	Kim, Christina\|Mulder, Karen\|Spratlin, Jennifer
PMID:	25142842

666.
Journal:	Pathol Int. 2014 Aug;64(8):402-8.
Title:	Gastric carcinoma with an invasive micropapillary carcinoma component showing HER2 gene amplification and CD10 expression: a case report and review of the literature.
Author:	Tajima, Shogo\|Kodama, Hiroki\|Kamiya, Tadahiro\|Terasaki, Masaki
PMID:	25143129

667.
Journal:	Mol Med Rep. 2014 Nov;10(5):2669-74.
Title:	Comparison of immunohistochemistry, four in situ hybridization methods and quantitative polymerase chain reaction for the molecular diagnosis of HER2 status in gastric cancer: a study of 55 cases.
Author:	Stanek, Libor\|Rozkos, Tomas\|Laco, Jan\|Ryska, Ales\|Petruzelka, Lubos\|Dura, Miroslav\|Dundr, Pavel
PMID:	25189406

668.
Journal:	Biomed Pharmacother. 2014 Jul;68(6):809-12.
Title:	The role of HER3 in gastric cancer.
Author:	Wang, Liying\|Yuan, Hengheng\|Li, Yanjing\|Han, Yu
PMID:	25194439

669.
Journal:	Anticancer Res. 2014 Sep;34(9):5083-6.
Title:	HER2-positive gastric cancer showing marked thickening of the gastric wall on ultrasonographic and computed tomographic scans. a chance phenomenon or a specific behaviour of this cancer type? Report of three cases.
Author:	DI Cicilia, Roberto\|Mordenti, Patrizia\|Anselmi, Elisa\|Paties, Carlo\|Carella, Egidio\|Cavanna, Luigi
PMID:	25202095

670.
Journal:	Pathol Int. 2014 Sep;64(9):453-9.
Title:	Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma.
Author:	Kondo, Yusuke\|Kikuchi, Tomoki\|Esteban, Joaquim Carreras\|Kumaki, Nobue\|Ogura, Go\|Inomoto, Chie\|Hirabayashi, Kenichi\|Kajiwara, Hiroshi\|Sakai, Akihiro\|Sugimoto, Ryousuke\|Otsuru, Mitsunobu\|Okami, Kenji\|Tsukinoki, Keiichi\|Nakamura, Naoya
PMID:	25209856

671.
Journal:	Br J Cancer. 2014 Nov 11;111(10):1977-84.
Title:	HER2/neu testing in primary colorectal carcinoma.
Author:	Ingold Heppner, B\|Behrens, H-M\|Balschun, K\|Haag, J\|Kruger, S\|Becker, T\|Rocken, C
PMID:	25211663

672.
Journal:	Asia Pac J Clin Oncol. 2014 Dec;10(4):297-307.
Title:	Human epidermal growth factor receptor 2 testing in gastric cancer: recommendations of an Asia-Pacific task force.
Author:	Kim, Kyoung-Mee\|Bilous, Michael\|Chu, Kent-Man\|Kim, Beom-Su\|Kim, Woo-Ho\|Park, Young Soo\|Ryu, Min-Hee\|Sheng, Weiqi\|Wang, John\|Chao, Yee\|Ying, Jianming\|Zhang, Sheng
PMID:	25227602

673.
Journal:	World J Gastroenterol. 2014 Sep 14;20(34):12355-8.
Title:	Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy.
Author:	Dong, Cai-Xia\|Fu, Jian-Fei\|Ye, Xian-Yun\|Li, Xiao-Fen\|Zhong, Xian\|Yuan, Ying
PMID:	25232273

674.
Journal:	Gan To Kagaku Ryoho. 2014 Sep;41(9):1155-7.
Title:	[A case of gastric cancer that responded to a preoperative combination therapy of S-1/CDDP plus trastuzumab].
Author:	Sueoka, Satoshi\|Ito, Akihiro\|Kawanishi, Jun\|Sakakima, Yoshikazu
PMID:	25248902

675.
Journal:	Gan To Kagaku Ryoho. 2014 Sep;41(9):1167-70.
Title:	[A case of advanced gastric cancer with multiple liver, lung, and lymph node metastases treated with S-1, CDDP, and trastuzumab].
Author:	Fukuda, Naoto\|Niki, Michio\|Sano, Masaya\|Ogura, Rena\|Wada, Joji
PMID:	25248905

676.
Journal:	Exp Ther Med. 2014 Nov;8(5):1501-1507.
Title:	Detection of Her-2/neu expression in gastric cancer: Quantitative PCR versus immunohistochemistry.
Author:	Zhu, Guang-Jun\|Xu, Chun-Wei\|Fang, Mei-Yu\|Zhang, Yu-Ping\|Li, Yang
PMID:	25289049

677.
Journal:	Asian Pac J Cancer Prev. 2014;15(18):7597-602.
Title:	Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
Author:	Rakhshani, Nasser\|Kalantari, Elham\|Bakhti, Hadi\|Sohrabi, Masoud Reza\|Mehrazma, Mitra
PMID:	25292034

678.
Journal:	Med Oncol. 2014 Nov;31(11):280.
Title:	Prognosis significance of HER2 status and TACC1 expression in patients with gastric carcinoma.
Author:	Lv, Jing\|Yao, Ya-sai\|Zhou, Fei\|Zhuang, Li-kun\|Yao, Ru-yong\|Liang, Jun\|Qiu, Wen-sheng\|Yue, Lu
PMID:	25297519

679.
Journal:	Expert Opin Ther Pat. 2014 Nov;24(11):1149-53.
Title:	Biosimilars lining up to compete with Herceptin--opportunity knocks.
Author:	Nelson, Kevin M\|Gallagher, Patrick C
PMID:	25307085

680.
Journal:	World J Gastroenterol. 2014 Oct 14;20(38):13637-47.
Title:	Medical management of gastric cancer: a 2014 update.
Author:	Elimova, Elena\|Shiozaki, Hironori\|Wadhwa, Roopma\|Sudo, Kazuki\|Chen, Qiongrong\|Estrella, Jeannelyn S\|Blum, Mariela A\|Badgwell, Brian\|Das, Prajnan\|Song, Shumei\|Ajani, Jaffer A
PMID:	25320502

681.
Journal:	World J Gastroenterol. 2014 Oct 14;20(38):13741-55.
Title:	Molecular targeting to treat gastric cancer.
Author:	Aoyagi, Keishiro\|Kouhuji, Kikuo\|Kizaki, Junya\|Isobe, Taro\|Hashimoto, Kousuke\|Shirouzu, Kazuo
PMID:	25320512

682.
Journal:	J Cancer Res Clin Oncol. 2014 Dec;140(12):2163-8.
Title:	IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status.
Author:	Damasceno, Emanuel Adelino M\|Carneiro, Fabiana Pirani\|Magalhaes, Albino Vercosa de\|Carneiro, Marcos de Vasconcelos\|Takano, Gustavo Henrique Soares\|Vianna, Leonora Maciel de Sousa\|Seidler, Heinrich Bender Kohnert\|Castro, Tercia Maria Mendes Lousa de\|Muniz-
PMID:	25323937

683.
Journal:	Oncotarget. 2014 Sep 30;5(18):8317-29.
Title:	Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression.
Author:	Li, Guangchao\|Zhao, Likun\|Li, Wei\|Fan, Kexing\|Qian, Weizhu\|Hou, Sheng\|Wang, Hao\|Dai, Jianxin\|Wei, Huafeng\|Guo, Yajun
PMID:	25327561

684.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2014 Jul;43(7):468-72.
Title:	[Delay in formalin fixation and HER2 testing in gastric cancer].
Author:	Zeng, Lixia\|Huang, Junqi\|Ma, Yun\|Liu, Yixiao\|Wei, Yuying\|Zheng, Qian\|Ye, Hongtao
PMID:	25327797

685.
Journal:	J Gastric Cancer. 2014 Sep;14(3):180-6.
Title:	Correlation between HER2 Overexpression and Clinicopathological Characteristics in Gastric Cancer Patients Who Have Undergone Curative Resection.
Author:	Son, Ho Sung\|Shin, Yeon Myung\|Park, Kwang Kuk\|Seo, Kyung Won\|Yoon, Ki Young\|Jang, Hee Kyung\|Lee, Sang-Ho\|Yang, Song I\|Kim, Jeong Hoon
PMID:	25328763

686.
Journal:	Gan To Kagaku Ryoho. 2014 Oct;41(10):1316-8.
Title:	[A case of unresectable Stage IV HER2-positive advanced gastric cancer treated by using trastuzumab combined with chemotherapy].
Author:	Aomatsu, Naoki\|Doi, Yosuke\|Takemura, Satoru\|Tanaka, Hiroaki\|Muguruma, Kazuya\|Yui, Saburo\|Hirakawa, Kosei
PMID:	25335729

687.
Journal:	Arch Pathol Lab Med. 2014 Nov;138(11):1495-502.
Title:	HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation.
Author:	Sheffield, Brandon S\|Garratt, John\|Kalloger, Steve E\|Li-Chang, Hector H\|Torlakovic, Emina E\|Gilks, C Blake\|Schaeffer, David F
PMID:	25357111

688.
Journal:	PLoS One. 2014 Nov 5;9(11):e111693.
Title:	High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.
Author:	Kim, Seokhwi\|Lee, Jeeyun\|Hong, Min Eui\|Do, In-Gu\|Kang, So Young\|Ha, Sang Yun\|Kim, Seung Tae\|Park, Se Hoon\|Kang, Won Ki\|Choi, Min-Gew\|Lee, Jun Ho\|Sohn, Tae Sung\|Bae, Jae Moon\|Kim, Sung\|Kim, Duk-Hwan\|Kim, Kyoung-Mee
PMID:	25372287

689.
Journal:	Asian Pac J Cancer Prev. 2014;15(20):8661-6.
Title:	Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2-negative advanced gastric cancer.
Author:	Bilici, Ahmet\|Selcukbiricik, Fatih\|Demir, Nazan\|Oven Ustaalioglu, Bala Basak\|Dikilitas, Mustafa\|Yildiz, Ozcan
PMID:	25374186

690.
Journal:	Clin Drug Investig. 2014 Dec;34(12):887-94.
Title:	A phase I dose-escalation and bioequivalence study of a trastuzumab biosimilar in healthy male volunteers.
Author:	Wisman, Liselijn A B\|De Cock, Eduard P M\|Reijers, Joannes A A\|Kamerling, Ingrid M C\|Van Os, Sandra H G\|de Kam, Marieke L\|Burggraaf, Jacobus\|Voortman, Gerrit
PMID:	25377592

691.
Journal:	BMC Cancer. 2014 Nov 7;14:823.
Title:	Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
Author:	Qiu, Miaozhen\|Zhou, Yixin\|Zhang, Xinke\|Wang, Zixian\|Wang, Fang\|Shao, Jianyong\|Lu, Jiabin\|Jin, Ying\|Wei, Xiaoli\|Zhang, Dongsheng\|Wang, Fenghua\|Li, Yuhong\|Yang, Dajun\|Xu, Ruihua
PMID:	25380654

692.
Journal:	PLoS One. 2014 Nov 17;9(11):e113276.
Title:	Photoimmunotherapy of gastric cancer peritoneal carcinomatosis in a mouse model.
Author:	Sato, Kazuhide\|Choyke, Peter L\|Kobayashi, Hisataka
PMID:	25401794

693.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(11):1421-4.
Title:	[Gastric cancer with liver metastasis and peritoneal dissemination treated with conversion surgery to achieve r0 resection after capecitabine, cisplatin, and trastuzumab chemotherapy-a case report].
Author:	Choda, Yasuhiro\|Ninomiya, Motoki\|Kanazawa, Takashi\|Sato, Daisuke\|Tokumoto, Noriaki\|Harano, Masao\|Matsukawa, Hiroyoshi\|Ojima, Yasutomo\|Idani, Hitoshi\|Shiozaki, Shigehiro\|Okajima, Masazumi
PMID:	25434447

694.
Journal:	Hepatogastroenterology. 2014 Sep;61(134):1817-21.
Title:	Immunohistochemical HER2 expression not associated with clinicopathological characteristics of stage I-III gastric cancer patients.
Author:	Chen, Xin-Zu\|Zhang, Wei-Han\|Yao, Wen-Qing\|Liu, Jian-Ping\|Zhou, Zong-Guang\|Chen, Zhi-Xin\|Zhang, Bo\|Chen, Jia-Ping\|Mo, Xian-Ming\|Hu, Jian-Kun
PMID:	25436385

695.
Journal:	Cancer Sci. 2014 Dec;105(12):1591-600.
Title:	Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.
Author:	Ema, Akira\|Yamashita, Keishi\|Ushiku, Hideki\|Kojo, Ken\|Minatani, Naoko\|Kikuchi, Mariko\|Mieno, Hiroaki\|Moriya, Hiromitsu\|Hosoda, Kei\|Katada, Natsuya\|Kikuchi, Shiro\|Watanabe, Masahiko
PMID:	25455899

696.
Journal:	Int J Mol Sci. 2014 Dec 3;15(12):22331-41.
Title:	Discordance rate of HER2 status in primary gastric carcinomas and synchronous lymph node metastases: a multicenter retrospective analysis.
Author:	Ieni, Antonio\|Barresi, Valeria\|Caltabiano, Rosario\|Caleo, Alessia\|Bonetti, Luca Reggiani\|Lanzafame, Salvatore\|Zeppa, Pio\|Caruso, Rosario Alberto\|Tuccari, Giovanni
PMID:	25479078

697.
Journal:	Genet Mol Res. 2014 Dec 19;13(4):10952-7.
Title:	Preoperative chemotherapy with a trastuzumab-containing regimen for a patient with gastric cancer and hepatic metastases.
Author:	Li, Z-Y\|Shan, F\|Zhang, L-H\|Bu, Z-D\|Wu, A-W\|Wu, X-J\|Zong, X-L\|Li, S-X\|Ji, X\|Ji, J-F
PMID:	25526216

698.
Journal:	Bull Cancer. 2014 Dec;101(12):1114-21.
Title:	[Pertuzumab and solid tumors: perspectives].
Author:	Barthelemy, Philippe\|Leblanc, Julie\|Wendling, Frederique\|Wissler, Marie-Pierre\|Bergerat, Jean-Pierre
PMID:	25532690

699.
Journal:	Indian J Med Paediatr Oncol. 2014 Oct;35(4):239-43.
Title:	Indian Council of Medical Research consensus document for the management of gastric cancer.
Author:	Shrikhande, Shailesh V\|Sirohi, Bhawna\|Barreto, Savio G\|Chacko, Raju T\|Parikh, Purvish M\|Pautu, Jeremy\|Arya, Supreeta\|Patil, Prachi\|Chilukuri, Srinivas C\|Ganesh, B\|Kaur, Tanvir\|Shukla, Deepak\|Rath, Goura Shankar
PMID:	25538398

700.
Journal:	Turk J Med Sci. 2014;44(3):461-70.
Title:	Detection of kinase amplifications in gastric adenocarcinomas.
Author:	Ozdemiri, Muhsin\|Oznur, Murat\|Ciftci, Evrim\|Durak Aras, Beyhan\|Aslan, Huseyin\|Saygili, Hande\|Oner, Kevser Setenay\|Erkasap, Serdar Mustafa\|Ozakyol, Aysegiil\|Pasaoglu, Ozgiil\|Cilingir, Oguz\|Artan, Sevilhan
PMID:	25558650

701.
Journal:	Asian Pac J Cancer Prev. 2014;15(24):10607-11.
Title:	Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Author:	Selcukbiricik, Fatih\|Erdamar, Sibel\|Buyukunal, Evin\|Serrdengecti, Suheyla\|Demirelli, Fuat
PMID:	25605147

702.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2259-61.
Title:	[A case of gastric cancer with solitary metachronous adrenal metastasis].
Author:	Namikawa, Tsutomu\|Munekage, Eri\|Munekage, Masaya\|Uemura, Sunao\|Shiga, Mai\|Maeda, Hiromichi\|Kitagawa, Hiroyuki\|Kobayashi, Michiya\|Hanazaki, Kazuhiro
PMID:	25731488

703.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2287-9.
Title:	[A case report of neuroendocrine carcinoma of the stomach with liver metastases curatively resected after neoadjuvant chemotherapy].
Author:	Hokonohara, Kentaro\|Takata, Akihiro\|Noda, Takehiro\|Imamura, Hiroshi\|Hirota, Masashi\|Oshima, Kazuteru\|Tanida, Tsukasa\|Hatano, Hisanori\|Komori, Takamichi\|Morita, Shunji\|Iwazawa, Takashi\|Akagi, Kenzo\|Adachi, Shiro\|Dono, Keizo
PMID:	25731498

704.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2296-8.
Title:	[A case of HER2-positive advanced gastric cancer with extensive lymph node metastasis treated via chemotherapy with a trastuzumab-containing regimen followed by conversion surgery].
Author:	Yamamoto, Kazuyoshi\|Fujitani, Kazumasa\|Tsujinaka, Toshimasa\|Hirao, Motohiro\|Nishikawa, Kazuhiro\|Fukuda, Yasunari\|Haraguchi, Naotsugu\|Miyake, Masakazu\|Asaoka, Tadafumi\|Miyamoto, Atsushi\|Omiya, Hideyasu\|Ikeda, Masataka\|Takami, Koji\|Nakamori, Shoji\|Sekimoto,
PMID:	25731501

705.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2302-4.
Title:	[A case of curative surgery for HER2-positive gastric cancer after chemotherapy using paclitaxel combined with trastuzumab].
Author:	Okubo, Satoshi\|Kawabata, Ryohei\|Kimura, Yutaka\|Kawase, Tomono\|Ishigaki, Takahiko\|Amano, Kouji\|Munakata, Satoru\|Fukunaga, Mutsumi\|Ohzato, Hiroki
PMID:	25731503

706.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2308-10.
Title:	[Two cases of Stage IV Gastric cancer responding to chemotherapy and leading to pathological complete response].
Author:	Kubota, Tetsushi\|Kagawa, Shunsuke\|Kikuchi, Satoru\|Kuroda, Shinji\|Nishizaki, Masahiko\|Fujiwara, Toshiyoshi
PMID:	25731505

707.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2311-3.
Title:	[A case of advanced gastric cancer successfully treated with trastuzumab, capecitabine, and Cisplatin therapy followed by curative resection].
Author:	Kato, Shigeru\|Asao, Yoshito\|Aisu, Yuki\|Honda, Kotaro\|Ando, Yasuhisa\|Nishino, Hiroto\|Nishiuchi, Aya\|Kadokawa, Yoshio\|Machimoto, Takafumi\|Furuyama, Hiroaki\|Yoshimura, Tsunehiro
PMID:	25731506

708.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2340-2.
Title:	[A case of advanced gastric cancer with portal vein thrombus leading to liver metastases].
Author:	Ebisui, Chikara\|Okada, Kazuyuki\|Yanagisawa, Tetsu\|Okamura, Shu\|Fukuchi, Nariaki\|Murata, Kohei\|Yokouchi, Hideoki\|Tamai, Masamitsu\|Kinuta, Masakatsu
PMID:	25731516

709.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2346-8.
Title:	[A case of advanced HER2- positive gastric cancer with a partial response to molecular targeted chemotherapy (S-1+CDDP+Trastuzumab)].
Author:	Michiura, Toshiya\|Miyazaki, Satoru\|Fujita, Shigeo\|Hirose, Hajime\|Miyazaki, Yasuaki\|Sugimoto, Satoshi\|Yamabe, Kazuo\|Nagaoka, Makio
PMID:	25731518

710.
Journal:	Gan To Kagaku Ryoho. 2014 Nov;41(12):2433-5.
Title:	[A case of locoregional recurrence after gastric cancer surgery, which was treated with XPT regimen chemotherapy].
Author:	Oka, Yoshio\|Okada, Kaoru\|Uemura, Hisashi\|Nakane, Shigeru\|Miyake, Yasuhiro\|Higaki, Naozumi\|Murakami, Masakazu\|Hayashida, Hirohito\|Nezu, Riichiro
PMID:	25731548

711.
Journal:	Arkh Patol. 2014 Nov-Dec;76(6):22-27.
Title:	[Comparative study of the determination of the HER2 status in gastric cancer in the biopsy and intraoperative specimens].
Author:	Zavalishina, L E\|Andreeva, Iu Iu\|Vinogradov, I Iu\|Danilova, N V\|Kuznetsova, O A\|Frank, G A
PMID:	25842922

712.
Journal:	Chemotherapy. 2014;60(4):224-7.
Title:	Advanced gastric cancer with liver and lymph node metastases successfully resected after induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil.
Author:	Cavanna, Luigi\|Bodini, Flavio Cesare\|Stroppa, Elisa Maria\|Banchini, Filippo\|Michieletti, Emanuele\|Capelli, Patrizio\|Zangrandi, Adriano\|Anselmi, Elisa
PMID:	25872022

713.
Journal:	Hepatogastroenterology. 2014 May;61(131):858-62.
Title:	Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
Author:	Yoo, Moon-Won\|Han, Hye Seung\|Kim, Sung Yong\|Cho, Yo Han\|Lee, Hong Ghi\|Kim, Jeong Hwan\|Bang, Ho-Yoon\|Lee, Kyung-Yung\|Yoon, So Young
PMID:	26176087

714.
Journal:	Chemotherapy. 2014;60(5-6):321-4.
Title:	Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer.
Author:	Orlandi, Elena\|Mordenti, Patrizia\|Zangrandi, Adriano\|Cavanna, Luigi
PMID:	26279275

715.
Journal:	Gastrointest Tumors. 2014 May;1(4):180-94.
Title:	Gastric Cancer: New Drugs - New Strategies.
Author:	Schulte, Nadin\|Ebert, Matthias P\|Hartel, Nicola
PMID:	26674336

716.
Journal:	Asia Ocean J Nucl Med Biol. 2014 Spring;2(1):12-8.
Title:	(18)F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value.
Author:	Kim, Jin Suk\|Young Park, Shin
PMID:	27408854

717.
Journal:	Gastric Cancer. 2015 Jan;18(1):65-76.
Title:	Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer.
Author:	Yoda, Yukie\|Takeshima, Hideyuki\|Niwa, Tohru\|Kim, Jeong Goo\|Ando, Takayuki\|Kushima, Ryoji\|Sugiyama, Toshiro\|Katai, Hitoshi\|Noshiro, Hirokazu\|Ushijima, Toshikazu
PMID:	24510342

718.
Journal:	J Gastroenterol. 2015 Jan;50(1):41-5.
Title:	Evaluation of serum HER2-ECD levels in patients with gastric cancer.
Author:	Oyama, Katsunobu\|Fushida, Sachio\|Tsukada, Tomoya\|Kinoshita, Jun\|Watanabe, Toshifumi\|Shoji, Masatoshi\|Nakanuma, Shinichi\|Okamoto, Koichi\|Sakai, Seisho\|Makino, Isamu\|Nakamura, Keishi\|Hayashi, Hironori\|Inokuchi, Masafumi\|Nakagawara, Hisatoshi\|Miyashita, Tomo
PMID:	24557054

719.
Journal:	Gastric Cancer. 2015 Jan;18(1):93-9.
Title:	Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis.
Author:	Zhang, Qingfu\|Ming, Jian\|Zhang, Siyang\|Li, Bo\|Yin, Liying\|Qiu, Xueshan
PMID:	24562421

720.
Journal:	Gastric Cancer. 2015 Apr;18(2):227-38.
Title:	Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
Author:	Nagatsuma, Akiko Kawano\|Aizawa, Masaki\|Kuwata, Takeshi\|Doi, Toshihiko\|Ohtsu, Atsushi\|Fujii, Hirofumi\|Ochiai, Atsushi
PMID:	24626858

721.
Journal:	Oncogene. 2015 Feb 26;34(9):1196-206.
Title:	Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer.
Author:	Hosoda, F\|Arai, Y\|Okada, N\|Shimizu, H\|Miyamoto, M\|Kitagawa, N\|Katai, H\|Taniguchi, H\|Yanagihara, K\|Imoto, I\|Inazawa, J\|Ohki, M\|Shibata, T
PMID:	24662817

722.
Journal:	Gastric Cancer. 2015 Jul;18(3):458-66.
Title:	A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity.
Author:	Nishida, Yasunori\|Kuwata, Takeshi\|Nitta, Hiroaki\|Dennis, Eslie\|Aizawa, Masaki\|Kinoshita, Takahiro\|Ohtsu, Atsushi\|Ochiai, Atsushi
PMID:	24917219

723.
Journal:	Gastric Cancer. 2015 Jul;18(3):467-75.
Title:	HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial).
Author:	Matsumoto, Tomohiro\|Sasako, Mitsuru\|Mizusawa, Junki\|Hirota, Seiichi\|Ochiai, Atsushi\|Kushima, Ryoji\|Katai, Hitoshi\|Tanaka, Yoichi\|Fukushima, Norimasa\|Nashimoto, Atsushi\|Tsuburaya, Akira
PMID:	24993498

724.
Journal:	Gastric Cancer. 2015 Jul;18(3):476-84.
Title:	HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer.
Author:	Van Cutsem, Eric\|Bang, Yung-Jue\|Feng-Yi, Feng\|Xu, Jian M\|Lee, Keun-Wook\|Jiao, Shun-Chang\|Chong, Jorge Leon\|Lopez-Sanchez, Roberto I\|Price, Timothy\|Gladkov, Oleg\|Stoss, Oliver\|Hill, Julie\|Ng, Vivian\|Lehle, Michaela\|Thomas, Marlene\|Kiermaier, Astrid\|Ruschof
PMID:	25038874

725.
Journal:	Oncogene. 2015 May 14;34(20):2556-65.
Title:	MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.
Author:	Li, B-S\|Zuo, Q-F\|Zhao, Y-L\|Xiao, B\|Zhuang, Y\|Mao, X-H\|Wu, C\|Yang, S-M\|Zeng, H\|Zou, Q-M\|Guo, G
PMID:	25043310

726.
Journal:	Int J Cancer. 2015 Apr 1;136(7):1629-35.
Title:	HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.
Author:	Ha, Sang Yun\|Lee, Jeeyun\|Jang, Jiryeon\|Hong, Jung Yong\|Do, In-Gu\|Park, Se Hoon\|Park, Joon Oh\|Choi, Min-Gew\|Sohn, Tae Sung\|Bae, Jae Moon\|Kim, Sung\|Kim, Minji\|Kim, Seonwoo\|Park, Cheol Keun\|Kang, Won Ki\|Kim, Kyoung-Mee
PMID:	25157953

727.
Journal:	Int J Cancer. 2015 Apr 1;136(7):1537-45.
Title:	The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway.
Author:	Eto, Kojiro\|Iwatsuki, Masaaki\|Watanabe, Masayuki\|Ishimoto, Takatsugu\|Ida, Satoshi\|Imamura, Yu\|Iwagami, Shiro\|Baba, Yoshifumi\|Sakamoto, Yasuo\|Miyamoto, Yuji\|Yoshida, Naoya\|Baba, Hideo
PMID:	25159729

728.
Journal:	Gastric Cancer. 2015 Oct;18(4):711-9.
Title:	Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer.
Author:	Saito, Takuya\|Nakanishi, Hayao\|Mochizuki, Yoshinari\|Ito, Seiji\|Ito, Yuichi\|Misawa, Kazunari\|Yatabe, Yasushi\|Yamamichi, Keigo\|Kondo, Eisaku
PMID:	25173363

729.
Journal:	Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):121-6.
Title:	HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis.
Author:	Yan, Yongjia\|Lu, Li\|Liu, Chunna\|Li, Weidong\|Liu, Tong\|Fu, Weihua
PMID:	25176587

730.
Journal:	Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):113-7.
Title:	The HER2 gene and HER2 protein status and chromosome 17 polysomy in gastric cancer cells in own material.
Author:	Ciesielski, Maciej\|Kruszewski, Wieslaw Janusz\|Smialek, Urszula\|Walczak, Jakub\|Szajewski, Mariusz\|Szefel, Jaroslaw\|Wydra, Jacek\|Kawecki, Krzysztof
PMID:	25203430

731.
Journal:	Gastric Cancer. 2015 Oct;18(4):691-7.
Title:	Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer.
Author:	Kurokawa, Yukinori\|Matsuura, Nariaki\|Kimura, Yutaka\|Adachi, Shinichi\|Fujita, Junya\|Imamura, Hiroshi\|Kobayashi, Kenji\|Yokoyama, Yuhki\|Shaker, Mohammed Nouri\|Takiguchi, Shuji\|Mori, Masaki\|Doki, Yuichiro
PMID:	25224659

732.
Journal:	Arch Pathol Lab Med. 2015 Jun;139(6):709-10.
Title:	College of American Pathologists Guidelines for Reporting HER2 Test Results in Gastric Cancer.
Author:	Whitney-Miller, Christa\|Hicks, David G
PMID:	25295581

733.
Journal:	Oncology. 2015;88(2):76-85.
Title:	PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer.
Author:	Zhang, Xianglan\|Park, Ji Soo\|Park, Kyu Hyun\|Kim, Ki Hyang\|Jung, Minkyu\|Chung, Hyun Cheol\|Rha, Sun Young\|Kim, Hyo Song
PMID:	25300346

734.
Journal:	Mol Oncol. 2015 Feb;9(2):398-408.
Title:	Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.
Author:	Ko, Bong-Kook\|Lee, Sook-Yeon\|Lee, Young-Ha\|Hwang, In-Sik\|Persson, Helena\|Rockberg, Johan\|Borrebaeck, Carl\|Park, Dongeun\|Kim, Kyu-Tae\|Uhlen, Mathias\|Lee, Jong-Seo
PMID:	25306393

735.
Journal:	Gastric Cancer. 2015 Oct;18(4):698-710.
Title:	HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study.
Author:	Shoda, Katsutoshi\|Masuda, Kiyoshi\|Ichikawa, Daisuke\|Arita, Tomohiro\|Miyakami, Yuko\|Watanabe, Miki\|Konishi, Hirotaka\|Imoto, Issei\|Otsuji, Eigo
PMID:	25322965

736.
Journal:	Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):31-5.
Title:	HER2 immunohistochemical assessment with A0485 polyclonal antibody: is it time to refine the scoring criteria for the "2+" category?
Author:	Pennacchia, Ilaria\|Vecchio, Fabio M\|Carbone, Arnaldo\|Arena, Vincenzo
PMID:	25356940

737.
Journal:	Diagn Cytopathol. 2015 Jan;43(1):80-5.
Title:	HER2 testing in malignant effusions of metastatic gastric carcinoma: is it feasible?
Author:	Wong, Daniel D\|de Boer, W Bastiaan\|Platten, Michael A\|Jo, Vickie Y\|Cibas, Edmund S\|Kumarasinghe, M Priyanthi
PMID:	25363414

738.
Journal:	Jpn J Clin Oncol. 2015 Jan;45(1):43-8.
Title:	Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients.
Author:	Sasaki, Takahide\|Fuse, Nozomu\|Kuwata, Takeshi\|Nomura, Shogo\|Kaneko, Kazuhiro\|Doi, Toshihiko\|Yoshino, Takayuki\|Asano, Hiromichi\|Ochiai, Atsushi\|Komatsu, Yoshito\|Sakamoto, Naoya\|Ohtsu, Atsushi
PMID:	25378649

739.
Journal:	Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):288-301.
Title:	Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging.
Author:	Goldstein, Robert\|Sosabowski, Jane\|Livanos, Maria\|Leyton, Julius\|Vigor, Kim\|Bhavsar, Gaurav\|Nagy-Davidescu, Gabriela\|Rashid, Mohammed\|Miranda, Enrique\|Yeung, Jenny\|Tolner, Berend\|Pluckthun, Andreas\|Mather, Stephen\|Meyer, Tim\|Chester, Kerry
PMID:	25391547

740.
Journal:	Mol Carcinog. 2015 Dec;54(12):1700-9.
Title:	Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer.
Author:	Yun, Chen\|Gang, Li\|Rongmin, Gu\|Xu, Wen\|Xuezhi, Ming\|Huanqiu, Chen
PMID:	25400108

741.
Journal:	Oncology. 2015;88(3):147-56.
Title:	Clinicopathological features and prognostic significance of HER2 expression in gastric cancer.
Author:	Park, Ji Soo\|Rha, Sun Young\|Chung, Hyun Cheol\|Jung, Minkyu\|Kim, Ki Hyang\|Jun, Hyun Jung\|Kim, Hyunki\|An, Ji Yeong\|Kim, Hyoung-Il\|Cheong, Jae-Ho\|Hyung, Woo Jin\|Noh, Sung Hoon\|Kim, Hyo Song
PMID:	25402270

742.
Journal:	Oncotarget. 2015 Jan 1;6(1):207-20.
Title:	Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.
Author:	Zhang, Yi-wang\|Zhao, Xiao-xiao\|Tan, Cui\|Zhang, Zhi-gang\|Jiang, Ye\|Chen, Jian-ning\|Wei, Hong-bo\|Xue, Ling\|Li, Hai-gang\|Du, Hong\|Shao, Chun-kui
PMID:	25402957

743.
Journal:	Cancer Lett. 2015 Jan 28;356(2 Pt B):846-54.
Title:	Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.
Author:	Hamano, Shingo\|Mori, Yoshinori\|Aoyama, Mineyoshi\|Kataoka, Hiromi\|Tanaka, Mamoru\|Ebi, Masahide\|Kubota, Eiji\|Mizoshita, Tsutomu\|Tanida, Satoshi\|Johnston, Randal N\|Asai, Kiyofumi\|Joh, Takashi
PMID:	25444894

744.
Journal:	Clin Transl Oncol. 2015 Jun;17(6):462-8.
Title:	The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer.
Author:	Kim, S T\|Do, I-G\|Lee, J\|Sohn, I\|Kim, K-M\|Kang, W K
PMID:	25445175

745.
Journal:	Oncology. 2015;88(3):189-94.
Title:	Loss of heterozygosity of PTEN (encoding phosphate and tensin homolog) associated with elevated HER2 expression is an adverse prognostic indicator in gastric cancer.
Author:	Zaitsu, Yoko\|Oki, Eiji\|Ando, Koji\|Ida, Satoshi\|Kimura, Yasue\|Saeki, Hiroshi\|Morita, Masaru\|Hirahashi, Minako\|Oda, Yoshinao\|Maehara, Yoshihiko
PMID:	25472613

746.
Journal:	Tumour Biol. 2015 Apr;36(4):3001-7.
Title:	TFF3 and HER2 expression and their correlation with survival in gastric cancer.
Author:	Gu, Jianchun\|Zheng, Leizhen\|Zhang, Li\|Chen, Siyu\|Zhu, Meiling\|Li, Xiaoping\|Wang, Yajie
PMID:	25514872

747.
Journal:	Cancer Med. 2015 Feb;4(2):235-44.
Title:	Reproducibility of Her2/neu scoring in gastric cancer and assessment of the 10% cut-off rule.
Author:	Behrens, Hans-Michael\|Warneke, Viktoria S\|Boger, Christine\|Garbrecht, Nele\|Juttner, Eva\|Klapper, Wolfram\|Mathiak, Micaela\|Oschlies, Ilske\|Rudolph, Ursula\|Stuhlmann-Laeisz, Christiane\|Trick, David\|Rocken, Christoph\|Hufnagl, Peter
PMID:	25515030

748.
Journal:	Onco Targets Ther. 2014 Dec 16;8:7-14.
Title:	Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas.
Author:	Tang, Daoqiang\|Liu, Charles Yj\|Shen, Danping\|Fan, Shuqiong\|Su, Xinying\|Ye, Peng\|Gavine, Paul R\|Yin, Xiaolu
PMID:	25565860

749.
Journal:	Expert Rev Mol Diagn. 2015 Mar;15(3):385-98.
Title:	HER2 assessment by silver in situ hybridization: where are we now?
Author:	Sanguedolce, Francesca\|Bufo, Pantaleo
PMID:	25578771

750.
Journal:	World J Clin Cases. 2015 Jan 16;3(1):42-51.
Title:	Recent advances in the HER2 targeted therapy of gastric cancer.
Author:	Matsuoka, Tasuku\|Yashiro, Masakazu
PMID:	25610849

751.
Journal:	Appl Immunohistochem Mol Morphol. 2015 Oct;23(9):628-32.
Title:	HER2 Genetic Heterogeneity in Gastric Cancer: Evaluation According to the College of American Pathologists Breast Cancer Criteria.
Author:	Treacy, Ann D\|Karamchandani, Jason R\|Streutker, Catherine J\|Grin, Andrea
PMID:	25611242

752.
Journal:	Oncol Lett. 2015 Feb;9(2):999-1005.
Title:	Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins.
Author:	Liu, Yongping\|Ling, Yang\|Qi, Qiufeng\|Zhu, Ming\|Wan, Meizhen\|Zhang, Yaping\|Zhang, Changsong
PMID:	25624920

753.
Journal:	Cancer Gene Ther. 2015 Apr;22(3):101-7.
Title:	MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2.
Author:	Shan, Y-Q\|Ying, R-C\|Zhou, C-H\|Zhu, A-K\|Ye, J\|Zhu, W\|Ju, T-F\|Jin, H-C
PMID:	25633484

754.
Journal:	BMC Gastroenterol. 2015 Feb 5;15:7.
Title:	Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.
Author:	Stahl, Phillip\|Seeschaaf, Carsten\|Lebok, Patrick\|Kutup, Asad\|Bockhorn, Maximillian\|Izbicki, Jakob R\|Bokemeyer, Carsten\|Simon, Ronald\|Sauter, Guido\|Marx, Andreas H
PMID:	25649416

755.
Journal:	Eur J Cancer. 2015 Mar;51(4):482-8.
Title:	Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer.
Author:	Ryu, Min-Hee\|Yoo, Changhoon\|Kim, Jong Gwang\|Ryoo, Baek-Yeol\|Park, Young Soo\|Park, Sook Ryun\|Han, Hye-Suk\|Chung, Ik Joo\|Song, Eun-Kee\|Lee, Kyung Hee\|Kang, Seok Yun\|Kang, Yoon-Koo
PMID:	25661103

756.
Journal:	Clin Transl Sci. 2015 Aug;8(4):320-5.
Title:	Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric Cancer.
Author:	Cheng, Yu\|Zhou, Jin\|Li, Honglun
PMID:	25684180

757.
Journal:	J Gastroenterol. 2015 Sep;50(9):955-61.
Title:	Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy.
Author:	Zhou, Jun\|Peng, Zhi\|Liu, Yi\|Gong, Jifang\|Zhang, Xiaotian\|Lu, Ming\|Gao, Jing\|Li, Yili\|Li, Yanyan\|Shen, Lin
PMID:	25702260

758.
Journal:	Ann Surg Oncol. 2015 Nov;22(12):3938-45.
Title:	The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.
Author:	Chon, Hong Jae\|Kim, Hye Ryun\|Shin, Eunah\|Kim, Chan\|Heo, Su Jin\|Lee, Choong-Kun\|Park, Jin Kyu\|Noh, Sung Hoon\|Chung, Hyun Cheol\|Rha, Sun Young
PMID:	25707491

759.
Journal:	Cancer Metastasis Rev. 2015 Mar;34(1):157-64.
Title:	HER2 expression status in diverse cancers: review of results from 37,992 patients.
Author:	Yan, Min\|Schwaederle, Maria\|Arguello, David\|Millis, Sherri Z\|Gatalica, Zoran\|Kurzrock, Razelle
PMID:	25712293

760.
Journal:	Clin Cancer Res. 2015 Jun 1;21(11):2520-9.
Title:	Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer.
Author:	Ock, Chan-Young\|Lee, Keun-Wook\|Kim, Jin Won\|Kim, Jin-Soo\|Kim, Tae-Yong\|Lee, Kyung-Hun\|Han, Sae-Won\|Im, Seock-Ah\|Kim, Tae-You\|Kim, Woo Ho\|Bang, Yung-Jue\|Oh, Do-Youn
PMID:	25712681

761.
Journal:	J Clin Pathol. 2015 May;68(5):374-80.
Title:	Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
Author:	He, Xiao Xiao\|Ding, Li\|Lin, Yuan\|Shu, Man\|Wen, Jian Ming\|Xue, Ling
PMID:	25731189

762.
Journal:	Jpn J Clin Oncol. 2015 May;45(5):416-21.
Title:	Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
Author:	Gumusay, Ozge\|Benekli, Mustafa\|Ekinci, Ozgur\|Baykara, Meltem\|Ozet, Ahmet\|Coskun, Ugur\|Demirci, Umut\|Uner, Aytug\|Dursun, Ayse\|Atak, Ecine Yesim\|Buyukberber, Suleyman
PMID:	25732909

763.
Journal:	Mod Pathol. 2015 Jun;28(6):861-71.
Title:	Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Author:	Ooi, Akishi\|Oyama, Takeru\|Nakamura, Ritsuko\|Tajiri, Ryosuke\|Ikeda, Hiroko\|Fushida, Sachio\|Nakamura, Hiroyuki\|Dobashi, Yoh
PMID:	25743022

764.
Journal:	Bull Cancer. 2015 Apr;102(4):324-31.
Title:	Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective study.
Author:	Soularue, Emilie\|Cohen, Romain\|Tournigand, Christophe\|Zaanan, Aziz\|Louvet, Christophe\|Bachet, Jean-Baptiste\|Hentic, Olivia\|Samalin, Emmanuelle\|Chibaudel, Benoist\|de Gramont, Aimery\|Andre, Thierry
PMID:	25744576

765.
Journal:	Pathol Oncol Res. 2015 Sep;21(4):947-55.
Title:	Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models.
Author:	Chen, Hao\|Ye, Qingqing\|Lv, Jing\|Ye, Peng\|Sun, Yun\|Fan, Shuqiong\|Su, Xinying\|Gavine, Paul\|Yin, Xiaolu
PMID:	25749810

766.
Journal:	Mol Med Rep. 2015 Jul;12(1):1177-82.
Title:	Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer.
Author:	Zhang, Su-Qing\|Sun, Ke-Kang\|Wu, Xiao-Yang\|Zhong, Ning\|Zhao, Hua\|Li, De-Chun
PMID:	25760308

767.
Journal:	Biosens Bioelectron. 2015 Jul 15;69:272-9.
Title:	A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.
Author:	Kao, Kai-Jie\|Tai, Chien-Hsuan\|Chang, Wen-Hsin\|Yeh, Ta-Sen\|Chen, Tse-Ching\|Lee, Gwo-Bin
PMID:	25770459

768.
Journal:	Cancer Biol Ther. 2015;16(5):764-9.
Title:	Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
Author:	Miura, John T\|Xiu, Joanne\|Thomas, James\|George, Ben\|Carron, Benjamin R\|Tsai, Susan\|Johnston, Fabian M\|Turaga, Kiran K\|Gamblin, T Clark
PMID:	25778705

769.
Journal:	Sci Rep. 2015 Mar 19;5:9289.
Title:	The impact of concomitant genomic alterations on treatment outcome for trastuzumab therapy in HER2-positive gastric cancer.
Author:	Lee, Ji Yun\|Hong, Mineui\|Kim, Seung Tae\|Park, Se Hoon\|Kang, Won Ki\|Kim, Kyoung-Mee\|Lee, Jeeyun
PMID:	25786580

770.
Journal:	Hum Pathol. 2015 May;46(5):665-72.
Title:	HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases.
Author:	Cappellesso, Rocco\|Fassan, Matteo\|Hanspeter, Esther\|Bornschein, Jan\|d'Amore, Emanuele S G\|Cuorvo, Lucia V\|Mazzoleni, Guido\|Barbareschi, Mattia\|Pizzi, Marco\|Guzzardo, Vincenza\|Malfertheiner, Peter\|Micev, Marjan\|Guido, Maria\|Giacomelli, Luciano\|Tsukanov, Vl
PMID:	25800719

771.
Journal:	Gan To Kagaku Ryoho. 2015 Mar;42(3):359-61.
Title:	[A case of HER2-positive advanced gastric cancer successfully treated via capecitabine, cisplatin, and trastuzumab combination chemotherapy].
Author:	Endo, Shunji\|Yamada, Terumasa\|Okuyama, Masaki\|Hiraoka, Kazuya\|Konishi, Ken\|Kim, Chiwan\|Nakagawa, Tomo\|Takeda, Koki\|Ueda, Yuji\|Matsumoto, Kenichi\|Nishikawa, Kazuhiro\|Nishijima, Junichi
PMID:	25812508

772.
Journal:	J Cancer Res Clin Oncol. 2015 Nov;141(11):1945-52.
Title:	The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR.
Author:	Janbabai, Ghasem\|Oladi, Ziaeddin\|Farazmandfar, Touraj\|Taghvaei, Tarang\|Naghshvar, Farshad
PMID:	25820598

773.
Journal:	Pathol Int. 2015 Jun;65(6):309-17.
Title:	Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case.
Author:	Saito, Takuya\|Kondo, Chihiro\|Shitara, Kohei\|Ito, Yuichi\|Saito, Noriko\|Ikehara, Yuzuru\|Yatabe, Yasushi\|Yamamichi, Keigo\|Tanaka, Hideo\|Nakanishi, Hayao
PMID:	25828363

774.
Journal:	J Gastrointest Oncol. 2015 Apr;6(2):143-54.
Title:	HER2 expression in gastric and oesophageal cancer: a meta-analytic review.
Author:	Nagaraja, Vinayak\|Eslick, Guy D
PMID:	25830034

775.
Journal:	Nihon Rinsho. 2015 Feb;73 Suppl 2:577-81.
Title:	[Chemotherapy and trastuzumab for HER2 positive gastric cancer].
Author:	Tono, Yasutaka\|Yamada, Yasuhide
PMID:	25831826

776.
Journal:	Adv Anat Pathol. 2015 May;22(3):194-201.
Title:	HER2 testing in gastric and gastroesophageal adenocarcinomas.
Author:	Vakiani, Efsevia
PMID:	25844677

777.
Journal:	Front Oncol. 2015 Mar 26;5:73.
Title:	Epstein-barr virus in gastro-esophageal adenocarcinomas - single center experiences in the context of current literature.
Author:	Genitsch, Vera\|Novotny, Alexander\|Seiler, Christian A\|Kroll, Dino\|Walch, Axel\|Langer, Rupert
PMID:	25859432

778.
Journal:	Anticancer Res. 2015 Apr;35(4):2441-6.
Title:	Correlation of HER2 expression with clinicopathological characteristics and prognosis in resectable gastric cancer.
Author:	Otsu, Hajime\|Oki, Eiji\|Ikawa-Yoshida, Ayae\|Kawano, Hiroyuki\|Ando, Koji\|Ida, Satoshi\|Kimura, Yasue\|Aishima, Shinichi\|Saeki, Hiroshi\|Morita, Masaru\|Kohnoe, Shunji\|Oda, Yoshinao\|Maehara, Yoshihiko
PMID:	25862912

779.
Journal:	Hum Pathol. 2015 Jun;46(6):850-7.
Title:	Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks.
Author:	Ge, Xiaowen\|Wang, Haixing\|Zeng, Haiying\|Jin, Xuejuan\|Sujie, Akesu\|Xu, Chen\|Liu, Yalan\|Huang, Jie\|Ji, Yuan\|Tan, Yunshan\|Liu, Tianshu\|Hou, Yingyong\|Qin, Jing\|Sun, Yihong\|Qin, Xinyu
PMID:	25863425

780.
Journal:	Genet Mol Res. 2015 Mar 13;14(1):1782-7.
Title:	C-erbB-2 expression and prognosis of gastric cancer: a meta-analysis.
Author:	Wang, Z Q\|Sun, B J
PMID:	25867322

781.
Journal:	J Cancer. 2015 Feb 26;6(5):403-8.
Title:	Multiplex Ligation-dependent Probe Amplification Can Clarify HER2 Status in Gastric Cancers with "Polysomy 17".
Author:	Wang, Tao\|Amemiya, Yutaka\|Henry, Pauline\|Seth, Arun\|Hanna, Wedad\|Hsieh, Eugene T
PMID:	25874002

782.
Journal:	BMC Cancer. 2015 Mar 24;15:169.
Title:	Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy.
Author:	Schmitt, Esther\|Vegran, Frederique\|Chevrier, Sandy\|Burillier, Laura\|Cadouot, Muriel\|Lizard-Nacol, Sarab\|Coudert, Bruno\|Fumoleau, Pierre\|Arnould, Laurent\|Boidot, Romain
PMID:	25879949

783.
Journal:	Expert Opin Pharmacother. 2015 Jun;16(8):1195-207.
Title:	Role of c-mesenchymal-epithelial transition pathway in gastric cancer.
Author:	Fioroni, Iacopo\|Dell'Aquila, Emanuela\|Pantano, Francesco\|Intagliata, Salvatore\|Caricato, Marco\|Vincenzi, Bruno\|Coppola, Roberto\|Santini, Daniele\|Tonini, Giuseppe
PMID:	25881479

784.
Journal:	Oncologist. 2015 May;20(5):499-507.
Title:	Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
Author:	Ali, Siraj M\|Sanford, Eric M\|Klempner, Samuel J\|Rubinson, Douglas A\|Wang, Kai\|Palma, Norma A\|Chmielecki, Juliann\|Yelensky, Roman\|Palmer, Gary A\|Morosini, Deborah\|Lipson, Doron\|Catenacci, Daniel V\|Braiteh, Fadi\|Erlich, Rachel\|Stephens, Philip J\|Ross, Jeffr
PMID:	25882375

785.
Journal:	BMC Res Notes. 2015 Mar 26;8:100.
Title:	A case of severe cerebral embolism after chemotherapy for HER2-positive gastric cancer.
Author:	Takahama, Takayuki\|Takeda, Masayuki\|Nishina, Shinichi\|Nakagawa, Kazuhiko
PMID:	25885256

786.
Journal:	J Transl Med. 2015 Apr 11;13:116.
Title:	Oncogenic HER2 fusions in gastric cancer.
Author:	Yu, De-Hua\|Tang, Lili\|Dong, Hua\|Dong, Zhengwei\|Zhang, Lianhai\|Fu, Jiangang\|Su, Xinying\|Zhang, Tianwei\|Fu, Haihua\|Han, Lu\|Xie, Liang\|Chen, Hao\|Qian, Ziliang\|Zhu, Guanshan\|Wang, Jia\|Ye, Qingqing\|Zhang, Jingchuan\|Yin, Xiaolu\|Zhang, Xiaolin\|Ji, Jiafu\|Ji, Quns
PMID:	25889497

787.
Journal:	Case Rep Gastrointest Med. 2015;2015:132030.
Title:	Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
Author:	Ishimine, Yu\|Goto, Akira\|Watanabe, Yoshito\|Yajima, Hidetaka\|Nakagaki, Suguru\|Yabana, Takashi\|Adachi, Takeya\|Kondo, Yoshihiro\|Kasai, Kiyoshi
PMID:	25893119

788.
Journal:	Br J Cancer. 2015 May 12;112(10):1652-5.
Title:	Droplet digital PCR measurement of HER2 in patients with gastric cancer.
Author:	Kinugasa, H\|Nouso, K\|Tanaka, T\|Miyahara, K\|Morimoto, Y\|Dohi, C\|Matsubara, T\|Okada, H\|Yamamoto, K
PMID:	25897674

789.
Journal:	Hepatogastroenterology. 2015 Jan-Feb;62(137):231-3.
Title:	HER2 expression variability between primary gastric cancers and corresponding lymph node metastases.
Author:	Qiu, Zhejun\|Sun, Weidong\|Zhou, Chengzhong\|Zhang, Jiandong
PMID:	25911901

790.
Journal:	World J Gastroenterol. 2015 Apr 21;21(15):4680-7.
Title:	Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma.
Author:	Wang, Yang-Kun\|Chen, Zhong\|Yun, Tian\|Li, Cong-Yang\|Jiang, Bo\|Lv, Xue-Xia\|Chu, Guang-Hui\|Wang, Su-Nan\|Yan, Hui\|Shi, Lei-Feng
PMID:	25914479

791.
Journal:	Chin J Cancer Res. 2015 Apr;27(2):163-71.
Title:	HER2 discordance between paired primary gastric cancer and metastasis: a meta-analysis.
Author:	Peng, Zhi\|Zou, Jianling\|Zhang, Xiaotian\|Yang, Yehong\|Gao, Jing\|Li, Yilin\|Li, Yanyan\|Shen, Lin
PMID:	25937778

792.
Journal:	J Clin Diagn Res. 2015 Mar;9(3):EC06-10.
Title:	HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas.
Author:	Rajagopal, Indu\|Niveditha, S R\|Sahadev, R\|Nagappa, Preethan Kamagere\|Rajendra, Sowmya Goddanakoppal
PMID:	25954623

793.
Journal:	Bioorg Med Chem Lett. 2015 Jul 1;25(13):2675-8.
Title:	Magnetic resonance imaging of tumor with a self-traceable polymer conjugated with an antibody fragment.
Author:	Yamada, Hisatsugu\|Hasegawa, Yoshinori\|Suzuki, Yuki\|Imai, Hirohiko\|Matsuda, Tetsuya\|Kimura, Yu\|Toshimitsu, Akio\|Aoyama, Yasuhiro\|Kondo, Teruyuki
PMID:	25958246

794.
Journal:	Gastroenterol Res Pract. 2015;2015:796380.
Title:	Therapeutic targeting of fibroblast growth factor receptors in gastric cancer.
Author:	Inokuchi, Mikito\|Fujimori, Yoshitaka\|Otsuki, Sho\|Sato, Yuya\|Nakagawa, Masatoshi\|Kojima, Kazuyuki
PMID:	26000013

795.
Journal:	Int J Surg Pathol. 2015 Oct;23(7):537-41.
Title:	alpha-Fetoprotein-Producing Hepatoid Gastric Adenocarcinoma With Osteoclast-Like Giant Cells and Neuroendocrine Differentiation: A Case Study With Molecular Profiling.
Author:	Wincewicz, Andrzej\|Kowalik, Artur\|Zieba, Sebastian\|Lewitowicz, Piotr\|Gozdz, Stanislaw\|Sulkowski, Stanislaw
PMID:	26009570

796.
Journal:	J Hematol Oncol. 2015 May 29;8:58.
Title:	HER2/neu-directed therapy for biliary tract cancer.
Author:	Javle, Milind\|Churi, Chaitanya\|Kang, HyunSeon C\|Shroff, Rachna\|Janku, Filip\|Surapaneni, Rakesh\|Zuo, Mingxin\|Barrera, Christian\|Alshamsi, Humaid\|Krishnan, Sunil\|Mishra, Lopa\|Wolff, Robert A\|Kaseb, Ahmed O\|Thomas, Melanie B\|Siegel, Abby B
PMID:	26022204

797.
Journal:	Cancer Sci. 2015 Aug;106(8):951-8.
Title:	Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype.
Author:	Oue, Naohide\|Sentani, Kazuhiro\|Sakamoto, Naoya\|Yasui, Wataru
PMID:	26033320

798.
Journal:	Arq Gastroenterol. 2015 Apr-Jun;52(2):152-5.
Title:	Immunohistochemical expression of HER2 in adenocarcinoma of the stomach.
Author:	De Carli, Diego Michelon\|Rocha, Marta Pires da\|Antunes, Luis Carlos Moreira\|Fagundes, Renato Borges
PMID:	26039836

799.
Journal:	J Natl Compr Canc Netw. 2015 Apr;13(4):e19-29.
Title:	Molecular biomarkers in gastric cancer.
Author:	Elimova, Elena\|Wadhwa, Roopma\|Shiozaki, Hironori\|Sudo, Kazuki\|Estrella, Jeannelyn S\|Badgwell, Brian D\|Das, Prajnan\|Matamoros, Aurelio Jr\|Song, Shumei\|Ajani, Jaffer A
PMID:	26052595

800.
Journal:	Gastroenterol Res Pract. 2015;2015:946359.
Title:	Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection.
Author:	Park, Kwang Kuk\|Yang, Song I\|Seo, Kyung Won\|Yoon, Ki Young\|Lee, Sang Ho\|Jang, Hee Kyung\|Shin, Yeon Myeong
PMID:	26060493

801.
Journal:	Cancer Biol Ther. 2015;16(8):1148-59.
Title:	A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
Author:	Ciliberto, Domenico\|Staropoli, Nicoletta\|Caglioti, Francesca\|Gualtieri, Simona\|Fiorillo, Lucia\|Chiellino, Silvia\|De Angelis, Antonina Maria\|Mendicino, Francesco\|Botta, Cirino\|Caraglia, Michele\|Tassone, Pierfrancesco\|Tagliaferri, Pierosandro
PMID:	26061272

802.
Journal:	Cancer Med. 2015 Sep;4(9):1344-55.
Title:	Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer.
Author:	Kanematsu, Masako\|Futamura, Manabu\|Takata, Masafumi\|Gaowa, Siqin\|Yamada, Atsuko\|Morimitsu, Kasumi\|Morikawa, Akemi\|Mori, Ryutaro\|Hara, Hideaki\|Yoshida, Kazuhiro
PMID:	26077887

803.
Journal:	Int J Oncol. 2015 Aug;47(2):499-505.
Title:	EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition.
Author:	Mizukami, Takuro\|Togashi, Yosuke\|Sogabe, Shunsuke\|Banno, Eri\|Terashima, Masato\|De Velasco, Marco A\|Sakai, Kazuko\|Fujita, Yoshihiko\|Tomida, Shuta\|Nakajima, Takako Eguchi\|Boku, Narikazu\|Nishio, Kazuto
PMID:	26081723

804.
Journal:	Mol Med Rep. 2015 Sep;12(3):4794.
Title:	HER 2/neu protein expression in gastric cancer is associated with poor survival.
Author:	Xie, S D\|Xu, C Y\|Shen, J G\|Jiang, Z N\|Shen, J Y\|Wang, L B
PMID:	26096440

805.
Journal:	Cancer Chemother Pharmacol. 2015 Aug;76(2):375-82.
Title:	Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS) for patients with HER2-positive metastatic gastric cancer: feasibility and preliminary efficacy.
Author:	Mitsui, Yasuhiro\|Sato, Yasushi\|Miyamoto, Hiroshi\|Fujino, Yasuteru\|Takaoka, Toshi\|Miyoshi, Jinsei\|Kagawa, Miwako\|Ohnuma, Hiroyuki\|Hirakawa, Masahiro\|Kubo, Tomohiro\|Osuga, Takahiro\|Sagawa, Tamotsu\|Sato, Yasuhiro\|Takahashi, Yasuo\|Katsuki, Shinich\|Okuda, Tosh
PMID:	26099968

806.
Journal:	Cancer Chemother Pharmacol. 2015 Aug;76(2):397-408.
Title:	Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer.
Author:	Chua, Clarinda\|Tan, Iain Beehuat\|Yamada, Yasuhide\|Rha, Sun Young\|Yong, Wei Peng\|Ong, Whee Sze\|Tham, Chee Kian\|Ng, Matthew\|Tai, David W M\|Iwasa, Satoru\|Lim, Hwee Yong\|Choo, Su-Pin
PMID:	26099969

807.
Journal:	J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):471-7.
Title:	CORRELATION BETWEEN C-erbB-2 WITH GASTRIC MUCOSAL ATYPICAL HYPERPLASIA AND GASTRIC CARCINOMA.
Author:	Song, B\|Yu, J\|Wu, T S
PMID:	26122239

808.
Journal:	Endosc Int Open. 2015 Apr;3(2):E165-70.
Title:	Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer.
Author:	Gullo, Irene\|Grillo, Federica\|Molinaro, Luca\|Fassan, Matteo\|De Silvestri, Annalisa\|Tinelli, Carmine\|Rugge, Massimo\|Fiocca, Roberto\|Mastracci, Luca
PMID:	26135662

809.
Journal:	World J Gastroenterol. 2015 Jun 28;21(24):7343-8.
Title:	Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
Author:	Choi, Audrey H\|Kim, Joseph\|Chao, Joseph
PMID:	26139980

810.
Journal:	Gan To Kagaku Ryoho. 2015 Jun;42(6):739-42.
Title:	[A Patient Who Underwent Surgery after CR to Chemotherapy for Scirrhous Gastric Cancer Suspected because of Lymphangitis Carcinomatosa].
Author:	Nishiki, Kohei\|Tanaka, Yumiko\|Sogabe, Shunsuke\|Iwama, Mitsuru\|Makino, Tomoki\|Shiraishi, Osamu\|Yasuda, Atsushi\|Shinkai, Masayuki\|Imano, Motohiro\|Imamoto, Haruhiko\|Furukawa, Hiroshi\|Yasuda, Takushi
PMID:	26199248

811.
Journal:	PLoS One. 2015 Jul 28;10(7):e0134493.
Title:	Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.
Author:	Zhang, Tianwei\|Zhang, Lin\|Fan, Shuqiong\|Zhang, Meizhuo\|Fu, Haihua\|Liu, Yuanjie\|Yin, Xiaolu\|Chen, Hao\|Xie, Liang\|Zhang, Jingchuan\|Gavine, Paul R\|Gu, Yi\|Ni, Xingzhi\|Su, Xinying
PMID:	26217940

812.
Journal:	Asian Pac J Cancer Prev. 2015;16(13):5289-96.
Title:	Individualized Chemotherapy for Metastatic Gastric Cancer: Retrospective Data from a University Hospital in Brazil.
Author:	Aguiar Junior, Pedro Nazareth\|Ribas, Christian\|Forones, Nora Manoukian
PMID:	26225668

813.
Journal:	PLoS One. 2015 Jul 30;10(7):e0134600.
Title:	Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer.
Author:	Ko, Bong-Kook\|Choi, Soyoung\|Cui, Lei Guang\|Lee, Young-Ha\|Hwang, In-Sik\|Kim, Kyu-Tae\|Shim, Hyunbo\|Lee, Jong-Seo
PMID:	26225765

814.
Journal:	Anticancer Res. 2015 Sep;35(9):4575-83.
Title:	Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives.
Author:	Chrom, Pawel\|Stec, Rafal\|Szczylik, Cezary
PMID:	26254345

815.
Journal:	Dtsch Med Wochenschr. 2015 Aug;140(16):1202-5.
Title:	[Current standards in the treatment of gastric cancer].
Author:	Hacker, Ulrich\|Lordick, Florian
PMID:	26261926

816.
Journal:	Int J Mol Sci. 2015 Aug 17;16(8):19447-57.
Title:	Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.
Author:	Gonzalez-Alonso, Paula\|Chamizo, Cristina\|Moreno, Victor\|Madoz-Gurpide, Juan\|Carvajal, Nerea\|Daoud, Lina\|Zazo, Sandra\|Martin-Aparicio, Ester\|Cristobal, Ion\|Rincon, Raul\|Garcia-Foncillas, Jesus\|Rojo, Federico
PMID:	26287187

817.
Journal:	PLoS One. 2015 Aug 20;10(8):e0136322.
Title:	Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis.
Author:	Zhang, Kecheng\|Cui, Jianxin\|Xi, Hongqing\|Bian, Shibo\|Ma, Liangang\|Shen, Weisong\|Li, Jiyang\|Wang, Ning\|Wei, Bo\|Chen, Lin
PMID:	26292093

818.
Journal:	Medicine (Baltimore). 2015 Aug;94(34):e1428.
Title:	A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients.
Author:	Zhu, Bo\|Wu, Jun-Rong\|Zhou, Xiao-Ping
PMID:	26313797

819.
Journal:	Gan To Kagaku Ryoho. 2015 Aug;42(8):997-1000.
Title:	[Stage IV Gastric Cancer Made Resectable Following a Chemotherapy Regimen That Included Trastuzumab-A Case Report].
Author:	Maruo, Hirotoshi\|Suzuki, Katsunori\|Ishikawa, Shintaro\|Higashi, Yukihiro\|Shoji, Tsuyoshi\|Nishiyama, Raisuke\|Kubota, Hiroyuki
PMID:	26321717

820.
Journal:	Jpn J Clin Oncol. 2015 Nov;45(11):1082-6.
Title:	A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JC
Author:	Kataoka, Kozo\|Tokunaga, Masanori\|Mizusawa, Junki\|Machida, Nozomu\|Katayama, Hiroshi\|Shitara, Kohei\|Tomita, Toshihiko\|Nakamura, Kenichi\|Boku, Narikazu\|Sano, Takeshi\|Terashima, Masanori\|Sasako, Mitsuru
PMID:	26355164

821.
Journal:	Expert Opin Pharmacother. 2015;16(15):2293-305.
Title:	Advancing pharmacological treatment options for advanced gastric cancer.
Author:	Sudo, Kazuki\|Yamada, Yasuhide
PMID:	26359224

822.
Journal:	Am J Transl Res. 2015 Aug 15;7(8):1429-39. eCollection 2015.
Title:	Delineation of gastric cancer subtypes by co-regulated expression of receptor tyrosine kinases and chemosensitivity genes.
Author:	Li, Shu-Chun\|Ma, Rong\|Wu, Jian-Zhong\|Xiao, Xia\|Wu, Wei\|Li, Gang\|Chen, Bo\|Sharma, Ashok\|Bai, Shan\|Dun, Bo-Ying\|She, Jin-Xiong\|Tang, Jin-Hai
PMID:	26396673

823.
Journal:	Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12492-7.
Title:	Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
Author:	Park, Hansoo\|Cho, Sung-Yup\|Kim, Hyerim\|Na, Deukchae\|Han, Jee Yun\|Chae, Jeesoo\|Park, Changho\|Park, Ok-Kyoung\|Min, Seoyeon\|Kang, Jinjoo\|Choi, Boram\|Min, Jimin\|Kwon, Jee Young\|Suh, Yun-Suhk\|Kong, Seong-Ho\|Lee, Hyuk-Joon\|Liu, Edison T\|Kim, Jong-Il\|Kim, Sungho
PMID:	26401016

824.
Journal:	Cancer Biomark. 2015;15(6):807-14.
Title:	MiR-4728-3p could act as a marker of HER2 status.
Author:	Li, Hai\|Zhou, Xin\|Zhu, Jun\|Cheng, Wenfang\|Zhu, Wei\|Shu, Yongqian\|Liu, Ping
PMID:	26406406

825.
Journal:	J Proteome Res. 2015 Dec 4;14(12):4995-5006.
Title:	Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues.
Author:	Yan, Julia Fangfei\|Kim, Hoguen\|Jeong, Seul-Ki\|Lee, Hyoung-Joo\|Sethi, Manveen K\|Lee, Ling Y\|Beavis, Ronald C\|Im, Hogune\|Snyder, Michael P\|Hofree, Matan\|Ideker, Trey\|Wu, Shiaw-Lin\|Paik, Young-Ki\|Fanayan, Susan\|Hancock, William S
PMID:	26435392

826.
Journal:	Br J Cancer. 2015 Oct 20;113(8):1186-96.
Title:	Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.
Author:	Ko, Young San\|Cho, Sung Jin\|Park, Jinju\|Kim, Younghoon\|Choi, Yong Joon\|Pyo, Jung-Soo\|Jang, Bo Gun\|Park, Jong-Wan\|Kim, Woo Ho\|Lee, Byung Lan
PMID:	26448177

827.
Journal:	Mod Pathol. 2015 Nov;28(11):1481-91.
Title:	Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Author:	Valtorta, Emanuele\|Martino, Cosimo\|Sartore-Bianchi, Andrea\|Penaullt-Llorca, Frederique\|Viale, Giuseppe\|Risio, Mauro\|Rugge, Massimo\|Grigioni, Walter\|Bencardino, Katia\|Lonardi, Sara\|Zagonel, Vittorina\|Leone, Francesco\|Noe, Johannes\|Ciardiello, Fortunato\|Pin
PMID:	26449765

828.
Journal:	Oncotarget. 2015 Nov 10;6(35):38372-80.
Title:	Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens.
Author:	Ahn, Sangjeong\|Ahn, Soomin\|Van Vrancken, Michael\|Lee, Minju\|Ha, Sang Yun\|Lee, Hyuk\|Min, Byung-Hoon\|Lee, Jun Haeng\|Kim, Jae J\|Choi, Sunkyu\|Jung, Sin-Ho\|Choi, Min Gew\|Lee, Jun-Ho\|Sohn, Tae Sung\|Bae, Jae Moon\|Kim, Sung\|Kim, Kyoung-Mee
PMID:	26460823

829.
Journal:	Expert Rev Gastroenterol Hepatol. 2015;9(12):1471-81.
Title:	Capecitabine for the treatment of gastric cancer.
Author:	Kim, Tae-Yong\|Oh, Do-Youn\|Bang, Yung-Jue
PMID:	26470733

830.
Journal:	Cancer Chemother Pharmacol. 2015 Dec;76(6):1267-72.
Title:	Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study.
Author:	Kim, Young Saing\|Sym, Sun Jin\|Baek, Min Young\|Park, Inkeun\|Hong, Junshik\|Ahn, Hee Kyung\|Park, Jinny\|Cho, Eun Kyung\|Lee, Woon Ki\|Chung, Min\|Kim, Hyung-Sik\|Lee, Jae Hoon\|Shin, Dong Bok
PMID:	26482716

831.
Journal:	Gan To Kagaku Ryoho. 2015 Oct;42(10):1289-91.
Title:	[Clinicopathological Features and Outcomes of Treatment for HER2 Positive Gastric Cancer].
Author:	Tsuchida, Kazuhito\|Murakami, Hitoshi\|Doi, Yuki\|Kikuchi, Akitomo\|Mori, Koichi\|Harada, Shingo\|Yabushita, Yasuhiro\|Watanabe, Takuo\|Hasegawa, Seiji\|Fukushima, Tadao\|Ike, Hideyuki\|Nakayama, Takashi\|Rino, Yasushi\|Imada, Toshio\|Masuda, Munetaka
PMID:	26489575

832.
Journal:	Gan To Kagaku Ryoho. 2015 Oct;42(10):1295-7.
Title:	[A Case of HER-2 Positive Advanced Gastric Cancer Responding to CapecitabineCisplatinTrastuzumab Chemotherapy].
Author:	Segami, Kenki\|Sato, Tsutomu\|Kawabe, Taiichi\|Hayashi, Shigeya\|Makuuchi, Yosuke\|Oshima, Takashi\|Rino, Yasushi\|Masuda, Munetaka\|Ogata, Takashi\|Cho, Haruhiko\|Yoshikawa, Takaki
PMID:	26489577

833.
Journal:	Dis Markers. 2015;2015:234851.
Title:	HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach.
Author:	Ieni, A\|Barresi, V\|Rigoli, L\|Caruso, R A\|Tuccari, G
PMID:	26494937

834.
Journal:	J Exp Clin Cancer Res. 2015 Oct 29;34:132.
Title:	Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer.
Author:	Huynh, Hung\|Ong, Richard\|Zopf, Dieter
PMID:	26514182

835.
Journal:	Clin Colorectal Cancer. 2015 Dec;14(4):239-50.
Title:	Current and Future Therapies for Advanced Gastric Cancer.
Author:	Davidson, Michael\|Okines, Alicia F C\|Starling, Naureen
PMID:	26524924

836.
Journal:	BMC Gastroenterol. 2015 Nov 4;15:157.
Title:	Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections.
Author:	Laboissiere, Renato Santos\|Buzelin, Marcelo Araujo\|Balabram, Debora\|De Brot, Marina\|Nunes, Cristiana Buzelin\|Rocha, Rafael Malagoli\|Cabral, Monica Maria Demas Alvares\|Gobbi, Helenice
PMID:	26530403

837.
Journal:	Rinsho Byori. 2015 Jun;63(6):769-73.
Title:	[Development of a Dual Detection Method with Fluorescence In Situ Hybridization and Immunostaining on Formalin-Fixed Paraffin-Embedded Tissue Sections--Molecular Pathological Detection Techniques and Their Applications to Pathological Diagnosis].
Author:	Ikeda, Satoshi
PMID:	26548243

838.
Journal:	BMC Cancer. 2015 Nov 11;15:894.
Title:	Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
Author:	Zhu, Yan\|Tian, Tiantian\|Zou, Jianling\|Wang, Qiwei\|Li, Zhongwu\|Li, Yanyan\|Liu, Xijuan\|Dong, Bin\|Li, Na\|Gao, Jing\|Shen, Lin
PMID:	26560145

839.
Journal:	PLoS One. 2015 Nov 13;10(11):e0142135.
Title:	Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method.
Author:	Chao, Wan-Ru\|Lee, Ming-Yung\|Ruan, Alexandra\|Sheng, Huang Pin\|Hsu, Jeng-Dong\|Han, Chih-Ping\|Koo, Chiew-Loon
PMID:	26566289

840.
Journal:	PLoS One. 2015 Nov 20;10(11):e0143207.
Title:	Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis.
Author:	Ye, Peng\|Zhang, Meizhuo\|Fan, Shuqiong\|Zhang, Tianwei\|Fu, Haihua\|Su, Xinying\|Gavine, Paul R\|Liu, Qiang\|Yin, Xiaolu
PMID:	26587992

841.
Journal:	World J Gastrointest Oncol. 2015 Nov 15;7(11):303-16.
Title:	Gastric cancer: The times they are a-changin'.
Author:	Satolli, Maria Antonietta\|Buffoni, Lucio\|Spadi, Rosella\|Roato, Ilaria
PMID:	26600930

842.
Journal:	Oncol Lett. 2015 Oct;10(4):2107-2117.
Title:	A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients.
Author:	Li, H E\|Wang, Xuefei\|Tang, Zhaoqing\|Liu, Fenglin\|Chen, Weidong\|Fang, Yong\|Wang, Cong\|Shen, Kuntang\|Qin, Jing\|Shen, Zhenbin\|Sun, Yihong\|Qin, Xinyu
PMID:	26622804

843.
Journal:	Mol Clin Oncol. 2015 Sep;3(5):987-994.
Title:	Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model.
Author:	Harada, Suguru\|Yanagisawa, Mieko\|Kaneko, Saori\|Yorozu, Keigo\|Yamamoto, Kaname\|Moriya, Yoichiro\|Harada, Naoki
PMID:	26623038

844.
Journal:	Asian Pac J Cancer Prev. 2015;16(17):7755-8.
Title:	Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma.
Author:	Madani, Seyed-Hamid\|Rahmati, Ali\|Sadeghi, Edris\|Khazaei, Sedighe\|Sadeghi, Masoud\|Payandeh, Mehrdad\|Amirifard, Nasrin
PMID:	26625793

845.
Journal:	Clin Transl Oncol. 2015 Dec;17(12):996-1004.
Title:	Seom guidelines for the treatment of gastric cancer 2015.
Author:	Martin-Richard, M\|Custodio, A\|Garcia-Giron, C\|Gravalos, C\|Gomez, C\|Jimenez-Fonseca, P\|Manzano, J L\|Pericay, C\|Rivera, F\|Carrato, A
PMID:	26691658

846.
Journal:	Indian J Surg. 2015 Dec;77(Suppl 2):447-51.
Title:	HER2 Expression in Gastric and Gastroesophageal Cancer: Report from a Tertiary Care Hospital in North India.
Author:	Tewari, Mallika\|Kumar, Akhileshwar\|Mishra, R R\|Kumar, Mohan\|Shukla, Hari S
PMID:	26730043

847.
Journal:	Oncol Lett. 2015 Dec;10(6):3483-3487.
Title:	Metastatic gastric carcinoma from breast cancer mimicking primary linitis plastica: A case report.
Author:	Yagi, Yasumichi\|Sasaki, Shozo\|Yoshikawa, Akemi\|Tsukioka, Yuji\|Fukushima, Wataru\|Fujimura, Takashi\|Hirosawa, Hisashi\|Izumi, Ryohei\|Saito, Katsuhiko
PMID:	26788154

848.
Journal:	Gan To Kagaku Ryoho. 2015 Nov;42(12):1635-7.
Title:	[Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Author:	Kim, Yongkook\|Hosoda, Yohei\|Nishino, Masaya\|Okano, Miho\|Kawada, Junji\|Yamasaki, Masaru\|Nagai, Ken-ichi\|Yasui, Masayosi\|Okuyama, Masaki\|Tsujinaka, Toshimasa
PMID:	26805121

849.
Journal:	Gan To Kagaku Ryoho. 2015 Nov;42(12):1668-70.
Title:	[Curative Surgery for Advanced Gastric Cancer with Extensive Lymph Node Metastasis after Long-Term Chemotherapy].
Author:	Fujita, Shotaro\|Monma, Tomoyuki\|Ohki, Shinji\|Murakami, Yuko\|Okayama, Hirokazu\|Yazawa, Takashi\|Takawa, Masashi\|Kumamoto, Kensuke\|Ohtake, Toru\|Kono, Koji\|Takenoshita, Seiichi
PMID:	26805132

850.
Journal:	Gan To Kagaku Ryoho. 2015 Nov;42(12):1968-70.
Title:	[A Case of Granulocyte-Colony Stimulating Factor-Producing Gastric Cancer Successfully Treated with Trastuzumab].
Author:	Matsushita, Katsunori\|Takeno, Atsushi\|Tamura, Shigeyuki\|Taniguchi, Hirokazu\|Ishida, Tomo\|Sato, Yasufumi\|Morimoto, Yoshihiro\|Kusama, Hiroki\|Hashimoto, Tadayoshi\|Kimura, Kei\|Katsura, Yoshiteru\|Ohmura, Yoshiaki\|Nitta, Kanae\|Kagawa, Yoshinori\|Okisiro, Masatsu
PMID:	26805233

851.
Journal:	Gan To Kagaku Ryoho. 2015 Nov;42(12):1971-3.
Title:	[A Case of a Submucosal Tumor-Like Gastric Cancer That Needed to Be Distinguished from Gastric Metastasis of Rectal Cancer].
Author:	Furuya, Kei\|Tokumitsu, Yukio\|Yoshino, Shigefumi\|Inoue, Yuka\|Iida, Michihisa\|Tamesa, Takao\|Takeda, Shigeru\|Ueno, Tomio\|Hazama, Shoichi\|Nagano, Hiroaki
PMID:	26805234

852.
Journal:	Gan To Kagaku Ryoho. 2015 Nov;42(12):1989-91.
Title:	[A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Treated with Combination Therapy].
Author:	Ebisui, Chikara\|Okada, Kazuyuki\|Nushijima, Youichirou\|Yanagisawa, Tetsu\|Okamura, Shu\|Fukuchi, Nariaki\|Murata, Kohei\|Yokouchi, Hideoki\|Ohishi, Kazuto\|Tamai, Masamitsu\|Kinuta, Masakatsu
PMID:	26805240

853.
Journal:	Gan To Kagaku Ryoho. 2015 Nov;42(12):2043-5.
Title:	[A Case of HER2-Positive Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy with S-1/CDDP/Trastuzumab].
Author:	Nishino, Masaya\|Hosoda, Yohei\|Okano, Miho\|Nagai, Ken-ichi\|Yasui, Masayoshi\|Kim, Yongkook\|Tsujinaka, Toshimasa
PMID:	26805258

854.
Journal:	Gan To Kagaku Ryoho. 2015 Nov;42(12):2094-6.
Title:	[A Case of Unresectable Local Recurrence of Gastric Cancer Successfully Resected after Pre-Operative Chemotherapy with Trastuzumab].
Author:	Okubo, Satoshi\|Takahashi, Tsuyoshi\|Miyazaki, Yasuhiro\|Makino, Tomoki\|Kurokawa, Yukinori\|Yamazaki, Makoto\|Nakajima, Kiyokazu\|Takiguchi, Shuji\|Mori, Masaki\|Doki, Yuichiro
PMID:	26805275

855.
Journal:	Gan To Kagaku Ryoho. 2015 Dec;42(13):2471-5.
Title:	[HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report].
Author:	Senoo, Satoru\|Mannami, Tomohiko\|Tamura, Tomoki\|Fujiwara, Nobukiyo\|Ikeda, Genyo\|Komoda, Minori\|Ohtawa, Yasuyuki\|Fujimoto, Yoshimi\|Sato, Naohiro\|Kambara, Takeshi\|Waku, Toshihiko\|Kenmotsu, Masaichi\|Kurimoto, Etsuko\|Okada, Toshiaki\|Harita, Shingo\|Sonobe, Hiro
PMID:	26809307

856.
Journal:	Indian J Med Paediatr Oncol. 2015 Jul-Sep;36(3):189-92.
Title:	Breast and gastrointestinal cancer updates from ASCO 2015.
Author:	Dawood, Shaheenah
PMID:	26855529

857.
Journal:	Viszeralmedizin. 2015 Oct;31(5):341-6.
Title:	Perioperative and Palliative Chemotherapy for Esophageal Cancer.
Author:	Behrens, Angelika\|Ell, Christian\|Lordick, Florian
PMID:	26989390

858.
Journal:	Materials (Basel). 2015 Feb 5;8(2):519-534.
Title:	Evaluation of Lapatinib Powder-Entrapped Biodegradable Polymeric Microstructures Fabricated by X-Ray Lithography for a Targeted and Sustained Drug Delivery System.
Author:	Jeong, Eun-Goo\|Yoo, Hyung Jung\|Song, Byeonghwa\|Kim, Hwang-Phill\|Han, Sae-Won\|Kim, Tae-You\|Cho, Dong-Il Dan
PMID:	28787954

859.
Journal:	Gastric Cancer. 2016 Jan;19(1):176-82.
Title:	HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance.
Author:	Huang, Shih-Chiang\|Ng, Kwai-Fong\|Lee, Shang-En\|Chen, Kuang-Hua\|Yeh, Ta-Sen\|Chen, Tse-Ching
PMID:	25512144

860.
Journal:	Mol Carcinog. 2016 Jan;55(1):90-6.
Title:	A functional lncRNA HOTAIR genetic variant contributes to gastric cancer susceptibility.
Author:	Pan, Wenting\|Liu, Lisheng\|Wei, Jinyu\|Ge, Yunxia\|Zhang, Jingfeng\|Chen, Hongwei\|Zhou, Liqing\|Yuan, Qipeng\|Zhou, Changchun\|Yang, Ming
PMID:	25640751

861.
Journal:	Gastric Cancer. 2016 Jan;19(1):183-91.
Title:	Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Author:	Fuse, Nozomu\|Kuboki, Yasutoshi\|Kuwata, Takeshi\|Nishina, Tomohiro\|Kadowaki, Shigenori\|Shinozaki, Eiji\|Machida, Nozomu\|Yuki, Satoshi\|Ooki, Akira\|Kajiura, Shinya\|Kimura, Tetsuo\|Yamanaka, Takeharu\|Shitara, Kohei\|Nagatsuma, Akiko Kawano\|Yoshino, Takayuki\|Ochia
PMID:	25682441

862.
Journal:	Cytotechnology. 2016 Aug;68(4):1095-102.
Title:	Detection and cultivation of circulating tumor cells in gastric cancer.
Author:	Kolostova, Katarina\|Matkowski, Rafal\|Gurlich, Robert\|Grabowski, Krzysztof\|Soter, Katarzyna\|Lischke, Robert\|Schutzner, Jan\|Bobek, Vladimir
PMID:	25862542

863.
Journal:	Curr Drug Targets. 2016;17(15):1818-1826.
Title:	Gastric Carcinoma at the Era of Targeted Therapies.
Author:	Dreanic, Johann\|Dhooge, Marion\|Sion, Elena\|Brezault, Catherine\|Chaussade, Stanislas\|Coriat, Romain
PMID:	25944013

864.
Journal:	Gastric Cancer. 2016 Apr;19(2):553-60.
Title:	Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer.
Author:	Tominaga, Naoyuki\|Gotoda, Takuji\|Hara, Megumi\|Hale, Matthew D\|Tsuchiya, Takayoshi\|Matsubayashi, Jun\|Kono, Shin\|Kusano, Chika\|Itoi, Takao\|Fujimoto, Kazuma\|Moriyasu, Fuminori\|Grabsch, Heike I
PMID:	25987463

865.
Journal:	Gastric Cancer. 2016 Apr;19(2):421-30.
Title:	Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications.
Author:	Ock, Chan-Young\|Kim, Tae-Yong\|Lee, Kyung-Hun\|Han, Sae-Won\|Im, Seock-Ah\|Kim, Tae-You\|Bang, Yung-Jue\|Oh, Do-Youn
PMID:	26002144

866.
Journal:	Histopathology. 2016 Jan;68(2):230-40.
Title:	Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
Author:	Hedner, Charlotta\|Tran, Lena\|Borg, David\|Nodin, Bjorn\|Jirstrom, Karin\|Eberhard, Jakob
PMID:	26016514

867.
Journal:	Gastric Cancer. 2016 Jul;19(3):839-51.
Title:	Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
Author:	Matsusaka, Satoshi\|Nashimoto, Atsushi\|Nishikawa, Kazuhiro\|Miki, Akira\|Miwa, Hiroto\|Yamaguchi, Kazuya\|Yoshikawa, Takaki\|Ochiai, Atsushi\|Morita, Satoshi\|Sano, Takeshi\|Kodera, Yasuhiro\|Kakeji, Yoshihiro\|Sakamoto, Junichi\|Saji, Shigetoyo\|Yoshida, Kazuhiro
PMID:	26265390

868.
Journal:	Appl Immunohistochem Mol Morphol. 2016 Aug;24(7):459-64.
Title:	HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) Compared With Immunohistochemistry (IHC) in 122 Equivocal Gastric Cancer Cases.
Author:	Liu, Xiaoyan\|Wang, Xiaoling\|Wang, Bo\|Ren, Guoping\|Ding, Wei
PMID:	26317310

869.
Journal:	Cancer Res Treat. 2016 Apr;48(2):553-60.
Title:	A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology.
Author:	Yi, Jun Ho\|Kang, Jung Hun\|Hwang, In Gyu\|Ahn, Hee Kyung\|Baek, Hyun Jin\|Lee, Soon Il\|Lim, Do Hyoung\|Won, Young-Woong\|Ji, Jun Ho\|Kim, Hyo Song\|Rha, Sun Young\|Oh, Sung Yong\|Lee, Kyung Eun\|Lim, Taekyu\|Maeng, Chi Hoon\|Kim, Moon Jin\|Kim, Seung Tae\|Lee, Jeeyun\|Pa
PMID:	26323641

870.
Journal:	Int J Biol Markers. 2016 Feb 28;31(1):e38-43.
Title:	Evaluation of HER2 by automated FISH and IHC in gastric carcinoma biopsies.
Author:	Silva, Maria R\|Alarcao, Ana\|Ferreira, Teresa\|d'Aguiar, Maria\|Ladeirinha, Ana\|Balseiro, Sandra\|Carvalho, Lina
PMID:	26349667

871.
Journal:	Int J Biol Markers. 2016 Feb 28;31(1):e1-10.
Title:	Concordance rate between HER2 immunohistochemistry and in situ hybridization in gastric carcinoma: systematic review and meta-analysis.
Author:	Pyo, Jung-Soo\|Sohn, Jin Hee\|Kim, Woo Ho
PMID:	26349670

872.
Journal:	Ann Oncol. 2016 Jan;27(1):127-33.
Title:	Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer.
Author:	Kuboki, Y\|Yamashita, S\|Niwa, T\|Ushijima, T\|Nagatsuma, A\|Kuwata, T\|Yoshino, T\|Doi, T\|Ochiai, A\|Ohtsu, A
PMID:	26489445

873.
Journal:	Expert Rev Anticancer Ther. 2016;16(1):111-22.
Title:	Targeting HER 2 and angiogenesis in gastric cancer.
Author:	Jomrich, G\|Schoppmann, S F
PMID:	26567753

874.
Journal:	Gastric Cancer. 2016 Oct;19(4):1095-103.
Title:	Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.
Author:	Oh, Do-Youn\|Lee, Kewn-Wook\|Cho, Jae Yong\|Kang, Won Ki\|Im, Seock-Ah\|Kim, Jin Won\|Bang, Yung-Jue
PMID:	26581547

875.
Journal:	Expert Opin Biol Ther. 2016;16(2):243-53.
Title:	Pertuzumab in gastrointestinal cancer.
Author:	Oh, Do-Youn\|Bang, Yung-Jue
PMID:	26619359

876.
Journal:	Gastric Cancer. 2016 Jul;19(3):1026.
Title:	Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
Author:	Matsusaka, Satoshi\|Nashimoto, Atsushi\|Nishikawa, Kazuhiro\|Miki, Akira\|Miwa, Hiroto\|Yamaguchi, Kazuya\|Yoshikawa, Takaki\|Ochiai, Atsushi\|Morita, Satoshi\|Sano, Takeshi\|Kodera, Yasuhiro\|Kakeji, Yoshihiro\|Sakamoto, Junichi\|Saji, Shigetoyo\|Yoshida, Kazuhiro
PMID:	26621522

877.
Journal:	Exp Mol Pathol. 2016 Apr;100(2):287-93.
Title:	Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Author:	Zhu, Yazhen\|Lu, Dan\|Lira, Maruja E\|Xu, Qing\|Du, Yunzhi\|Xiong, Jianghong\|Mao, Mao\|Chung, Hyun Cheol\|Zheng, Guangjuan
PMID:	26626802

878.
Journal:	Invest New Drugs. 2016 Feb;34(1):119-28.
Title:	Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study.
Author:	Meulendijks, Didier\|Beerepoot, Laurens V\|Boot, Henk\|de Groot, Jan Willem B\|Los, Maartje\|Boers, James E\|Vanhoutvin, Steven A L W\|Polee, Marco B\|Beeker, Aart\|Portielje, Johanna E A\|de Jong, Robert S\|Goey, Swan H\|Kuiper, Maria\|Sikorska, Karolina\|Beijnen, Jos
PMID:	26643663

879.
Journal:	Mol Med Rep. 2016 Feb;13(2):1909-13.
Title:	Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells.
Author:	Zhu, Miaolin\|Yao, Xiaoyuan\|Wu, Min\|Qian, Hai\|Wu, Yan\|Chen, Yongchang
PMID:	26676300

880.
Journal:	Am J Surg Pathol. 2016 May;40(5):636-44.
Title:	A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Author:	Carleton, Claire\|Hoang, Lien\|Sah, Shatrughan\|Kiyokawa, Takako\|Karamurzin, Yevgeniy S\|Talia, Karen L\|Park, Kay J\|McCluggage, W Glenn
PMID:	26685087

881.
Journal:	J Pathol. 2016 Mar;238(4):562-70.
Title:	HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.
Author:	Richman, Susan D\|Southward, Katie\|Chambers, Philip\|Cross, Debra\|Barrett, Jennifer\|Hemmings, Gemma\|Taylor, Morag\|Wood, Henry\|Hutchins, Gordon\|Foster, Joseph M\|Oumie, Assa\|Spink, Karen G\|Brown, Sarah R\|Jones, Marc\|Kerr, David\|Handley, Kelly\|Gray, Richard\|Se
PMID:	26690310

882.
Journal:	Eur J Cancer. 2016 Jan;53:42-50.
Title:	Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1).
Author:	Park, Sook Ryun\|Park, Young Soo\|Ryu, Min-Hee\|Ryoo, Baek-Yeol\|Woo, Chang Gok\|Jung, Hwoon-Yong\|Lee, Jeong Hoon\|Lee, Gin Hyug\|Kang, Yoon-Koo
PMID:	26693898

883.
Journal:	Crit Rev Oncol Hematol. 2016 Mar;99:1-12.
Title:	Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials.
Author:	Galdy, Salvatore\|Cella, Chiara Alessandra\|Spada, Francesca\|Murgioni, Sabina\|Frezza, Anna Maria\|Ravenda, Simona Paola\|Zampino, Maria Giulia\|Fazio, Nicola
PMID:	26697987

884.
Journal:	Oncotarget. 2016 Jan 26;7(4):4925-38.
Title:	Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer.
Author:	Takahashi, Naoki\|Furuta, Koh\|Taniguchi, Hirokazu\|Sasaki, Yusuke\|Shoji, Hirokazu\|Honma, Yoshitaka\|Iwasa, Satoru\|Okita, Natsuko\|Takashima, Atsuo\|Kato, Ken\|Hamaguchi, Tetsuya\|Shimada, Yasuhiro\|Yamada, Yasuhide
PMID:	26716644

885.
Journal:	Oncol Rep. 2016 Mar;35(3):1245-54.
Title:	Targeted therapy for gastric cancer: Current status and future directions (Review).
Author:	Yuan, Dan-Dan\|Zhu, Zhong-Xiu\|Zhang, Xia\|Liu, Jie
PMID:	26718131

886.
Journal:	Mol Cells. 2016 Mar;39(3):217-28.
Title:	Substitution of Heavy Complementarity Determining Region 3 (CDR-H3) Residues Can Synergistically Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen.
Author:	Moon, Seung Kee\|Park, So Ra\|Park, Ami\|Oh, Hyun Mi\|Shin, Hyun Jung\|Jeon, Eun Ju\|Kim, Seiwhan\|Park, Hyun June\|Yeon, Young Joo\|Yoo, Young Je
PMID:	26743905

887.
Journal:	Cancer Sci. 2016 Apr;107(4):536-42.
Title:	Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH, and dual-color in situ hybridization.
Author:	Kanayama, Kazuki\|Imai, Hiroshi\|Yoneda, Misao\|Hirokawa, Yoshifumi S\|Shiraishi, Taizo
PMID:	26752196

888.
Journal:	Acta Oncol. 2016;55(3):309-17.
Title:	Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK).
Author:	Saito, Mayuko\|Yamashita, Kentaro\|Arimura, Yoshiaki\|Kaneto, Hiroyuki\|Okuda, Hiroyuki\|Nojima, Masanori\|Hagiwara, Takeshi\|Suzuki, Kazuya\|Adachi, Takeya\|Goto, Akira\|Nakachi, Kohei\|Yawata, Atsushi\|Yoshimoto, Mitsuru\|Tanuma, Tokuma\|Adachi, Yasushi\|Yamaoka, Sato
PMID:	26757197

889.
Journal:	Cancer Res. 2016 Mar 15;76(6):1517-27.
Title:	Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer.
Author:	Espelin, Christopher W\|Leonard, Shannon C\|Geretti, Elena\|Wickham, Thomas J\|Hendriks, Bart S
PMID:	26759238

890.
Journal:	Cancer Lett. 2016 Mar 28;372(2):187-91.
Title:	Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer.
Author:	Roviello, Giandomenico\|Ravelli, Andrea\|Polom, Karol\|Petrioli, Roberto\|Marano, Luigi\|Marrelli, Daniele\|Roviello, Franco\|Generali, Daniele
PMID:	26797419

891.
Journal:	BMC Cancer. 2016 Jan 25;16:37.
Title:	Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
Author:	Ito, Kimihiro\|Mitsunaga, Makoto\|Arihiro, Seiji\|Saruta, Masayuki\|Matsuoka, Mika\|Kobayashi, Hisataka\|Tajiri, Hisao
PMID:	26810644

892.
Journal:	World J Gastroenterol. 2016 Jan 14;22(2):471-89.
Title:	Targeted therapies in gastric cancer and future perspectives.
Author:	Yazici, Ozan\|Sendur, M Ali Nahit\|Ozdemir, Nuriye\|Aksoy, Sercan
PMID:	26811601

893.
Journal:	World J Gastroenterol. 2016 Jan 21;22(3):1160-71.
Title:	Personalized medicine in gastric cancer: Where are we and where are we going?
Author:	Jacome, Alexandre A\|Coutinho, Anelisa K\|Lima, Enaldo M\|Andrade, Aline C\|Dos Santos, Jose Sebastiao
PMID:	26811654

894.
Journal:	Pathol Int. 2016 Feb;66(2):57-62.
Title:	New guidelines for HER2 pathological diagnostics in gastric cancer.
Author:	Wada, Ryo\|Hirabayashi, Kenichi\|Ohike, Nobuyuki\|Morii, Eiichi
PMID:	26814046

895.
Journal:	Mol Cancer Ther. 2016 Mar;15(3):402-11.
Title:	Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer.
Author:	Ishida, Michihiro\|Kagawa, Shunsuke\|Shimoyama, Kyoko\|Takehara, Kiyoto\|Noma, Kazuhiro\|Tanabe, Shunsuke\|Shirakawa, Yasuhiro\|Tazawa, Hiroshi\|Kobayashi, Hisataka\|Fujiwara, Toshiyoshi
PMID:	26832799

896.
Journal:	Future Oncol. 2016 Mar;12(6):839-54.
Title:	Current advances in targeted therapies for metastatic gastric cancer: improving patient care.
Author:	Aguiar, Pedro Nazareth Jr\|Muniz, Thiago Pimentel\|Miranda, Raelson Rodrigues\|Tadokoro, Hakaru\|Forones, Nora Manoukian\|Monteiro, Ines-de-Paula\|Castelo-Branco, Pedro\|Janjigian, Yelena Y\|De Mello, Ramon Andrade
PMID:	26838766

897.
Journal:	Sci Rep. 2016 Feb 5;6:20502.
Title:	Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.
Author:	Huang, Dongsheng\|Duan, Hongying\|Huang, Hao\|Tong, Xiangmin\|Han, Yong\|Ru, Guoqing\|Qu, Like\|Shou, Chengchao\|Zhao, Zhongsheng
PMID:	26846307

898.
Journal:	Ann Surg Oncol. 2016 Jun;23(6):1986-92.
Title:	Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer.
Author:	Hisamatsu, Yuichi\|Oki, Eiji\|Otsu, Hajime\|Ando, Koji\|Saeki, Hiroshi\|Tokunaga, Eriko\|Aishima, Shinichi\|Morita, Masaru\|Oda, Yoshinao\|Maehara, Yoshihiko
PMID:	26847684

899.
Journal:	Cancer Res. 2016 Apr 1;76(7):1714-23.
Title:	Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.
Author:	Hu, Nan\|Kadota, Mitsutaka\|Liu, Huaitian\|Abnet, Christian C\|Su, Hua\|Wu, Hailong\|Freedman, Neal D\|Yang, Howard H\|Wang, Chaoyu\|Yan, Chunhua\|Wang, Lemin\|Gere, Sheryl\|Hutchinson, Amy\|Song, Guohong\|Wang, Yuan\|Ding, Ti\|Qiao, You-Lin\|Koshiol, Jill\|Dawsey, Sanford
PMID:	26857264

900.
Journal:	BMC Cancer. 2016 Feb 8;16:68.
Title:	Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
Author:	Gong, Jifang\|Liu, Tianshu\|Fan, Qingxia\|Bai, Li\|Bi, Feng\|Qin, Shukui\|Wang, Jinwan\|Xu, Nong\|Cheng, Ying\|Bai, Yuxian\|Liu, Wei\|Wang, Liwei\|Shen, Lin
PMID:	26857702

901.
Journal:	Lancet Oncol. 2016 Mar;17(3):367-77.
Title:	Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Author:	Chan, Arlene\|Delaloge, Suzette\|Holmes, Frankie A\|Moy, Beverly\|Iwata, Hiroji\|Harvey, Vernon J\|Robert, Nicholas J\|Silovski, Tajana\|Gokmen, Erhan\|von Minckwitz, Gunter\|Ejlertsen, Bent\|Chia, Stephen K L\|Mansi, Janine\|Barrios, Carlos H\|Gnant, Michael\|Buyse, Ma
PMID:	26874901

902.
Journal:	J Gastrointest Cancer. 2016 Jun;47(2):125-34.
Title:	Advances of Molecular Targeted Therapy in Gastric Cancer.
Author:	Cetin, Bulent\|Gumusay, Ozge\|Cengiz, Mustafa\|Ozet, Ahmet
PMID:	26875080

903.
Journal:	Target Oncol. 2016 Aug;11(4):469-77.
Title:	Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints.
Author:	Alsina, Maria\|Moehler, Markus\|Hierro, Cinta\|Guardeno, Raquel\|Tabernero, Josep
PMID:	26880697

904.
Journal:	Gastroenterol Res Pract. 2016;2016:4105615.
Title:	Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application.
Author:	Li, Kaichun\|Li, Jin
PMID:	26880889

905.
Journal:	J Gastroenterol. 2016 May;51(5):506-7.
Title:	Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?
Author:	Yamada, Takeshi\|Yamamoto, Yoshiyuki\|Moriwaki, Toshikazu\|Hyodo, Ichisnosuke
PMID:	26891910

906.
Journal:	Exp Ther Med. 2016 Feb;11(2):625-630.
Title:	Upregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2.
Author:	Zhou, Ning\|Qu, Yanli\|Xu, Chunlei\|Tang, Yong
PMID:	26893657

907.
Journal:	Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):246-52.
Title:	Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy.
Author:	Illei, Peter B\|Alewine, Christine\|Zahurak, Marianna\|Cowan, Morgan L\|Montgomery, Elizabeth\|Hassan, Raffit\|Xiang, Laiman\|Pastan, Ira\|Kelly, Ronan J
PMID:	26894650

908.
Journal:	J Gastroenterol. 2016 May;51(5):508.
Title:	Reply to the letter by Takeshi Yamada et al. concerning "Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?".
Author:	Zhou, Jun\|Peng, Zhi\|Shen, Lin
PMID:	26897738

909.
Journal:	Oncotarget. 2016 Apr 5;7(14):18424-39.
Title:	Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.
Author:	Arienti, Chiara\|Zanoni, Michele\|Pignatta, Sara\|Del Rio, Alberto\|Carloni, Silvia\|Tebaldi, Michela\|Tedaldi, Gianluca\|Tesei, Anna
PMID:	26919099

910.
Journal:	Nat Rev Clin Oncol. 2016 Jun;13(6):348-60.
Title:	Clinical impact of tumour biology in the management of gastroesophageal cancer.
Author:	Lordick, Florian\|Janjigian, Yelena Y
PMID:	26925958

911.
Journal:	World J Gastroenterol. 2016 Feb 28;22(8):2403-14.
Title:	Advanced gastric cancer: Current treatment landscape and future perspectives.
Author:	Digklia, Antonia\|Wagner, Anna Dorothea
PMID:	26937129

912.
Journal:	Oncotarget. 2016 Apr 19;7(16):21601-17.
Title:	APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.
Author:	Hong, Se-Hoon\|Lee, Won Jae\|Kim, Young Doo\|Kim, Hyunjoo\|Jeon, Young-Jun\|Lim, Bitna\|Cho, Dong-Hyung\|Heo, Won Do\|Yang, Doo-Hyun\|Kim, Chan-Young\|Yang, Han-Kwang\|Yang, Jin Kuk\|Jung, Yong-Keun
PMID:	26942872

913.
Journal:	Crit Rev Oncol Hematol. 2016 Apr;100:141-6.
Title:	Translating gastric cancer genomics into targeted therapies.
Author:	Ang, Yvonne L E\|Yong, Wei Peng\|Tan, Patrick
PMID:	26947813

914.
Journal:	BMC Cancer. 2016 Mar 9;16:200.
Title:	Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.
Author:	Chang, Hae Ryung\|Park, Hee Seo\|Ahn, Young Zoo\|Nam, Seungyoon\|Jung, Hae Rim\|Park, Sungjin\|Lee, Sang Jin\|Balch, Curt\|Powis, Garth\|Ku, Ja-Lok\|Kim, Yon Hui
PMID:	26955870

915.
Journal:	J Gastroenterol. 2016 May;51(5):509-10.
Title:	Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy.
Author:	Zhou, Jun\|Peng, Zhi\|Liu, Yi\|Gong, Jifang\|Zhang, Xiaotian\|Lu, Ming\|Gao, Jing\|Li, Yili\|Li, Yanyan\|Shen, Lin
PMID:	26956873

916.
Journal:	J Nucl Med. 2016 Jul;57(7):1040-4.
Title:	Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Author:	Chen, Ruohua\|Zhou, Xiang\|Liu, Jianjun\|Huang, Gang
PMID:	26966162

917.
Journal:	Cancer. 2016 May 1;122(9):1434-43.
Title:	Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study.
Author:	Meulendijks, Didier\|de Groot, Jan Willem B\|Los, Maartje\|Boers, James E\|Beerepoot, Laurens V\|Polee, Marco B\|Beeker, Aart\|Portielje, Johanna E A\|Goey, Swan H\|de Jong, Robert S\|Vanhoutvin, Steven A L W\|Kuiper, Maria\|Sikorska, Karolina\|Pluim, Dick\|Beijnen, Jo
PMID:	26970343

918.
Journal:	Expert Opin Biol Ther. 2016 Jun;16(6):759-69.
Title:	Monoclonal antibodies for treating gastric cancer: promises and pitfalls.
Author:	Sibertin-Blanc, Camille\|Ciccolini, Joseph\|Norguet, Emmanuelle\|Lacarelle, Bruno\|Dahan, Laetitia\|Seitz, Jean-Francois
PMID:	26971395

919.
Journal:	Cancer Chemother Pharmacol. 2016 May;77(5):957-62.
Title:	A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer.
Author:	Kataoka, Hiromi\|Mori, Yoshinori\|Shimura, Takaya\|Nishie, Hirotada\|Natsume, Makoto\|Mochizuki, Hisato\|Hirata, Yoshikazu\|Sobue, Satoshi\|Mizushima, Takashi\|Sano, Hitoshi\|Mizuno, Yusuke\|Nakamura, Makoto\|Hirano, Atsuyuki\|Tsuchida, Kenji\|Adachi, Kazunori\|Seno, Ky
PMID:	27002325

920.
Journal:	J Hematol Oncol. 2016 Mar 24;9:29.
Title:	Case report: mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance.
Author:	Chen, Kuo-Hsing\|Yuan, Chang-Tsu\|Tseng, Li-Hui\|Shun, Chia-Tung\|Yeh, Kun-Huei
PMID:	27012666

921.
Journal:	Onco Targets Ther. 2016 Feb 26;9:949-58.
Title:	Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.
Author:	Liu, Xuechao\|Xu, Pengfei\|Qiu, Haibo\|Liu, Jianjun\|Chen, Shangxiang\|Xu, Dazhi\|Li, Wei\|Zhan, Youqing\|Li, Yuanfang\|Chen, Yingbo\|Zhou, Zhiwei\|Sun, Xiaowei
PMID:	27013889

922.
Journal:	Genes Cancer. 2016 Jan;7(1-2):27-35.
Title:	Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy.
Author:	Matsusaka, Satoshi\|Kobunai, Takashi\|Yamamoto, Noriko\|Chin, Keisho\|Ogura, Mariko\|Tanaka, Gotaro\|Matsuoka, Kazuaki\|Ishikawa, Yuichi\|Mizunuma, Nobuyuki\|Yamaguchi, Toshiharu
PMID:	27014419

923.
Journal:	Clin Cancer Res. 2016 Oct 15;22(20):5097-5108.
Title:	DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1.
Author:	Ogitani, Yusuke\|Aida, Tetsuo\|Hagihara, Katsunobu\|Yamaguchi, Junko\|Ishii, Chiaki\|Harada, Naoya\|Soma, Masako\|Okamoto, Hiromi\|Oitate, Masataka\|Arakawa, Shingo\|Hirai, Takehiro\|Atsumi, Ryo\|Nakada, Takashi\|Hayakawa, Ichiro\|Abe, Yuki\|Agatsuma, Toshinori
PMID:	27026201

924.
Journal:	Oncotarget. 2016 Apr 26;7(17):23647-57.
Title:	Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.
Author:	Chen, Xin-Zu\|Zhang, Wei-Han\|Chen, Hai-Ning\|Liu, Jian-Ping\|He, Du\|Liu, Yang\|Liu, Kai\|Chen, Xiao-Long\|Mo, Xian-Ming\|Zhou, Zong-Guang\|Hu, Jian-Kun
PMID:	27027339

925.
Journal:	Biochem J. 2016 Jun 15;473(12):1703-18.
Title:	Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.
Author:	Marcus, Elizabeth A\|Tokhtaeva, Elmira\|Turdikulova, Shahlo\|Capri, Joseph\|Whitelegge, Julian P\|Scott, David R\|Sachs, George\|Berditchevski, Fedor\|Vagin, Olga
PMID:	27048593

926.
Journal:	Indian J Surg Oncol. 2016 Mar;7(1):18-24.
Title:	HER2 Expression in Gastric Adenocarcinoma-a Study in a Tertiary Care Centre in South India.
Author:	Aditi, Raj\|Aarathi, Rau\|Pradeep, Rudramurthy\|Hemalatha, Lokanatha\|Akshatha, C\|Amar, Kumar
PMID:	27065677

927.
Journal:	Gan To Kagaku Ryoho. 2016 Mar;43(3):281-5.
Title:	[Molecular Subtypes of Gastric Cancer].
Author:	Hatogai, Ken\|Doi, Toshihiko
PMID:	27067842

928.
Journal:	Anticancer Res. 2016 Apr;36(4):1581-90.
Title:	HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
Author:	Makatsoris, Thomas\|Tsamandas, Athanassios C\|Strimpakos, Alexios\|Alexopoulou, Zoi\|Dionysopoulos, Dimitrios\|Pervana, Stavroula\|Konstantara, Athina\|Papakostas, Pavlos\|Samantas, Epaminontas\|Rallis, Grigoris\|Dimou, Anastasios\|Pentheroudakis, George\|Papaparaske
PMID:	27069134

929.
Journal:	Pharmacogn Mag. 2016 Apr-Jun;12(46):139-44.
Title:	Discovery of Novel Human Epidermal Growth Factor Receptor-2 Inhibitors by Structure-based Virtual Screening.
Author:	Shi, Zheng\|Yu, Tian\|Sun, Rong\|Wang, Shan\|Chen, Xiao-Qian\|Cheng, Li-Jia\|Liu, Rong
PMID:	27076751

930.
Journal:	Curr Opin Oncol. 2016 Jul;28(4):367-75.
Title:	Insights into next developments in advanced gastric cancer.
Author:	Obermannova, Radka\|Lordick, Florian
PMID:	27092990

931.
Journal:	Oncotarget. 2016 May 10;7(19):28670-83.
Title:	A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.
Author:	Park, Jihyun\|Kim, Sun Young\|Kim, Ha-Jung\|Kim, Kyoung-Mee\|Choi, Eun Young\|Kang, Myung-Soo
PMID:	27107424

932.
Journal:	PLoS One. 2016 Apr 27;11(4):e0154430.
Title:	Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens.
Author:	Matsusaka, Keisuke\|Ishikawa, Shumpei\|Nakayama, Atsuhito\|Ushiku, Tetsuo\|Nishimoto, Aiko\|Urabe, Masayuki\|Kaneko, Nobuyuki\|Kunita, Akiko\|Kaneda, Atsushi\|Aburatani, Hiroyuki\|Fujishiro, Mitsuhiro\|Seto, Yasuyuki\|Fukayama, Masashi
PMID:	27119558

933.
Journal:	Mol Clin Oncol. 2016 May;4(5):719-722.
Title:	HER2-positive double primary tumor of gastric and breast cancer occur synchronously in a patient: A case report.
Author:	Ouyang, Quchang\|Tian, Can\|Gao, Jianxiang\|Huang, Jin\|Fu, Hua\|He, Jinsong\|Yang, Jianbo
PMID:	27123269

934.
Journal:	Sci Rep. 2016 May 3;6:25467.
Title:	Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.
Author:	Werner, Simone\|Chen, Hongda\|Butt, Julia\|Michel, Angelika\|Knebel, Phillip\|Holleczek, Bernd\|Zornig, Inka\|Eichmuller, Stefan B\|Jager, Dirk\|Pawlita, Michael\|Waterboer, Tim\|Brenner, Hermann
PMID:	27140836

935.
Journal:	Dig Liver Dis. 2016 Sep;48(9):984-94.
Title:	Recent insights in the therapeutic management of patients with gastric cancer.
Author:	de Mestier, Louis\|Lardiere-Deguelte, Sophie\|Volet, Julien\|Kianmanesh, Reza\|Bouche, Olivier
PMID:	27156069

936.
Journal:	Lancet. 2016 Nov 26;388(10060):2654-2664.
Title:	Gastric cancer.
Author:	Van Cutsem, Eric\|Sagaert, Xavier\|Topal, Baki\|Haustermans, Karin\|Prenen, Hans
PMID:	27156933

937.
Journal:	Oncotarget. 2016 Jun 14;7(24):36865-36884.
Title:	JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patients.
Author:	Qian, Jing\|Zhu, Weiyou\|Wang, Keming\|Ma, Lin\|Xu, Jin\|Xu, Tongpeng\|Roe, Oluf Dimitri\|Li, Aiping\|Zhou, Jianwei\|Shu, Yongqian
PMID:	27167206

938.
Journal:	Br J Cancer. 2016 May 24;114(11):1185-90.
Title:	Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis.
Author:	Yoo, Changhoon\|Ryu, Min-Hee\|Na, Young-Soon\|Ryoo, Baek-Yeol\|Lee, Chae-Won\|Kang, Yoon-Koo
PMID:	27172248

939.
Journal:	Oncotarget. 2016 Jun 28;7(26):39758-39767.
Title:	The chronological sequence of somatic mutations in early gastric carcinogenesis inferred from multiregion sequencing of gastric adenomas.
Author:	Lim, Chul-Hyun\|Cho, Yu Kyung\|Kim, Sang Woo\|Choi, Myung-Gyu\|Rhee, Je-Keun\|Chung, Yeun-Jun\|Lee, Sug-Hyung\|Kim, Tae-Min
PMID:	27175599

940.
Journal:	Mol Med Rep. 2016 Jul;14(1):413-9.
Title:	Evodiamine sensitizes BGC-823 gastric cancer cells to radiotherapy in vitro and in vivo.
Author:	Hu, Chengqi\|Gao, Xuexiang\|Han, Yuanyuan\|Guo, Qi\|Zhang, Kailiang\|Liu, Miaomiao\|Wang, Yugang\|Wang, Jing
PMID:	27176933

941.
Journal:	Mol Diagn Ther. 2016 Aug;20(4):375-83.
Title:	A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.
Author:	Ahn, Soomin\|Hong, Mineui\|Van Vrancken, Michael\|Lyou, You Jeong\|Kim, Seung Tae\|Park, Se Hoon\|Kang, Won Ki\|Park, Young Suk\|Jung, Sin-Ho\|Woo, Minah\|Lee, Jeeyun\|Kim, Kyoung-Mee
PMID:	27179810

942.
Journal:	Cancer Res. 2016 May 1;76(9):2573-86.
Title:	Stromal-Based Signatures for the Classification of Gastric Cancer.
Author:	Uhlik, Mark T\|Liu, Jiangang\|Falcon, Beverly L\|Iyer, Seema\|Stewart, Julie\|Celikkaya, Hilal\|O'Mahony, Marguerita\|Sevinsky, Christopher\|Lowes, Christina\|Douglass, Larry\|Jeffries, Cynthia\|Bodenmiller, Diane\|Chintharlapalli, Sudhakar\|Fischl, Anthony\|Gerald, Da
PMID:	27197264

943.
Journal:	Nanoscale. 2016 Jun 2;8(22):11543-58.
Title:	Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
Author:	Yang, Zhe\|Luo, Huiyan\|Cao, Zhong\|Chen, Ya\|Gao, Jinbiao\|Li, Yingqin\|Jiang, Qing\|Xu, Ruihua\|Liu, Jie
PMID:	27203688

944.
Journal:	Gan To Kagaku Ryoho. 2016 May;43(5):625-7.
Title:	[Complete Response in a Patient with HER2-Positive Gastric Cancer and Multiple Lung Metastases with Trastuzumab-Containing Chemotherapy].
Author:	Nakata, Wachiko\|Tokuyama, Nobuyuki\|Yagioka, Hiroshi\|Suyama, Yuki\|Ogura, Keiji
PMID:	27210096

945.
Journal:	Eur Rev Med Pharmacol Sci. 2016 May;20(9):1725-32.
Title:	The role of targeted agents in the treatment of advanced gastric cancer: a meta-analysis of randomized controlled trials.
Author:	Wang, C-W\|Fang, X-H
PMID:	27212163

946.
Journal:	Curr Oncol Rep. 2016 Jul;18(7):41.
Title:	Personalised Treatment in Gastric Cancer: Myth or Reality?
Author:	Tarazona, Noelia\|Gambardella, Valentina\|Huerta, Marisol\|Rosello, Susana\|Cervantes, Andres
PMID:	27215435

947.
Journal:	World J Gastroenterol. 2016 May 21;22(19):4619-25.
Title:	HER2 testing in gastric cancer: An update.
Author:	Abrahao-Machado, Lucas Faria\|Scapulatempo-Neto, Cristovam
PMID:	27217694

948.
Journal:	J Cancer Res Clin Oncol. 2016 Aug;142(8):1727-38.
Title:	Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.
Author:	Takahashi, Naoki\|Iwasa, Satoru\|Sasaki, Yusuke\|Shoji, Hirokazu\|Honma, Yoshitaka\|Takashima, Atsuo\|Okita, Natsuko Tsuda\|Kato, Ken\|Hamaguchi, Tetsuya\|Yamada, Yasuhide
PMID:	27256004

949.
Journal:	Sci Rep. 2016 Jun 3;6:26997.
Title:	Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue.
Author:	Cederbye, Camilla Natasha\|Palshof, Jesper Andreas\|Hansen, Tine Plato\|Duun-Henriksen, Anne Katrine\|Linnemann, Dorte\|Stenvang, Jan\|Nielsen, Dorte Lisbet\|Brunner, Nils\|Viuff, Birgitte Martine
PMID:	27257141

950.
Journal:	Am J Surg Pathol. 2016 Oct;40(10):1326-33.
Title:	Pathologic Response of HER2-positive Gastric Cancer to Trastuzumab-based Chemotherapy.
Author:	Urabe, Masayuki\|Ushiku, Tetsuo\|Seto, Yasuyuki\|Fukayama, Masashi
PMID:	27259008

951.
Journal:	Clin Cancer Res. 2016 Dec 15;22(24):6164-6175.
Title:	An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.
Author:	Piro, Geny\|Carbone, Carmine\|Cataldo, Ivana\|Di Nicolantonio, Federica\|Giacopuzzi, Simone\|Aprile, Giuseppe\|Simionato, Francesca\|Boschi, Federico\|Zanotto, Marco\|Mina, Maria Mihaela\|Santoro, Raffaela\|Merz, Valeria\|Sbarbati, Andrea\|de Manzoni, Giovanni\|Scarpa,
PMID:	27267856

952.
Journal:	Asian Pac J Cancer Prev. 2016;17(5):2555-8.
Title:	Profile of HER2 +ve Gastric Cancers in Brunei Darussalam.
Author:	Chong, Vui Heng\|Telisinghe, Pemasari Upali\|Tan, Jackson\|Abdullah, Muhamad Syafiq\|Chong, Chee Fui
PMID:	27268629

953.
Journal:	Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016 May;41(5):471-6.
Title:	[Correlation between cyclin-dependent kinase inhibitor p27kip1 and trastuzumab-resistance in gastric cancer].
Author:	Wu, Mengwan\|Guo, Lihong\|Zuo, Qiang
PMID:	27269920

954.
Journal:	Oncol Lett. 2016 Jun;11(6):3575-3578.
Title:	HER2-positive gastric cancer identified by serum HER2: A case report.
Author:	Saito, Mayuko\|Kawakami, Yujiro\|Yamashita, Kentaro\|Nasuno, Hiroshi\|Ishimine, Y U\|Fukuda, Koichiro\|Isshiki, Hiroyuki\|Suzuki, Ryo\|Arimura, Yoshiaki\|Shinomura, Yasuhisa
PMID:	27284358

955.
Journal:	Gan To Kagaku Ryoho. 2016 Jun;43(6):761-4.
Title:	[A Case of HER2-Positive Esophagogastric Junction Cancer with Perforation Curatively Resected after Neoadjuvant Chemotherapy plus Trastuzumab].
Author:	Toshima, Hirokazu\|Hisamatsu, Atsushi\|Shimada, Ken\|Saito, Mitsuo\|Suzuki, Michitaka\|Matsukawa, Masaaki\|Inoue, Haruhiro
PMID:	27306816

956.
Journal:	Cancer Biomark. 2016 Jun 7;17(1):49-54.
Title:	The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
Author:	Qu, Jianjun\|Qu, Xiangyang
PMID:	27314292

957.
Journal:	Mol Cancer Ther. 2016 Sep;15(9):2251-8.
Title:	A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer.
Author:	LaBonte, Melissa J\|Yang, Dongyun\|Zhang, Wu\|Wilson, Peter M\|Nagarwala, Yasir M\|Koch, Kevin M\|Briner, Colleen\|Kaneko, Tomomi\|Rha, Sun-Young\|Gladkov, Oleg\|Urba, Susan G\|Sakaeva, Dina\|Pishvaian, Michael J\|Hsieh, Ruey-Kuen\|Lee, Wei-Ping\|Lenz, Heinz-Josef
PMID:	27325685

958.
Journal:	Cell Res. 2016 Jul;26(7):850-3.
Title:	Bifunctional alphaHER2/CD3 RNA-engineered CART-like human T cells specifically eliminate HER2(+) gastric cancer.
Author:	Luo, Feifei\|Qian, Jiawen\|Yang, Jiao\|Deng, Yuting\|Zheng, Xiujuan\|Liu, Jie\|Chu, Yiwei
PMID:	27339087

959.
Journal:	World J Gastroenterol. 2016 Jun 21;22(23):5406-14.
Title:	Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China.
Author:	Shen, Guo-Shuang\|Zhao, Jiu-Da\|Zhao, Jun-Hui\|Ma, Xin-Fu\|Du, Feng\|Kan, Jie\|Ji, Fa-Xiang\|Ma, Fei\|Zheng, Fang-Chao\|Wang, Zi-Yi\|Xu, Bing-He
PMID:	27340357

960.
Journal:	Biochem Biophys Res Commun. 2016 Sep 2;477(4):755-760.
Title:	A bispecific anti-ErbB2 antibody potently induces ErbB2 internalization and suppresses ErbB2-overexpressing tumor growth.
Author:	Zhang, Yajun\|Wang, Lingfei\|Chong, Xiaodan\|Yu, Xiaojie\|Meng, Yanchun\|Dong, Jian\|Wang, Chao\|Wang, Huajing\|Yang, Yang\|Xia, Tian\|Zhao, Jian\|Li, Bohua
PMID:	27363335

961.
Journal:	Sci Rep. 2016 Jul 1;6:28044.
Title:	Prognostic values of four Notch receptor mRNA expression in gastric cancer.
Author:	Wu, Xiaoyu\|Liu, Wentao\|Tang, Ding\|Xiao, Haijuan\|Wu, Zhenfeng\|Chen, Che\|Yao, Xuequan\|Liu, Fukun\|Li, Gang
PMID:	27363496

962.
Journal:	Pathologe. 2016 Jul;37(4):361-6.
Title:	[HER2 testing in gastric cancer : Results of a meeting of German experts].
Author:	Baretton, G\|Dietel, M\|Gaiser, T\|Kirchner, T\|Kreipe, H H\|Quaas, A\|Rocken, C\|Ruschoff, J\|Tannapfel, A\|Lordick, F\|Al-Batran, S\|Hofheinz, R\|Lorenzen, S\|Moehler, M\|Thuss-Patience, P
PMID:	27376648

963.
Journal:	Oncotarget. 2016 Aug 2;7(31):49322-49333.
Title:	Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients.
Author:	Szasz, A Marcell\|Lanczky, Andras\|Nagy, Adam\|Forster, Susann\|Hark, Kim\|Green, Jeffrey E\|Boussioutas, Alex\|Busuttil, Rita\|Szabo, Andras\|Gyorffy, Balazs
PMID:	27384994

964.
Journal:	BMC Cancer. 2016 Jul 7;16:420.
Title:	A phase I trial of the trifunctional anti Her2 x anti CD3 antibody ertumaxomab in patients with advanced solid tumors.
Author:	Haense, N\|Atmaca, A\|Pauligk, C\|Steinmetz, K\|Marme, F\|Haag, G M\|Rieger, M\|Ottmann, O G\|Ruf, P\|Lindhofer, H\|Al-Batran, S-E
PMID:	27387446

965.
Journal:	Oncotarget. 2016 Aug 2;7(31):50656-50665.
Title:	Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study.
Author:	Li, Qian\|Jiang, Huiqin\|Li, Hong\|Xu, Ruihua\|Shen, Lin\|Yu, Yiyi\|Wang, Yan\|Cui, Yuehong\|Li, Wei\|Yu, Shan\|Liu, Tianshu
PMID:	27409420

966.
Journal:	Oncotarget. 2016 Aug 23;7(34):54445-54462.
Title:	Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation.
Author:	Saisana, Marina\|Griffin, S Michael\|May, Felicity E B
PMID:	27437872

967.
Journal:	World J Gastroenterol. 2016 Jul 14;22(26):5879-87.
Title:	HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.
Author:	Grillo, Federica\|Fassan, Matteo\|Sarocchi, Francesca\|Fiocca, Roberto\|Mastracci, Luca
PMID:	27468182

968.
Journal:	Cancer Lett. 2016 Oct 10;381(1):104-12.
Title:	Dual targeting and enhanced cytotoxicity to HER2-overexpressing tumors by immunoapoptotin-armored mesenchymal stem cells.
Author:	Cai, Yanhui\|Xi, Yujing\|Cao, Zhongyuan\|Xiang, Geng\|Ni, Qingrong\|Zhang, Rui\|Chang, Jing\|Du, Xiao\|Yang, Angang\|Yan, Bo\|Zhao, Jing
PMID:	27473824

969.
Journal:	Oncol Res Treat. 2016;39(3):153-4; discussion 155.
Title:	Integration of Trastuzumab, with or without Pertuzumab, into Perioperative Chemotherapy of HER2- Positive Stomach Cancer: The INNOVATION Trial (EORTC-1203-GITCG).
Author:
PMID:	27486629

970.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2016 Aug 8;45(8):528-32.
Title:	[Guidelines for HER2 detection in gastric cancer(2016)].
Author:
PMID:	27510777

971.
Journal:	World J Surg Oncol. 2016 Aug 11;14(1):212.
Title:	Gastric biomarkers: a global review.
Author:	Baniak, Nick\|Senger, Jenna-Lynn\|Ahmed, Shahid\|Kanthan, S C\|Kanthan, Rani
PMID:	27514667

972.
Journal:	PLoS One. 2016 Aug 12;11(8):e0161278.
Title:	Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment.
Author:	Yoon, Sung Hyun\|Kim, Young Hoon\|Lee, Yoon Jin\|Park, Jihoon\|Kim, Jin Won\|Lee, Hye Seung\|Kim, Bohyoung
PMID:	27517841

973.
Journal:	PLoS One. 2016 Aug 18;11(8):e0161219.
Title:	HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
Author:	Cao, Guo-Dong\|Chen, Ke\|Xiong, Mao-Ming\|Chen, Bo
PMID:	27536774

974.
Journal:	Int J Cancer. 2016 Dec 15;139(12):2859-2864.
Title:	HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
Author:	Pietrantonio, F\|Caporale, M\|Morano, F\|Scartozzi, M\|Gloghini, A\|De Vita, F\|Giommoni, E\|Fornaro, L\|Aprile, G\|Melisi, D\|Berenato, R\|Mennitto, A\|Volpi, C C\|Laterza, M M\|Pusceddu, V\|Antonuzzo, L\|Vasile, E\|Ongaro, E\|Simionato, F\|de Braud, F\|Torri, V\|Di Bartolom
PMID:	27578417

975.
Journal:	J Hematol Oncol. 2016 Aug 31;9(1):76.
Title:	A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway.
Author:	Liu, Jing\|Pan, Changqie\|Guo, Lihong\|Wu, Mengwan\|Guo, Jing\|Peng, Sheng\|Wu, Qianying\|Zuo, Qiang
PMID:	27581375

976.
Journal:	Br J Cancer. 2016 Oct 11;115(8):974-982.
Title:	Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab.
Author:	Fuchs, Charles S\|Tabernero, Josep\|Tomasek, Jiri\|Chau, Ian\|Melichar, Bohuslav\|Safran, Howard\|Tehfe, Mustapha A\|Filip, Dumitru\|Topuzov, Eldar\|Schlittler, Luis\|Udrea, Anghel Adrian\|Campbell, William\|Brincat, Stephen\|Emig, Michael\|Melemed, Symantha A\|Hozak, R
PMID:	27623234

977.
Journal:	Gan To Kagaku Ryoho. 2016 Sep;43(9):1113-6.
Title:	[A Case of HER2-Positive Stage IV Advanced Gastric Cancer Treated with Chemotherapy Combined with Trastuzumab].
Author:	Takaya, Kai\|Takahashi, Ryosuke\|Honma, Satoru\|Horii, Shinichiro\|Takahashi, Hirokazu\|Hagiwara, Motohisa\|Chin, Masahiro\|Hashizume, Eiji
PMID:	27628555

978.
Journal:	Intern Med. 2016;55(18):2605-9.
Title:	Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review.
Author:	Uneno, Yu\|Yokoyama, Akira\|Nishikawa, Yoshitaka\|Funakoshi, Taro\|Ozaki, Yoshinao\|Aoyama, Ikuo\|Baba, Kiichiro\|Yamaguchi, Daisuke\|Morita, Shuko\|Mori, Yukiko\|Kanai, Masashi\|Kinoshita, Hisanori\|Inoue, Takeshi\|Sawamoto, Nobukatsu\|Matsumoto, Riki\|Matsumoto, Shige
PMID:	27629954

979.
Journal:	Oncol Rep. 2016 Nov;36(5):2689-2696.
Title:	HER2-targeted recombinant protein immuno-caspase-6 effectively induces apoptosis in HER2-overexpressing GBM cells in vitro and in vivo.
Author:	Zhang, Leiming\|Ren, Junlin\|Zhang, Hangyu\|Cheng, Gang\|Xu, Yanming\|Yang, Shuangwu\|Dong, Chao\|Fang, Dandong\|Zhang, Jianning\|Yang, Angang
PMID:	27633091

980.
Journal:	Curr Opin Gastroenterol. 2016 Nov;32(6):501-506.
Title:	An update in the nonendoscopic treatment of gastric cancer.
Author:	Ilson, David H
PMID:	27636304

981.
Journal:	Oncotarget. 2016 Nov 22;7(47):78180-78205.
Title:	Management of advanced gastric cancer: An overview of major findings from meta-analysis.
Author:	Qi, Xiaolong\|Liu, Yanna\|Wang, Wei\|Cai, Danxian\|Li, Wende\|Hui, Jialiang\|Liu, Chuan\|Zhao, Yanxia\|Li, Guoxin
PMID:	27655725

982.
Journal:	J Theor Biol. 2016 Dec 21;411:68-80.
Title:	3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors.
Author:	Gogoi, Dhrubajyoti\|Baruah, Vishwa Jyoti\|Chaliha, Amrita Kashyap\|Kakoti, Bibhuti Bhushan\|Sarma, Diganta\|Buragohain, Alak Kumar
PMID:	27693363

983.
Journal:	J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312.
Title:	Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.
Author:	Ajani, Jaffer A\|D'Amico, Thomas A\|Almhanna, Khaldoun\|Bentrem, David J\|Chao, Joseph\|Das, Prajnan\|Denlinger, Crystal S\|Fanta, Paul\|Farjah, Farhood\|Fuchs, Charles S\|Gerdes, Hans\|Gibson, Michael\|Glasgow, Robert E\|Hayman, James A\|Hochwald, Steven\|Hofstetter, W
PMID:	27697982

984.
Journal:	J Natl Compr Canc Netw. 2016 Oct;14(10):1313-1320.
Title:	Advances in Systemic Therapy for Metastatic or Advanced Gastric Cancer.
Author:	Shitara, Kohei\|Ohtsu, Atsushi
PMID:	27697983

985.
Journal:	Oncotarget. 2016 Nov 1;7(44):71790-71801.
Title:	JWA down-regulates HER2 expression via c-Cbl and induces lapatinib resistance in human gastric cancer cells.
Author:	Ma, Ling\|Zhu, Weiyou\|Wang, Qiang\|Yang, Fengming\|Qian, Jing\|Xu, Tongpeng\|Wang, Shouyu\|Zhou, Jianwei\|Shu, Yongqian
PMID:	27708243

986.
Journal:	APMIS. 2016 Dec;124(12):1046-1053.
Title:	Both high expression of nucleophosmin/B23 and CRM1 predicts poorer prognosis in human gastric cancer.
Author:	Zhou, Fang\|Chen, Ercheng\|You, Dong\|Song, Yipeng\|Sun, Zhenni\|Yue, Lu
PMID:	27714846

987.
Journal:	Onco Targets Ther. 2016 Sep 27;9:5919-5929.
Title:	The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study.
Author:	Jia, Yong-Xu\|Li, Teng-Fei\|Zhang, Dan-Dan\|Fan, Zong-Min\|Fan, Hui-Jie\|Yan, Jie\|Chen, Li-Juan\|Tang, Hong\|Qin, Yan-Ru\|Li, Xing-Ya
PMID:	27729801

988.
Journal:	Tumour Biol. 2016 Oct 12. pii: 10.1007/s13277-016-5405-3.
Title:	Involvement of microRNAs in HER2 signaling and trastuzumab treatment.
Author:	Mao, Ling\|Sun, Ai-Jun\|Wu, Jian-Zhong\|Tang, Jin-Hai
PMID:	27734339

989.
Journal:	Expert Opin Biol Ther. 2016 Dec;16(12):1549-1555.
Title:	The prospect of patritumab for treating non-small cell lung cancer.
Author:	Horinouchi, Hidehito
PMID:	27744717

990.
Journal:	J Gastrointest Oncol. 2016 Oct;7(5):750-762.
Title:	The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond.
Author:	Kelly, Ciara M\|Janjigian, Yelena Y
PMID:	27747089

991.
Journal:	J Gastric Cancer. 2016 Sep;16(3):141-151.
Title:	Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.
Author:	Pyo, Jung-Soo\|Kang, Guhyun\|Cho, Hyunjin
PMID:	27752391

992.
Journal:	Gan To Kagaku Ryoho. 2016 Oct;43(10):1207-1209.
Title:	[Remarkable Response to Trastuzumab Observed in a Case of Gastric Cancer with HER2-Negative Conversion].
Author:	Horii, Nobutoshi\|Morioka, Daisuke\|Yamaguchi, Kazuya\|Sato, Yoshiki
PMID:	27760939

993.
Journal:	Gan To Kagaku Ryoho. 2016 Oct;43(10):1211-1214.
Title:	[A Case of HER2-Positive Advanced Gastric Cancer with Multiple Liver Metastases Effectively Treated with Trastuzumab, Capecitabine, and Cisplatin Combination Therapy].
Author:	Kuga, Yoshio\|Kitamura, Shosuke\|Okanobu, Hideharu\|Sakimoto, Hideto\|Nishida, Toshihiro
PMID:	27760940

994.
Journal:	Oncotarget. 2016 Nov 1;7(44):72099-72112.
Title:	Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
Author:	Park, Cheol Keun\|Park, Ji Soo\|Kim, Hyo Song\|Rha, Sun Young\|Hyung, Woo Jin\|Cheong, Jae-Ho\|Noh, Sung Hoon\|Lee, Sang Kil\|Lee, Yong Chan\|Huh, Yong-Min\|Kim, Hyunki
PMID:	27765925

995.
Journal:	Front Pharmacol. 2016 Oct 6;7:356.
Title:	Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention.
Author:	Nocera, Nadia F\|Lee, M Catherine\|De La Cruz, Lucy M\|Rosemblit, Cinthia\|Czerniecki, Brian J
PMID:	27766079

996.
Journal:	Oncotarget. 2016 Dec 20;7(51):84860-84871.
Title:	Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1.
Author:	Nonagase, Yoshikane\|Yonesaka, Kimio\|Kawakami, Hisato\|Watanabe, Satomi\|Haratani, Koji\|Takahama, Takayuki\|Takegawa, Naoki\|Ueda, Hiroto\|Tanizaki, Junko\|Hayashi, Hidetoshi\|Yoshida, Takeshi\|Takeda, Masayuki\|Chiba, Yasutaka\|Tamura, Takao\|Nakagawa, Kazuhiko\|Tsur
PMID:	27768588

997.
Journal:	Cell Death Dis. 2016 Oct 27;7(10):e2442.
Title:	Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.
Author:	Shi, Jing\|Qu, Yiping\|Li, Xinru\|Sui, Fang\|Yao, Demao\|Yang, Qi\|Shi, Bingyin\|Ji, Meiju\|Hou, Peng
PMID:	27787520

998.
Journal:	Eur Surg. 2016;48(5):278-284.
Title:	Targeted therapy in gastric cancer.
Author:	Jomrich, G\|Schoppmann, S F
PMID:	27795701

999.
Journal:	Int J Surg Case Rep. 2016;29:133-136.
Title:	A case report of chylous ascites after gastric bypass for morbid obesity.
Author:	Capristo, Esmeralda\|Spuntarelli, Valerio\|Treglia, Giorgio\|Arena, Vincenzo\|Giordano, Alessandro\|Mingrone, Geltrude
PMID:	27846453

1000.
Journal:	Drug Des Devel Ther. 2016 Nov 4;10:3611-3632.
Title:	Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of Syzygium alternifolium through molecular dynamics and pharmacophore-based screening.
Author:	Babu, Tirumalasetty Muni Chandra\|Rammohan, Aluru\|Baki, Vijaya Bhaskar\|Devi, Savita\|Gunasekar, Duvvuru\|Rajendra, Wudayagiri
PMID:	27853354

1001.
Journal:	World J Gastroenterol. 2016 Nov 7;22(41):9141-9153.
Title:	HER2-induced metastasis is mediated by AKT/JNK/EMT signaling pathway in gastric cancer.
Author:	Choi, Yiseul\|Ko, Young San\|Park, Jinju\|Choi, Youngsun\|Kim, Younghoon\|Pyo, Jung-Soo\|Jang, Bo Gun\|Hwang, Douk Ho\|Kim, Woo Ho\|Lee, Byung Lan
PMID:	27895401

1002.
Journal:	Open Access Maced J Med Sci. 2016 Dec 15;4(4):535-542.
Title:	Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients.
Author:	Hadi, Ahmed Abdel\|Hindawi, Ali El\|Hareedy, Amal\|Khalil, Heba\|Ashiry, Ranya Al\|Elia, Shady\|Sadek, Ahmed\|Magdy, Mona\|Atta, Rafatt\|Anas, Amgad\|Bakr, Hisham\|Hammam, Olfat
PMID:	28028387

1003.
Journal:	Am J Transl Res. 2016 Dec 15;8(12):5729-5740. eCollection 2016.
Title:	Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers.
Author:	Wu, Jianzhong\|Li, Shuchun\|Ma, Rong\|Sharma, Ashok\|Bai, Shan\|Dun, Boying\|Cao, Haixia\|Jing, Changwen\|She, Jinxiong\|Feng, Jifeng
PMID:	28078044

1004.
Journal:	ScientificWorldJournal. 2016;2016:7951365.
Title:	Evaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric Carcinoma.
Author:	Cordts Filho, Roberto de Moraes\|Kassab, Paulo\|Claro, Laura Carolina Lopez\|Fracassi, Mabel Tatty de Medeiros\|Colombo-Souza, Patricia\|Fukuhara, Daniel Kenji\|Thuler, Fabio Rodrigues\|de Freitas Junior, Wilson Rodrigues\|Ilias, Elias Jirjoss\|Malheiros, Carlos A
PMID:	28105465

1005.
Journal:	Gan To Kagaku Ryoho. 2016 Nov;43(12):1502-1504.
Title:	[A Case of Port Site Recurrence after Laparoscopic Distal Gastrectomy for Advanced Gastric Cancer].
Author:	Fujita, Shotaro\|Ohki, Shinji\|Kase, Koji\|Yamauchi, Naoto\|Chida, Shun\|Hayase, Suguru\|Sakamoto, Wataru\|Monma, Tomoyuki\|Takawa, Masashi\|Ohtake, Toru\|Kono, Koji\|Takenoshita, Seiichi
PMID:	28133037

1006.
Journal:	Gan To Kagaku Ryoho. 2016 Nov;43(12):1923-1925.
Title:	[A Case of Advanced Gastric Cancer with Extensive Lymph Node Metastases Treated by Capecitabine plus Cisplatin plus Trastuzumab Chemotherapy,Followed by Conversion Surgery].
Author:	Yasuta, Sho\|Yamauchi, Junichiro\|Miyazaki, Kento\|Sato, Mamoru\|Ikeda, Tomoya\|Fujita, Shota\|Shirasaki, Keiichi\|Kobayashi, Shin\|Ajiki, Takashi\|Tsuchihara, Katsuo\|Kondo, Noriko\|Ishiyama, Shuichi
PMID:	28133177

1007.
Journal:	Gan To Kagaku Ryoho. 2016 Nov;43(12):1942-1944.
Title:	[A Patient with HER2-Positive Stage IV Advanced Gastric Cancer Who Received Chemotherapy with Trastuzumab plus XP Followed by Conversion Surgery].
Author:	Yamamoto, Kei\|Yamamoto, Kazuyoshi\|Maeda, Sakae\|Uemura, Mamoru\|Miyake, Masakazu\|Hama, Naoki\|Nishikawa, Kazuhiro\|Miyamoto, Atsushi\|Omiya, Hideyasu\|Miyazaki, Michihiko\|Ikeda, Masataka\|Hirao, Motohiro\|Takami, Koji\|Nakamori, Shoji\|Sekimoto, Mitsugu
PMID:	28133183

1008.
Journal:	Gan To Kagaku Ryoho. 2016 Nov;43(12):2213-2215.
Title:	[A Case of Advanced Gastric Cancer Successfully Treated with Curative Conversion Surgery after Chemotherapy with S-1 plus Oxaliplatin].
Author:	Ishiguro, Toru\|Fukuchi, Minoru\|Ogura, Toshiro\|Muta, Yu\|Mochiki, Erito\|Ishida, Hideyuki
PMID:	28133273

1009.
Journal:	S Afr J Surg. 2016 Mar;54(1):15-21.
Title:	A morphological and immunohistochemical evaluation of gastric carcinoma in the Western Cape province of South Africa.
Author:	Roberts, R\|Govender, P\|Naidoo, R\|Locketz, M
PMID:	28240491

1010.
Journal:	J Nucl Med. 2016 Nov 10.
Title:	Prospective evaluation of changes in tumor size and tumor metabolism in advanced gastric cancer undergoing chemotherapy: association and clinical implication
Author:	Park, Seongyeol\|Ha, Seunggyun\|Kwon, Hyun Woo\|Kim, Woo Hyoung\|Kim, Tae-Yong\|Oh, Do-Youn\|Cheon, Gi Jeong\|Bang, Yung-Jue
PMID:	28271703

1011.
Journal:	Indian J Cancer. 2016 Oct-Dec;53(4):505-511.
Title:	Human epidermal growth factor receptor 2 expression in gastric carcinoma and its association with histopathological parameters in Indian population.
Author:	Gupta, P\|Rao, S\|Bhalla, S
PMID:	28485339

1012.
Journal:	Tumori. 2017 May 12;103(3):249-254.
Title:	Impact of c-erbB-2 protein on 5-year survival rate of gastric cancer patients after surgery: a cohort study and meta-analysis.
Author:	Wu, Hao\|Cai, Zhenzhai\|Lu, Guangrong\|Cao, Shuguang\|Huang, He\|Jiang, Yi\|Sun, Weijian
PMID:	26549693

1013.
Journal:	Gastric Cancer. 2017 Jan;20(1):126-135.
Title:	Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer.
Author:	Shoda, Katsutoshi\|Ichikawa, Daisuke\|Fujita, Yuji\|Masuda, Kiyoshi\|Hiramoto, Hidekazu\|Hamada, Junichi\|Arita, Tomohiro\|Konishi, Hirotaka\|Komatsu, Shuhei\|Shiozaki, Atsushi\|Kakihara, Naoki\|Okamoto, Kazuma\|Taniguchi, Hiroki\|Imoto, Issei\|Otsuji, Eigo
PMID:	26874951

1014.
Journal:	Clin Transl Oncol. 2017 Feb;19(2):197-203.
Title:	Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis.
Author:	Jiang, H\|Li, Q\|Yu, S\|Yu, Y\|Wang, Y\|Li, W\|Cui, Y\|Liu, T
PMID:	27324991

1015.
Journal:	Pathol Oncol Res. 2017 Jan;23(1):55-61.
Title:	HER2 Status in Gastric Cancer: Comparison between Primary and Distant Metastatic Disease.
Author:	Amato, Michelina\|Perrone, Giuseppe\|Righi, Daniela\|Pellegrini, Claudio\|Rabitti, Carla\|Di Matteo, Francesco\|Crucitti, Pierfilippo\|Caputo, Damiano\|Coppola, Roberto\|Tonini, Giuseppe\|Santini, Daniele\|Onetti Muda, Andrea
PMID:	27363700

1016.
Journal:	Int J Cancer. 2017 Jan 1;140(1):188-196.
Title:	Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naive patients with HER2-positive, previously treated, advanced, or recurrent gastric cancer (JFMC45-1102).
Author:	Nishikawa, Kazuhiro\|Takahashi, Tsunehiro\|Takaishi, Hiromasa\|Miki, Akira\|Noshiro, Hirokazu\|Yoshikawa, Takaki\|Nishida, Yasunori\|Iwasa, Satoru\|Miwa, Hiroto\|Masuishi, Toshiki\|Boku, Narikazu\|Yamada, Yasuhide\|Kodera, Yasuhiro\|Yoshida, Kazuhiro\|Morita, Satoshi\|S
PMID:	27521503

1017.
Journal:	Gastric Cancer. 2017 May;20(3):465-474.
Title:	Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.
Author:	Jimenez-Fonseca, Paula\|Carmona-Bayonas, Alberto\|Sanchez Lorenzo, Maria Luisa\|Plazas, Javier Gallego\|Custodio, Ana\|Hernandez, Raquel\|Garrido, Marcelo\|Garcia, Teresa\|Echavarria, Isabel\|Cano, Juana Maria\|Rodriguez Palomo, Alberto\|Mangas, Monserrat\|Macias Dec
PMID:	27599830

1018.
Journal:	J Oncol Pharm Pract. 2017 Dec;23(8):635-637.
Title:	Plasma levels of trastuzumab in gastric cancer: Case report.
Author:	Gonzalez-Garcia, J\|Alonso-Alvarez, B\|Nazco-Casariego, G J\|Batista-Lopez, N\|Guttierrez-Nicolas, F
PMID:	27664112

1019.
Journal:	Ann Oncol. 2017 Jan 1;28(1):110-115.
Title:	Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment.
Author:	An, E\|Ock, C-Y\|Kim, T-Y\|Lee, K-H\|Han, S-W\|Im, S-A\|Kim, T-Y\|Liao, W-L\|Cecchi, F\|Blackler, A\|Thyparambil, S\|Kim, W H\|Burrows, J\|Hembrough, T\|Catenacci, D V T\|Oh, D-Y\|Bang, Y-J
PMID:	27687309

1020.
Journal:	Gastric Cancer. 2017 Mar;20(Suppl 1):92-101.
Title:	Global chemotherapy development for gastric cancer.
Author:	Harada, Kazuto\|Mizrak Kaya, Dilsa\|Shimodaira, Yusuke\|Ajani, Jaffer A
PMID:	27718136

1021.
Journal:	Gastric Cancer. 2017 Jul;20(4):612-619.
Title:	Distinct expression profile of key molecules in crawling-type early gastric carcinoma.
Author:	Woo, Ha Young\|Bae, Yoon Sung\|Kim, Jie-Hyun\|Lee, Sang Kil\|Lee, Yong Chan\|Cheong, Jae-Ho\|Noh, Sung Hoon\|Kim, Hyunki
PMID:	27734272

1022.
Journal:	Hum Pathol. 2017 Mar;61:58-67.
Title:	Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Author:	Ooi, Akishi\|Oyama, Takeru\|Nakamura, Ritsuko\|Tajiri, Ryousuke\|Ikeda, Hiroko\|Fushida, Sachio\|Dobashi, Yoh
PMID:	27864121

1023.
Journal:	Biosens Bioelectron. 2017 Jul 15;93:32-39.
Title:	Detection of Her2-overexpressing cancer cells using keyhole shaped chamber array employing a magnetic droplet-handling system.
Author:	Okochi, Mina\|Koike, Shinji\|Tanaka, Masayoshi\|Honda, Hiroyuki
PMID:	27866824

1024.
Journal:	Oncotarget. 2017 Jan 3;8(1):692-704.
Title:	Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival.
Author:	Chang, Wei-Chun\|Huang, Shang-Fen\|Lee, Yang-Ming\|Lai, Hsueh-Chou\|Cheng, Bi-Hua\|Cheng, Wei-Chung\|Ho, Jason Yen-Ping\|Jeng, Long-Bin\|Ma, Wen-Lung
PMID:	27893427

1025.
Journal:	J Cancer Res Clin Oncol. 2017 Apr;143(4):573-600.
Title:	Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.
Author:	Kneissl, Julia\|Hartmann, Anja\|Pfarr, Nicole\|Erlmeier, Franziska\|Lorber, Thomas\|Keller, Simone\|Zwingenberger, Gwen\|Weichert, Wilko\|Luber, Birgit
PMID:	27933395

1026.
Journal:	Cancer Chemother Pharmacol. 2017 Jan;79(1):131-138.
Title:	LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer.
Author:	Takahashi, Shunji\|Kobayashi, Takayuki\|Tomomatsu, Junichi\|Ito, Yoshinori\|Oda, Hisanobu\|Kajitani, Tatsuhiro\|Kakizume, Tomoyuki\|Tajima, Takeshi\|Takeuchi, Hiromi\|Maacke, Heiko\|Esaki, Taito
PMID:	27942917

1027.
Journal:	Expert Opin Drug Saf. 2017 Mar;16(3):319-327.
Title:	Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
Author:	Narita, Yukiya\|Muro, Kei
PMID:	27976952

1028.
Journal:	Cancer Metastasis Rev. 2017 Mar;36(1):141-157.
Title:	HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
Author:	Galdy, Salvatore\|Lamarca, Angela\|McNamara, Mairead G\|Hubner, Richard A\|Cella, Chiara A\|Fazio, Nicola\|Valle, Juan W
PMID:	27981460

1029.
Journal:	Asia Pac J Clin Oncol. 2017 Jun;13(3):249-260.
Title:	Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study.
Author:	Pathmanathan, Nirmala\|Geng, Jing-Shu\|Li, Wencai\|Nie, Xiu\|Veloso, Januario\|Wang, John\|Hill, Julie\|Mccloud, Philip\|Bilous, Michael
PMID:	28008715

1030.
Journal:	J Mol Diagn. 2017 Mar;19(2):244-254.
Title:	Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.
Author:	Ross, Dara S\|Zehir, Ahmet\|Cheng, Donavan T\|Benayed, Ryma\|Nafa, Khedoudja\|Hechtman, Jaclyn F\|Janjigian, Yelena Y\|Weigelt, Britta\|Razavi, Pedram\|Hyman, David M\|Baselga, Jose\|Berger, Michael F\|Ladanyi, Marc\|Arcila, Maria E
PMID:	28027945

1031.
Journal:	Gene. 2017 Mar 20;605:114-122.
Title:	Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
Author:	El Hadi, Hicham\|Abdellaoui-Maane, Imane\|Kottwitz, Denise\|El Amrani, Manal\|Bouchoutrouch, Nadia\|Qmichou, Zineb\|Karkouri, Mehdi\|ElAttar, Hicham\|Errihani, Hassan\|Fernandez, Pedro L\|Bakri, Youssef\|Sefrioui, Hassan\|Moumen, Abdeladim
PMID:	28039034

1032.
Journal:	Oncotarget. 2017 Feb 7;8(6):10264-10273.
Title:	MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
Author:	Zhang, Jing\|Guo, Lei\|Liu, Xiuyun\|Li, Wenbin\|Ying, Jianming
PMID:	28052014

1033.
Journal:	Cir Cir. 2017 Nov - Dec;85(6):504-509.
Title:	[Immunohistochemical assessment of HER2 expression in gastric cancer. A clinicopathologic study of 93 cases].
Author:	Alvarado-Cabrero, Isabel\|Gil-Hernandez, Sara\|Ruelas-Perea, Ana\|Villaverde-Rodriguez, Diego\|Montes-Ochoa, Jose Roberto\|Medrano-Guzman, Rafael
PMID:	28069112

1034.
Journal:	PLoS One. 2017 Jan 18;12(1):e0170298.
Title:	miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
Author:	Shan, Xia\|Wen, Wei\|Zhu, Danxia\|Yan, Ting\|Cheng, Wenfang\|Huang, Zebo\|Zhang, Lan\|Zhang, Huo\|Wang, Tongshan\|Zhu, Wei\|Zhu, Yichao\|Zhu, Jun
PMID:	28099468

1035.
Journal:	Oncol Res. 2017 Aug 7;25(7):1169-1176.
Title:	MicroRNA-133a Inhibits Proliferation of Gastric Cancer Cells by Downregulating ERBB2 Expression.
Author:	Li, Chang\|Li, Xiaoping\|Gao, Shuohui\|Li, Chang\|Ma, Lianjun
PMID:	28109082

1036.
Journal:	Biochem Biophys Res Commun. 2017 Mar 4;484(2):248-254.
Title:	Development of a highly specific HER2 monoclonal antibody for immunohistochemistry using protein microarray chips.
Author:	Qi, Lili\|Zhou, Lixin\|Lu, Mingmin\|Yuan, Kehu\|Li, Zhongwu\|Wu, Guiyin\|Huang, Xiaozheng\|Shen, Yi\|Zhao, Min\|Fu, Wei\|Chu, Boyang\|Wang, Guangli\|Ren, Fangfang\|Ma, Donghui\|Chen, Jian
PMID:	28111342

1037.
Journal:	Ann Oncol. 2017 Apr 1;28(4):855-861.
Title:	First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors.
Author:	Bang, Y J\|Giaccone, G\|Im, S A\|Oh, D Y\|Bauer, T M\|Nordstrom, J L\|Li, H\|Chichili, G R\|Moore, P A\|Hong, S\|Stewart, S J\|Baughman, J E\|Lechleider, R J\|Burris, H A
PMID:	28119295

1038.
Journal:	Oncotarget. 2017 Apr 4;8(14):23008-23019.
Title:	Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.
Author:	Lu, Mingjie\|Wang, Tongshan\|He, Mingfeng\|Cheng, Wenfang\|Yan, Ting\|Huang, Zebo\|Zhang, Lan\|Zhang, Huo\|Zhu, Wei\|Zhu, Yichao\|Liu, Ping
PMID:	28160563

1039.
Journal:	Gan To Kagaku Ryoho. 2017 Jan;44(1):67-69.
Title:	[A Case of Synchronous Double Cancer of the Lung and Stomach That Responded to Cisplatin and S-1 Combination Chemotherapy].
Author:	Sugiyama, Tomohide\|Kasai, Takashi\|Nakamura, Yoichi\|Kamiyama, Yukari\|Mori, Kiyoshi
PMID:	28174383

1040.
Journal:	Ann Oncol. 2017 Aug 1;28(8):1767-1775.
Title:	New agents on the horizon in gastric cancer.
Author:	Lordick, F\|Shitara, K\|Janjigian, Y Y
PMID:	28184417

1041.
Journal:	Sci Rep. 2017 Feb 16;7:42713.
Title:	Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.
Author:	Kiss, Bernhard\|Wyatt, Alexander W\|Douglas, James\|Skuginna, Veronika\|Mo, Fan\|Anderson, Shawn\|Rotzer, Diana\|Fleischmann, Achim\|Genitsch, Vera\|Hayashi, Tetsutaro\|Neuenschwander, Maja\|Buerki, Christine\|Davicioni, Elai\|Collins, Colin\|Thalmann, George N\|Black,
PMID:	28205537

1042.
Journal:	Pathologe. 2017 Mar;38(2):87-92.
Title:	[Novel pharmaceutical treatment approaches for gastric cancer].
Author:	Lordick, F
PMID:	28220199

1043.
Journal:	Mol Cancer Ther. 2017 Jun;16(6):1145-1154.
Title:	Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition.
Author:	Jin, Mei Hua\|Nam, Ah-Rong\|Park, Ji Eun\|Bang, Ju-Hee\|Bang, Yung-Jue\|Oh, Do-Youn
PMID:	28223426

1044.
Journal:	Clin Transl Oncol. 2017 Aug;19(8):976-988.
Title:	Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
Author:	Sett, A\|Borthakur, B B\|Bora, U
PMID:	28224267

1045.
Journal:	Oncol Rep. 2017 Apr;37(4):2366-2374.
Title:	Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line.
Author:	Tamaki, Rie\|Kanai-Mori, Aya\|Morishige, Yuta\|Koike, Atsushi\|Yanagihara, Kazuyoshi\|Amano, Fumio
PMID:	28260018

1046.
Journal:	Pathophysiology. 2017 Jun;24(2):99-106.
Title:	Immunohistochemical analysis of PTEN, HER2/neu, and ki67 expression in patients with gastric cancer and their association with survival.
Author:	Badary, Dalia M\|Abdel-Wanis, Mostafa E\|Hafez, Mohamed Z\|Aboulhagag, Noha A
PMID:	28262306

1047.
Journal:	Expert Rev Anticancer Ther. 2017 May;17(5):417-425.
Title:	Predictive biomarkers along gastric cancer pathogenetic pathways.
Author:	Panarese, Iacopo\|De Vita, Ferdinando\|Ronchi, Andrea\|Romano, Marco\|Alfano, Roberto\|Di Martino, Natale\|Zito Marino, Federica\|Ferraraccio, Francesca\|Franco, Renato
PMID:	28277834

1048.
Journal:	J Cancer Res Clin Oncol. 2017 May;143(5):835-841.
Title:	HER2 testing in gastric cancer: results of a German expert meeting.
Author:	Lordick, Florian\|Al-Batran, Salah-Eddin\|Dietel, Manfred\|Gaiser, Timo\|Hofheinz, Ralf-Dieter\|Kirchner, Thomas\|Kreipe, Hans H\|Lorenzen, Sylvie\|Mohler, Markus\|Quaas, Alexander\|Rocken, Christoph\|Ruschoff, Josef\|Tannapfel, Andrea\|Thuss-Patience, Peter\|Baretton,
PMID:	28285403

1049.
Journal:	BMC Cancer. 2017 Mar 14;17(1):191.
Title:	Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
Author:	Wang, Haiyong\|Lu, Jun\|Tang, Jian\|Chen, Shitu\|He, Kuifeng\|Jiang, Xiaoxia\|Jiang, Weiqin\|Teng, Lisong
PMID:	28292264

1050.
Journal:	World J Surg Oncol. 2017 Mar 21;15(1):68.
Title:	The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Author:	Lei, Yu-Ying\|Huang, Jin-Yu\|Zhao, Qiong-Rui\|Jiang, Nan\|Xu, Hui-Mian\|Wang, Zhen-Ning\|Li, Hai-Qing\|Zhang, Shi-Bo\|Sun, Zhe
PMID:	28327158

1051.
Journal:	Ann Oncol. 2017 Jun 1;28(6):1207-1216.
Title:	Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?
Author:	Hierro, C\|Alsina, M\|Sanchez, M\|Serra, V\|Rodon, J\|Tabernero, J
PMID:	28327938

1052.
Journal:	J Gastric Cancer. 2017 Mar;17(1):52-62.
Title:	Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Cancer.
Author:	Seo, Kyung Won\|Jeon, Taeyong\|Kim, Sewon\|Kim, Sung Soo\|Kim, Kwanghee\|Suh, Byoung-Jo\|Hwang, Sunhwi\|Choi, SeongHee\|Ryu, Seungwan\|Min, Jae Seok\|Lee, Young-Joon\|Jee, Ye Seob\|Chae, Hyeondong\|Yang, Doo Hyun\|Lee, Sang Ho
PMID:	28337363

1053.
Journal:	Mol Med Rep. 2017 May;15(5):3055-3061.
Title:	Reduction of miR1323p contributes to gastric cancer proliferation by targeting MUC13.
Author:	He, Liang\|Qu, Linlin\|Wei, Lijing\|Chen, Yan\|Suo, Jian
PMID:	28339011

1054.
Journal:	Lancet Oncol. 2017 May;18(5):640-653.
Title:	Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Author:	Thuss-Patience, Peter C\|Shah, Manish A\|Ohtsu, Atsushi\|Van Cutsem, Eric\|Ajani, Jaffer A\|Castro, Hugo\|Mansoor, Wasat\|Chung, Hyun Cheol\|Bodoky, Gyorgy\|Shitara, Kohei\|Phillips, Gail D Lewis\|van der Horst, Tina\|Harle-Yge, Marie-Laurence\|Althaus, Betsy L\|Kang,
PMID:	28343975

1055.
Journal:	World J Gastroenterol. 2017 Mar 14;23(10):1836-1842.
Title:	Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer.
Author:	Shi, Hong-Zhi\|Wang, Yu-Ning\|Huang, Xiao-Hui\|Zhang, Ke-Cheng\|Xi, Hong-Qing\|Cui, Jian-Xin\|Liu, Guo-Xiao\|Liang, Wen-Tao\|Wei, Bo\|Chen, Lin
PMID:	28348489

1056.
Journal:	Gastric Cancer. 2017 Nov;20(6):1011-1012.
Title:	About HER2 monitoring using liquid biopsies in patients with gastric cancer.
Author:	Uguen, Arnaud
PMID:	28357608

1057.
Journal:	Clin Colorectal Cancer. 2017 Dec;16(4):247-251.
Title:	HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti-Epidermal Growth Factor Receptor Therapy.
Author:	Takegawa, Naoki\|Yonesaka, Kimio
PMID:	28363756

1058.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2017 Apr 8;46(4):245-248.
Title:	[Clinical significance of HER2 positivity in gallbladder adenocarcinoma].
Author:	Yao, J G\|Wang, C H\|Liu, Y
PMID:	28376590

1059.
Journal:	Cancer Sci. 2017 Jul;108(7):1458-1468.
Title:	Aberrant intracellular metabolism of T-DM1 confers T-DM1 resistance in human epidermal growth factor receptor 2-positive gastric cancer cells.
Author:	Wang, Hongbin\|Wang, Wenqian\|Xu, Yongping\|Yang, Yong\|Chen, Xiaoyan\|Quan, Haitian\|Lou, Liguang
PMID:	28388007

1060.
Journal:	Oncotarget. 2017 May 16;8(20):33185-33196.
Title:	Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type.
Author:	Xu, Chen\|Liu, Yalan\|Jiang, Dongxian\|Li, Qian\|Ge, Xiaowen\|Zhang, Ying\|Huang, Jie\|Su, Jieakesu\|Ji, Yuan\|Hou, Jun\|Lu, Shaohua\|Hou, Yingyong\|Liu, Tianshu
PMID:	28388541

1061.
Journal:	Pathobiology. 2017;84(4):210-217.
Title:	Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
Author:	Byeon, Sun-Ju\|Lee, Hye Seung\|Kim, Min-A\|Lee, Byung Lan\|Kim, Woo Ho
PMID:	28399526

1062.
Journal:	Oncotarget. 2017 May 30;8(22):36171-36184.
Title:	Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer.
Author:	Wang, Qinchuan\|Shu, Xiang\|Dong, Yong\|Zhou, Jichun\|Teng, Rongyue\|Shen, Jianguo\|Chen, Yongxia\|Dong, Mingjun\|Zhang, Wenjun\|Huang, Yasheng\|Xie, Shuduo\|Wei, Qun\|Zhao, Wenhe\|Chen, Wenjun\|Yuan, Xiaoming\|Qi, Xu\|Wang, Linbo
PMID:	28404903

1063.
Journal:	Oncoimmunology. 2017 Mar 10;6(3):e1267891.
Title:	Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody.
Author:	Lopez-Albaitero, Andres\|Xu, Hong\|Guo, Hongfen\|Wang, Linlin\|Wu, Zhihao\|Tran, Hoa\|Chandarlapaty, Sarat\|Scaltriti, Maurizio\|Janjigian, Yelena\|de Stanchina, Elisa\|Cheung, Nai-Kong V
PMID:	28405494

1064.
Journal:	Minerva Chir. 2017 Aug;72(4):317-333.
Title:	The role of chemotherapy in unresectable or metastatic adenocarcinoma of the stomach and gastroesophageal junction.
Author:	Bozkurt, Mustafa\|Amlashi, Fatemeh G\|Blum Murphy, Mariela
PMID:	28415835

1065.
Journal:	BMC Clin Pathol. 2017 Apr 27;17:8.
Title:	High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival.
Author:	Nasri, Baongoc\|Inokuchi, Mikito\|Ishikawa, Toshiaki\|Uetake, Hiroyuki\|Takagi, Yoko\|Otsuki, Sho\|Kojima, Kazuyuki\|Kawano, Tatsuyuki
PMID:	28465671

1066.
Journal:	Oncotarget. 2017 Jul 18;8(29):48253-48262.
Title:	Efficacy and safety of different molecular targeted agents based on chemotherapy for gastric cancer patients treatment: a network meta-analysis.
Author:	Ren, Zheng\|Sun, Jinping\|Sun, Xinfang\|Hou, Hongtao\|Li, Ke\|Ge, Quanxing
PMID:	28477027

1067.
Journal:	Hematol Oncol Clin North Am. 2017 Jun;31(3):469-483.
Title:	Management of Metastatic Gastric Cancer.
Author:	Obermannova, Radka\|Lordick, Florian
PMID:	28501088

1068.
Journal:	Oncotarget. 2017 Jul 11;8(28):45793-45806.
Title:	Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance.
Author:	Liu, Wenhu\|Chang, Jinxia\|Liu, Mingwei\|Yuan, Jiangbei\|Zhang, Jinqiang\|Qin, Jun\|Xia, Xuefeng\|Wang, Yi
PMID:	28507275

1069.
Journal:	Target Oncol. 2017 Jun;12(3):341-351.
Title:	Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.
Author:	Mishima, Yuji\|Matsusaka, Satoshi\|Chin, Keisho\|Mikuniya, Mariko\|Minowa, Sayuri\|Takayama, Tomoko\|Shibata, Harumi\|Kuniyoshi, Ryoko\|Ogura, Mariko\|Terui, Yasuhito\|Mizunuma, Nobuyuki\|Hatake, Kiyohiko
PMID:	28508152

1070.
Journal:	Histopathology. 2017 Oct;71(4):570-579.
Title:	HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks.
Author:	Xu, Chen\|Liu, Yalan\|Jiang, Dongxian\|Ge, Xiaowen\|Zhang, Ying\|Su, Jieakesu\|Zeng, Haiying\|Huang, Jie\|Ji, Yuan\|Hou, Jun\|Sun, Yihong\|Shen, Kuntang\|Liu, Tianshu\|Hou, Yingyong\|Qin, Jing
PMID:	28513868

1071.
Journal:	Oncotarget. 2017 Jul 25;8(30):49293-49302.
Title:	Role of intravoxel incoherent motion MR imaging in preoperative assessing HER2 status of gastric cancers.
Author:	Ji, Changfeng\|Zhang, Qinglei\|Guan, Wenxian\|Guo, Tingting\|Chen, Ling\|Liu, Song\|He, Jian\|Zhou, Zhengyang
PMID:	28514733

1072.
Journal:	Oncotarget. 2017 Jun 27;8(26):42742-42751.
Title:	Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody.
Author:	Wang, Chao\|Wang, Lingfei\|Yu, Xiaojie\|Zhang, Yajun\|Meng, Yanchun\|Wang, Huajing\|Yang, Yang\|Gao, Jie\|Wei, Huafeng\|Zhao, Jian\|Lu, Cuihua\|Chen, Han\|Sun, Yanping\|Li, Bohua
PMID:	28514745

1073.
Journal:	World J Gastrointest Oncol. 2017 May 15;9(5):194-208.
Title:	Molecular classifications of gastric cancers: Novel insights and possible future applications.
Author:	Garattini, Silvio Ken\|Basile, Debora\|Cattaneo, Monica\|Fanotto, Valentina\|Ongaro, Elena\|Bonotto, Marta\|Negri, Francesca V\|Berenato, Rosa\|Ermacora, Paola\|Cardellino, Giovanni Gerardo\|Giovannoni, Mariella\|Pella, Nicoletta\|Scartozzi, Mario\|Antonuzzo, Lorenzo\|
PMID:	28567184

1074.
Journal:	J Nucl Med. 2017 Jun;58(6):899-904.
Title:	Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication.
Author:	Park, Seongyeol\|Ha, Seunggyun\|Kwon, Hyun Woo\|Kim, Woo Hyoung\|Kim, Tae-Yong\|Oh, Do-Youn\|Cheon, Gi Jeong\|Bang, Yung-Jue
PMID:	28572288

1075.
Journal:	Chonnam Med J. 2017 May;53(2):140-146.
Title:	Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer.
Author:	Baek, Dong Won\|Kang, Byung Woog\|Hwang, Soyoon\|Kim, Jong Gwang\|Seo, An Na\|Bae, Han Ik\|Kwon, Oh Kyoung\|Lee, Seung Soo\|Chung, Ho Young\|Yu, Wansik
PMID:	28584793

1076.
Journal:	Mymensingh Med J. 2017 Apr;26(2):372-379.
Title:	HER2 status in Gastric and Gastroesophageal Junction Adenocarcinoma.
Author:	Rima, F A\|Hussain, M\|Haque, N\|Dewan, R K\|Rahman, N\|Jinnah, M A\|Jeba, R\|Chowdhury, F
PMID:	28588175

1077.
Journal:	Dig Dis Sci. 2017 Sep;62(9):2498-2510.
Title:	Human Epidermal Growth Factor Receptor-2 in Sri Lankan Gastric Carcinoma Patients with Clinicopathological Association and Survival.
Author:	Subasinghe, Duminda\|Sivaganesh, Sivasuriya\|Samarsekera, Ananthi\|Kumarasinghe, Mariyan Priyanthi\|Samarasekera, Dharmabandhu Nandadeva\|Lokuhetty, Menaka Dilani Samarwickrema
PMID:	28612195

1078.
Journal:	JAMA Oncol. 2017 Nov 1;3(11):1546-1553.
Title:	Genomic Profiling of Small-Bowel Adenocarcinoma.
Author:	Schrock, Alexa B\|Devoe, Craig E\|McWilliams, Robert\|Sun, James\|Aparicio, Thomas\|Stephens, Philip J\|Ross, Jeffrey S\|Wilson, Richard\|Miller, Vincent A\|Ali, Siraj M\|Overman, Michael J
PMID:	28617917

1079.
Journal:	Cancer Med. 2017 Jul;6(7):1665-1672.
Title:	Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.
Author:	Yoshioka, Yuichiro\|Suzuki, Takehiro\|Matsuo, Yo\|Tsurita, Giichiro\|Watanabe, Toshiaki\|Dohmae, Naoshi\|Nakamura, Yusuke\|Hamamoto, Ryuji
PMID:	28639750

1080.
Journal:	Medicine (Baltimore). 2017 Jun;96(25):e7224.
Title:	Distribution of somatic mutations of cancer-related genes according to microsatellite instability status in Korean gastric cancer.
Author:	Park, Joonhong\|Yoo, Han Mo\|Jang, Woori\|Shin, Soyoung\|Kim, Myungshin\|Kim, Yonggoo\|Lee, Seung-Woo\|Kim, Jeong Goo
PMID:	28640116

1081.
Journal:	Ann Pharmacother. 2017 Nov;51(11):976-980.
Title:	Influence of Anthropometric Characteristics in Patients With Her2-Positive Breast Cancer on Initial Plasma Concentrations of Trastuzumab.
Author:	Gonzalez Garcia, Jonathan\|Gutierrez Nicolas, Fernando\|Nazco Casariego, Gloria Julia\|Batista Lopez, Jose Norberto\|Ceballos Lenza, Isaac\|Ramos Diaz, Ruth\|Llabres Martinez, Matias
PMID:	28643558

1082.
Journal:	Exp Ther Med. 2017 Jul;14(1):657-663.
Title:	Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer.
Author:	Sui, Minghua\|Jiao, Aihong\|Zhai, Huiyuan\|Wang, Yan\|Wang, Yong\|Sun, Dengjun\|Li, Peng
PMID:	28672982

1083.
Journal:	Int J Cancer. 2017 Oct 15;141(8):1682-1689.
Title:	DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
Author:	Takegawa, Naoki\|Nonagase, Yoshikane\|Yonesaka, Kimio\|Sakai, Kazuko\|Maenishi, Osamu\|Ogitani, Yusuke\|Tamura, Takao\|Nishio, Kazuto\|Nakagawa, Kazuhiko\|Tsurutani, Junji
PMID:	28677116

1084.
Journal:	Gan To Kagaku Ryoho. 2017 Jun;44(6):521-523.
Title:	[A Case of Long-Term Survival of a Patient with Gastric Cancer with Synchronous Liver Metastasis and Portal Vein Thrombus after Multidisciplinary Treatment].
Author:	Nomura, Hajime\|Okamura, Masahiko\|Sumii, Atsuhiko\|Tsuboi, Kunihiko\|Mizukami, You\|Ota, Syuichi\|Adachi, Yukihito
PMID:	28698446

1085.
Journal:	Int J Oncol. 2017 Sep;51(3):967-974.
Title:	Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.
Author:	Lee, Harry\|Saini, Nipun\|Parris, Amanda B\|Zhao, Ming\|Yang, Xiaohe
PMID:	28713919

1086.
Journal:	J Gastrointest Oncol. 2017 Jun;8(3):405-417.
Title:	Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment.
Author:	Verdaguer, Helena\|Sauri, Tamara\|Macarulla, Teresa
PMID:	28736628

1087.
Journal:	J Gastrointest Oncol. 2017 Jun;8(3):418-429.
Title:	Biologic therapy in esophageal and gastric malignancies: current therapies and future directions.
Author:	Samson, Pamela\|Lockhart, A Craig
PMID:	28736629

1088.
Journal:	Am J Cancer Res. 2017 Jul 1;7(7):1540-1553. eCollection 2017.
Title:	Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.
Author:	Ge, Sai\|Li, Beifang\|Li, Yanyan\|Li, Zhongwu\|Liu, Zhentao\|Chen, Zuhua\|Wu, Jian\|Gao, Jing\|Shen, Lin
PMID:	28744403

1089.
Journal:	Br J Cancer. 2017 Sep 5;117(6):775-782.
Title:	Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
Author:	Jimenez Fonseca, Paula\|Carmona-Bayonas, Alberto\|Hernandez, Raquel\|Custodio, Ana\|Cano, Juana Maria\|Lacalle, Alejandra\|Echavarria, Isabel\|Macias, Ismael\|Mangas, Monserrat\|Visa, Laura\|Buxo, Elvira\|Alvarez Mancenido, Felipe\|Viudez, Antonio\|Pericay, Carles\|Azk
PMID:	28765618

1090.
Journal:	Oncol Lett. 2017 Aug;14(2):2545-2551.
Title:	Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer.
Author:	Narita, Yukiya\|Kadowaki, Shigenori\|Masuishi, Toshiki\|Taniguchi, Hiroya\|Takahari, Daisuke\|Ura, Takashi\|Ando, Masashi\|Tajika, Masahiro\|Niwa, Yasumasa\|Eto, Tetsuya\|Hara, Hiroki\|Asayama, Masako\|Yamaguchi, Kensei\|Yatabe, Yasushi\|Muro, Kei
PMID:	28781693

1091.
Journal:	Z Gastroenterol. 2017 Sep;55(9):866-871.
Title:	[Good remission under HER2 blockade in an advanced carcinoma of the oesophagogastric junction with only focal HER2 overexpression].
Author:	Gaiser, Timo\|Hirsch, Daniela\|Hofheinz, Ralf-Dieter
PMID:	28787750

1092.
Journal:	Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):394-403.
Title:	Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
Author:	Creemers, A\|Krausz, S\|Strijker, M\|van der Wel, M J\|Soer, E C\|Reinten, R J\|Besselink, M G\|Wilmink, J W\|van de Vijver, M J\|van Noesel, C J M\|Verheij, J\|Meijer, S L\|Dijk, F\|Bijlsma, M F\|van Oijen, M G H\|van Laarhoven, H W M
PMID:	28801248

1093.
Journal:	Cancer Chemother Pharmacol. 2017 Oct;80(4):807-813.
Title:	Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy.
Author:	Kadowaki, Shigenori\|Masuishi, Toshiki\|Eto, Tetsuya\|Narita, Yukiya\|Taniguchi, Hiroya\|Ura, Takashi\|Ando, Masashi\|Tajika, Masahiro\|Niwa, Yasumasa\|Yatabe, Yasushi\|Muro, Kei
PMID:	28821938

1094.
Journal:	Pathology. 2017 Oct;49(6):575-581.
Title:	HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program.
Author:	Kumarasinghe, M Priyanthi\|Morey, Adrienne\|Bilous, Michael\|Farshid, Gelareh\|Francis, Glenn\|Lampe, Guy\|McCue, Glenda\|Von Neumann-Cosel, Vita\|Fox, Stephen B
PMID:	28823752

1095.
Journal:	Case Rep Oncol. 2017 Jul 11;10(2):644-648.
Title:	The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2.
Author:	Saavedra Santa Gadea, Omar\|Valdivia Garcia, Francisco Jose
PMID:	28868025

1096.
Journal:	Oncotarget. 2017 Apr 29;8(32):52584-52593.
Title:	siRNA-mediated inactivation of HER3 improves the antitumour activity and sensitivity of gefitinib in gastric cancer cells.
Author:	Yuan, Heng-Heng\|Yang, Ying-Nan\|Zhou, Jian-Hua\|Li, Yan-Jing\|Wang, Li-Ying\|Qin, Jun-Wei\|Liu, Tao\|Li, Zhen-Zhen\|Zhou, Qing-Xin\|Wei, Xiao-Li\|Zhang, Ting-Ting\|Huang, Peng\|Zhang, Wen-Jie\|Liu, Lei\|Du, Xiao-Xue\|Han, Yu
PMID:	28881753

1097.
Journal:	BMC Cancer. 2017 Sep 12;17(1):646.
Title:	A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
Author:	Reynolds, Kerry Lynn\|Bedard, Philippe L\|Lee, Se-Hoon\|Lin, Chia-Chi\|Tabernero, Josep\|Alsina, Maria\|Cohen, Ezra\|Baselga, Jose\|Blumenschein, George Jr\|Graham, Donna M\|Garrido-Laguna, Ignacio\|Juric, Dejan\|Sharma, Sunil\|Salgia, Ravi\|Seroutou, Abdelkader\|Tian,
PMID:	28899363

1098.
Journal:	Indian J Med Paediatr Oncol. 2017 Apr-Jun;38(2):153-157.
Title:	Detection and Significance of Human Epidermal Growth Factor Receptor 2 Expression in Gastric Adenocarcinoma.
Author:	Halder, Sutapa\|Mallick, Debjani\|Mondal, Priyanka\|Roy, Debajyoti Singha\|Halder, Aniket\|Chakrabarti, Sudipta
PMID:	28900323

1099.
Journal:	J Cancer Res Ther. 2017;13(4):730-734.
Title:	Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.
Author:	Wang, Xingwen\|Wu, Yunyan\|Song, Xueling\|Sun, Chengtao\|Wu, Changshun\|Feng, Hong
PMID:	28901323

1100.
Journal:	Oncology. 2017;93(6):387-394.
Title:	Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma.
Author:	Oki, Eiji\|Okano, Shinji\|Saeki, Hiroshi\|Umemoto, Yuichiro\|Teraishi, Koji\|Nakaji, Yu\|Ando, Koji\|Zaitsu, Yoko\|Yamashita, Nami\|Sugiyama, Masahiko\|Nakashima, Yuichiro\|Ohgaki, Kippei\|Oda, Yoshinao\|Maehara, Yoshihiko
PMID:	28910818

1101.
Journal:	Cancer Chemother Pharmacol. 2017 Nov;80(5):939-943.
Title:	Multicenter phase II study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107.
Author:	Sato, Kei\|Kunisaki, Chikara\|Kosaka, Takashi\|Takagawa, Ryo\|Takahashi, Masazumi\|Izumisawa, Yusuke\|Miyamoto, Hiroshi\|Sato, Sho\|Tanaka, Yusaku\|Yamaguchi, Naotaka\|Kimura, Jun\|Ono, Hidetaka A\|Makino, Hirochika\|Akiyama, Hirotoshi\|Endo, Itaru
PMID:	28913549

1102.
Journal:	Oncotarget. 2017 Jan 26;8(34):57654-57669.
Title:	Targeted therapies for gastric cancer: failures and hopes from clinical trials.
Author:	Apicella, Maria\|Corso, Simona\|Giordano, Silvia
PMID:	28915702

1103.
Journal:	Ann Diagn Pathol. 2017 Oct;30:1-7.
Title:	Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages.
Author:	Abdel-Aziz, Azza\|Ahmed, Rehab Allah\|Ibrahiem, Afaf Taha
PMID:	28965621

1104.
Journal:	Oncotarget. 2017 Jun 27;8(37):61837-61845.
Title:	Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer.
Author:	Soo Park, Ji\|Youn, Jong-Chan\|Shim, Chi Young\|Hong, Geu-Ru\|Lee, Choong-Kun\|Kim, Jee Hyung\|Park, Hyung Soon\|Heo, Su Jin\|Beom, Seung Hoon\|Kim, Hyo Song\|Rha, Sun Young\|Chung, Hyun Cheol\|Kang, Seok-Min\|Jung, Minkyu
PMID:	28977908

1105.
Journal:	Front Med (Lausanne). 2017 Sep 28;4:164.
Title:	Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature.
Author:	Fakhruddin, Najla\|Bahmad, Hisham F\|Aridi, Tarek\|Yammine, Yara\|Mahfouz, Rami\|Boulos, Fouad\|Awada, Ahmad\|Farhat, Fadi
PMID:	29034239

1106.
Journal:	Cancer Chemother Pharmacol. 2017 Dec;80(6):1147-1159.
Title:	Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC).
Author:	Chen, Shang-Chiung\|Kagedal, Matts\|Gao, Yuying\|Wang, Bei\|Harle-Yge, Marie-Laurence\|Girish, Sandhya\|Jin, Jin\|Li, Chunze
PMID:	29043411

1107.
Journal:	Oncotarget. 2017 Sep 8;8(43):74359-74370.
Title:	Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer.
Author:	Shen, Xiaobing\|Li, Pengfei\|Xu, Yuchao\|Chen, Xiaowei\|Sun, Haixiang\|Zhao, Ying\|Liu, Mengqi\|Zhang, Wenwen
PMID:	29088792

1108.
Journal:	Genome Med. 2017 Oct 31;9(1):93.
Title:	Actionable gene-based classification toward precision medicine in gastric cancer.
Author:	Ichikawa, Hiroshi\|Nagahashi, Masayuki\|Shimada, Yoshifumi\|Hanyu, Takaaki\|Ishikawa, Takashi\|Kameyama, Hitoshi\|Kobayashi, Takashi\|Sakata, Jun\|Yabusaki, Hiroshi\|Nakagawa, Satoru\|Sato, Nobuaki\|Hirata, Yuki\|Kitagawa, Yuko\|Tanahashi, Toshiyuki\|Yoshida, Kazuhiro\|
PMID:	29089060

1109.
Journal:	Biomed Res Int. 2017;2017:7869802.
Title:	Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.
Author:	Carlomagno, Nicola\|Incollingo, Paola\|Tammaro, Vincenzo\|Peluso, Gaia\|Rupealta, Niccolo\|Chiacchio, Gaetano\|Sandoval Sotelo, Maria Laura\|Minieri, Gianluca\|Pisani, Antonio\|Riccio, Eleonora\|Sabbatini, Massimo\|Bracale, Umberto Marcello\|Calogero, Armando\|Dodaro,
PMID:	29094049

1110.
Journal:	Medicine (Baltimore). 2017 Nov;96(44):e8437.
Title:	Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis.
Author:	Wang, Hong-Bo\|Liao, Xiao-Feng\|Zhang, Jian
PMID:	29095284

1111.
Journal:	Int J Mol Sci. 2017 Oct 28;18(11). pii: ijms18112262.
Title:	Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor.
Author:	Duarte, Henrique O\|Balmana, Meritxell\|Mereiter, Stefan\|Osorio, Hugo\|Gomes, Joana\|Reis, Celso A
PMID:	29143776

1112.
Journal:	World J Gastroenterol. 2017 Nov 7;23(41):7407-7414.
Title:	Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer.
Author:	Cho, Jang Ho\|Lim, Jae Yun\|Cho, Jae Yong
PMID:	29151694

1113.
Journal:	Monoclon Antib Immunodiagn Immunother. 2017 Dec;36(6):287-290.
Title:	Establishment of H2Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer.
Author:	Yamada, Shinji\|Itai, Shunsuke\|Nakamura, Takuro\|Chang, Yao-Wen\|Harada, Hiroyuki\|Suzuki, Hiroyoshi\|Kaneko, Mika K\|Kato, Yukinari
PMID:	29172998

1114.
Journal:	Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Nov 25;20(11):1293-1299.
Title:	[Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer].
Author:	Li, Yilin\|Peng, Zhi\|Zhang, Xiaotian\|Gong, Jifang\|Shen, Lin
PMID:	29178102

1115.
Journal:	Arch Med Sci. 2017 Oct;13(6):1255-1261.
Title:	Functions of the AP-2alpha gene in activating apoptosis and inhibiting proliferation of gastric cancer cells both in vitro and in vivo.
Author:	Zeng, Changqing\|Liu, Zhimin\|Zhang, Jian\|Fang, Hongwei\|Fang, Cheng\|Wang, Yueming\|Seeruttun, Sharvesh Raj\|Chen, Jun\|Huang, Liangxiang\|Wang, Wei
PMID:	29181055

1116.
Journal:	Curr Cancer Drug Targets. 2017 Nov 29. pii: CCDT-EPUB-87189.
Title:	Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity.
Author:	An, Jie\|Sheikh, M Saeed
PMID:	29189161

1117.
Journal:	Oncotarget. 2017 Sep 21;8(54):92209-92226.
Title:	Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer.
Author:	Kwon, Mi Jeong\|Kim, Ryong Nam\|Song, Kyoung\|Jeon, Sinyoung\|Jeong, Hae Min\|Kim, Joo Seok\|Han, Jinil\|Hong, Sungyoul\|Oh, Ensel\|Choi, Jong-Sun\|An, Jungsuk\|Pollack, Jonathan R\|Choi, Yoon-La\|Park, Cheol-Keun\|Shin, Young Kee
PMID:	29190909

1118.
Journal:	Oncotarget. 2017 Oct 4;8(56):96396-96408.
Title:	DNMT1 overexpression predicting gastric carcinogenesis, subsequent progression and prognosis: a meta and bioinformatic analysis.
Author:	Ma, Tianmiao\|Li, Hao\|Sun, Mingjun\|Yuan, Yuan\|Sun, Li-Ping
PMID:	29221215

1119.
Journal:	BMC Cancer. 2017 Dec 12;17(1):841.
Title:	Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
Author:	Cao, Guo-Dong\|Chen, Ke\|Chen, Bo\|Xiong, Mao-Ming
PMID:	29233126

1120.
Journal:	Cell Physiol Biochem. 2017;44(6):2158-2173.
Title:	Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
Author:	Hu, Nan\|Yin, Jun Feng\|Ji, Ze\|Hong, Yidong\|Wu, Puyuan\|Bian, Baoxiang\|Song, Ziyan\|Li, Rutian\|Liu, Qin\|Wu, Fenglei
PMID:	29241186

1121.
Journal:	Oncotarget. 2017 Sep 8;8(60):101383-101393.
Title:	Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.
Author:	Palle, Juliette\|Tougeron, David\|Pozet, Astrid\|Soularue, Emilie\|Artru, Pascal\|Leroy, Florence\|Dubreuil, Olivier\|Sarabi, Matthieu\|Williet, Nicolas\|Manfredi, Sylvain\|Martin-Babau, Jerome\|Rebischung, Christine\|Abdelghani, Meher Ben\|Evesque, Ludovic\|Dreanic, J
PMID:	29254172

1122.
Journal:	World J Gastroenterol. 2017 Dec 7;23(45):8000-8007.
Title:	Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series.
Author:	Baiocchi, Gian Luca\|Molfino, Sarah\|Baronchelli, Carla\|Giacopuzzi, Simone\|Marrelli, Daniele\|Morgagni, Paolo\|Bencivenga, Maria\|Saragoni, Luca\|Vindigni, Carla\|Portolani, Nazario\|Botticini, Maristella\|De Manzoni, Giovanni
PMID:	29259375

1123.
Journal:	Cancer Biother Radiopharm. 2017 Dec;32(10):351-363.
Title:	Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma.
Author:	Curea, Fabiana G\|Hebbar, Mohamed\|Ilie, Silvia M\|Bacinschi, Xenia E\|Trifanescu, Oana G\|Botnariuc, Inga\|Anghel, Rodica M
PMID:	29265917

1124.
Journal:	Int J Mol Sci. 2017 Dec 23;19(1). pii: ijms19010047.
Title:	Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.
Author:	Caggiari, Laura\|Miolo, Gianmaria\|Buonadonna, Angela\|Basile, Debora\|Santeufemia, Davide A\|Cossu, Antonio\|Palmieri, Giuseppe\|De Zorzi, Mariangela\|Fornasarig, Mara\|Alessandrini, Lara\|Canzonieri, Vincenzo\|Lo Re, Giovanni\|Puglisi, Fabio\|Steffan, Agostino\|Canni
PMID:	29295527

1125.
Journal:	J Gastrointest Oncol. 2017 Dec;8(6):1046-1050.
Title:	HER-2/neu gene amplification in gastric adenocarcinoma and its relationship with clinical and pathological findings.
Author:	Azarhoosh, Ramin\|Ebneghasem, Rokhsare\|Besharat, Sima
PMID:	29299365

1126.
Journal:	World J Gastroenterol. 2017 Dec 21;23(47):8291-8299.
Title:	Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
Author:	Youssef, Omar\|Sarhadi, Virinder\|Ehsan, Homa\|Bohling, Tom\|Carpelan-Holmstrom, Monika\|Koskensalo, Selja\|Puolakkainen, Pauli\|Kokkola, Arto\|Knuutila, Sakari
PMID:	29307989

1127.
Journal:	Oncotarget. 2017 Dec 4;8(67):111795-111806.
Title:	First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis f
Author:	Tomasello, Gianluca\|Valeri, Nicola\|Ghidini, Michele\|Smyth, Elizabeth C\|Liguigli, Wanda\|Toppo, Laura\|Mattioli, Rodolfo\|Curti, Alessandra\|Hahne, Jens C\|Negri, Federica M\|Panni, Stefano\|Ratti, Margherita\|Lazzarelli, Silvia\|Gerevini, Fabiana\|Colombi, Chiara\|P
PMID:	29340092

1128.
Journal:	Acta Gastroenterol Belg. 2017 Jan-Mar;80(1):31-37.
Title:	Immunohistochemical expression of CDX2, CK7, HER2 and HER4 in periampullary adenocarcinoma : implications for clinicopathology and patient outcomes.
Author:	Ugras, Nesrin\|Yerci, Omer\|Ozgun, Gonca\|Deligonul, Adem\|Dundar, Halit Ziya\|Sarkut, Pinar\|Kanat, Ozkan
PMID:	29364095

1129.
Journal:	Oncotarget. 2017 Dec 9;8(69):113494-113501.
Title:	PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer.
Author:	Kim, Chan\|Lee, Choong-Kun\|Chon, Hong Jae\|Kim, Joo Hoon\|Park, Hyung Soon\|Heo, Su Jin\|Kim, Hyun Jeong\|Kim, Tae Soo\|Kwon, Woo Sun\|Chung, Hyun Cheol\|Rha, Sun Young
PMID:	29371924

1130.
Journal:	Gan To Kagaku Ryoho. 2017 Nov;44(12):1263-1265.
Title:	[A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)].
Author:	Ebisui, Chikara\|Hamano, Rie\|Minoji, Takayuki\|Kitahara, Tomohiro\|Yanagisawa, Tetsu\|Okamura, Shu\|Fukuchi, Nariaki\|Murata, Kohei\|Yokouchi, Hideoki\|Kinuta, Masakatsu\|Ohishi, Kazuhito
PMID:	29394601

1131.
Journal:	Gan To Kagaku Ryoho. 2017 Nov;44(12):1266-1268.
Title:	[A Case of HER2-Positive Unresectable Gastric Cancer with Multiple Lymph Node and Liver Metastases Controlled Effectively by Combination Chemotherapy with Capecitabine, Oxaliplatin, and Trastuzumab].
Author:	Sato, Nariatsu\|Nakayama, Akira\|Takai, Yuki\|Kamata, Toru
PMID:	29394602

1132.
Journal:	Gan To Kagaku Ryoho. 2017 Nov;44(12):1455-1457.
Title:	[The Case of HER2 Positive Advanced Gastric Cancer with Para-Aorta Lymph Node Recurrence Responding to Capecitabine plus CDDP plus Trastuzumab Chemotherapy].
Author:	Hashimoto, Itaru\|Murakami, Hitoshi\|Arisaka, Sayaka\|Sugawara, Yuko\|Segami, Kenki\|Takagawa, Ryo\|Hayashi, Tsutomu\|Shimada, Kazuhiro\|Hirakawa, Shohei\|Hasegawa, Seiji\|Fukushima, Tadao\|Ike, Hideyuki\|Imada, Toshio\|Rino, Yasushi\|Masuda, Munetaka
PMID:	29394666

1133.
Journal:	Gan To Kagaku Ryoho. 2017 Nov;44(12):1626-1628.
Title:	[A Case Report of Gastric Cancer with Positive Peritoneal Lavage Cytology and Metachronous Schnitzler's Metastasis Treated with Multimodality Therapy].
Author:	Udagawa, Masaru\|Mizuno, Yuuki\|Ohnishi, Iichirou\|Sugishita, Tetsuo\|Kakuta, Satoru\|Murase, Yoshiki\|Watanabe, Yuuichirou\|Adikrisna, Rama
PMID:	29394723

1134.
Journal:	Gan To Kagaku Ryoho. 2017 Nov;44(12):1662-1664.
Title:	[Two Cases of HER2-Positive Gastric Cancer with Multiple Liver Metastases Leading to Conversion Therapy with Chemotherapy].
Author:	Ono, Hidetaka Andrew\|Kaneshiro, Miyuki\|Nakashima, Masayuki\|Baba, Hiroyuki\|Abe, Tetsuo\|Kumagai, Jiro\|Sugita, Mitsutaka
PMID:	29394735

1135.
Journal:	Gan To Kagaku Ryoho. 2017 Nov;44(12):1871-1873.
Title:	[A Case of Synchronous Quadruple Cancers Treated with Neoadjuvant Chemotherapy Followed by Surgery].
Author:	Muramoto, Keiji\|Miyake, Toru\|Shimizu, Tomoharu\|Sonoda, Hiromichi\|Ueki, Tomoyuki\|Terada, Yoshitaka\|Mori, Haruki\|Maehira, Hiromitsu\|Takebayashi, Katsushi\|Kaida, Sachiko\|Iida, Hiroya\|Yamaguchi, Tsuyoshi\|Tani, Masaji
PMID:	29394804

1136.
Journal:	Appl Immunohistochem Mol Morphol. 2018 Apr;26(4):239-245.
Title:	HER2 Status in Gastric and Gastroesophageal Junction Cancer: Results of the Large, Multinational HER-EAGLE Study.
Author:	Kim, Woo-Ho\|Gomez-Izquierdo, Lourdes\|Vilardell, Felip\|Chu, Kent-Man\|Soucy, Genevieve\|Dos Santos, Lucas V\|Monges, Genevieve\|Viale, Giuseppe\|Brito, Maria Jose\|Osborne, Stuart\|Noe, Johannes\|Du, Xiang
PMID:	27490762

1137.
Journal:	J Gastrointest Cancer. 2018 Mar;49(1):21-24.
Title:	Characteristics of Gastric Cancer in Lebanon: a Descriptive Study from a Single Institutional Experience.
Author:	Assi, Tarek\|El Rassy, Elie\|Khazzaka, Aline\|Moussa, Tania\|Ibrahim, Tony\|Kattan, Clarisse\|El Karak, Fadi\|Farhat, Fadi\|Ghosn, Marwan\|Kattan, Joseph
PMID:	27975180

1138.
Journal:	J Gastrointest Cancer. 2018 Jun;49(2):150-157.
Title:	Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia.
Author:	Rajadurai, Pathmanathan\|Fatt, Ho Kean\|Ching, Foo Yoke
PMID:	28124769

1139.
Journal:	Protein Cell. 2018 Oct;9(10):867-878.
Title:	Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo.
Author:	Song, Yanjing\|Tong, Chuan\|Wang, Yao\|Gao, Yunhe\|Dai, Hanren\|Guo, Yelei\|Zhao, Xudong\|Wang, Yi\|Wang, Zizheng\|Han, Weidong\|Chen, Lin
PMID:	28284008

1140.
Journal:	Cancer Res Treat. 2018 Jan;50(1):239-254.
Title:	FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.
Author:	Park, Jinju\|Choi, Yiseul\|Ko, Young San\|Kim, Younghoon\|Pyo, Jung-Soo\|Jang, Bo Gun\|Kim, Min A\|Lee, Jae-Seon\|Chang, Mee Soo\|Park, Jong-Wan\|Lee, Byung Lan
PMID:	28343375

1141.
Journal:	Gastric Cancer. 2018 Jan;21(1):84-95.
Title:	Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).
Author:	Miura, Yuji\|Sukawa, Yasutaka\|Hironaka, Shuichi\|Mori, Misuzu\|Nishikawa, Kazuhiro\|Tokunaga, Shinya\|Okuda, Hiroyuki\|Sakamoto, Takeshi\|Taku, Keisei\|Nishikawa, Kazuo\|Moriwaki, Toshikazu\|Negoro, Yuji\|Kimura, Yutaka\|Uchino, Keita\|Shinozaki, Katsunori\|Shinozaki,
PMID:	28497176

1142.
Journal:	Gastric Cancer. 2018 Mar;21(2):267-275.
Title:	Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer.
Author:	Osumi, Hiroki\|Takahari, Daisuke\|Shinozaki, Eiji\|Chin, Keisho\|Ogura, Mariko\|Wakatsuki, Takeru\|Ichimura, Takashi\|Nakayama, Izuma\|Matsushima, Tomohiro\|Yamaguchi, Kensei
PMID:	28584889

1143.
Journal:	Gastric Cancer. 2018 Mar;21(2):213-224.
Title:	The prognostic value of volume-based parameters using (18)F-FDG PET/CT in gastric cancer according to HER2 status.
Author:	Park, Ji Soo\|Lee, Nare\|Beom, Seung Hoon\|Kim, Hyo Song\|Lee, Choong-Kun\|Rha, Sun Young\|Chung, Hyun Cheol\|Yun, Mijin\|Cho, Arthur\|Jung, Minkyu
PMID:	28643145

1144.
Journal:	Clin Transl Oncol. 2018 Feb;20(2):212-220.
Title:	An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.
Author:	Wang, Y\|He, L\|Cheng, Y
PMID:	28681313

1145.
Journal:	Eur Urol Focus. 2018 Apr;4(3):399-404.
Title:	Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
Author:	Behzatoglu, Kemal\|Yorukoglu, Kutsal\|Demir, Hale\|Bal, Nebil
PMID:	28753766

1146.
Journal:	Cancer Res Treat. 2018 Jul;50(3):835-842.
Title:	Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors.
Author:	Kim, Tae Min\|Lee, Keun-Wook\|Oh, Do-Youn\|Lee, Jong-Seok\|Im, Seock-Ah\|Kim, Dong-Wan\|Han, Sae-Won\|Kim, Yu Jung\|Kim, Tae-You\|Kim, Jee Hyun\|Han, Hyesun\|Kim, Woo Ho\|Bang, Yung-Jue
PMID:	28859471

1147.
Journal:	Hum Antibodies. 2018 Feb 5;26(2):103-111.
Title:	Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2.
Author:	Sarina, Nurgul\|Abeldenov, Sailau\|Turgimbayeva, Aigerim\|Zhylkibayev, Assylbek\|Ramankulov, Yerlan\|Khassenov, Bekbolat\|Eskendirova, Saule
PMID:	29036807

1148.
Journal:	Virchows Arch. 2018 Mar;472(3):369-382.
Title:	Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics.
Author:	Birkman, Eva-Maria\|Mansuri, Naziha\|Kurki, Samu\|Algars, Annika\|Lintunen, Minnamaija\|Ristamaki, Raija\|Sundstrom, Jari\|Carpen, Olli
PMID:	29046940

1149.
Journal:	Target Oncol. 2018 Feb;13(1):107-112.
Title:	Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study.
Author:	Zaanan, Aziz\|Palle, Juliette\|Soularue, Emilie\|Leroy, Florence\|Louafi, Samy\|Tougeron, David\|Manfredi, Sylvain\|Artru, Pascal\|Pozet, Astrid\|Taieb, Julien
PMID:	29090377

1150.
Journal:	Recent Pat Anticancer Drug Discov. 2018;13(1):118-124.
Title:	The Epithelial-Mesenchymal Transition Pathway in Two Cases with Gastric Metastasis Originating from Breast Carcinoma, One with a Metachronous Primary Gastric Cancer.
Author:	Gurzu, Simona\|Banias, Laura\|Bara, Tivadar\|Feher, I\|Bara, Tivadar\|Jung, Ioan
PMID:	29090670

1151.
Journal:	Oncogene. 2018 Feb 22;37(8):1075-1085.
Title:	CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2.
Author:	Qi, M\|Jiao, M\|Li, X\|Hu, J\|Wang, L\|Zou, Y\|Zhao, M\|Zhang, R\|Liu, H\|Mi, J\|Zhang, L\|Liu, L\|Gong, Y\|Han, B
PMID:	29106389

1152.
Journal:	Cancer Biomark. 2018 Feb 6;21(2):439-447.
Title:	Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer.
Author:	Wang, Yang-Kun\|Wang, Su-Nan\|Li, Ying-Ying\|Wang, Gong-Ping\|Yun, Tian\|Zhu, Chao-Ya\|Yang, Bin-Feng\|Li, Cong-Yang\|Jiang, Bo\|Zhu, Mei-Ling
PMID:	29125480

1153.
Journal:	J Clin Pathol. 2018 May;71(5):451-462.
Title:	Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Author:	Hedner, Charlotta\|Borg, David\|Nodin, Bjorn\|Karnevi, Emelie\|Jirstrom, Karin\|Eberhard, Jakob
PMID:	29138285

1154.
Journal:	Clin Transl Oncol. 2018 Jun;20(6):695-702.
Title:	Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study.
Author:	Li, Q\|Li, H\|Jiang, H\|Feng, Y\|Cui, Y\|Wang, Y\|Ji, Y\|Yu, Y\|Li, W\|Xu, C\|Yu, S\|Zhuang, R\|Liu, T
PMID:	29168107

1155.
Journal:	Br J Cancer. 2018 Feb 6;118(3):378-387.
Title:	HER2 expression patterns in paired primary and metastatic endometrial cancer lesions.
Author:	Halle, Mari Kylleso\|Tangen, Ingvild Loberg\|Berg, Hege Fredriksen\|Hoivik, Erling Andre\|Mauland, Karen K\|Kusonmano, Kanthida\|Berg, Anna\|Hurtado, Antoni\|Kalland, Karl Henning\|Oyan, Anne M\|Stefansson, Ingunn\|Vintermyr, Olav K\|Werner, Henrica M\|Haldorsen, Ingf
PMID:	29169184

1156.
Journal:	J Infect Chemother. 2018 Apr;24(4):298-301.
Title:	Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Author:	Hayashi, Kazumi\|Nagasaki, Eijiro\|Nakada, Koji\|Tamura, Miho\|Arakawa, Yasuhiro\|Uwagawa, Tadashi\|Yano, Shingo
PMID:	29174919

1157.
Journal:	Cancer Chemother Pharmacol. 2018 Feb;81(2):421-422.
Title:	Correction to: Population pharmacokinetics of trastuzumab emtansine in previously treated patients with HER2-positive advanced gastric cancer (AGC).
Author:	Chen, Shang-Chiung\|Kagedal, Matts\|Gao, Yuying\|Wang, Bei\|Harle-Yge, Marie-Laurence\|Girish, Sandhya\|Jin, Jin\|Li, Chunze
PMID:	29189914

1158.
Journal:	Mol Med Rep. 2018 Feb;17(2):2600-2606.
Title:	H19 functions as a competing endogenous RNA to regulate human epidermal growth factor receptor expression by sequestering let7c in gastric cancer.
Author:	Wei, Yueguang\|Liu, Zhaoyang\|Fang, Jinhui
PMID:	29207111

1159.
Journal:	Eur J Cancer. 2018 Jan;88:92-100.
Title:	HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer.
Author:	Wang, Haixing\|Li, Beifang\|Liu, Zhentao\|Gong, Jifang\|Shao, Lin\|Ren, Jun\|Niu, Yunyun\|Bo, Shiping\|Li, Zhongwu\|Lai, Yumei\|Lu, Sijia\|Gao, Jing\|Shen, Lin
PMID:	29207318

1160.
Journal:	J Cell Biochem. 2018 Aug;119(8):6398-6407.
Title:	NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer.
Author:	Tang, Laiqin\|Long, Zhiguo\|Zhao, Na\|Feng, Guangjia\|Guo, Xianzhi\|Yu, Minghua
PMID:	29231994

1161.
Journal:	Gastric Cancer. 2018 May;21(3):428.
Title:	Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC06).
Author:	Kimura, Yutaka\|Fujii, Masashi\|Masuishi, Toshiki\|Nishikawa, Kazuhiro\|Kunisaki, Chikara\|Matsusaka, Satoshi\|Segawa, Yoshihiko\|Nakamura, Masato\|Sasaki, Kinro\|Nagao, Narutoshi\|Hatachi, Yukimasa\|Yuasa, Yasuhiro\|Asami, Shinya\|Takeuchi, Masahiro\|Furukawa, Hiroshi
PMID:	29234896

1162.
Journal:	Cell Biol Int. 2018 Jul;42(7):781-793.
Title:	Chk1 activation attenuates sensitivity of lapatinib in HER2-positive gastric cancer.
Author:	Bai, Ming\|Song, Na\|Che, Xiaofang\|Wang, Xiaoxun\|Qu, Xiujuan\|Liu, Yunpeng
PMID:	29271513

1163.
Journal:	Anticancer Res. 2018 Jan;38(1):287-293.
Title:	Establishment of a Patient-derived Xenograft for Development of Personalized HER2-targeting Therapy in Gastric Cancer.
Author:	Shin, Seol Hwa\|Park, Seok Soon\|Ju, Eun Jin\|Park, Jin\|Ko, Eun Jeong\|Hwang, Jung Jin\|Suh, Young-Ah\|Jang, Se Jin\|Lee, Jung Shin\|Ko, Bong-Kook\|Kim, Kyu-Tae\|Lee, Jong-Seo\|Song, Si Yeol\|Jeong, Seong-Yun\|Choi, Eun Kyung
PMID:	29277785

1164.
Journal:	Anticancer Res. 2018 Jan;38(1):367-372.
Title:	Evaluation of Expression of Human Epidermal Growth Factor Receptor 2 (HER2) in Gastric and Gastroesophageal Junction Adenocarcinoma Using IHC and Dual-ISH.
Author:	Dominguez, Carolina\|Rosa, Marilin\|George, Taara B\|Pimiento, Jose\|Lauwers, Gregory Y\|Coppola, Domenico
PMID:	29277796

1165.
Journal:	Cancer Biomark. 2018 Feb 14;21(3):731-741.
Title:	EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
Author:	Petrini, Iacopo\|Lencioni, Monica\|Vasile, Enrico\|Fornaro, Lorenzo\|Belluomini, Lorenzo\|Pasquini, Giulia\|Ginocchi, Laura\|Caparello, Chiara\|Musettini, Gianna\|Vivaldi, Caterina\|Caponi, Sara\|Ricci, Sergio\|Proietti, Agenese\|Fontanini, Gabriella\|Naccarato, Antoni
PMID:	29278885

1166.
Journal:	Cancer Chemother Pharmacol. 2018 Feb;81(2):387-392.
Title:	A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study).
Author:	Kagawa, Shunsuke\|Muraoka, Atsushi\|Kambara, Takeshi\|Nakayama, Hiroshi\|Hamano, Ryosuke\|Tanaka, Norimitsu\|Noma, Kazuhiro\|Tanakaya, Kohji\|Kishimoto, Hiroyuki\|Shigeyasu, Kunitoshi\|Kuroda, Shinji\|Kikuchi, Satoru\|Kuwada, Kazuya\|Nishizaki, Masahiko\|Shirakawa, Yas
PMID:	29290024

1167.
Journal:	Cancer Gene Ther. 2018 May;25(3-4):68-76.
Title:	miR-200c inhibits TGF-beta-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
Author:	Zhou, Xinliang\|Men, Xinyi\|Zhao, Riyang\|Han, Jing\|Fan, Zhisong\|Wang, Yudong\|Lv, Yalei\|Zuo, Jing\|Zhao, Lianmei\|Sang, Meixiang\|Liu, Xian-De\|Shan, Baoen
PMID:	29302045

1168.
Journal:	J Clin Pathol. 2018 Jul;71(7):600-607.
Title:	HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
Author:	Fujimoto, Masakazu\|Matsuzaki, Ibu\|Nishino, Masaru\|Iwahashi, Yoshifumi\|Warigaya, Kenji\|Kojima, Fumiyoshi\|Ono, Kazuo\|Murata, Shin-Ichi
PMID:	29305518

1169.
Journal:	BMC Cancer. 2018 Jan 8;18(1):57.
Title:	Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.
Author:	Saeki, Hiroshi\|Emi, Yasunori\|Oki, Eiji\|Tokunaga, Shoji\|Kakeji, Yoshihiro\|Akagi, Yoshito\|Baba, Hideo\|Baba, Eishi\|Maehara, Yoshihiko
PMID:	29310611

1170.
Journal:	Monoclon Antib Immunodiagn Immunother. 2018 Feb;37(1):59-62.
Title:	Development of an Anti-HER2 Monoclonal Antibody H2Mab-139 Against Colon Cancer.
Author:	Kaneko, Mika K\|Yamada, Shinji\|Itai, Shunsuke\|Kato, Yukinari
PMID:	29315012

1171.
Journal:	Sci Rep. 2018 Jan 10;8(1):397.
Title:	Correlation of Gli1 and HER2 expression in gastric cancer: Identification of novel target.
Author:	Shao, Xinyu\|Kuai, Xiaoyi\|Pang, Zhi\|Zhang, Liping\|Wu, Longyun\|Xu, Lijuan\|Zhou, Chunli
PMID:	29321573

1172.
Journal:	Mol Oncol. 2018 Apr;12(4):441-462.
Title:	Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.
Author:	Keller, Simone\|Zwingenberger, Gwen\|Ebert, Karolin\|Hasenauer, Jan\|Wasmuth, Jacqueline\|Maier, Dieter\|Haffner, Ivonne\|Schierle, Katrin\|Weirich, Gregor\|Luber, Birgit
PMID:	29325228

1173.
Journal:	Oncol Rep. 2018 Mar;39(3):1396-1404.
Title:	Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor 2-positive gastric cancer.
Author:	Xiong, Jian\|Han, Shuhua\|Ding, Shuang\|He, Jingchao\|Zhang, Haijun
PMID:	29328489

1174.
Journal:	J Cancer. 2018 Jan 1;9(2):358-366.
Title:	Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer.
Author:	Tajima, Jesse Yu\|Futamura, Manabu\|Gaowa, Siqin\|Mori, Ryutaro\|Tanahashi, Toshiyuki\|Tanaka, Yoshihiro\|Matsuhashi, Nobuhisa\|Takahashi, Takao\|Yamaguchi, Kazuya\|Miyazaki, Tatsuhiko\|Yoshida, Kazuhiro
PMID:	29344282

1175.
Journal:	Int J Mol Med. 2018 Apr;41(4):2389-2396.
Title:	Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway.
Author:	Su, Chin-Cheng
PMID:	29393362

1176.
Journal:	Ann Oncol. 2018 Apr 1;29(4):1037-1048.
Title:	Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients.
Author:	Kim, S T\|Banks, K C\|Pectasides, E\|Kim, S Y\|Kim, K\|Lanman, R B\|Talasaz, A\|An, J\|Choi, M G\|Lee, J H\|Sohn, T S\|Bae, J M\|Kim, S\|Park, S H\|Park, J O\|Park, Y S\|Lim, H Y\|Kim, N K D\|Park, W\|Lee, H\|Bass, A J\|Kim, K\|Kang, W K\|Lee, J
PMID:	29409051

1177.
Journal:	Oncotarget. 2017 Dec 14;9(2):2105-2119.
Title:	The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin.
Author:	Zhang, Xinyue\|Yao, Jie\|Guo, Kai\|Huang, Hu\|Huai, Siyuan\|Ye, Rui\|Niu, Baolong\|Ji, Tiannan\|Han, Weidong\|Li, Jianxiong
PMID:	29416757

1178.
Journal:	Am J Cancer Res. 2018 Jan 1;8(1):106-119. eCollection 2018.
Title:	Antitumor effects and persistence of a novel HER2 CAR T cells directed to gastric cancer in preclinical models.
Author:	Han, Yali\|Liu, Chuanyong\|Li, Guanhua\|Li, Juan\|Lv, Xingyan\|Shi, Huan\|Liu, Jie\|Liu, Shuai\|Yan, Peng\|Wang, Shuyun\|Sun, Yuping\|Sun, Meili
PMID:	29416924

1179.
Journal:	J Hematol Oncol. 2018 Feb 13;11(1):20.
Title:	Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer.
Author:	Chen, Zuhua\|Huang, Wenwen\|Tian, Tiantian\|Zang, Wanchun\|Wang, Jingyuan\|Liu, Zhentao\|Li, Zhongwu\|Lai, Yumei\|Jiang, Zhi\|Gao, Jing\|Shen, Lin
PMID:	29433585

1180.
Journal:	Oncol Lett. 2018 Feb;15(2):1758-1762.
Title:	Mechanisms for DNA-damaging agent-induced inactivation of ErbB2 and ErbB3 via the ERK and p38 signaling pathways.
Author:	Park, Chul Min\|Kawasaki, Yuki\|Refaat, Alaa\|Sakurai, Hiroaki
PMID:	29434871

1181.
Journal:	Appl Immunohistochem Mol Morphol. 2018 Feb 12.
Title:	Morphologic and Immunohistochemical Appraisal of Primary Gastric Carcinomas.
Author:	Guner, Gunes\|Isik, Aynur\|Karabulut, Erdem\|Gedikoglu, Gokhan\|Sokmensuer, Cenk\|Akyol, Aytekin
PMID:	29438113

1182.
Journal:	Am J Surg Pathol. 2018 Apr;42(4):453-462.
Title:	Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
Author:	Hissong, Erika\|Ramrattan, Girish\|Zhang, Pan\|Zhou, Xi Kathy\|Young, Gloria\|Klimstra, David S\|Shia, Jinru\|Fernandes, Helen\|Yantiss, Rhonda K
PMID:	29438172

1183.
Journal:	Mol Cancer Ther. 2018 Apr;17(4):786-794.
Title:	MI130004, a Novel Antibody-Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors.
Author:	Aviles, Pablo\|Dominguez, Juan Manuel\|Guillen, Maria Jose\|Munoz-Alonso, Maria Jose\|Mateo, Cristina\|Rodriguez-Acebes, Raquel\|Molina-Guijarro, Jose Manuel\|Francesch, Andres\|Martinez-Leal, Juan Fernando\|Munt, Simon\|Galmarini, Carlos M\|Cuevas, Carmen
PMID:	29440297

1184.
Journal:	Int J Cancer. 2018 Jul 15;143(2):438-448.
Title:	Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in human epidermal growth factor receptor 2-positive advanced oesophagogastric cancer: A meta-analysis.
Author:	Ter Veer, Emil\|Creemers, Aafke\|de Waal, Laura\|van Oijen, Martijn G H\|van Laarhoven, Hanneke W M
PMID:	29451302

1185.
Journal:	Ann Oncol. 2018 Apr 1;29(4):801-802.
Title:	Toward optimizing outcomes in Her2-positive gastric cancer: timing and genomic context matter.
Author:	Klempner, S J\|Chao, J
PMID:	29462252

1186.
Journal:	BMC Cancer. 2018 Feb 20;18(1):206.
Title:	Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.
Author:	Jiao, Xiao-Dong\|Ding, Chunming\|Zang, Yuan-Sheng\|Yu, Guanzhen
PMID:	29463236

1187.
Journal:	Cancer Sci. 2018 Apr;109(4):1166-1176.
Title:	Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.
Author:	Yoshioka, Takahiro\|Shien, Kazuhiko\|Namba, Kei\|Torigoe, Hidejiro\|Sato, Hiroki\|Tomida, Shuta\|Yamamoto, Hiromasa\|Asano, Hiroaki\|Soh, Junichi\|Tsukuda, Kazunori\|Nagasaka, Takeshi\|Fujiwara, Toshiyoshi\|Toyooka, Shinichi
PMID:	29465762

1188.
Journal:	Future Oncol. 2018 Aug;14(19):1909-1919.
Title:	Efficacy and safety of the trastuzumab biosimilar candidate CT-P6.
Author:	Esteva, Francisco J\|Saeki, Toshiaki\|Kim, HoUng\|Stebbing, Justin
PMID:	29482364

1189.
Journal:	Gan To Kagaku Ryoho. 2018 Feb;45(2):336-338.
Title:	[Indication of Palliative Gastrojejunostomy for Unresectable Advanced Gastric Cancer with Obstruction from the View Point of Preoperative Inflammatory Biomarkers].
Author:	Oka, Yoshio\|Okada, Kaoru\|Nagata, Hideki\|Yoshioka, Shinichi\|Ueshima, Shigeyuki\|Higaki, Naozumi\|Hayashida, Hirohito\|Nezu, Riichiro
PMID:	29483439

1190.
Journal:	Gastric Cancer. 2018 Sep;21(5):811-818.
Title:	A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.
Author:	Nishikawa, Kazuhiro\|Tsuburaya, Akira\|Yoshikawa, Takaki\|Takahashi, Masazumi\|Tanabe, Kazuaki\|Yamaguchi, Kensei\|Yoshino, Shigefumi\|Namikawa, Tsutomu\|Aoyama, Toru\|Rino, Yasushi\|Kawada, Junji\|Tsuji, Akihito\|Taira, Koichi\|Kimura, Yutaka\|Kodera, Yasuhiro\|Hirashi
PMID:	29488122

1191.
Journal:	Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):185-189.
Title:	[Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Author:	Dong, Ruizeng\|Zhang, Zewei\|Zhou, Yiming\|Hua, Yonghong\|Guo, Jianmin
PMID:	29492918

1192.
Journal:	Surg Endosc. 2018 Sep;32(9):3964-3971.
Title:	Clinicopathological features and endoscopic findings of HER2-positive gastric cancer.
Author:	Oono, Yasuhiro\|Kuwata, Takeshi\|Takashima, Kenji\|Yoda, Yusuke\|Ikematsu, Hiroaki\|Shitara, Kohei\|Kinoshita, Takahiro\|Yano, Tomonori
PMID:	29500656

1193.
Journal:	Oncotarget. 2018 Jan 18;9(10):9262-9272.
Title:	Prognostic implications of HER2 heterogeneity in gastric cancer.
Author:	Motoshima, Shigenobu\|Yonemoto, Koji\|Kamei, Hideki\|Morita, Michi\|Yamaguchi, Rin
PMID:	29507688

1194.
Journal:	Mol Med Rep. 2018 May;17(5):6387-6396.
Title:	Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis.
Author:	Huang, Ru\|Gu, Wenchao\|Sun, Bin\|Gao, Lei
PMID:	29512712

1195.
Journal:	Oncotarget. 2018 Jan 12;9(11):9741-9750.
Title:	Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers.
Author:	Cabel, Luc\|Fuerea, Alina\|Lacroix, Ludovic\|Baldini, Capucine\|Martin, Patricia\|Hollebecque, Antoine\|Postel-Vinay, Sophie\|Varga, Andrea\|Balheda, Rastilav\|Gazzah, Anas\|Michot, Jean-Marie\|Marabelle, Aurelien\|Rouleau, Etienne\|Solary, Eric\|De Baere, Thierry\|Ange
PMID:	29515767

1196.
Journal:	Biomedicines. 2018 Mar 9;6(1). pii: biomedicines6010032.
Title:	Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets.
Author:	Kankeu Fonkoua, Lionel\|Yee, Nelson S
PMID:	29522457

1197.
Journal:	Diagn Pathol. 2018 Mar 12;13(1):19.
Title:	Physical basis of the 'magnification rule' for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer.
Author:	Scheel, Andreas H\|Penault-Llorca, Frederique\|Hanna, Wedad\|Baretton, Gustavo\|Middel, Peter\|Burchhardt, Judith\|Hofmann, Manfred\|Jasani, Bharat\|Ruschoff, Josef
PMID:	29530054

1198.
Journal:	Oncogene. 2018 May;37(22):3022-3038.
Title:	The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.
Author:	Shi, Jiaolong\|Li, Fengping\|Yao, Xingxing\|Mou, Tingyu\|Xu, Zhijun\|Han, Zheng\|Chen, Siyu\|Li, Wende\|Yu, Jiang\|Qi, Xiaolong\|Liu, Hao\|Li, Guoxin
PMID:	29535422

1199.
Journal:	Oncol Lett. 2018 Apr;15(4):4143-4150.
Title:	Autophagy flux inhibition augments gastric cancer resistance to the anti-human epidermal growth factor receptor 2 antibody trastuzumab.
Author:	Ye, Hua\|Chai, Xuyu\|Wang, Xiaoyu\|Zheng, Qi\|Zheng, Dingcheng\|Wu, Feng\|Zheng, Cheng\|Chen, Ping
PMID:	29541179

1200.
Journal:	BMC Cancer. 2018 Mar 15;18(1):295.
Title:	Long-term trastuzumab (Herceptin(R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer.
Author:	Muller, Volkmar\|Clemens, Michael\|Jassem, Jacek\|Al-Sakaff, Nedal\|Auclair, Petra\|Nuesch, Eveline\|Holloway, Debbie\|Shing, Mona\|Bang, Yung-Jue
PMID:	29544445

1201.
Journal:	Cesk Patol. 2018 Spring;54(1):23-26.
Title:	[Predictive diagnostics of gastric cancer in 2018].
Author:	Daum, Ondrej\|Dubova, Magdalena\|Skalova, Alena\|Rozkos, Tomas\|Laco, Jan
PMID:	29631408

1202.
Journal:	J Gastroenterol. 2018 Apr 9. pii: 10.1007/s00535-018-1464-0.
Title:	Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.
Author:	Wakatsuki, Takeru\|Yamamoto, Noriko\|Sano, Takeshi\|Chin, Keisho\|Kawachi, Hiroshi\|Takahari, Daisuke\|Ogura, Mariko\|Ichimura, Takashi\|Nakayama, Izuma\|Osumi, Hiroki\|Matsushima, Tomohiro\|Suenaga, Mitsukuni\|Shinozaki, Eiji\|Hiki, Naoki\|Ishikawa, Yuichi\|Yamaguchi,
PMID:	29633013

1203.
Journal:	Mol Carcinog. 2018 Aug;57(8):1008-1016.
Title:	Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib.
Author:	Wang, Liying\|Zhang, Hongfeng\|Zheng, Jiaxin\|Wei, Xiaoli\|Du, Jingwen\|Lu, Haibo\|Sun, Qiuying\|Zhou, Weiyu\|Zhang, Rui\|Han, Yu
PMID:	29637613

1204.
Journal:	Ann Oncol. 2018 May 1;29(5):1108-1119.
Title:	Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
Author:	Siena, S\|Sartore-Bianchi, A\|Marsoni, S\|Hurwitz, H I\|McCall, S J\|Penault-Llorca, F\|Srock, S\|Bardelli, A\|Trusolino, L
PMID:	29659677

1205.
Journal:	Cancer Med. 2018 Jun;7(6):2612-2620.
Title:	Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status.
Author:	Wang, Lei\|Zhang, Qiongyan\|Ni, Shujuan\|Tan, Cong\|Cai, Xu\|Huang, Dan\|Sheng, Weiqi
PMID:	29673110

1206.
Journal:	Biosci Rep. 2018 Jun 12;38(3). pii: BSR20171687.
Title:	Significance of aquaporins' expression in the prognosis of gastric cancer.
Author:	Thapa, Saroj\|Chetry, Mandika\|Huang, Kaiyu\|Peng, Yangpei\|Wang, Jinsheng\|Wang, Jiaoni\|Zhou, Yingying\|Shen, Yigen\|Xue, Yangjing\|Ji, Kangting
PMID:	29678898

1207.
Journal:	Eur J Surg Oncol. 2018 Aug;44(8):1191-1198.
Title:	Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
Author:	Carmona-Bayonas, Alberto\|Jimenez-Fonseca, Paula\|Echavarria, Isabel\|Sanchez Canovas, Manuel\|Aguado, Gema\|Gallego, Javier\|Custodio, Ana\|Hernandez, Raquel\|Viudez, Antonio\|Cano, Juana Maria\|Martinez de Castro, Eva\|Macias, Ismael\|Martin Carnicero, Alfonso\|Garr
PMID:	29685755

1208.
Journal:	Sci Rep. 2018 Apr 23;8(1):6423.
Title:	RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells.
Author:	Mitsuda, Yoshihide\|Morita, Ken\|Kashiwazaki, Gengo\|Taniguchi, Junichi\|Bando, Toshikazu\|Obara, Moeka\|Hirata, Masahiro\|Kataoka, Tatsuki R\|Muto, Manabu\|Kaneda, Yasufumi\|Nakahata, Tatsutoshi\|Liu, Pu Paul\|Adachi, Souichi\|Sugiyama, Hiroshi\|Kamikubo, Yasuhiko
PMID:	29686309

1209.
Journal:	APMIS. 2018 May;126(5):389-395.
Title:	The association among HER2, MET and FOXP3 expression and tumor regression grading in gastric adenocarcinoma.
Author:	Neves Filho, Eduardo Henrique Cunha\|Pires, Adriana Pinheiro Bezerra\|de Sant'Ana, Rosane Oliveira\|Rabenhorst, Silvia Helena Barem\|Hirth, Carlos Gustavo\|da Cunha, Maria Do Perpetuo Socorro Saldanha
PMID:	29696715

1210.
Journal:	Libyan J Med. 2018 Dec;13(1):1466573.
Title:	Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma.
Author:	Ahmed, Ayesha\|Al-Tamimi, Dalal M
PMID:	29697008

1211.
Journal:	Oncologist. 2018 Sep;23(9):1092-1102.
Title:	Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
Author:	Diaz-Serrano, Asuncion\|Angulo, Barbara\|Dominguez, Carolina\|Pazo-Cid, Roberto\|Salud, Antonieta\|Jimenez-Fonseca, Paula\|Leon, Ana\|Galan, Maria Carmen\|Alsina, Maria\|Rivera, Fernando\|Plaza, J Carlos\|Paz-Ares, Luis\|Lopez-Rios, Fernando\|Gomez-Martin, Carlos
PMID:	29700210

1212.
Journal:	Gut. 2018 Apr 27. pii: gutjnl-2017-314549.
Title:	Human gastric cancer modelling using organoids.
Author:	Seidlitz, Therese\|Merker, Sebastian R\|Rothe, Alexander\|Zakrzewski, Falk\|von Neubeck, Clare\|Grutzmann, Konrad\|Sommer, Ulrich\|Schweitzer, Christine\|Scholch, Sebastian\|Uhlemann, Heike\|Gaebler, Anne-Marlene\|Werner, Kristin\|Krause, Mechthild\|Baretton, Gustavo
PMID:	29703791

1213.
Journal:	Tumori. 2018 Mar 1:300891618763215.
Title:	Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.
Author:	Mahjoubi, Linda\|Cecchi, Fabiola\|Massard, Christophe\|Calabro, Fabio\|Gazzah, Anas\|Bahleda, Rastislav\|Jamme, Philippe\|Gelli, Maximiliano\|Goere, Diane\|Lacroix, Ludovic\|Adam, Julien\|Heukamp, Lukas\|Trenta, Patrizia\|Hembrough, Todd\|Soria, Jean-Charles\|Sternberg,
PMID:	29714649

1214.
Journal:	Anticancer Res. 2018 May;38(5):3151-3156.
Title:	Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy.
Author:	Hwang, Gi Yong\|Baek, Dong Won\|Cho, Hee Jeong\|Lee, Soo Jung\|Chae, Yee Soo\|Kang, Byung Woog\|Lee, In Hee\|Kim, Jong Gwang\|Seo, An Na\|Bae, Han Ik\|Park, Ki Bum\|Park, Ji Yeon\|Kwon, Oh Kyoung\|Lee, Seung Soo\|Chung, Ho Young
PMID:	29715156

1215.
Journal:	BMC Cancer. 2018 May 2;18(1):504.
Title:	Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation.
Author:	Barok, Mark\|Puhka, Maija\|Vereb, Gyorgy\|Szollosi, Janos\|Isola, Jorma\|Joensuu, Heikki
PMID:	29720111

1216.
Journal:	BMC Cancer. 2018 May 2;18(1):508.
Title:	Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients.
Author:	Hsieh, Yung-Yu\|Tung, Shui-Yi\|Pan, Hung-Yu\|Yen, Chih-Wei\|Xu, Huang-Wei\|Deng, Yi-Fang\|Lin, Ying-Jhen\|Hsu, Wan-Ting\|Wu, Cheng-Shyong\|Li, Chin
PMID:	29720137

1217.
Journal:	Appl Immunohistochem Mol Morphol. 2018 May 4.
Title:	Human Epidermal Growth Factor Receptor-2 Promotes Invasion and Metastasis in Gastric Cancer by Activating Mitogen-activated Protein Kinase Signaling.
Author:	Hou, Feng\|Shi, Duan-Bo\|Chen, Yun-Qing\|Gao, Peng
PMID:	29734245

1218.
Journal:	Open Med (Wars). 2018 May 9;13:178-188.
Title:	Distinct Expression and Prognostic Value of MS4A in Gastric Cancer.
Author:	Sun, Lei\|Zhang, Yanli\|Zhang, Chao
PMID:	29756054

1219.
Journal:	Int J Mol Med. 2018 Aug;42(2):998-1007.
Title:	miR494 inhibits cancerinitiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2positive gastric cancer.
Author:	Yu, Yanxia\|Yu, Xuejuan\|Liu, Hong\|Song, Qingxun\|Yang, Yongmei
PMID:	29786108

1220.
Journal:	Biochem Cell Biol. 2018 Jun;96(3):295-305.
Title:	A systematic understanding of signaling by ErbB2 in cancer using phosphoproteomics.
Author:	Sidhanth, C\|Manasa, P\|Krishnapriya, S\|Sneha, S\|Bindhya, S\|Nagare, R P\|Garg, M\|Ganesan, T S
PMID:	29792724

1221.
Journal:	Asian Pac J Cancer Prev. 2018 May 26;19(5):1381-1385.
Title:	Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India
Author:	Nadaf, Asmanaz Saleem\|Rani, Hephzibah\|Dinesh, Udipi Shastri
PMID:	29802704

1222.
Journal:	Saudi J Gastroenterol. 2018 Sep-Oct;24(5):289-293.
Title:	Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population.
Author:	Shabbir, Asma\|Qureshi, Muhammad Asif\|Khalid, Abdullah Bin\|Mirza, Talat\|Shaikh, Asma\|Hasan, Syed Mehmood
PMID:	29806596

1223.
Journal:	Int J Mol Med. 2018 Sep;42(3):1473-1483.
Title:	Paeonol induces the apoptosis of the SGC7901 gastric cancer cell line by downregulating ERBB2 and inhibiting the NFkappaB signaling pathway.
Author:	Fu, Jun\|Yu, Luhua\|Luo, Jie\|Huo, Rui\|Zhu, Bing
PMID:	29845222

1224.
Journal:	AAPS J. 2018 May 29;20(4):72.
Title:	A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy.
Author:	Chae, Dongwoo\|Nam, Chung Mo\|Kim, Joo Hoon\|Lee, Choong-Kun\|Kim, Seung-Seob\|Kim, Hyo Song\|Jung, Minkyu\|Cheong, Jae Ho\|Chung, Hyun Cheol\|Rha, Sun Young\|Park, Kyungsoo
PMID:	29845329

1225.
Journal:	Am J Surg Pathol. 2018 Aug;42(8):989-1000.
Title:	Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Author:	Stolnicu, Simona\|Barsan, Iulia\|Hoang, Lien\|Patel, Prusha\|Chiriboga, Luis\|Terinte, Cristina\|Pesci, Anna\|Aviel-Ronen, Sarit\|Kiyokawa, Takako\|Alvarado-Cabrero, Isabel\|Pike, Malcolm C\|Oliva, Esther\|Park, Kay J\|Soslow, Robert A
PMID:	29851704

1226.
Journal:	Nanomedicine. 2018 Aug;14(6):1919-1929.
Title:	HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer.
Author:	Kubota, Tetsushi\|Kuroda, Shinji\|Kanaya, Nobuhiko\|Morihiro, Toshiaki\|Aoyama, Katsuyuki\|Kakiuchi, Yoshihiko\|Kikuchi, Satoru\|Nishizaki, Masahiko\|Kagawa, Shunsuke\|Tazawa, Hiroshi\|Fujiwara, Toshiyoshi
PMID:	29885899

1227.
Journal:	Dig Liver Dis. 2018 Aug;50(8):768-779.
Title:	Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).
Author:	Zaanan, Aziz\|Bouche, Olivier\|Benhaim, Leonor\|Buecher, Bruno\|Chapelle, Nicolas\|Dubreuil, Olivier\|Fares, Nadim\|Granger, Victoire\|Lefort, Christine\|Gagniere, Johan\|Meilleroux, Julie\|Baumann, Anne-Sophie\|Vendrely, Veronique\|Ducreux, Michel\|Michel, Pierre
PMID:	29886081

1228.
Journal:	J Transl Med. 2018 Jun 19;16(1):168.
Title:	Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.
Author:	Guan, Siao-Syun\|Wu, Cheng-Tien\|Chiu, Chen-Yuan\|Luo, Tsai-Yueh\|Wu, Jeng-Yih\|Liao, Tse-Zung\|Liu, Shing-Hwa
PMID:	29921305

1229.
Journal:	Tohoku J Exp Med. 2018 Jun;245(2):123-129.
Title:	Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective Analysis.
Author:	Okita, Akira\|Imai, Hiroo\|Takahashi, Masahiro\|Takahashi, Hidekazu\|Umegaki, Sho\|Kawamura, Yoshifumi\|Hiraide, Sakura\|Ouchi, Kota\|Sato, Yuko\|Okada, Yoshinari\|Komine, Keigo\|Saijo, Ken\|Takahashi, Shin\|Takahashi, Masanobu\|Shirota, Hidekazu\|Ohori, Hisatsugu\|Gamoh
PMID:	29937450

1230.
Journal:	Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1721-1725.
Title:	HER2 Expression Status and Prognostic, Diagnostic, and Demographic Properties of Patients with Gastric Cancer: a Single Center Cohort Study from Iran
Author:	Feizy, Abdolamir\|Karami, Aida\|Eghdamzamiri, Reza\|Moghimi, Minoosh\|Taheri, Hadi\|Mousavinasab, Nouraddin
PMID:	29938472

1231.
Journal:	Gastric Cancer. 2018 Jun 27. pii: 10.1007/s10120-018-0853-7.
Title:	Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples.
Author:	Oono, Yasuhiro\|Kuwata, Takeshi\|Takashima, Kenji\|Shinmura, Kensuke\|Hori, Keisuke\|Yoda, Yusuke\|Ikematsu, Hiroaki\|Shitara, Kohei\|Kinoshita, Takahiro\|Yano, Tomonori
PMID:	29951752

1232.
Journal:	Cell Death Dis. 2018 Jul 3;9(7):745.
Title:	Consequences of blunting the mevalonate pathway in cancer identified by a pluri-omics approach.
Author:	Goulitquer, Sophie\|Croyal, Mikael\|Lalande, Julie\|Royer, Anne-Lise\|Guitton, Yann\|Arzur, Danielle\|Durand, Stephanie\|Le Jossic-Corcos, Catherine\|Bouchereau, Alain\|Potin, Philippe\|Akoka, Serge\|Antignac, Jean-Philippe\|Krempf, Michel\|Ferchaud-Roucher, Veronique
PMID:	29970880

1233.
Journal:	Surg Case Rep. 2018 Jul 5;4(1):71.
Title:	Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab.
Author:	Namikawa, Tsutomu\|Ishida, Nobuko\|Tsuda, Sachi\|Fujisawa, Kazune\|Munekage, Eri\|Iwabu, Jun\|Munekage, Masaya\|Uemura, Sunao\|Tsujii, Shigehiro\|Maeda, Hiromichi\|Kitagawa, Hiroyuki\|Kobayashi, Michiya\|Hanazaki, Kazuhiro
PMID:	29978335

1234.
Journal:	Int J Mol Sci. 2018 Jul 6;19(7). pii: ijms19071981.
Title:	Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/beta-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer.
Author:	Liu, Wenhu\|Yuan, Jiangbei\|Liu, Zhenzhong\|Zhang, Jianwu\|Chang, Jinxia
PMID:	29986466

1235.
Journal:	Int J Mol Sci. 2018 Jul 9;19(7). pii: ijms19072005.
Title:	DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells.
Author:	Tajirika, Toshihiro\|Tokumaru, Yoshihisa\|Taniguchi, Kohei\|Sugito, Nobuhiko\|Matsuhashi, Nobuhisa\|Futamura, Manabu\|Yanagihara, Kazuyoshi\|Akao, Yukihiro\|Yoshida, Kazuhiro
PMID:	29987267

1236.
Journal:	Med Mol Morphol. 2018 Jul 10. pii: 10.1007/s00795-018-0202-2.
Title:	Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification.
Author:	Nakamura, Ayano\|Yamaguchi, Ken\|Minamiguchi, Sachiko\|Murakami, Ryusuke\|Abiko, Kaoru\|Hamanishi, Junzo\|Kondoh, Eiji\|Baba, Tsukasa\|Mandai, Masaki\|Matsumura, Noriomi
PMID:	29992451

1237.
Journal:	Virchows Arch. 2018 Jul 13. pii: 10.1007/s00428-018-2406-1.
Title:	Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features.
Author:	Ferreira, Catarina\|Lobo, Joao\|Antunes, Luis\|Lopes, Paula\|Jeronimo, Carmen\|Henrique, Rui
PMID:	30006753

1238.
Journal:	Oncol Lett. 2018 Aug;16(2):2085-2090.
Title:	Conversion therapy for advanced gastric cancer with trastuzumab combined with chemotherapy: A case report.
Author:	Xiao, Shuo-Meng\|Xu, Rui\|Tang, Xiao-Li\|Ding, Zhi\|Li, Ji-Man\|Zhou, Xiang
PMID:	30008904

1239.
Journal:	Clin Cancer Res. 2018 Jul 16. pii: 1078-0432.CCR-18-1205.
Title:	Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance.
Author:	Li, Yilin\|Zhang, Xiaotian\|Liu, Dan\|Gong, Jifang\|Wang, Daisy Dandan\|Li, Shan\|Peng, Zhi\|Li, Yanyan\|Wang, Xiaojuan\|Lin, Peter Ping\|Li, Min\|Shen, Lin
PMID:	30012565

1240.
Journal:	Pharmacogenomics. 2018 Aug 1;19(13):1047-1068.
Title:	Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies.
Author:	Raimondi, Alessandra\|Nichetti, Federico\|Peverelli, Giorgia\|Di Bartolomeo, Maria\|De Braud, Filippo\|Pietrantonio, Filippo
PMID:	30041572

1241.
Journal:	Open Access Maced J Med Sci. 2018 Jun 30;6(7):1187-1192.
Title:	HER2 Positive Gastric Carcinomas and Their Clinico-Pathological Characteristics.
Author:	Ognjenovic, Ljubomir\|Trajkovski, Gjorgji\|Gjoshev, Stojan\|Shumkovski, Aleksandar\|Dzambaz, Darko\|Hadzi-Manchev, Dragan\|Volcevski, Goce\|Fildishevski, Igor\|Nikolova, Dafina\|Petrushevska, Gordana\|Janevska, Vesna\|Janevski, Vlado
PMID:	30087720

1242.
Journal:	Am J Transl Res. 2018 Jul 15;10(7):2055-2067. eCollection 2018.
Title:	The molecular mechanism and clinical significance of LDHA in HER2-mediated progression of gastric cancer.
Author:	Zhu, Weiyou\|Ma, Ling\|Qian, Jing\|Xu, Jin\|Xu, Tongpeng\|Pang, Lijun\|Zhou, Hong\|Shu, Yongqian\|Zhou, Jianwei
PMID:	30093943

1243.
Journal:	Curr Probl Cancer. 2018 Jul 19. pii: S0147-0272(17)30139-3.
Title:	HER2: An emerging target in colorectal cancer.
Author:	Greally, Megan\|Kelly, Ciara M\|Cercek, Andrea
PMID:	30100092

1244.
Journal:	Cancer Chemother Pharmacol. 2018 Oct;82(4):733-739.
Title:	Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071).
Author:	Moehler, Markus\|Schad, Arno\|Maderer, Annett\|Atasoy, Ajlan\|Mauer, Murielle E\|Caballero, Carmela\|Thomaidis, Thomas\|John, Jestinah M Mahachie\|Lang, Istvan\|Van Cutsem, Eric\|Freire, Joao\|Lutz, Manfred P\|Roth, Arnaud
PMID:	30105460

1245.
Journal:	Oncologist. 2018 Aug 16. pii: theoncologist.2018-0175.
Title:	Randomized, Open-Label Phase II Study Comparing Capecitabine-Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naive Patients with HER2-Negative Advanced Gastric Cancer: OGSG1105, HERBIS-4A Trial.
Author:	Kawakami, Hisato\|Takeno, Atsushi\|Endo, Shunji\|Makari, Yoichi\|Kawada, Junji\|Taniguchi, Hirokazu\|Tamura, Shigeyuki\|Sugimoto, Naotoshi\|Kimura, Yutaka\|Tamura, Takao\|Fujitani, Kazumasa\|Sakai, Daisuke\|Shimokawa, Toshio\|Kurokawa, Yukinori\|Satoh, Taroh
PMID:	30115736

1246.
Journal:	Oncologist. 2018 Aug 17. pii: theoncologist.2018-0221.
Title:	FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1.
Author:	Fashoyin-Aje, Lola\|Donoghue, Martha\|Chen, Huanyu\|He, Kun\|Veeraraghavan, Janaki\|Goldberg, Kirsten B\|Keegan, Patricia\|McKee, Amy E\|Pazdur, Richard
PMID:	30120163

1247.
Journal:	Virchows Arch. 2018 Aug 17. pii: 10.1007/s00428-018-2433-y.
Title:	Association of HER2 gene amplification and tumor progression in early gastric cancer.
Author:	Kanayama, Kazuki\|Imai, Hiroshi\|Usugi, Eri\|Shiraishi, Taizo\|Hirokawa, Yoshifumi S\|Watanabe, Masatoshi
PMID:	30120594

1248.
Journal:	Front Pharmacol. 2018 Aug 3;9:861.
Title:	Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer.
Author:	Xiang, Zhen\|Huang, Xia\|Wang, Jiexuan\|Zhang, Jun\|Ji, Jun\|Yan, Ranlin\|Zhu, Zhenggang\|Cai, Wei\|Yu, Yingyan
PMID:	30123134

1249.
Journal:	Anticancer Drugs. 2018 Aug 17.
Title:	Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer.
Author:	Horita, Yosuke\|Nishino, Michiko\|Sugimoto, Saiho\|Kida, Akihiko\|Mizukami, Atsuyoshi\|Yano, Masaaki\|Arihara, Fumitaka\|Matsuda, Koichiro\|Matsuda, Mitsuru\|Sakai, Akito
PMID:	30124494

1250.
Journal:	J Cell Biochem. 2018 Aug 20.
Title:	Berberine: A potential adjunct for the treatment of gastrointestinal cancers?
Author:	Hesari, AmirReza\|Ghasemi, Faezeh\|Cicero, Arrigo F G\|Mohajeri, Mohammad\|Rezaei, Omid\|Hayat, Seyed Mohammad Gheibi\|Sahebkar, Amirhossein
PMID:	30125974

1251.
Journal:	World J Surg Oncol. 2018 Aug 22;16(1):174.
Title:	Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
Author:	Yu, Chaoran\|Xue, Pei\|Zhang, Luyang\|Pan, Ruijun\|Cai, Zhenhao\|He, Zirui\|Sun, Jing\|Zheng, Minhua
PMID:	30134903

1252.
Journal:	Med Sci Monit. 2018 Aug 27;24:5960-5972.
Title:	MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2).
Author:	Li, Na\|Han, Mei\|Zhou, Ning\|Tang, Yong\|Tang, Xu-Shan
PMID:	30147110

1253.
Journal:	Gastric Cancer. 2018 Aug 31. pii: 10.1007/s10120-018-0871-5.
Title:	Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination.
Author:	Nagaya, Tadanobu\|Okuyama, Shuhei\|Ogata, Fusa\|Maruoka, Yasuhiro\|Choyke, Peter L\|Kobayashi, Hisataka
PMID:	30171392

1254.
Journal:	Sci Rep. 2018 Sep 13;8(1):13735.
Title:	Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model.
Author:	Kuo, Wei-Ying\|Lin, Jia-Jia\|Hsu, Hung-Ju\|Chen, Hong-Sen\|Yang, An-Suei\|Wu, Chun-Yi
PMID:	30214017

1255.
Journal:	Oncol Lett. 2018 Oct;16(4):4614-4620.
Title:	Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report.
Author:	Chen, Zhe-Ling\|Zhao, Andi\|Li, Pan\|Zhang, Mi\|Yang, Jiao\|Zhang, Lingxiao\|Zhao, Xiaoai\|Yang, Jin\|Wang, Le
PMID:	30214596

1256.
Journal:	Mol Biol Rep. 2018 Sep 17. pii: 10.1007/s11033-018-4386-2.
Title:	Development of a novel anti-HER2 scFv by ribosome display and in silico evaluation of its 3D structure and interaction with HER2, alone and after fusion to LAMP2B.
Author:	Salimi, Fatemeh\|Forouzandeh Moghadam, Mehdi\|Rajabibazl, Masoumeh
PMID:	30225583

1257.
Journal:	Oncol Rep. 2018 Nov;40(5):2997-3005.
Title:	Increasing HER2 alpha2,6 sialylation facilitates gastric cancer progression and resistance via the Akt and ERK pathways.
Author:	Liu, Naihua\|Zhu, Menglu\|Linhai, Yingjie\|Song, Yuwei\|Gui, Xiujuan\|Tan, Guoqiang\|Li, Jinyuan\|Liu, Yan\|Deng, Zhendong\|Chen, Xiaoting\|Wang, Jing\|Jia, Lili\|He, Xiuzhen\|Wang, Xiaoyu\|Lin, Shaoqiang
PMID:	30226606

1258.
Journal:	Hum Pathol. 2018 Sep 18. pii: S0046-8177(18)30357-5.
Title:	Clinicopathological significance of claspin overexpression and its association with spheroid formation in gastric cancer.
Author:	Kobayashi, Go\|Sentani, Kazuhiro\|Hattori, Takuya\|Yamamoto, Yuji\|Imai, Takeharu\|Sakamoto, Naoya\|Kuraoka, Kazuya\|Oue, Naohide\|Sasaki, Naomi\|Taniyama, Kiyomi\|Yasui, Wataru
PMID:	30240769

1259.
Journal:	Mol Pharm. 2018 Sep 25.
Title:	Non-invasive Detection of HER2 Expression in Gastric Cancer by 64Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients.
Author:	Guo, Xiaoyi\|Zhu, Hua\|Zhou, Nina\|Chen, Zuhua\|Liu, Teli\|Liu, Fei\|Xu, Xiaoxia\|Jin, Hongjun\|Shen, Lin\|Gao, Jing\|Yang, Zhi
PMID:	30251865

1260.
Journal:	Onco Targets Ther. 2018 Sep 20;11:6091-6100.
Title:	Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer.
Author:	Fu, Xiaomin\|Zhang, Yong\|Yang, Jing\|Qi, Yalong\|Ming, Yue\|Sun, Miaomiao\|Shang, Yiman\|Yang, Yonghao\|Zhu, Xiaoyan\|Gao, Quanli
PMID:	30275713

1261.
Journal:	BioDrugs. 2018 Oct;32(5):515-518.
Title:	PF-05280014: A Trastuzumab Biosimilar.
Author:	Paik, Julia
PMID:	30280367

1262.
Journal:	Cancer Manag Res. 2018 Sep 26;10:3945-3954.
Title:	Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis.
Author:	Zhou, Chenfei\|Feng, Xiaojing\|Yuan, Fei\|Ji, Jun\|Shi, Min\|Yu, Yingyan\|Zhu, Zhenggang\|Zhang, Jun
PMID:	30310315

1263.
Journal:	Expert Opin Drug Saf. 2018 Nov;17(11):1145-1150.
Title:	The safety of apatinib for the treatment of gastric cancer.
Author:	Geng, Ruixuan\|Song, Li\|Li, Jin\|Zhao, Lin
PMID:	30324820

1264.
Journal:	Gastric Cancer. 2018 Oct 17. pii: 10.1007/s10120-018-0887-x.
Title:	Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
Author:	Yagi, Shusuke\|Wakatsuki, Takeru\|Yamamoto, Noriko\|Chin, Keisho\|Takahari, Daisuke\|Ogura, Mariko\|Ichimura, Takashi\|Nakayama, Izuma\|Osumi, Hiroki\|Shinozaki, Eiji\|Suenaga, Mitsukuni\|Fujisaki, Junko\|Ishikawa, Yuichi\|Yamaguchi, Kensei\|Namikawa, Ken\|Horiuchi, Yus
PMID:	30328533

1265.
Journal:	In Vivo. 2018 Nov-Dec;32(6):1491-1498.
Title:	Changes in HER2 Expression and Amplification Status Following Preoperative Chemotherapy for Gastric Cancer.
Author:	Shu, Sei\|Iimori, Makoto\|Nakanishi, Ryota\|Jogo, Tomoko\|Saeki, Hiroshi\|Oki, Eiji\|Maehara, Yoshihiko
PMID:	30348707

1266.
Journal:	Cancer Manag Res. 2018 Oct 9;10:4349-4361.
Title:	LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1.
Author:	Zhang, Di\|Li, Song\|Yu, Wenbin\|Chen, Cheng\|Liu, Teng\|Sun, Yiting\|Zhao, Zeyi\|Liu, Lian
PMID:	30349368

1267.
Journal:	Cancer Chemother Pharmacol. 2018 Oct 22. pii: 10.1007/s00280-018-3689-2.
Title:	Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancer.
Author:	Martin, Nicolas\|Isambert, Nicolas\|Gomez-Roca, Carlos\|Goeldner, Rainer-Georg\|Zanetta, Sylvie\|Sadrolhefazi, Behbood\|de Mont-Serrat, Helene\|Campone, Mario\|Delord, Jean-Pierre
PMID:	30350178

1268.
Journal:	MAbs. 2018 Oct 26.
Title:	Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.
Author:	Kuo, Wei-Ying\|Hsu, Hung-Ju\|Wu, Chun-Yi\|Chen, Hong-Sen\|Chou, Yu-Chi\|Tsou, Yueh-Liang\|Peng, Hung-Pin\|Jian, Jhih-Wei\|Yu, Chung-Ming\|Chiu, Yi-Kai\|Chen, Ing-Chien\|Tung, Chao-Ping\|Hsiao, Michael\|Lin, Chia-Lung\|Wang, Yong Alison\|Wang, Andrew H-J\|Yang, An-Suei
PMID:	30365359

1269.
Journal:	Future Oncol. 2018 Oct 31.
Title:	Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.
Author:	Moehler, Markus\|Ryu, Min-Hee\|Dvorkin, Mikhail\|Lee, Keun-Wook\|Coskun, Hasan S\|Wong, Rachel\|Chung, Hyun C\|Poltoratsky, Artem\|Tsuji, Akihito\|Yen, Chia Jui\|Muntean, Alina S\|Sourd, Samuel Le\|Vaccaro, Gina M\|Overton, Lindsay\|Boku, Narikazu\|Wainberg, Zev A\|Patel
PMID:	30379568

1270.
Journal:	Gan To Kagaku Ryoho. 2018 Oct;45(10):1489-1491.
Title:	[A Case of Long-Term Survival with Multidisciplinary Treatment in Unresectable Advanced Gastric Cancer Found with Ovarian Tumor].
Author:	Nukada, Suguru\|Aoyama, Toru\|Kamiya, Mariko\|Morita, Junya\|Maezawa, Yukio\|Amano, Shinya\|Kano, Kazuki\|Numata, Masakatsu\|Sawazaki, Sho\|Hayashi, Tsutomu\|Yamada, Takanobu\|Sato, Tsutomu\|Yukawa, Norio\|Oshima, Takashi\|Rino, Yasushi\|Masuda, Munetaka
PMID:	30382054

1271.
Journal:	Gastric Cancer. 2018 Nov 1. pii: 10.1007/s10120-018-0891-1.
Title:	Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3).
Author:	Seo, Seyoung\|Ryu, Min-Hee\|Park, Young Soo\|Ahn, Ji Yong\|Park, Yangsoon\|Park, Sook Ryun\|Ryoo, Baek-Yeol\|Lee, Gin Hyug\|Jung, Hwoon-Young\|Kang, Yoon-Koo
PMID:	30386954